data_2rne_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rne _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.886 0.374 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -105.39 102.59 12.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.317 1.847 . . . . 0.0 107.894 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 146.82 25.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.306 0.643 . . . . 0.0 110.568 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.61 138.18 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.344 1.858 . . . . 0.0 110.207 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -86.82 143.0 27.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.242 1.817 . . . . 0.0 106.686 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.13 137.37 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.5 -174.54 17.79 Favored Glycine 0 N--CA 1.463 0.498 0 O-C-N 120.865 -1.147 . . . . 0.0 111.164 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.7 8.94 4.8 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.067 2.147 . . . . 0.0 112.36 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -55.84 148.13 17.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.009 1.323 . . . . 0.0 111.519 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.11 162.32 69.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.14 -16.78 49.77 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.623 2.215 . . . . 0.0 114.632 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.87 -15.06 17.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.583 1.083 . . . . 0.0 112.288 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -57.69 114.25 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 109.387 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 t -95.34 178.83 5.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 m -64.54 -30.91 71.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.928 -1.107 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -73.02 -30.12 63.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.315 1.046 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.04 -48.6 70.54 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -51.65 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -55.37 -38.65 69.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 120.904 -1.122 . . . . 0.0 112.34 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.17 64.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.672 0.608 . . . . 0.0 110.078 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.73 84.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.742 1.217 . . . . 0.0 113.547 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.47 -6.34 57.69 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.27 94.95 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.862 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.92 -5.96 14.7 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.529 1.486 . . . . 0.0 113.535 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -98.82 -20.97 16.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.775 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 169.33 175.16 38.36 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-O 122.943 1.301 . . . . 0.0 114.155 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.9 mtm105 -81.61 121.54 26.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.3 mt -100.79 153.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.377 1.071 . . . . 0.0 109.073 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 t -130.28 -61.07 0.99 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.77 132.89 45.95 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 134.71 6.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.198 0.999 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -162.84 163.38 26.53 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.957 0.798 . . . . 0.0 112.228 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 52.2 t -105.02 120.59 55.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.03 140.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -133.23 147.1 51.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.71 130.26 45.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.079 1.352 . . . . 0.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.6 ptm -76.02 -9.41 58.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.77 -24.29 16.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.864 1.211 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.5 p -128.48 -18.49 3.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.433 1.015 . . . . 0.0 113.043 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.52 19.11 78.47 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.592 1.091 . . . . 0.0 113.391 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -100.3 163.35 12.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.542 1.171 . . . . 0.0 109.867 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -46.27 126.21 7.55 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.885 1.274 . . . . 0.0 113.885 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -22.5 43.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.699 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.93 -30.12 8.31 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.547 2.023 . . . . 0.0 110.644 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.264 29.9 p90 -102.88 169.37 8.63 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.422 1.089 . . . . 0.0 112.171 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.57 172.72 33.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.371 2.415 . . . . 0.0 108.379 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -140.37 149.95 43.33 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.54 155.75 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.662 1.985 . . . . 0.0 106.031 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.0 t -145.32 118.02 8.65 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.506 1.122 . . . . 0.0 108.354 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -99.46 152.12 20.35 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.17 1.388 . . . . 0.0 110.631 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -74.37 -24.41 59.15 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.394 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -125.44 151.27 46.44 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.782 1.233 . . . . 0.0 110.55 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.01 -49.24 73.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -31.46 17.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.456 1.903 . . . . 0.0 113.307 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.78 -55.28 10.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 108.347 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.71 76.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.971 1.708 . . . . 0.0 110.81 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.18 -50.01 70.42 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.583 1.153 . . . . 0.0 109.295 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -55.22 -50.91 68.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.752 0.421 . . . . 0.0 111.294 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.22 -55.12 37.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.033 1.733 . . . . 0.0 111.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.4 mt -46.68 -49.9 6.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 120.367 1.44 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.36 -60.78 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.288 0.992 . . . . 0.0 112.316 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -66.02 -58.07 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.2 mmm -58.19 -28.58 64.92 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.93 77.43 0.81 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 125.021 1.296 . . . . 0.0 110.123 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.17 -10.35 2.26 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 127.3 2.381 . . . . 0.0 111.838 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -80.18 165.52 22.34 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.879 1.34 . . . . 0.0 109.456 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -107.6 133.54 51.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.991 0.916 . . . . 0.0 108.853 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.88 130.48 46.91 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.565 1.946 . . . . 0.0 106.645 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 12.55 58.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.106 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.88 0.25 62.24 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.312 1.556 . . . . 0.0 112.564 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.26 157.06 46.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.427 1.614 . . . . 0.0 108.928 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.78 174.84 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.787 0.803 . . . . 0.0 109.308 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 pt -142.96 160.05 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.734 2.014 . . . . 0.0 108.025 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -123.51 140.6 52.84 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.4 p -138.93 149.23 44.56 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.957 0.903 . . . . 0.0 111.808 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -173.43 178.07 2.45 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.906 2.082 . . . . 0.0 109.352 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.12 126.65 30.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 112.855 -179.509 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -113.08 161.36 17.18 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -132.72 133.79 43.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.36 134.27 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 126.169 1.788 . . . . 0.0 109.571 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -85.59 136.1 33.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.8 t -131.71 133.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.02 -174.35 18.1 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 62.8 12.33 5.62 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.227 2.611 . . . . 0.0 111.951 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.55 142.68 52.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.639 1.576 . . . . 0.0 111.322 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 t -59.87 143.81 86.89 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -59.95 -5.33 3.61 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 115.382 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.4 -14.38 18.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.285 2.234 . . . . 0.0 112.721 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.1 mm -58.05 136.2 21.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 119.316 0.962 . . . . 0.0 109.831 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 112' ' ' ASP . 5.8 t -108.33 168.85 9.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.387 1.089 . . . . 0.0 108.843 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.0 m -60.82 -29.51 69.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.895 1.278 . . . . 0.0 109.381 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -70.24 -40.8 74.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 109.277 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 109' ' ' THR . 6.6 m-20 -59.75 -47.54 85.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.738 0.815 . . . . 0.0 109.17 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.9 mt -60.75 -49.53 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -54.88 -48.53 72.86 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.762 -1.211 . . . . 0.0 110.99 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.33 -34.4 73.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.967 0.907 . . . . 0.0 112.614 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.31 -44.89 42.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.756 1.223 . . . . 0.0 113.842 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.04 -10.68 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.0 -50.37 86.82 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 126.481 1.913 . . . . 0.0 114.445 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -65.03 -4.17 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.464 1.443 . . . . 0.0 113.282 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -99.05 -9.63 23.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.47 15.1 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.094 1.316 . . . . 0.0 109.89 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -75.18 116.35 15.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.596 -0.943 . . . . 0.0 109.827 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -77.48 153.5 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 p -112.53 -73.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.011 1.724 . . . . 0.0 107.032 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.97 142.8 32.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.988 2.115 . . . . 0.0 108.117 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.84 124.03 2.9 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 110.101 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -153.53 164.5 38.12 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.594 0.712 . . . . 0.0 111.8 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.2 121.64 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.341 1.857 . . . . 0.0 106.968 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.68 139.28 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -134.84 153.35 52.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -60.84 116.41 4.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.368 1.467 . . . . 0.0 109.115 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.4 ptp -64.09 -9.01 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.26 -15.87 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.467 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.4 p -137.91 -29.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.94 1.246 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.66 62.55 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.217 1.389 . . . . 0.0 112.037 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -80.14 154.97 27.69 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.696 1.248 . . . . 0.0 109.094 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 m -56.04 123.58 14.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.857 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -76.88 -22.56 53.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.121 0.568 . . . . 0.0 111.692 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.73 -26.53 10.68 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 127.006 2.241 . . . . 0.0 112.619 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -103.06 168.09 9.41 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.764 1.225 . . . . 0.0 112.389 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.84 177.85 31.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.785 2.136 . . . . 0.0 109.307 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -138.79 155.42 48.18 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.031 0.932 . . . . 0.0 109.938 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.3 t -142.89 125.56 13.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.174 1.39 . . . . 0.0 108.405 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -112.92 142.15 45.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.16 163.07 22.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.65 -19.95 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.892 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.19 169.12 16.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.722 1.209 . . . . 0.0 111.607 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -77.81 -52.74 8.43 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.578 1.151 . . . . 0.0 110.808 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -49.61 -48.92 48.66 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.182 1.793 . . . . 0.0 111.096 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.86 -43.96 69.97 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.091 0.869 . . . . 0.0 110.124 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.42 -56.04 12.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.135 1.374 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.08 -48.33 64.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.333 1.453 . . . . 0.0 111.185 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -53.14 -46.0 68.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 109.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.88 -43.23 65.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.855 1.262 . . . . 0.0 110.18 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 95.5 mt -49.52 -44.54 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 120.8 1.636 . . . . 0.0 108.704 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.4 -70.87 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.14 -43.46 98.84 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 68.2 mmm -71.93 -22.59 61.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.594 1.543 . . . . 0.0 111.494 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.0 113.55 5.75 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 118.96 0.8 . . . . 0.0 111.834 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.22 60.29 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.325 -1.264 . . . . 0.0 113.119 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.6 169.05 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.964 1.382 . . . . 0.0 108.795 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -105.33 137.29 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 50.4 tp -124.79 127.88 47.87 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.78 -101.17 0.44 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 105.695 -2.962 . . . . 0.0 105.695 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.75 10.85 7.5 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 116.355 -2.358 . . . . 0.0 115.729 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.98 159.25 43.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.971 2.886 . . . . 0.0 112.969 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -72.37 153.97 41.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.17 151.97 27.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 123.409 0.684 . . . . 0.0 111.457 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -111.64 126.52 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.995 1.318 . . . . 0.0 108.387 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.9 p -113.54 141.58 46.98 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.238 1.415 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -167.45 177.12 6.16 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.086 1.755 . . . . 0.0 107.459 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -77.69 152.62 33.64 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.416 0 O-C-N 121.478 -0.764 . . . . 0.0 112.21 179.471 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.095 0.474 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -113.52 139.56 48.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.468 ' CG ' ' HG ' ' A' ' 144' ' ' SER . 2.1 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.042 1.292 . . . . 0.0 110.214 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.08 154.36 28.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.668 2.387 . . . . 0.0 109.704 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -103.82 141.42 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.579 3.152 . . . . 0.0 108.709 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.61 140.33 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.44 178.86 24.78 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 119.652 1.114 . . . . 0.0 111.543 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t0 70.41 -1.69 2.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.762 2.825 . . . . 0.0 114.525 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 mt -47.78 139.01 7.91 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 127.283 2.233 . . . . 0.0 113.892 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.7 t -62.65 148.12 91.64 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.83 -18.1 58.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.161 1.908 . . . . 0.0 113.822 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -76.43 -25.49 54.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mm -57.84 124.11 11.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.448 1.499 . . . . 0.0 110.613 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -106.93 175.3 5.54 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.134 0.974 . . . . 0.0 109.03 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -56.73 -33.52 66.62 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.52 -0.737 . . . . 0.0 111.851 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.39 -42.56 78.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.133 1.773 . . . . 0.0 112.142 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.63 -51.54 65.08 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.326 1.05 . . . . 0.0 109.482 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.0 mt -60.12 -53.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.2 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -51.1 -44.77 61.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 117.885 -1.055 . . . . 0.0 112.092 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.09 81.88 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.948 0.78 . . . . 0.0 110.734 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.79 83.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.12 -5.76 59.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.402 1.081 . . . . 0.0 113.152 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -47.2 99.3 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.54 -3.9 12.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 CA-C-N 121.111 1.432 . . . . 0.0 112.388 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.95 -18.91 18.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.251 0.932 . . . . 0.0 110.719 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.4 168.19 25.0 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 118.887 0.767 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.85 130.72 40.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.2 mt -100.26 154.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.0 t -116.06 -72.65 0.68 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.12 139.97 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.815 1.646 . . . . 0.0 109.303 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.33 135.53 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -162.77 163.01 26.9 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.577 0.626 . . . . 0.0 110.703 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.6 t -102.59 123.28 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.66 138.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -132.15 151.5 51.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 107.739 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -60.01 123.23 16.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.356 1.462 . . . . 0.0 109.97 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.84 -12.9 27.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.835 0.854 . . . . 0.0 113.166 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.82 -10.77 18.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.8 p -141.93 -25.17 0.68 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.95 11.95 75.39 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.183 0.897 . . . . 0.0 110.907 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -82.31 143.92 30.95 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -55.46 125.8 22.46 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -73.07 -22.91 60.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.13 -18.28 42.84 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.936 1.255 . . . . 0.0 112.128 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.282 31.8 p90 -103.14 161.75 13.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.332 1.566 . . . . 0.0 109.573 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.38 175.03 28.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.938 1.256 . . . . 0.0 110.763 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.93 153.37 51.81 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.102 1.361 . . . . 0.0 108.96 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.65 131.22 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 126.254 1.822 . . . . 0.0 106.516 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.468 ' HG ' ' CG ' ' A' ' 98' ' ' HIS . 58.3 m -122.14 132.02 54.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.081 0.952 . . . . 0.0 109.368 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.96 156.29 26.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.189 1.396 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -72.59 -24.05 61.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.717 1.207 . . . . 0.0 112.959 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -131.18 156.25 45.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.23 0.923 . . . . 0.0 110.183 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -67.16 -48.39 68.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.852 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -47.72 -49.28 28.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.71 1.604 . . . . 0.0 112.881 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.77 -49.78 67.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.636 1.574 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.82 63.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.716 1.206 . . . . 0.0 112.018 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -51.38 -49.0 62.36 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.422 1.889 . . . . 0.0 109.867 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -54.23 -52.18 62.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.061 0.944 . . . . 0.0 110.54 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.22 89.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.363 -1.303 . . . . 0.0 111.755 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.4 mt -51.42 -48.05 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 121.739 2.063 . . . . 0.0 109.44 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.42 -60.17 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -68.57 -48.44 64.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.34 2.256 . . . . 0.0 115.516 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.41 -22.84 58.97 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.176 0.898 . . . . 0.0 111.807 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.87 97.84 0.17 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.496 1.046 . . . . 0.0 111.203 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 114.14 -7.72 23.17 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.246 -1.308 . . . . 0.0 113.857 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.27 174.54 9.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.754 1.277 . . . . 0.0 109.951 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -109.38 146.42 34.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.5 tp -139.58 128.37 23.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.994 2.118 . . . . 0.0 106.904 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 48.19 32.22 9.36 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.78 1.181 . . . . 0.0 114.818 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.65 -5.24 51.04 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 117.704 1.841 . . . . 0.0 117.704 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -141.76 157.58 44.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 122.037 2.919 . . . . 0.0 110.738 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.93 161.21 21.78 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.296 0.997 . . . . 0.0 110.658 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.82 155.96 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.541 1.136 . . . . 0.0 108.717 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.3 p -137.2 155.37 49.61 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.992 0.917 . . . . 0.0 110.174 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -176.24 165.05 2.77 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.742 1.217 . . . . 0.0 108.719 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -73.77 122.36 22.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.222 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.339 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.8 m170 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.74 112.4 25.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.57 148.75 22.05 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.812 0.695 . . . . 0.0 111.157 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.32 140.72 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 129.07 2.948 . . . . 0.0 109.166 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -92.03 141.14 28.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.845 2.858 . . . . 0.0 107.24 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.9 143.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 -176.21 23.59 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.88 14.12 9.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.35 2.26 . . . . 0.0 113.126 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.6 mt -62.98 137.18 58.19 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.164 1.785 . . . . 0.0 112.415 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.5 t -62.85 143.46 97.1 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.24 -14.37 33.7 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.806 2.337 . . . . 0.0 114.679 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.26 -23.96 37.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.314 0.961 . . . . 0.0 111.667 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.24 143.24 12.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.62 1.568 . . . . 0.0 110.231 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.5 t -121.75 179.29 4.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.859 1.314 . . . . 0.0 110.038 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 m -57.03 -39.37 74.69 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.591 1.956 . . . . 0.0 112.145 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.51 -37.48 80.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.251 1.82 . . . . 0.0 111.417 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.03 -49.71 76.29 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.4 mt -57.58 -52.29 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -54.11 -46.58 72.17 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.163 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.99 81.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.149 0.886 . . . . 0.0 111.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.27 -53.05 50.04 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.852 1.261 . . . . 0.0 113.67 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -84.46 -15.55 45.66 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.18 -48.75 93.37 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.875 1.27 . . . . 0.0 112.329 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.61 -5.16 8.13 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.548 1.498 . . . . 0.0 113.479 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -99.11 -14.89 19.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.413 1.006 . . . . 0.0 111.091 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 161.31 157.96 9.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.636 1.589 . . . . 0.0 110.528 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -73.39 107.21 5.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.086 1.354 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.3 140.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 126.507 1.923 . . . . 0.0 109.229 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 p -99.8 -71.44 0.7 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.24 142.86 32.8 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 128.319 2.647 . . . . 0.0 109.823 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -162.73 131.67 4.13 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.903 1.281 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -155.42 157.3 36.81 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.223 0.92 . . . . 0.0 111.948 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.3 t -106.26 119.19 55.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.61 139.08 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 121.716 -0.615 . . . . 0.0 109.361 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -133.65 150.39 51.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.326 1.05 . . . . 0.0 108.533 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.82 137.96 52.24 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.589 0.356 . . . . 0.0 111.875 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.2 ptm -71.61 -17.83 62.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.38 -11.93 31.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.378 1.445 . . . . 0.0 114.217 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 62.1 p -140.24 -16.15 0.96 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.17 74.15 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.79 148.79 25.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 118.323 1.061 . . . . 0.0 110.48 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 123.62 14.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.293 1.437 . . . . 0.0 111.156 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -71.45 -53.82 12.7 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.232 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 141.11 -28.08 2.39 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.131 2.301 . . . . 0.0 112.78 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -102.59 161.55 13.63 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.257 1.423 . . . . 0.0 112.704 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.66 168.99 26.67 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.643 1.116 . . . . 0.0 110.382 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -132.72 142.08 48.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.578 1.151 . . . . 0.0 108.789 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.6 t -133.51 143.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.302 1.441 . . . . 0.0 107.484 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.4 t -119.94 130.58 54.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.572 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -114.43 150.23 35.04 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.441 1.096 . . . . 0.0 113.677 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -70.81 -14.76 62.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.313 1.445 . . . . 0.0 114.134 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -138.89 159.75 41.38 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.963 1.711 . . . . 0.0 108.13 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -64.64 -53.16 51.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -29.07 68.65 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 126.145 1.778 . . . . 0.0 112.661 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -64.06 -43.15 96.36 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.32 -47.33 50.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.705 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -55.69 -47.15 77.26 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.176 0.898 . . . . 0.0 110.873 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -49.95 -51.36 41.84 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 126.08 1.752 . . . . 0.0 108.002 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.53 66.72 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 117.189 -1.386 . . . . 0.0 111.936 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 78.5 mt -49.55 -48.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 122.452 2.387 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -64.74 -59.9 3.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.834 1.653 . . . . 0.0 112.789 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -71.31 -44.61 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.907 1.683 . . . . 0.0 115.231 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.5 mmm -72.63 -21.41 61.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 110.27 2.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.16 62.36 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.869 -1.517 . . . . 0.0 113.903 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -69.73 166.45 19.2 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.518 1.659 . . . . 0.0 108.982 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -106.27 99.2 8.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.542 1.137 . . . . 0.0 109.642 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.3 tp -85.01 111.98 20.2 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.11 -129.87 38.19 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.93 87.81 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 115.826 -2.652 . . . . 0.0 117.497 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -147.41 157.21 43.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 123.209 3.505 . . . . 0.0 115.267 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.03 163.19 17.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.5 pt -134.92 165.8 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.013 0.911 . . . . 0.0 110.673 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -123.31 147.13 47.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.474 2.31 . . . . 0.0 105.462 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.6 p -138.22 148.35 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.44 1.096 . . . . 0.0 110.702 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -170.08 171.08 7.14 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -69.67 138.75 53.24 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 m170 . . . . . 0 C--O 1.237 0.395 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.69 100.94 6.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.73 144.52 32.13 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.39 135.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.296 1.838 . . . . 0.0 107.853 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -85.92 136.43 33.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.047 2.139 . . . . 0.0 106.492 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.41 142.52 41.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.62 179.36 25.52 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.283 0.944 . . . . 0.0 111.168 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.91 15.45 9.14 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.073 2.549 . . . . 0.0 113.901 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.48 145.59 55.93 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.857 1.263 . . . . 0.0 111.333 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 t -68.46 149.79 97.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.46 -16.75 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.038 1.825 . . . . 0.0 113.5 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -78.46 -16.59 57.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.301 1.04 . . . . 0.0 112.777 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.82 121.49 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.5 1.12 . . . . 0.0 109.669 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 111' ' ' GLU . 4.7 t -99.78 -179.19 4.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.426 1.091 . . . . 0.0 109.923 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.3 m -62.93 -33.08 74.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.405 ' H ' HG22 ' A' ' 109' ' ' THR . 26.0 mt-10 -69.49 -41.81 75.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.786 0.834 . . . . 0.0 109.914 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -56.15 -49.96 72.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.745 0.818 . . . . 0.0 109.172 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.77 -54.51 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -51.91 -41.44 61.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 116.945 -1.502 . . . . 0.0 112.584 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.05 -45.97 79.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.345 0.975 . . . . 0.0 110.085 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.02 -5.99 54.57 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.02 99.74 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-O 117.471 -1.252 . . . . 0.0 114.164 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.34 -5.65 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 121.721 1.65 . . . . 0.0 112.131 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.06 -43.93 7.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 119.751 1.159 . . . . 0.0 108.806 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.84 164.27 36.32 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -80.8 118.47 22.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.43 157.99 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 126.035 1.734 . . . . 0.0 107.748 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.7 t -123.84 -69.45 0.81 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.38 130.16 47.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 107.817 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.2 137.84 9.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.051 1.296 . . . . 0.0 108.774 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.16 173.09 15.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 111.313 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.47 138.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.28 133.83 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -123.6 164.32 19.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.31 142.52 43.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.724 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.6 ptp -75.63 -29.68 59.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.788 -0.57 . . . . 0.0 109.892 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.84 -45.27 15.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -104.75 -18.36 14.29 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.94 12.26 74.93 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.978 -0.451 . . . . 0.0 113.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -85.46 155.06 21.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.481 1.112 . . . . 0.0 109.966 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 t -57.81 126.35 27.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.896 0.878 . . . . 0.0 108.849 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -70.08 -65.85 0.67 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.698 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 150.72 -18.82 0.99 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 128.152 2.786 . . . . 0.0 110.245 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -102.93 162.88 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.072 -1.252 . . . . 0.0 112.585 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.49 176.99 29.68 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.28 1.419 . . . . 0.0 110.613 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.33 151.29 46.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.603 0.761 . . . . 0.0 109.359 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 50.2 t -143.8 121.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.382 1.473 . . . . 0.0 109.072 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -107.0 125.37 50.91 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 109.317 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -105.47 159.65 15.77 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.288 1.035 . . . . 0.0 110.709 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.17 -30.0 65.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.196 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -132.02 158.78 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.773 1.17 . . . . 0.0 111.033 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -60.56 -53.94 51.43 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.03 1.332 . . . . 0.0 112.33 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -41.16 67.75 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.788 2.035 . . . . 0.0 112.619 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -58.31 -45.43 88.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.209 1.004 . . . . 0.0 109.301 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.53 -50.36 45.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.271 1.028 . . . . 0.0 110.687 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.47 -48.73 62.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.207 1.403 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -56.17 -34.93 66.65 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.53 -45.33 16.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 116.923 -1.513 . . . . 0.0 109.6 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 79.5 mt -49.03 -39.39 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 122.083 2.22 . . . . 0.0 109.747 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -68.69 -71.09 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.528 1.131 . . . . 0.0 111.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -64.18 -45.61 87.61 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 127.802 2.441 . . . . 0.0 116.14 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.8 mmm -76.65 -21.14 55.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.737 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.43 0.62 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 116.266 1.266 . . . . 0.0 116.266 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.93 -11.15 0.5 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.504 2.002 . . . . 0.0 112.231 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.04 167.38 11.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.174 0.987 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.25 123.04 47.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.38 118.18 32.51 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.273 1.429 . . . . 0.0 109.255 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.11 5.99 17.58 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.7 1.143 . . . . 0.0 113.686 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 124.6 -5.96 8.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 117.042 -1.977 . . . . 0.0 114.683 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -133.28 148.17 51.93 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.519 2.659 . . . . 0.0 112.018 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -64.49 154.78 34.85 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.496 0.718 . . . . 0.0 110.413 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 26.4 pt -128.58 163.45 33.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 110.698 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -124.84 141.37 52.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.7 p -139.52 141.78 37.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.484 1.038 . . . . 0.0 111.035 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -163.28 176.79 9.56 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.857 1.663 . . . . 0.0 108.166 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -70.38 152.9 43.59 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.149 -1.595 . . . . 0.0 109.031 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.751 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.8 m170 . . . . . 0 C--O 1.238 0.459 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.07 100.16 7.04 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.957 1.303 . . . . 0.0 110.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.98 146.3 35.51 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.102 0.954 . . . . 0.0 111.545 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.2 t -129.2 141.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 129.524 3.13 . . . . 0.0 109.426 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -95.23 136.52 35.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.611 2.364 . . . . 0.0 107.578 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 t -132.33 135.3 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.68 -178.57 21.28 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 121.537 -0.727 . . . . 0.0 111.64 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.93 7.22 6.12 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.957 2.503 . . . . 0.0 113.268 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.6 mt -58.14 145.51 36.67 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.66 2.384 . . . . 0.0 111.36 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -67.14 148.0 98.91 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.36 -10.53 11.09 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.098 2.532 . . . . 0.0 114.4 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.18 -23.45 21.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.627 1.103 . . . . 0.0 113.002 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.8 mm -57.97 128.15 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.008 0.923 . . . . 0.0 109.395 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.5 t -107.76 177.9 4.68 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.893 1.33 . . . . 0.0 111.131 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 m -60.23 -31.42 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.428 1.091 . . . . 0.0 111.042 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.7 -36.52 65.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.054 0.942 . . . . 0.0 111.267 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -60.53 -49.62 76.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.3 mt -59.44 -54.2 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -51.79 -47.26 64.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.316 0.962 . . . . 0.0 111.38 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.68 83.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.531 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -39.54 63.03 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -88.85 -10.98 46.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.016 0.926 . . . . 0.0 112.608 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.83 97.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.936 1.294 . . . . 0.0 111.236 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.22 -3.82 6.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 CA-C-N 121.872 1.704 . . . . 0.0 113.906 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.92 -15.28 18.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.216 0.916 . . . . 0.0 112.003 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.48 177.72 30.85 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 122.407 1.004 . . . . 0.0 111.702 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -74.08 131.45 41.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.21 135.75 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -74.89 0.59 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -103.53 141.5 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.846 2.059 . . . . 0.0 108.655 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.22 127.48 2.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.932 1.242 . . . . 0.0 109.03 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -154.85 162.54 41.07 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.1 0.864 . . . . 0.0 111.601 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.01 120.08 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.82 135.43 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -131.7 151.16 51.84 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.77 144.4 56.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.88 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 tpt -83.0 -19.43 37.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.036 0.835 . . . . 0.0 111.701 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.85 -9.36 37.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.002 -1.061 . . . . 0.0 113.509 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.7 p -136.79 -25.36 1.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.355 0.979 . . . . 0.0 112.398 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.0 81.22 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -92.2 156.45 17.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.884 1.342 . . . . 0.0 109.559 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -54.16 126.15 21.8 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.382 1.073 . . . . 0.0 111.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -75.36 -32.78 60.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.828 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.22 -25.52 7.39 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.714 2.578 . . . . 0.0 111.259 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -102.57 161.2 13.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.527 1.163 . . . . 0.0 112.281 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.1 172.79 28.31 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.642 1.591 . . . . 0.0 109.317 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -135.03 155.02 51.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.51 1.124 . . . . 0.0 108.555 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.8 t -145.31 146.81 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.071 2.548 . . . . 0.0 104.509 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 t -145.2 112.76 6.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.755 1.616 . . . . 0.0 109.79 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -86.88 152.39 22.49 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.588 1.155 . . . . 0.0 112.131 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -70.27 -34.82 73.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.642 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -112.52 146.86 37.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.16 1.384 . . . . 0.0 108.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.55 -49.24 74.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.42 -33.47 59.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.52 1.128 . . . . 0.0 113.913 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -62.24 -46.79 87.29 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.14 -49.41 69.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 110.186 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.47 -45.13 76.96 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.162 0.585 . . . . 0.0 110.501 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.36 -50.59 67.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.144 0.577 . . . . 0.0 110.465 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.12 78.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.413 1.485 . . . . 0.0 111.285 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 89.0 mt -51.49 -47.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 121.815 2.098 . . . . 0.0 110.375 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 156' ' ' GLN . 7.1 mt-30 -67.77 -56.13 10.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 124.129 0.893 . . . . 0.0 112.109 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.05 -52.8 21.1 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.57 -17.62 64.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -75.99 79.91 1.12 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 123.793 0.711 . . . . 0.0 111.918 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 132.69 -5.75 5.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.795 2.14 . . . . 0.0 111.379 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -73.76 178.8 4.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.208 1.004 . . . . 0.0 108.77 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -118.85 150.47 39.79 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.9 tp -138.44 126.97 23.3 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.808 1.643 . . . . 0.0 106.64 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 -86.84 0.49 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.72 5.6 1.79 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.83 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -141.19 164.28 30.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.93 1.865 . . . . 0.0 112.98 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.0 160.86 31.16 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.581 1.152 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.3 pt -137.62 171.9 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.614 1.166 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.1 144.32 47.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.612 1.565 . . . . 0.0 108.026 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -136.83 137.27 39.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.843 0.747 . . . . 0.0 111.217 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.12 169.98 21.08 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -64.53 141.42 58.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.392 178.662 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 m170 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.44 100.89 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.563 ' CE1' ' HG ' ' A' ' 144' ' ' SER . 22.5 m-70 -86.95 142.48 27.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.334 0.588 . . . . 0.0 112.235 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.66 143.18 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.81 2.444 . . . . 0.0 108.515 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -93.78 136.04 34.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.417 2.687 . . . . 0.0 108.014 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.6 140.71 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.495 -2.78 . . . . 0.0 103.495 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 175.98 29.65 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.84 16.96 10.49 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 124.618 1.167 . . . . 0.0 112.68 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.25 149.3 45.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 0.0 110.961 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -70.83 144.49 90.72 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.45 -3.74 6.97 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 114.929 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.5 -21.83 20.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.949 1.7 . . . . 0.0 111.662 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.64 134.48 30.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 127.891 2.476 . . . . 0.0 111.123 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -106.15 173.07 6.47 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.182 0.991 . . . . 0.0 108.792 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.5 m -60.24 -30.37 69.37 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.562 -1.336 . . . . 0.0 109.714 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -68.99 -32.42 71.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 110.343 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.43 -41.21 85.16 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.46 -48.42 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -55.22 -41.54 72.19 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.068 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -52.25 60.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.819 0.847 . . . . 0.0 110.928 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.89 77.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -94.93 -2.72 49.98 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.74 99.54 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.639 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.73 -2.93 9.39 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-N 121.792 1.676 . . . . 0.0 112.727 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.75 -19.55 18.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.139 0.881 . . . . 0.0 111.452 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.06 170.12 30.55 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 122.096 0.831 . . . . 0.0 112.394 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -78.14 101.94 7.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.61 1.195 . . . . 0.0 109.15 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mt -76.74 148.36 6.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 t -111.41 -73.26 0.68 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.39 136.39 41.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.943 1.697 . . . . 0.0 108.778 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -163.65 138.83 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.25 151.22 22.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.353 0.979 . . . . 0.0 111.485 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 t -99.26 117.36 44.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.99 145.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -131.51 151.26 51.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -61.66 115.88 4.32 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -58.0 -17.34 16.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.843 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.6 -7.07 28.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.4 p -139.81 -28.54 0.75 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.72 1.145 . . . . 0.0 111.869 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 13.02 71.52 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.859 1.218 . . . . 0.0 110.617 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.15 153.63 22.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.797 1.298 . . . . 0.0 108.387 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.3 t -55.8 128.44 34.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.721 0.691 . . . . 0.0 111.406 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -78.8 -17.43 55.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.03 -23.8 34.25 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.167 0.889 . . . . 0.0 112.931 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.265 27.0 p90 -102.64 159.61 15.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.366 1.583 . . . . 0.0 110.43 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.42 178.17 33.04 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.609 1.099 . . . . 0.0 110.768 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -142.49 159.84 41.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.94 151.36 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.675 1.99 . . . . 0.0 106.939 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.563 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 2.6 t -132.88 119.67 20.49 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.643 1.977 . . . . 0.0 108.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -103.69 149.59 24.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.723 1.609 . . . . 0.0 111.202 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -71.16 -35.83 71.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.196 0.998 . . . . 0.0 110.279 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -122.99 153.31 39.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.717 1.207 . . . . 0.0 111.562 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -61.44 -50.2 73.76 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 110.753 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.0 -44.4 20.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.797 2.039 . . . . 0.0 112.577 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.87 -50.12 73.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.787 1.235 . . . . 0.0 109.844 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.39 94.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.075 0.95 . . . . 0.0 110.576 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -59.4 -54.7 43.67 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.69 1.196 . . . . 0.0 109.678 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -53.92 -45.36 71.16 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.02 62.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.224 1.409 . . . . 0.0 111.803 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.33 -39.53 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.818 1.645 . . . . 0.0 110.511 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.02 -62.17 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -65.55 -52.16 54.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 116.406 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -71.67 -21.79 61.75 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.032 1.287 . . . . 0.0 112.746 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.15 121.92 25.64 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.859 0.743 . . . . 0.0 111.857 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.86 71.41 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 118.627 -1.096 . . . . 0.0 113.963 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.87 175.04 9.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.105 1.452 . . . . 0.0 108.68 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -105.23 157.96 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.69 120.44 9.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.18 -39.23 0.56 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.448 1.023 . . . . 0.0 115.178 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.79 -5.19 0.03 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.954 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -137.4 162.26 34.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.421 2.111 . . . . 0.0 109.413 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -70.83 159.37 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.101 0.56 . . . . 0.0 110.809 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 pt -130.54 165.81 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.782 1.233 . . . . 0.0 110.248 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -121.66 147.76 45.46 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 56.0 p -133.91 142.43 47.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 108.571 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -166.31 167.56 15.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.805 1.184 . . . . 0.0 109.138 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -68.46 126.85 30.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.025 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.788 0.327 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -112.11 146.63 37.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.6 147.92 49.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.536 0.684 . . . . 0.0 111.524 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.21 138.17 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.7 2.0 . . . . 0.0 109.38 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -96.1 134.13 39.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.604 2.362 . . . . 0.0 106.036 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.37 142.2 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.59 -179.98 23.13 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.897 0.771 . . . . 0.0 111.961 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 62.0 18.76 10.2 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.701 2.0 . . . . 0.0 111.749 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.3 mt -62.42 132.61 53.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.245 1.418 . . . . 0.0 110.717 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.42 151.33 77.49 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -60.19 -24.05 75.84 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.94 2.427 . . . . 0.0 114.955 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.13 -22.52 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.08 -1.012 . . . . 0.0 113.061 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.3 mm -58.89 122.7 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.022 0.915 . . . . 0.0 111.226 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.5 t -110.66 176.11 5.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.516 1.526 . . . . 0.0 107.173 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.8 m -65.19 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 120.428 -1.42 . . . . 0.0 112.8 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -70.42 -33.49 71.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -48.25 79.55 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 110.33 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 mt -60.54 -50.33 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -55.36 -48.16 74.66 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.591 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.38 68.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.911 0.885 . . . . 0.0 110.398 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -44.28 96.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -89.94 -8.88 50.72 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.03 -46.88 99.83 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 117.1 -1.429 . . . . 0.0 114.122 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.11 -3.83 10.48 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.115 1.791 . . . . 0.0 112.775 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.4 -11.82 22.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.601 0.637 . . . . 0.0 111.967 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.98 164.99 14.19 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -72.32 124.75 25.76 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.58 147.73 5.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.27 -65.41 1.18 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -102.4 133.71 46.89 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.904 0.882 . . . . 0.0 110.893 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -157.56 136.34 11.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.586 0.755 . . . . 0.0 109.759 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -163.34 158.42 21.29 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.97 1.708 . . . . 0.0 110.642 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.72 130.44 50.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 138.15 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -132.79 158.28 42.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.484 0.714 . . . . 0.0 109.858 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -61.53 114.83 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.23 -20.33 26.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.216 1.371 . . . . 0.0 112.81 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.8 -21.13 23.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.7 p -135.71 -15.46 1.82 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.94 1.245 . . . . 0.0 114.051 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.3 86.31 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.936 1.255 . . . . 0.0 114.02 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.2 152.17 30.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.364 1.582 . . . . 0.0 109.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -54.77 126.84 25.78 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.792 0.837 . . . . 0.0 112.059 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -72.59 -52.38 15.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 143.75 -21.54 2.17 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.712 3.053 . . . . 0.0 110.449 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.269 7.1 p90 -103.13 168.59 9.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.652 1.581 . . . . 0.0 113.997 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.82 175.06 33.02 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.509 1.528 . . . . 0.0 111.005 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -135.91 147.17 48.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.48 1.112 . . . . 0.0 109.553 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.64 144.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.9 t -136.13 140.27 43.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.233 1.413 . . . . 0.0 107.438 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.11 150.77 46.52 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.443 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -67.58 -14.24 62.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.221 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -133.82 156.12 48.61 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 120.161 1.346 . . . . 0.0 110.234 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -71.37 -53.05 15.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -51.03 -34.94 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.419 2.288 . . . . 0.0 112.018 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -60.27 -54.54 44.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.011 0.924 . . . . 0.0 108.608 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.33 76.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -56.28 -48.77 75.96 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.357 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.91 -45.03 87.14 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.166 0.439 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.16 85.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.076 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 88.9 mt -54.26 -35.94 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.387 1.903 . . . . 0.0 110.312 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -76.63 -62.35 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.054 0.542 . . . . 0.0 111.656 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -63.85 -45.25 90.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.02 2.128 . . . . 0.0 114.032 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.31 -24.97 57.52 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.82 98.36 0.29 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.29 -9.41 11.03 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.878 1.228 . . . . 0.0 112.264 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -76.15 178.64 6.24 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.749 1.275 . . . . 0.0 108.469 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -121.01 158.84 26.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.25 1.42 . . . . 0.0 107.986 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 tp -154.92 130.69 10.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.45 -25.52 0.47 Allowed Glycine 0 N--CA 1.464 0.566 0 C-N-CA 125.208 1.385 . . . . 0.0 115.707 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.56 -2.24 0.47 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 117.791 -1.56 . . . . 0.0 113.605 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -136.81 157.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.474 2.137 . . . . 0.0 110.99 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -66.97 153.56 43.3 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.75 152.55 32.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.801 0.84 . . . . 0.0 111.008 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -106.52 145.42 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.817 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.0 p -139.04 123.32 18.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.634 1.106 . . . . 0.0 110.202 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -149.22 172.2 15.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.756 0.707 . . . . 0.0 109.603 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -66.98 130.5 43.33 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.715 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.4 m170 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -125.45 107.07 10.29 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.005 1.322 . . . . 0.0 111.653 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -85.07 128.43 34.64 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 110.727 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.46 138.98 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.984 2.514 . . . . 0.0 106.908 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -93.53 142.18 27.63 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.659 1.983 . . . . 0.0 107.075 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.94 137.1 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.49 179.43 18.76 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.407 -0.808 . . . . 0.0 111.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.57 15.43 6.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.156 3.382 . . . . 0.0 115.007 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.69 149.26 22.32 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.732 1.613 . . . . 0.0 111.596 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.4 t -65.45 145.35 99.07 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.98 -8.3 7.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.089 2.526 . . . . 0.0 115.304 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -98.12 -16.41 19.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.806 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.5 mm -58.29 116.81 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 t -91.1 174.34 7.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.655 0.741 . . . . 0.0 109.273 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -64.15 -31.93 73.31 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.391 -1.443 . . . . 0.0 111.595 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.42 -24.96 57.17 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.554 -0.716 . . . . 0.0 111.237 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.1 -46.66 76.83 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.19 -51.41 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -53.65 -49.27 68.28 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 117.579 -1.2 . . . . 0.0 110.709 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.37 81.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.375 0.989 . . . . 0.0 111.77 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.49 92.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.67 -9.95 39.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -47.14 99.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.61 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.06 -5.83 11.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.267 1.845 . . . . 0.0 112.39 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.04 -11.24 23.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.707 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 160.21 165.8 17.79 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 120.071 1.305 . . . . 0.0 114.17 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -76.4 119.18 19.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.2 mt -94.9 149.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 t -114.38 -67.39 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.23 125.26 48.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.77 136.14 32.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -160.94 153.41 20.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 119.441 1.019 . . . . 0.0 111.873 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.6 t -106.98 115.06 47.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.7 139.1 17.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 125.182 1.393 . . . . 0.0 107.625 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -130.83 153.66 48.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.607 -0.683 . . . . 0.0 110.484 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.55 107.57 1.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.5 ptm -54.03 -13.97 0.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 -19.04 17.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.688 1.131 . . . . 0.0 112.816 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 p -130.24 -22.44 2.81 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.98 16.97 73.52 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.605 2.05 . . . . 0.0 112.716 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -84.77 155.22 21.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 1.435 . . . . 0.0 109.105 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.9 t -62.95 122.4 15.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.882 0.31 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -71.5 -25.4 62.25 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.34 38.48 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.003 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -103.79 165.95 10.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.256 2.028 . . . . 0.0 110.506 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.52 177.4 33.51 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.841 0.734 . . . . 0.0 111.819 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -135.5 148.24 49.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.09 1.356 . . . . 0.0 109.698 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.7 t -137.43 120.17 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.138 1.775 . . . . 0.0 107.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -105.27 114.23 28.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.259 1.823 . . . . 0.0 108.898 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.93 148.95 23.45 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.66 1.184 . . . . 0.0 109.12 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -67.88 -40.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.211 0.604 . . . . 0.0 110.243 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -110.91 145.54 38.14 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.03 0.932 . . . . 0.0 112.183 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.32 -46.94 86.45 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.012 0.925 . . . . 0.0 112.141 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -34.26 69.4 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.485 1.114 . . . . 0.0 112.966 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.05 -47.49 79.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.39 71.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.968 1.307 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.51 -47.91 78.32 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.504 0.721 . . . . 0.0 110.293 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -55.57 -49.3 73.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.63 72.56 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 81.4 mt -49.91 -44.42 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.633 1.561 . . . . 0.0 110.221 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -73.09 -58.24 3.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.193 0.997 . . . . 0.0 113.294 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -68.58 -51.06 46.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.403 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -67.69 -20.79 65.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.191 0.905 . . . . 0.0 112.749 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.98 90.29 0.58 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.86 -6.15 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.776 1.655 . . . . 0.0 111.752 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -86.84 172.85 9.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.946 0.873 . . . . 0.0 110.172 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -113.03 154.77 25.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.997 1.319 . . . . 0.0 109.199 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.0 tp -153.71 128.01 9.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.593 1.557 . . . . 0.0 107.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.92 22.96 67.13 Favored Glycine 0 N--CA 1.464 0.504 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.401 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 98.38 -2.75 59.35 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 115.956 -2.58 . . . . 0.0 115.836 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -140.4 160.91 38.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 121.525 2.663 . . . . 0.0 111.655 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.73 159.08 28.65 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.76 154.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.477 1.111 . . . . 0.0 109.112 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -115.99 129.76 56.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.5 p -116.7 153.61 32.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.248 1.419 . . . . 0.0 108.961 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -175.51 166.57 3.26 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.733 1.213 . . . . 0.0 108.928 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -70.12 126.13 28.79 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.221 0 CA-C-N 118.27 0.486 . . . . 0.0 110.75 179.402 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 . . . . . 0 C--O 1.237 0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -99.74 101.45 12.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.27 154.5 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.413 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 110.745 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.96 129.52 34.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.13 137.69 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.93 -176.98 21.15 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 61.84 18.89 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.627 1.971 . . . . 0.0 112.627 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 mt -69.86 151.24 45.92 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.473 -1.392 . . . . 0.0 110.909 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -67.63 146.41 98.53 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.44 -4.36 6.62 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.626 2.884 . . . . 0.0 113.682 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -96.81 -21.34 17.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.882 1.273 . . . . 0.0 111.156 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.3 132.38 23.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.309 1.044 . . . . 0.0 108.953 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -112.13 172.17 7.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.227 1.013 . . . . 0.0 108.809 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -56.3 -29.85 61.77 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.146 1.378 . . . . 0.0 110.776 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -73.03 -34.94 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.704 0.801 . . . . 0.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.47 -49.13 74.84 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mt -59.17 -49.57 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -54.92 -42.32 72.08 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.656 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.97 77.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.828 0.74 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.53 98.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -89.42 -14.52 35.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.349 0.66 . . . . 0.0 112.354 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.72 99.51 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.047 0.939 . . . . 0.0 113.405 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.72 -6.68 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 121.396 1.534 . . . . 0.0 112.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.89 -18.59 17.05 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.364 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 168.23 169.34 31.58 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 119.57 1.077 . . . . 0.0 112.04 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -74.41 124.01 25.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.7 mt -100.1 150.48 5.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.58 -61.55 1.6 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -101.41 140.5 35.61 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.7 5.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.421 1.088 . . . . 0.0 108.384 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -162.77 161.64 26.29 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.713 1.205 . . . . 0.0 110.74 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.47 134.66 53.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.46 144.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -133.9 162.88 30.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.556 1.143 . . . . 0.0 109.583 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -71.31 119.14 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.447 1.499 . . . . 0.0 107.589 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.4 ptp -59.18 -16.59 21.28 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.65 -13.92 20.09 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.2 p -137.6 -15.46 1.4 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.306 1.412 . . . . 0.0 113.975 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.64 14.34 81.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.57 1.081 . . . . 0.0 110.904 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.92 141.58 37.48 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.834 1.253 . . . . 0.0 108.567 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.29 123.36 14.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.094 0.957 . . . . 0.0 112.209 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.56 -42.68 64.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.22 -15.27 7.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.757 1.17 . . . . 0.0 112.621 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.027 1.413 . . . . 0.0 108.075 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.05 33.74 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.813 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -131.89 156.4 46.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.323 1.062 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.67 135.22 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.4 m -123.96 112.74 17.57 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.425 1.09 . . . . 0.0 108.16 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -97.53 155.6 16.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.24 0.962 . . . . 0.0 110.025 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.72 -41.51 62.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -103.1 147.44 26.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.004 0.522 . . . . 0.0 111.751 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.444 ' HE3' ' CH2' ' A' ' 172' ' ' TRP . 11.0 tptm -64.42 -46.69 82.14 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.989 0.916 . . . . 0.0 109.248 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -33.3 68.6 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.538 1.535 . . . . 0.0 113.606 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.61 -49.82 71.83 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.47 -51.74 67.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.183 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -51.67 -52.65 46.4 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.116 0.966 . . . . 0.0 111.615 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -55.07 -50.47 69.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.104 0.562 . . . . 0.0 110.283 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.98 86.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 117.281 -1.342 . . . . 0.0 110.399 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.75 -36.98 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 123.513 2.869 . . . . 0.0 110.968 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -76.27 -65.19 0.95 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -62.37 -49.49 75.32 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.638 1.975 . . . . 0.0 114.3 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 86.0 mmm -68.95 -28.8 66.96 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.79 78.26 0.2 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.69 1.138 . . . . 0.0 114.633 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.26 -15.24 2.09 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.567 2.032 . . . . 0.0 111.802 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -71.58 171.37 11.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.039 0.92 . . . . 0.0 109.792 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -109.45 143.45 39.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.31 121.37 24.6 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.55 -57.48 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.03 1.776 . . . . 0.0 111.488 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.48 2.06 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.809 -1.55 . . . . 0.0 115.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -143.84 157.86 44.08 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.66 2.73 . . . . 0.0 112.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -67.49 136.17 54.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.246 0.618 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.0 166.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.272 1.035 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.49 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.898 1.679 . . . . 0.0 107.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 39.2 p -137.18 134.84 36.76 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.27 170.78 21.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.444 ' CH2' ' HE3' ' A' ' 148' ' ' LYS . 22.2 m95 -62.18 128.2 34.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.002 0.819 . . . . 0.0 109.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.324 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.6 m170 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -105.56 143.25 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -109.84 153.5 24.33 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.077 0.551 . . . . 0.0 112.062 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.45 148.72 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.712 2.005 . . . . 0.0 110.39 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -100.22 139.78 35.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.349 2.66 . . . . 0.0 107.014 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.03 129.5 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.47 179.87 17.66 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 111.94 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 64.34 9.95 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.74 3.216 . . . . 0.0 113.784 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.4 146.3 16.17 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.953 1.301 . . . . 0.0 111.04 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.5 t -63.04 141.23 97.71 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.06 -15.55 18.03 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.937 2.425 . . . . 0.0 114.928 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.79 -17.95 39.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 113.054 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.9 mm -58.51 135.22 23.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.243 1.417 . . . . 0.0 110.724 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.3 t -116.53 176.33 5.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.985 0.898 . . . . 0.0 111.488 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 -35.25 72.64 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.082 -1.011 . . . . 0.0 111.458 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.97 -18.12 51.18 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.317 0.647 . . . . 0.0 111.329 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.94 -50.09 21.64 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 mt -57.96 -50.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -54.87 -47.71 73.9 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.539 -1.22 . . . . 0.0 110.903 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.6 -33.87 70.49 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.691 1.132 . . . . 0.0 111.898 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.22 -46.37 64.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.923 0.889 . . . . 0.0 112.246 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -92.51 -1.66 56.79 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.41 95.37 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.876 1.67 . . . . 0.0 112.334 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.65 -0.57 5.41 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 121.091 1.425 . . . . 0.0 113.75 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -98.64 -10.75 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.955 0.798 . . . . 0.0 111.156 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.19 175.57 19.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -70.56 137.95 50.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.172 -0.605 . . . . 0.0 110.017 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.95 138.41 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.5 t -100.47 -72.93 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -102.43 142.52 33.51 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.08 1.752 . . . . 0.0 110.235 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.68 129.1 2.56 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.064 0.847 . . . . 0.0 109.409 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -162.26 150.85 14.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.618 0.367 . . . . 0.0 111.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.06 136.99 23.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.11 146.78 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -139.53 145.8 39.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -67.43 129.65 40.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -65.59 -18.78 65.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.466 0.706 . . . . 0.0 111.465 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.41 -12.43 22.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -134.3 -18.9 1.97 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.358 0.981 . . . . 0.0 113.287 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.49 72.78 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.94 153.62 18.23 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -59.91 130.15 45.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -20.57 57.45 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.466 -0.778 . . . . 0.0 111.947 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.16 -30.2 10.88 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.98 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -101.89 163.86 12.03 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.527 1.164 . . . . 0.0 108.315 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.7 171.64 27.43 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.849 1.69 . . . . 0.0 109.091 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -136.02 146.66 47.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -133.61 158.69 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.856 1.663 . . . . 0.0 106.726 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.4 t -143.18 135.4 27.11 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.45 166.28 15.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.448 0.699 . . . . 0.0 111.12 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -79.66 -26.42 41.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 117.753 -1.117 . . . . 0.0 113.939 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.35 150.76 45.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.814 1.643 . . . . 0.0 110.714 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -62.25 -48.6 79.22 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.114 0.483 . . . . 0.0 110.153 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -29.66 67.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.973 1.309 . . . . 0.0 112.615 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.03 -54.65 38.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.83 -57.88 11.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.201 2.2 . . . . 0.0 111.838 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.23 -51.49 25.23 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.364 1.466 . . . . 0.0 111.387 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -55.06 -45.69 75.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.412 0.445 . . . . 0.0 111.257 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.96 78.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.559 -1.21 . . . . 0.0 110.85 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.5 mt -52.02 -44.42 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 120.634 1.561 . . . . 0.0 108.069 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -68.08 -61.45 1.85 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.186 1.394 . . . . 0.0 111.678 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.7 -60.04 4.06 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.92 2.088 . . . . 0.0 114.465 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.31 -20.35 66.03 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.29 1.036 . . . . 0.0 113.665 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.11 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.46 49.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.593 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -69.72 167.56 16.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.44 1.62 . . . . 0.0 108.218 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -108.81 141.95 40.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.7 tp -140.97 129.55 22.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.56 -53.87 4.3 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.668 1.127 . . . . 0.0 110.326 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.11 6.15 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.429 1.014 . . . . 0.0 113.809 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -136.31 159.02 43.02 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.867 1.834 . . . . 0.0 108.595 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -68.15 166.04 16.99 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.44 145.35 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 109.351 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 ptt-85 -108.41 136.53 47.88 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 p -122.6 153.37 39.39 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.023 1.329 . . . . 0.0 108.191 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -173.21 165.86 4.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.843 0.857 . . . . 0.0 109.124 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -66.64 120.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-N 118.326 0.512 . . . . 0.0 111.177 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m170 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.42 100.34 8.24 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.35 131.4 36.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.05 141.72 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 128.102 2.561 . . . . 0.0 109.521 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -88.89 131.0 35.31 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 127.013 2.125 . . . . 0.0 105.671 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.33 139.33 51.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.39 -177.94 22.26 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.268 77.1 m-20 68.12 13.93 9.19 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.62 1.968 . . . . 0.0 113.251 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.7 mt -64.53 140.06 58.83 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 t -67.89 150.14 97.91 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -60.76 -4.05 3.23 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.809 3.006 . . . . 0.0 114.927 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.85 -17.12 17.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.016 1.326 . . . . 0.0 111.783 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.3 mm -61.85 136.9 24.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.03 1.332 . . . . 0.0 109.517 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -108.57 174.52 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.033 0.92 . . . . 0.0 108.715 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -64.67 -27.54 68.99 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.547 -1.345 . . . . 0.0 110.647 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.91 -32.66 67.61 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.86 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.32 -47.29 84.92 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mt -60.11 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -53.53 -47.63 69.8 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 120.329 -1.482 . . . . 0.0 111.97 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.51 93.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.755 0.822 . . . . 0.0 111.633 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.55 -45.87 88.03 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.711 1.204 . . . . 0.0 113.602 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -89.56 -10.77 44.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 113.035 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.05 -47.56 98.56 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 124.817 1.247 . . . . 0.0 112.192 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.91 -7.16 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 121.791 1.675 . . . . 0.0 113.184 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.64 -13.28 20.41 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.428 1.013 . . . . 0.0 112.003 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 159.19 174.09 28.46 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 120.541 1.519 . . . . 0.0 112.724 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -71.7 127.55 32.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.9 mt -102.16 139.51 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.8 p -99.29 -79.02 0.49 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.66 126.05 49.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.764 2.826 . . . . 0.0 110.793 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.05 140.31 23.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.664 1.186 . . . . 0.0 107.943 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -162.7 151.54 14.86 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 t -94.32 127.26 46.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.18 141.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -125.63 161.03 28.15 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.885 1.326 . . . . 0.0 110.22 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.29 130.37 40.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.633 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -7.97 55.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 -21.81 12.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.626 1.103 . . . . 0.0 112.208 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -131.68 -8.24 3.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 31.31 78.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.209 -0.773 . . . . 0.0 112.143 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -100.98 157.19 16.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.192 1.397 . . . . 0.0 108.235 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -62.08 125.9 25.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.215 0.916 . . . . 0.0 111.314 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -74.65 -21.05 59.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.49 -15.7 55.73 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.36 1.457 . . . . 0.0 113.027 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.256 49.5 p90 -103.02 163.36 12.26 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.277 1.539 . . . . 0.0 109.282 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.5 169.3 32.8 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.337 -0.852 . . . . 0.0 111.384 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -129.77 149.82 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.913 0.885 . . . . 0.0 109.111 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.43 138.81 47.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 131.81 53.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.81 155.75 31.97 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.172 0.989 . . . . 0.0 109.744 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -76.39 -20.02 57.56 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.094 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -129.45 151.14 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.865 1.211 . . . . 0.0 112.781 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.496 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 7.6 ttmt -68.95 -50.74 46.62 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 110.196 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -47.71 69.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.097 1.359 . . . . 0.0 113.271 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -60.61 -46.93 88.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.41 83.29 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.961 1.305 . . . . 0.0 109.981 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -57.09 -45.67 83.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.82 1.248 . . . . 0.0 110.448 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -53.62 -48.05 69.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.55 87.82 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.936 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.7 mt -55.21 -37.93 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 121.804 2.093 . . . . 0.0 110.274 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -72.71 -65.77 0.75 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.616 0.766 . . . . 0.0 111.427 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -67.07 -44.41 80.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.872 2.069 . . . . 0.0 116.547 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -77.79 -20.79 52.66 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.831 1.196 . . . . 0.0 112.872 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.21 112.35 4.64 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.31 -9.54 65.04 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -70.91 169.71 14.2 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 119.753 1.776 . . . . 0.0 109.842 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -104.65 132.11 51.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 108.941 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.9 tp -123.83 118.95 28.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 108.143 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.82 -6.51 1.4 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.273 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.0 3.61 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.232 1.516 . . . . 0.0 115.331 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.796 2.298 . . . . 0.0 110.342 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.37 163.03 11.33 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.448 0.468 . . . . 0.0 109.976 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.23 153.76 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.753 1.221 . . . . 0.0 109.756 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -113.74 142.86 45.52 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.4 p -136.89 135.99 38.31 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.552 0.741 . . . . 0.0 109.524 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.46 174.08 15.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.218 0.607 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.496 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 83.9 m95 -70.57 118.24 13.11 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.538 -1.352 . . . . 0.0 108.153 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 118.78 0.718 . . . . 0.0 109.077 179.3 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--O 1.236 0.359 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.13 100.65 6.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 144' ' ' SER . 1.3 m80 -71.38 167.29 19.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.369 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.32 142.94 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 127.875 2.47 . . . . 0.0 106.561 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -103.65 137.06 42.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -132.72 140.25 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 -179.26 21.15 Favored Glycine 0 N--CA 1.454 -0.153 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.26 4.69 2.22 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.466 2.306 . . . . 0.0 113.258 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -51.2 139.09 19.26 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 110.527 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 t -62.59 145.26 95.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.49 -18.1 37.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.489 2.793 . . . . 0.0 115.136 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.62 -13.21 43.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.084 -1.01 . . . . 0.0 112.652 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.66 138.71 22.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.5 t -118.45 175.13 5.86 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.502 1.144 . . . . 0.0 109.117 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.3 m -58.92 -30.15 67.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.226 1.01 . . . . 0.0 111.748 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.75 -43.37 68.96 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 125.92 1.688 . . . . 0.0 110.878 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.74 -51.92 65.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.214 1.405 . . . . 0.0 109.28 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.67 -48.14 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.59 -45.24 69.95 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.814 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.27 -45.94 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.084 0.856 . . . . 0.0 110.796 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.67 -47.54 85.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 113.197 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -87.35 -10.89 50.95 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.39 -48.52 95.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.66 -3.3 6.47 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 CA-C-N 121.47 1.561 . . . . 0.0 112.959 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.88 -17.71 18.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.069 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.57 162.17 16.21 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.584 1.084 . . . . 0.0 111.503 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -73.65 120.53 19.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.62 153.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.5 t -117.31 -68.44 0.92 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -102.03 145.04 29.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.469 1.107 . . . . 0.0 108.891 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.04 129.85 2.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.2 158.16 32.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.473 0.654 . . . . 0.0 110.777 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.22 120.1 56.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.43 141.8 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -135.41 157.3 47.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.5 ptp -59.88 -20.47 57.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.59 -9.22 16.65 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -131.83 -19.55 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.048 1.295 . . . . 0.0 113.083 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.81 2.41 56.96 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.291 0.948 . . . . 0.0 112.865 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -80.05 148.55 31.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.8 m -63.78 134.79 55.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.507 1.146 . . . . 0.0 112.33 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -77.71 -13.7 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.534 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.9 55.23 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.016 -1.435 . . . . 0.0 113.464 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -102.52 165.1 11.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.019 1.41 . . . . 0.0 109.112 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.32 179.79 28.55 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.471 1.034 . . . . 0.0 111.966 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.28 154.04 51.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 109.089 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -145.83 149.3 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 37.9 t -142.48 115.49 8.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.005 1.722 . . . . 0.0 107.393 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.91 158.17 15.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.805 1.242 . . . . 0.0 111.391 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.1 -14.83 61.95 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.66 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -143.56 156.84 44.71 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.857 1.208 . . . . 0.0 110.195 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.8 tttt -68.49 -43.03 77.77 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.923 1.289 . . . . 0.0 111.93 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.51 -41.75 66.66 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 111.658 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -62.15 -48.98 77.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.901 1.28 . . . . 0.0 108.893 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.56 66.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.367 1.067 . . . . 0.0 110.311 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.37 -50.0 63.29 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.844 1.658 . . . . 0.0 109.753 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -55.41 -55.4 32.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.552 1.141 . . . . 0.0 109.16 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.48 91.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.748 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.52 -49.26 44.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 121.136 1.789 . . . . 0.0 108.411 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.31 -67.22 0.46 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.132 0.573 . . . . 0.0 111.991 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -58.93 -50.43 74.07 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 83.8 mmm -69.29 -17.75 63.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.346 0.975 . . . . 0.0 111.95 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.26 79.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.445 2.45 . . . . 0.0 113.37 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 126.78 -8.74 7.25 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.062 1.791 . . . . 0.0 112.627 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -70.99 170.32 13.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.033 1.417 . . . . 0.0 109.67 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -111.14 150.79 28.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.385 1.074 . . . . 0.0 109.991 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 47.0 tp -155.51 130.1 9.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.805 2.042 . . . . 0.0 106.505 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.1 27.3 71.22 Favored Glycine 0 N--CA 1.465 0.59 0 O-C-N 121.49 -0.756 . . . . 0.0 114.032 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.78 4.4 87.34 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.439 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -137.57 155.35 49.31 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.81 2.305 . . . . 0.0 110.899 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -71.55 160.44 32.7 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.57 169.96 15.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -123.63 152.24 42.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.9 p -141.83 150.21 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 107.575 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -175.52 171.12 2.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -67.17 111.36 3.88 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.582 -0.699 . . . . 0.0 109.817 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 C-N-CA 124.549 1.14 . . . . 0.0 110.843 179.427 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 m80 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.6 99.23 7.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.0 127.4 32.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 113.338 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.55 148.21 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 126.788 2.035 . . . . 0.0 108.091 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -105.01 136.62 44.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 129.471 3.109 . . . . 0.0 106.95 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -129.27 142.83 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -149.84 -178.83 25.14 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.04 1.97 2.98 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.854 2.461 . . . . 0.0 114.382 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -50.19 149.26 2.97 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.829 2.452 . . . . 0.0 113.681 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 161.76 68.1 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.83 -29.44 15.46 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.145 1.23 . . . . 0.0 113.111 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.41 -16.94 61.84 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.851 1.66 . . . . 0.0 114.117 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -59.74 117.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.668 1.187 . . . . 0.0 110.116 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -100.3 171.03 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.3 m -55.1 -30.95 60.78 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 121.019 -1.05 . . . . 0.0 111.53 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.71 -33.75 64.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.122 0.969 . . . . 0.0 111.761 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -47.98 83.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.6 mt -61.22 -55.55 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -51.68 -47.93 63.65 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.501 1.046 . . . . 0.0 112.301 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.12 72.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.596 0.758 . . . . 0.0 112.14 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.08 -43.85 61.28 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.364 1.066 . . . . 0.0 112.014 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.26 -9.58 47.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.824 1.249 . . . . 0.0 112.851 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.3 99.54 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 126.6 1.96 . . . . 0.0 113.318 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.9 -0.84 9.04 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.501 1.572 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.66 -25.18 14.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.087 0.858 . . . . 0.0 110.967 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.44 34.7 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 121.137 -0.977 . . . . 0.0 111.201 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -77.78 117.45 19.18 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -88.4 145.3 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 p -100.54 -81.42 0.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -103.04 141.46 35.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.299 1.84 . . . . 0.0 111.196 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.13 141.85 5.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.106 2.163 . . . . 0.0 108.065 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.9 169.6 20.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.784 1.234 . . . . 0.0 109.136 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.98 124.98 67.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.88 140.78 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.37 148.21 50.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 59.6 t0 -59.02 131.14 50.16 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.7 tpt -59.78 -30.41 68.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.366 0.53 . . . . 0.0 112.25 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.12 -41.05 9.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.3 p -95.85 -15.87 22.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.15 0.886 . . . . 0.0 112.943 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.92 12.52 57.46 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.283 0.944 . . . . 0.0 112.584 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.92 150.01 27.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.888 1.275 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 t -56.15 109.66 0.63 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.323 2.249 . . . . 0.0 109.142 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 131' ' ' ASP . 20.7 mttt -67.81 -23.4 65.18 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.47 -18.84 46.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.288 27.5 p90 -103.21 157.9 16.69 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.635 -1.509 . . . . 0.0 109.71 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.22 176.6 25.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.564 1.554 . . . . 0.0 111.077 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.77 152.0 44.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.02 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.0 t -147.25 130.65 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 108.027 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -118.77 127.81 53.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.744 2.018 . . . . 0.0 107.011 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.55 165.69 12.25 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.701 1.137 . . . . 0.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -74.43 -9.57 58.72 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.575 -0.703 . . . . 0.0 112.512 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -146.59 165.86 28.25 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.595 1.088 . . . . 0.0 112.09 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -73.85 -47.28 39.49 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.802 1.241 . . . . 0.0 111.543 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -39.06 76.9 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.702 0.801 . . . . 0.0 111.935 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.66 -48.42 77.64 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -54.89 15.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.322 1.849 . . . . 0.0 111.45 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -55.87 -44.15 77.83 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.176 0.99 . . . . 0.0 111.918 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.74 -45.26 86.07 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.74 79.62 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.684 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.69 -37.62 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 120.354 1.434 . . . . 0.0 110.399 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -73.07 -67.6 0.56 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.417 1.087 . . . . 0.0 110.632 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -58.69 -57.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.467 2.307 . . . . 0.0 114.295 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -65.34 -24.51 67.28 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.48 90.47 0.12 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.222 0.915 . . . . 0.0 111.971 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.49 -6.88 9.79 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.193 1.378 . . . . 0.0 113.308 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -74.97 174.3 9.51 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.093 1.446 . . . . 0.0 109.481 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -109.74 129.35 55.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 39.3 tp -125.25 124.22 41.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.901 1.68 . . . . 0.0 108.934 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.1 -59.21 1.84 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 125.005 1.288 . . . . 0.0 111.554 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.75 -3.04 0.03 OUTLIER Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.947 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -141.49 165.98 26.02 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.384 2.092 . . . . 0.0 111.5 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -67.57 161.67 25.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.351 0.66 . . . . 0.0 110.645 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.7 pt -138.71 157.64 29.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.533 1.133 . . . . 0.0 109.977 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -122.32 148.02 45.54 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.1 p -138.91 134.66 33.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.649 1.113 . . . . 0.0 110.409 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -157.02 176.92 12.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.571 1.148 . . . . 0.0 108.895 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -74.44 133.75 42.39 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.593 -1.317 . . . . 0.0 110.47 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.174 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m170 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.41 109.91 13.89 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -91.03 150.32 21.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.658 0.742 . . . . 0.0 111.733 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.2 t -129.39 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.126 1.77 . . . . 0.0 108.907 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -101.3 143.29 31.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.996 3.318 . . . . 0.0 106.753 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.78 146.39 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.89 173.91 26.04 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 119.031 0.832 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.5 t0 61.38 17.81 8.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.986 2.914 . . . . 0.0 114.211 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.31 135.68 57.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.343 1.457 . . . . 0.0 110.143 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 t -60.12 148.48 77.98 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.21 52.23 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.665 1.576 . . . . 0.0 113.364 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -76.48 -29.85 57.05 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.862 0.756 . . . . 0.0 110.591 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.31 115.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.517 1.527 . . . . 0.0 108.986 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 t -100.05 174.39 6.19 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.138 1.375 . . . . 0.0 109.714 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.4 m -57.76 -36.84 72.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.317 -0.864 . . . . 0.0 111.463 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.59 -44.36 78.31 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.08 1.352 . . . . 0.0 109.981 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.63 80.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.276 1.03 . . . . 0.0 109.666 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.14 -50.55 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -52.78 -48.05 67.12 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.259 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.14 -34.68 70.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.658 1.117 . . . . 0.0 111.675 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.74 -45.82 60.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.285 1.034 . . . . 0.0 111.503 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -87.69 -4.49 58.91 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.54 94.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.655 2.382 . . . . 0.0 114.664 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.21 -1.34 7.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 122.181 1.815 . . . . 0.0 112.516 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.4 -9.5 25.15 Favored 'General case' 0 N--CA 1.461 0.116 0 O-C-N 121.175 -0.953 . . . . 0.0 111.503 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.46 -155.83 26.54 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 111.832 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -100.27 131.24 46.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.384 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.18 133.63 43.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.726 1.61 . . . . 0.0 108.772 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.7 p -99.8 -73.03 0.65 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -103.47 148.99 25.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.288 1.835 . . . . 0.0 109.053 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.62 4.21 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.899 1.28 . . . . 0.0 108.967 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.8 ptm85 -161.01 147.67 15.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.44 0.564 . . . . 0.0 112.173 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.02 120.18 40.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.37 137.58 24.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -136.25 160.93 37.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.92 135.78 54.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -68.87 -14.37 62.99 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.773 -0.58 . . . . 0.0 110.015 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.5 17.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.079 1.752 . . . . 0.0 115.157 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 p -136.72 -23.32 1.21 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 112.254 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.8 4.54 62.26 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.345 -1.253 . . . . 0.0 110.839 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -81.82 150.9 27.63 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.93 1.865 . . . . 0.0 108.467 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 t -56.35 120.4 7.58 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -70.55 -35.3 73.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 127.89 -29.63 4.13 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.987 1.755 . . . . 0.0 110.404 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -102.15 166.51 10.56 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.601 1.16 . . . . 0.0 111.749 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.85 170.84 31.29 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.419 1.485 . . . . 0.0 110.173 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -129.38 150.15 50.86 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.091 1.356 . . . . 0.0 108.523 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.78 159.8 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 127.515 2.326 . . . . 0.0 105.028 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.9 t -142.63 130.75 21.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.806 2.042 . . . . 0.0 107.721 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.52 134.84 54.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.111 1.364 . . . . 0.0 109.368 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -64.31 -39.41 93.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.425 0.69 . . . . 0.0 109.639 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -111.11 145.64 38.22 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.04 1.336 . . . . 0.0 107.905 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.39 -45.11 81.13 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -38.66 55.75 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 112.882 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.83 -49.93 75.49 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.4 77.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.25 -51.31 67.03 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.115 0.566 . . . . 0.0 110.82 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.85 -48.82 74.84 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.34 70.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.995 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.24 -42.07 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 121.006 1.73 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -77.52 -36.94 51.95 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -87.93 -53.46 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.137 1.375 . . . . 0.0 112.044 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 72.7 mmm -68.28 -21.62 64.78 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.881 0.764 . . . . 0.0 112.329 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 109.03 1.96 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 124.478 1.037 . . . . 0.0 111.266 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.25 -6.35 66.01 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.155 -0.803 . . . . 0.0 113.611 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -73.05 179.15 3.92 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.34 1.07 . . . . 0.0 109.176 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.52 152.67 27.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.885 0.874 . . . . 0.0 109.041 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.1 tp -158.87 131.21 6.77 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.229 2.212 . . . . 0.0 105.66 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.9 30.23 77.1 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 119.085 0.857 . . . . 0.0 111.074 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.68 14.14 72.29 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.228 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -135.19 150.61 50.16 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.876 1.838 . . . . 0.0 109.339 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 21.1 pt -130.09 172.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.27 1.028 . . . . 0.0 108.989 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -131.62 154.4 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.982 1.713 . . . . 0.0 107.304 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.4 p -142.92 147.28 35.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.709 0.804 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -167.19 167.37 14.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -69.44 136.06 51.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.526 1.057 . . . . 0.0 108.322 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.9 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.33 114.45 20.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.23 1.412 . . . . 0.0 107.246 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.573 ' CG ' ' HG ' ' A' ' 144' ' ' SER . 0.2 OUTLIER -89.21 132.7 34.74 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.337 1.055 . . . . 0.0 111.506 -178.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.87 144.97 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.501 2.32 . . . . 0.0 109.013 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.84 139.03 38.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 127.455 2.302 . . . . 0.0 106.552 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.94 143.9 36.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.71 173.54 26.89 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.582 1.083 . . . . 0.0 113.91 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 57.45 23.26 8.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 129.085 2.954 . . . . 0.0 115.289 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.5 mt -60.95 145.82 49.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.513 1.525 . . . . 0.0 109.467 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t -59.38 143.75 85.01 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.69 -15.5 31.89 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.595 2.197 . . . . 0.0 116.294 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.05 -28.9 29.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.932 1.693 . . . . 0.0 111.551 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -56.42 113.73 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.656 1.582 . . . . 0.0 110.57 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -97.52 179.43 4.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.135 0.969 . . . . 0.0 109.241 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 m -55.97 -33.08 64.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.632 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -69.3 -46.8 66.29 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 110.057 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.84 -44.49 73.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 110.186 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.67 -54.65 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -50.65 -51.05 52.72 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.871 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.92 69.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.089 1.356 . . . . 0.0 111.257 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.59 96.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -90.8 -7.78 51.43 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.29 94.61 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.806 1.642 . . . . 0.0 113.282 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.79 -0.96 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 121.251 1.482 . . . . 0.0 113.099 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.97 -34.56 10.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.403 1.001 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.13 177.9 47.2 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 122.991 1.328 . . . . 0.0 111.473 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -74.35 123.11 24.0 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.756 -1.222 . . . . 0.0 107.938 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.5 mt -101.17 154.71 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.2 t -125.73 -65.33 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -102.02 134.6 44.97 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.94 128.94 2.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -162.99 170.91 17.32 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.109 0.564 . . . . 0.0 111.724 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.93 130.26 51.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.536 1.534 . . . . 0.0 107.936 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 135.5 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -134.81 160.28 38.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.29 158.42 35.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.302 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.6 ptm -91.02 -16.22 28.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.792 1.237 . . . . 0.0 113.491 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.4 -26.64 11.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.872 1.214 . . . . 0.0 112.706 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.5 p -114.84 -19.75 10.87 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.87 50.36 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 121.655 0.586 . . . . 0.0 112.746 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.62 145.59 34.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -66.1 139.0 58.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.631 0.729 . . . . 0.0 112.274 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -81.75 -8.68 59.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.242 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.9 -12.91 65.96 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 124.43 1.014 . . . . 0.0 112.723 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.292 3.2 p90 -102.96 169.35 8.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.777 1.788 . . . . 0.0 109.876 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 178.44 30.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.356 0.503 . . . . 0.0 112.33 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.9 148.15 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.256 1.422 . . . . 0.0 108.117 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.99 124.83 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.035 1.734 . . . . 0.0 106.939 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.573 ' HG ' ' CG ' ' A' ' 98' ' ' HIS . 62.9 m -109.62 125.92 53.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.815 1.189 . . . . 0.0 108.69 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -109.98 148.52 31.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -69.63 -17.92 63.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.334 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -132.03 148.52 52.51 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.703 1.138 . . . . 0.0 109.124 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -63.62 -55.72 21.42 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.247 0.619 . . . . 0.0 109.497 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -39.53 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.687 1.595 . . . . 0.0 113.107 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.19 -48.25 80.87 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.66 74.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.772 0.829 . . . . 0.0 110.117 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.48 -47.3 69.93 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.172 1.389 . . . . 0.0 110.909 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -57.23 -43.62 83.05 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.31 84.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.851 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 89.0 mt -53.05 -52.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.997 1.726 . . . . 0.0 107.633 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -60.25 -66.46 0.52 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.38 1.472 . . . . 0.0 113.011 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.89 -49.74 69.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.736 2.014 . . . . 0.0 115.183 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -73.15 -19.61 61.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.696 1.135 . . . . 0.0 112.638 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.45 96.88 0.36 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.64 -11.05 11.24 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.607 1.099 . . . . 0.0 111.428 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -73.91 170.13 16.0 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.594 1.197 . . . . 0.0 107.836 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -113.38 136.51 52.69 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.449 1.1 . . . . 0.0 108.268 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.21 121.58 18.18 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.13 21.82 79.47 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.025 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.98 6.14 79.74 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.975 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -133.77 147.04 51.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.301 2.05 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.83 138.6 52.75 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -108.15 163.94 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.982 0.896 . . . . 0.0 109.849 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -124.49 149.48 46.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.901 1.281 . . . . 0.0 107.66 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.9 p -139.29 140.36 37.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.298 1.039 . . . . 0.0 109.628 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -163.3 173.03 13.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.157 1.383 . . . . 0.0 108.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -71.45 124.44 24.63 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.343 1.057 . . . . 0.0 110.957 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.636 178.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m170 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.72 115.48 30.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.1 151.7 18.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.151 0.907 . . . . 0.0 110.91 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.95 136.97 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 126.899 2.079 . . . . 0.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -85.59 132.67 34.13 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.448 2.299 . . . . 0.0 105.646 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.73 135.02 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.4 -175.97 14.27 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.613 -0.679 . . . . 0.0 111.444 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 61.74 21.13 11.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.972 2.509 . . . . 0.0 114.25 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.32 153.5 43.63 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.884 -1.135 . . . . 0.0 111.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 t -71.39 157.32 90.26 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.63 -6.51 18.82 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.424 2.083 . . . . 0.0 114.173 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.29 -15.32 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 112.811 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -58.25 137.37 20.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 109.84 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -112.21 168.86 9.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.669 1.187 . . . . 0.0 108.284 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 m -60.37 -30.2 69.41 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.907 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.86 -34.23 62.24 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.77 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -48.07 80.66 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.7 mt -58.76 -52.4 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 126' ' ' ALA . 24.0 mtmt -52.77 -47.62 67.38 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 117.679 -1.153 . . . . 0.0 112.093 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.24 67.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.254 0.934 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.58 -50.12 68.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.122 1.369 . . . . 0.0 113.413 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 -11.34 47.11 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.44 90.58 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.423 1.489 . . . . 0.0 112.395 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.1 -10.76 21.94 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.752 1.661 . . . . 0.0 112.583 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -98.13 -10.51 24.08 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.501 1.046 . . . . 0.0 111.532 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.51 165.89 21.43 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 120.026 1.285 . . . . 0.0 111.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 68.3 mtt-85 -77.17 130.12 36.88 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.2 mt -101.99 132.42 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.2 1.0 . . . . 0.0 109.229 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.18 -66.21 0.92 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.05 133.56 46.69 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.314 0.645 . . . . 0.0 110.132 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.433 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . . . -155.61 137.43 14.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -160.36 157.98 28.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.663 0.665 . . . . 0.0 111.626 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.21 119.56 50.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.9 t -66.09 133.09 31.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -129.88 151.64 50.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.06 128.55 36.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.8 ptp -66.89 -10.35 47.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.844 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.57 -17.03 26.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.296 1.039 . . . . 0.0 113.738 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.3 p -141.93 -34.08 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.09 14.48 51.54 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.558 -1.135 . . . . 0.0 111.053 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.94 149.56 24.71 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.539 1.67 . . . . 0.0 107.896 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.5 m -53.34 117.31 2.96 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.598 1.159 . . . . 0.0 112.345 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -64.24 -25.03 67.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.334 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.67 -30.81 4.78 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.442 1.972 . . . . 0.0 111.915 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -102.9 172.72 6.66 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.001 1.32 . . . . 0.0 113.501 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.99 175.95 34.36 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.938 2.208 . . . . 0.0 108.908 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.04 151.45 45.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.03 143.59 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.7 m -130.64 128.86 41.83 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.648 1.579 . . . . 0.0 107.708 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -110.75 163.3 13.91 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.544 1.138 . . . . 0.0 110.085 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.53 -28.8 52.08 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.589 0.756 . . . . 0.0 111.748 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -124.89 160.36 29.01 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.083 0.953 . . . . 0.0 111.957 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.542 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 20.1 tptm -65.32 -51.82 58.09 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.632 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -50.99 -45.79 61.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 125.579 1.552 . . . . 0.0 113.134 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -56.96 -43.88 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.963 0.79 . . . . 0.0 110.227 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -50.96 43.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.042 0.937 . . . . 0.0 110.307 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -54.08 -50.79 66.0 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.623 1.169 . . . . 0.0 110.668 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -51.51 -52.67 44.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.709 2.004 . . . . 0.0 108.847 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -47.46 79.54 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.333 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.01 -27.07 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 121.481 1.946 . . . . 0.0 111.342 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -84.77 -70.99 0.54 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.923 0.889 . . . . 0.0 109.932 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -56.62 -50.26 72.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.333 2.253 . . . . 0.0 113.588 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 66.4 mmm -78.01 -20.95 51.54 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.286 1.035 . . . . 0.0 113.659 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.11 75.74 0.25 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.731 1.157 . . . . 0.0 114.563 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.6 -5.15 2.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.049 1.785 . . . . 0.0 112.556 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -76.82 -177.02 4.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.226 1.41 . . . . 0.0 110.819 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -112.85 157.47 21.36 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.347 1.459 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.5 tp -151.35 126.28 9.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.366 1.466 . . . . 0.0 108.774 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.89 -67.8 0.13 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 126.555 2.026 . . . . 0.0 112.776 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.26 1.99 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.841 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -148.58 167.99 23.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.123 2.461 . . . . 0.0 111.947 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -72.95 147.77 44.92 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -115.6 169.29 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 110.776 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -127.59 146.84 50.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.804 2.041 . . . . 0.0 107.888 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.9 p -142.56 151.04 41.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.23 0.923 . . . . 0.0 109.913 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -173.75 172.73 3.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.148 2.179 . . . . 0.0 108.767 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.542 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 40.1 m95 -67.63 148.53 51.26 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.242 -1.536 . . . . 0.0 111.155 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 178.052 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.0 m170 . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.889 0.376 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.61 100.5 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.407 ' CE1' ' HG ' ' A' ' 144' ' ' SER . 14.4 m-70 -81.83 153.88 26.18 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.1 133.68 55.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 127.379 2.272 . . . . 0.0 109.735 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -84.83 142.81 29.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.99 135.61 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.61 27.64 Favored Glycine 0 C--O 1.228 -0.254 0 O-C-N 121.206 -0.934 . . . . 0.0 111.47 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.79 7.47 5.9 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.746 2.418 . . . . 0.0 113.749 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt -52.45 149.22 5.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.384 2.274 . . . . 0.0 112.4 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.53 150.71 93.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.63 -14.14 42.91 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.115 1.876 . . . . 0.0 114.632 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.3 -10.66 29.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.613 1.565 . . . . 0.0 112.433 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -61.5 143.26 15.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 119.587 1.085 . . . . 0.0 110.102 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.6 t -122.17 173.72 7.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.9 m -62.29 -31.66 72.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.937 0.895 . . . . 0.0 110.715 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -74.03 -34.1 63.98 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.95 -42.91 99.18 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.77 -54.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -50.36 -45.96 55.55 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.321 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.61 75.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.668 0.605 . . . . 0.0 111.544 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.9 85.8 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.01 -8.36 55.72 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.169 0.587 . . . . 0.0 111.13 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.15 97.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 116.956 -1.497 . . . . 0.0 113.523 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.08 -3.42 8.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 122.31 1.861 . . . . 0.0 112.467 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -99.46 -16.15 18.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.42 1.088 . . . . 0.0 109.803 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.48 171.66 20.89 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 122.495 1.053 . . . . 0.0 113.079 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -77.87 123.04 26.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.3 mt -94.48 163.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.97 -69.32 0.82 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.7 136.77 41.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.872 1.269 . . . . 0.0 110.255 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.06 139.27 4.94 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.637 1.108 . . . . 0.0 109.184 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -162.63 169.34 20.3 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.17 119.78 59.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.887 2.075 . . . . 0.0 105.698 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.3 t -67.24 141.55 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -132.8 155.42 48.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 110.188 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -57.03 117.96 4.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.07 -18.41 64.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 -13.53 18.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 -18.34 2.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.863 1.21 . . . . 0.0 113.997 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.24 87.8 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.213 0.911 . . . . 0.0 113.775 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.84 155.82 25.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.644 1.722 . . . . 0.0 109.408 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.0 t -60.19 126.47 27.64 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.866 0.866 . . . . 0.0 111.091 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -73.27 -48.43 34.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.59 -25.79 3.09 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -103.22 159.02 15.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.464 1.105 . . . . 0.0 111.495 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.9 176.39 29.46 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.932 1.729 . . . . 0.0 109.504 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.29 156.85 45.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.78 0.832 . . . . 0.0 109.348 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.3 t -138.57 154.9 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.407 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 8.2 t -144.07 125.68 15.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.34 156.65 24.03 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.677 1.191 . . . . 0.0 111.237 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.96 -23.07 61.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.975 1.31 . . . . 0.0 113.681 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -137.22 153.99 50.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.479 1.036 . . . . 0.0 109.972 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.49 -48.82 79.36 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -34.68 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.914 1.285 . . . . 0.0 112.874 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.24 -47.63 73.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.1 54.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.645 1.178 . . . . 0.0 111.538 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -53.32 -45.55 69.06 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.395 1.078 . . . . 0.0 111.85 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -53.86 -47.56 70.89 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.775 0.83 . . . . 0.0 108.876 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.73 -47.37 72.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.424 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.8 mt -51.74 -44.5 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.682 1.583 . . . . 0.0 110.154 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -69.89 -67.96 0.45 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.23 1.412 . . . . 0.0 112.925 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -66.68 -43.19 85.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.565 1.546 . . . . 0.0 115.053 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 74.0 mmm -75.97 -21.55 56.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.598 1.545 . . . . 0.0 112.332 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.31 4.87 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.95 -5.7 69.04 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.527 1.061 . . . . 0.0 112.898 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -73.61 171.21 13.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.467 1.634 . . . . 0.0 109.468 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -101.94 143.82 31.34 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.06 122.81 12.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.194 0.998 . . . . 0.0 109.434 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.59 3.66 2.39 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 118.073 -1.404 . . . . 0.0 115.896 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 133.65 -13.23 4.81 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-O 116.767 -2.129 . . . . 0.0 115.183 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -137.22 162.54 33.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 121.037 2.419 . . . . 0.0 110.019 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -72.85 162.86 28.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.979 0.354 . . . . 0.0 110.318 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.1 pt -136.94 163.44 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.517 1.127 . . . . 0.0 110.974 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -126.5 151.35 47.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.31 1.444 . . . . 0.0 108.464 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.8 p -141.83 156.74 45.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.671 1.188 . . . . 0.0 109.534 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 172' ' ' TRP . 3.5 t-20 -173.95 173.84 3.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 109.259 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . 0.453 ' H ' ' ND2' ' A' ' 171' ' ' ASN . 50.4 m95 -67.51 116.19 7.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 123.691 0.796 . . . . 0.0 112.821 -179.781 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m170 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.381 0.61 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 101.19 8.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.53 146.99 24.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.025 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -123.93 142.83 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.253 1.821 . . . . 0.0 108.47 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -97.02 135.32 39.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 106.351 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.39 139.3 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 -178.33 22.28 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.53 12.63 4.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.722 2.009 . . . . 0.0 113.162 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -55.16 148.13 14.87 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.753 2.021 . . . . 0.0 111.645 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -64.26 142.61 98.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.3 -17.67 27.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.524 2.816 . . . . 0.0 116.315 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -98.62 -5.64 31.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.277 0.944 . . . . 0.0 113.042 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 142.72 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 119.569 1.077 . . . . 0.0 108.374 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.8 t -115.31 169.2 9.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 122.233 1.016 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -61.73 -35.32 77.73 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.766 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -66.29 -34.8 78.82 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.824 1.25 . . . . 0.0 109.998 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.58 -42.77 86.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 108.762 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.34 -43.5 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -54.52 -43.75 72.16 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.606 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.91 73.9 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.85 0.719 . . . . 0.0 111.519 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.35 -43.62 71.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -94.61 -9.39 35.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.756 -0.59 . . . . 0.0 112.295 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.67 93.98 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.94 1.296 . . . . 0.0 114.015 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.04 -7.16 14.53 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 121.87 1.703 . . . . 0.0 112.63 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.41 -12.95 19.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.307 0.958 . . . . 0.0 112.053 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 171.0 -173.7 44.7 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.475 1.489 . . . . 0.0 111.499 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -101.64 129.77 47.85 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.2 mt -100.33 160.8 3.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 126.437 1.895 . . . . 0.0 109.408 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 t -126.93 -69.24 0.77 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.578 1.551 . . . . 0.0 106.837 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.99 138.17 38.39 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.46 4.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.893 1.677 . . . . 0.0 107.435 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -160.74 156.04 24.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.55 1.068 . . . . 0.0 111.726 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.65 121.59 51.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.97 144.49 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -140.91 148.66 40.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.53 121.71 12.21 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.485 1.114 . . . . 0.0 108.165 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.1 ptm -58.49 -22.63 55.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.57 -9.8 18.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.4 p -131.99 -20.27 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.94 1.246 . . . . 0.0 113.02 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.78 6.56 82.04 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.375 0.988 . . . . 0.0 112.756 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -76.51 149.16 36.76 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 t -58.17 129.59 42.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -78.05 -12.79 60.02 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.51 -24.59 28.6 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-O 118.564 -1.131 . . . . 0.0 113.75 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -102.87 166.45 10.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.252 1.026 . . . . 0.0 109.311 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.63 174.14 33.68 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.215 1.388 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.16 157.01 46.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.489 0.716 . . . . 0.0 109.121 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -143.95 133.81 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.074 1.75 . . . . 0.0 106.775 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 t -115.95 129.75 56.53 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.749 2.02 . . . . 0.0 108.254 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.12 155.43 26.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.55 -23.29 61.73 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.528 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -135.81 156.47 48.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.507 1.503 . . . . 0.0 110.994 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.38 -46.11 74.26 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.573 0.749 . . . . 0.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -39.87 72.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.21 1.804 . . . . 0.0 111.177 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -57.44 -52.92 63.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.69 53.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.732 1.213 . . . . 0.0 111.122 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -50.29 -49.02 54.71 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.373 1.069 . . . . 0.0 111.221 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -52.23 -57.35 9.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.275 1.03 . . . . 0.0 110.211 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.17 94.7 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 116.779 -1.582 . . . . 0.0 113.523 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.0 mt -50.97 -34.74 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 121.581 1.991 . . . . 0.0 110.69 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -79.96 -63.42 1.42 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.33 0.652 . . . . 0.0 111.009 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.58 -49.91 69.32 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.7 mmm -68.29 -31.39 70.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.441 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.68 92.7 0.11 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.817 0.722 . . . . 0.0 111.31 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 138.56 -18.0 3.26 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.901 1.239 . . . . 0.0 111.786 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 167.72 20.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.402 1.101 . . . . 0.0 110.672 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -107.0 116.3 31.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.0 tp -116.3 127.3 54.58 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.753 1.221 . . . . 0.0 107.763 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 -63.28 4.18 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.31 5.9 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.208 -1.884 . . . . 0.0 112.808 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -136.13 154.49 50.97 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.213 2.007 . . . . 0.0 110.358 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -68.73 148.45 50.36 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.6 pt -116.88 160.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.454 1.102 . . . . 0.0 110.974 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -118.16 143.91 46.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.389 1.876 . . . . 0.0 105.985 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.6 p -138.89 123.09 18.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -149.94 174.36 12.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -69.07 155.22 40.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.029 179.688 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -123.86 113.61 18.74 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.09 1.356 . . . . 0.0 108.086 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.77 151.65 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.76 0.79 . . . . 0.0 111.229 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.17 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 128.859 2.863 . . . . 0.0 107.875 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -95.45 133.06 39.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 106.172 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -127.31 138.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.07 179.63 19.83 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.706 -0.621 . . . . 0.0 111.835 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.284 7.2 t0 60.57 10.88 2.76 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 129.93 3.292 . . . . 0.0 114.982 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.2 mt -52.35 138.61 26.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.66 1.984 . . . . 0.0 110.462 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.83 151.35 64.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.96 -19.43 68.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.038 1.826 . . . . 0.0 114.239 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -82.73 -23.41 34.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.691 1.197 . . . . 0.0 113.598 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mm -56.89 130.61 19.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.283 1.033 . . . . 0.0 110.451 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -107.9 167.53 9.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.159 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.8 m -61.32 -21.61 64.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.056 -1.652 . . . . 0.0 111.969 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.76 -36.77 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.828 1.651 . . . . 0.0 109.96 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.91 -50.95 71.78 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.32 -52.62 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.271 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -53.55 -48.36 69.18 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.994 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.66 -45.87 90.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.623 0.769 . . . . 0.0 111.833 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.35 -49.13 78.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.67 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -84.48 -8.28 59.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.947 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.3 93.75 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 120.215 1.371 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.58 -6.07 15.72 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 122.1 1.786 . . . . 0.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.62 -18.21 17.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.73 0.812 . . . . 0.0 110.913 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 170.17 175.23 38.91 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 123.596 1.665 . . . . 0.0 114.651 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -86.03 117.68 25.03 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.5 mt -100.36 158.01 3.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.12 1.368 . . . . 0.0 107.818 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 t -134.95 -62.61 0.72 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.83 126.47 48.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.831 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.22 136.62 13.09 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -162.65 157.03 21.32 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.492 0.587 . . . . 0.0 112.004 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.91 122.65 58.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.49 141.8 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -130.85 155.69 46.3 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.747 0.784 . . . . 0.0 109.083 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.49 124.51 23.77 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.068 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.8 ptp -64.54 -20.2 66.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.87 10.47 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.826 1.194 . . . . 0.0 113.845 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 80.5 p -104.05 -19.25 14.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.017 1.327 . . . . 0.0 114.303 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.0 78.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.195 0.903 . . . . 0.0 112.607 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -83.6 157.27 22.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.06 1.344 . . . . 0.0 109.154 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 t -62.06 124.99 22.3 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.718 0.807 . . . . 0.0 111.221 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -71.4 -31.61 67.47 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.27 -29.96 5.98 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.081 1.324 . . . . 0.0 110.601 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -103.31 164.99 11.3 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.305 -1.115 . . . . 0.0 111.574 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.6 178.37 33.09 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.695 1.616 . . . . 0.0 110.015 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.38 153.87 51.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.399 1.079 . . . . 0.0 108.419 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.2 t -140.24 143.61 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 12.9 t -131.35 135.3 47.12 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.738 1.615 . . . . 0.0 107.234 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 148.58 43.37 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 124.529 1.143 . . . . 0.0 109.381 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.03 -48.12 59.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -92.33 143.1 26.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.652 0.781 . . . . 0.0 109.238 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.34 -45.32 84.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.527 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -36.71 63.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.976 1.711 . . . . 0.0 112.078 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.17 -47.05 87.95 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.25 -52.54 61.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.73 0.812 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.08 -54.75 14.62 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 110.511 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -51.15 -56.55 12.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.882 1.673 . . . . 0.0 111.537 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.45 91.89 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.079 -1.438 . . . . 0.0 112.111 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.8 mt -53.01 -45.77 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 122.06 2.209 . . . . 0.0 109.784 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.72 -64.76 0.79 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.049 1.34 . . . . 0.0 111.106 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.89 -57.62 10.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.247 1.819 . . . . 0.0 114.193 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.3 mmm -64.91 -21.96 66.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.361 1.437 . . . . 0.0 113.669 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.34 110.45 3.12 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 119.227 0.921 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.4 -5.71 70.99 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.752 1.168 . . . . 0.0 112.134 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -76.71 170.67 16.03 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 118.852 1.326 . . . . 0.0 107.605 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -102.01 142.67 32.92 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.7 tp -131.71 124.08 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.014 2.126 . . . . 0.0 106.214 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.39 -78.35 0.84 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.9 -2.27 0.15 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.069 -1.961 . . . . 0.0 114.544 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -129.22 163.72 25.0 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.16 2.48 . . . . 0.0 109.995 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -77.93 165.18 24.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.338 0.589 . . . . 0.0 109.581 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.14 159.08 38.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.675 0.79 . . . . 0.0 110.925 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -113.77 139.54 49.03 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 p -137.06 132.37 34.07 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.138 0.881 . . . . 0.0 109.448 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -157.1 167.43 30.45 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -61.08 132.87 55.16 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.19 0 CA-C-N 118.134 0.425 . . . . 0.0 111.673 -179.785 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.432 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 126.33 26.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.608 0.763 . . . . 0.0 109.744 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.4 m -71.76 178.44 3.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.75 1.22 . . . . 0.0 110.825 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.48 102.03 2.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.7 m -79.71 157.38 27.2 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.939 0.869 . . . . 0.0 109.949 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 m -63.2 -50.66 69.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.447 0.699 . . . . 0.0 112.294 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 91.48 0.1 Allowed Glycine 0 C--N 1.336 0.537 0 O-C-N 121.384 -0.822 . . . . 0.0 112.206 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -84.42 1.29 46.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.027 0.931 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -110.99 127.32 55.48 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 119.831 -1.793 . . . . 0.0 108.014 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -29.11 69.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.191 0.45 . . . . 0.0 110.722 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.99 141.42 38.94 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.25 . . . . 0.0 111.621 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -93.18 76.77 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.791 1.637 . . . . 0.0 108.127 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.8 m -109.87 -43.12 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -89.11 21.89 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.551 0.741 . . . . 0.0 110.129 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -113.38 159.01 19.89 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.106 -0.996 . . . . 0.0 110.715 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -105.39 102.59 12.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.317 1.847 . . . . 0.0 107.894 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 146.82 25.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.306 0.643 . . . . 0.0 110.568 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.61 138.18 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.344 1.858 . . . . 0.0 110.207 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -86.82 143.0 27.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.242 1.817 . . . . 0.0 106.686 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.13 137.37 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.5 -174.54 17.79 Favored Glycine 0 N--CA 1.463 0.498 0 O-C-N 120.865 -1.147 . . . . 0.0 111.164 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.7 8.94 4.8 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.067 2.147 . . . . 0.0 112.36 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -55.84 148.13 17.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.009 1.323 . . . . 0.0 111.519 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.11 162.32 69.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.14 -16.78 49.77 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.623 2.215 . . . . 0.0 114.632 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.87 -15.06 17.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.583 1.083 . . . . 0.0 112.288 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -57.69 114.25 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 109.387 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 t -95.34 178.83 5.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 m -64.54 -30.91 71.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.928 -1.107 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -73.02 -30.12 63.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.315 1.046 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.04 -48.6 70.54 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -51.65 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -55.37 -38.65 69.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 120.904 -1.122 . . . . 0.0 112.34 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.17 64.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.672 0.608 . . . . 0.0 110.078 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.73 84.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.742 1.217 . . . . 0.0 113.547 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.47 -6.34 57.69 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.27 94.95 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.862 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.92 -5.96 14.7 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.529 1.486 . . . . 0.0 113.535 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -98.82 -20.97 16.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.775 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 169.33 175.16 38.36 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-O 122.943 1.301 . . . . 0.0 114.155 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.9 mtm105 -81.61 121.54 26.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.3 mt -100.79 153.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.377 1.071 . . . . 0.0 109.073 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 t -130.28 -61.07 0.99 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.77 132.89 45.95 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 134.71 6.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.198 0.999 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -162.84 163.38 26.53 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.957 0.798 . . . . 0.0 112.228 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 52.2 t -105.02 120.59 55.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.03 140.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -133.23 147.1 51.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.71 130.26 45.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.079 1.352 . . . . 0.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.6 ptm -76.02 -9.41 58.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.77 -24.29 16.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.864 1.211 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.5 p -128.48 -18.49 3.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.433 1.015 . . . . 0.0 113.043 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.52 19.11 78.47 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.592 1.091 . . . . 0.0 113.391 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -100.3 163.35 12.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.542 1.171 . . . . 0.0 109.867 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -46.27 126.21 7.55 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.885 1.274 . . . . 0.0 113.885 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -22.5 43.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.699 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.93 -30.12 8.31 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.547 2.023 . . . . 0.0 110.644 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.264 29.9 p90 -102.88 169.37 8.63 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.422 1.089 . . . . 0.0 112.171 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.57 172.72 33.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.371 2.415 . . . . 0.0 108.379 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -140.37 149.95 43.33 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.54 155.75 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.662 1.985 . . . . 0.0 106.031 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.0 t -145.32 118.02 8.65 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.506 1.122 . . . . 0.0 108.354 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -99.46 152.12 20.35 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.17 1.388 . . . . 0.0 110.631 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -74.37 -24.41 59.15 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.394 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -125.44 151.27 46.44 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.782 1.233 . . . . 0.0 110.55 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.01 -49.24 73.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -31.46 17.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.456 1.903 . . . . 0.0 113.307 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.78 -55.28 10.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 108.347 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.71 76.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.971 1.708 . . . . 0.0 110.81 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.18 -50.01 70.42 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.583 1.153 . . . . 0.0 109.295 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -55.22 -50.91 68.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.752 0.421 . . . . 0.0 111.294 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.22 -55.12 37.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.033 1.733 . . . . 0.0 111.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.4 mt -46.68 -49.9 6.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 120.367 1.44 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.36 -60.78 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.288 0.992 . . . . 0.0 112.316 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -66.02 -58.07 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.2 mmm -58.19 -28.58 64.92 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.93 77.43 0.81 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 125.021 1.296 . . . . 0.0 110.123 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.17 -10.35 2.26 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 127.3 2.381 . . . . 0.0 111.838 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -80.18 165.52 22.34 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.879 1.34 . . . . 0.0 109.456 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -107.6 133.54 51.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.991 0.916 . . . . 0.0 108.853 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.88 130.48 46.91 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.565 1.946 . . . . 0.0 106.645 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 12.55 58.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.106 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.88 0.25 62.24 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.312 1.556 . . . . 0.0 112.564 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.26 157.06 46.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.427 1.614 . . . . 0.0 108.928 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.78 174.84 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.787 0.803 . . . . 0.0 109.308 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 pt -142.96 160.05 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.734 2.014 . . . . 0.0 108.025 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -123.51 140.6 52.84 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.4 p -138.93 149.23 44.56 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.957 0.903 . . . . 0.0 111.808 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -173.43 178.07 2.45 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.906 2.082 . . . . 0.0 109.352 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.12 126.65 30.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.55 -37.21 77.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 112.855 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.9 t -148.36 139.89 23.58 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -141.24 -178.0 5.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.553 1.541 . . . . 0.0 108.276 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -138.63 135.47 17.99 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.147 1.379 . . . . 0.0 108.062 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.13 148.39 56.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.223 2.615 . . . . 0.0 111.984 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.04 167.36 27.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.532 2.822 . . . . 0.0 111.957 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.72 156.28 77.77 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.36 -66.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.36 2.04 . . . . 0.0 112.172 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 182' ' ' SER . 13.9 tttm -150.93 171.77 16.73 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.968 0.907 . . . . 0.0 109.443 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.431 ' H ' ' HG2' ' A' ' 181' ' ' LYS . 7.2 t -137.47 152.05 49.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.471 1.109 . . . . 0.0 109.05 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.14 -176.72 5.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.708 2.003 . . . . 0.0 107.649 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -137.42 158.59 44.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.83 174.99 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.774 0.829 . . . . 0.0 109.817 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 p -144.6 8.39 1.32 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.614 1.565 . . . . 0.0 111.463 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -53.05 -38.89 62.85 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.965 2.106 . . . . 0.0 113.772 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.1 m -69.76 56.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.465 1.906 . . . . 0.0 113.689 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -91.72 161.71 14.78 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.519 -1.363 . . . . 0.0 108.485 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 174.94 13.92 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 127.483 2.313 . . . . 0.0 108.618 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.8 t -137.31 -80.81 0.37 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.93 65.39 1.55 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.149 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.05 89.88 0.77 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.788 2.326 . . . . 0.0 107.916 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.46 169.04 25.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 109.278 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.4 p -153.75 179.18 9.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.742 1.617 . . . . 0.0 108.221 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.838 0 C-N-CA 128.25 2.833 . . . . 0.0 106.882 179.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.1 p -62.95 169.44 3.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.602 1.201 . . . . 0.0 112.221 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 p -59.34 129.09 40.37 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.245 1.418 . . . . 0.0 109.419 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.11 -170.59 54.76 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.3 t -141.25 132.11 25.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.04 1.32 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.888 2.875 . . . . 0.0 117.956 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.36 -153.54 21.4 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.924 1.693 . . . . 0.0 111.267 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -52.16 91.68 0.01 OUTLIER 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.785 2.434 . . . . 0.0 113.197 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -130.37 160.64 33.37 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.1 0.96 . . . . 0.0 111.361 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -164.6 162.76 21.75 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.847 2.459 . . . . 0.0 107.159 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -135.64 73.53 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.3 p 48.8 19.37 0.25 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.32 2.248 . . . . 0.0 115.373 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -49.47 -24.41 2.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.361 2.664 . . . . 0.0 117.273 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -133.82 11.85 4.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.741 1.155 . . . . 0.0 110.305 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -90.17 167.3 12.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.723 0.809 . . . . 0.0 109.405 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -113.08 161.36 17.18 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -132.72 133.79 43.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.36 134.27 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 126.169 1.788 . . . . 0.0 109.571 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -85.59 136.1 33.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.8 t -131.71 133.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.02 -174.35 18.1 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 62.8 12.33 5.62 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.227 2.611 . . . . 0.0 111.951 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.55 142.68 52.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.639 1.576 . . . . 0.0 111.322 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 t -59.87 143.81 86.89 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -59.95 -5.33 3.61 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 115.382 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.4 -14.38 18.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.285 2.234 . . . . 0.0 112.721 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.1 mm -58.05 136.2 21.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 119.316 0.962 . . . . 0.0 109.831 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 112' ' ' ASP . 5.8 t -108.33 168.85 9.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.387 1.089 . . . . 0.0 108.843 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.0 m -60.82 -29.51 69.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.895 1.278 . . . . 0.0 109.381 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -70.24 -40.8 74.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 109.277 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 109' ' ' THR . 6.6 m-20 -59.75 -47.54 85.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.738 0.815 . . . . 0.0 109.17 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.9 mt -60.75 -49.53 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -54.88 -48.53 72.86 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.762 -1.211 . . . . 0.0 110.99 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.33 -34.4 73.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.967 0.907 . . . . 0.0 112.614 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.31 -44.89 42.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.756 1.223 . . . . 0.0 113.842 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.04 -10.68 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.0 -50.37 86.82 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 126.481 1.913 . . . . 0.0 114.445 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -65.03 -4.17 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.464 1.443 . . . . 0.0 113.282 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -99.05 -9.63 23.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.47 15.1 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.094 1.316 . . . . 0.0 109.89 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -75.18 116.35 15.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.596 -0.943 . . . . 0.0 109.827 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -77.48 153.5 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 p -112.53 -73.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.011 1.724 . . . . 0.0 107.032 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.97 142.8 32.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.988 2.115 . . . . 0.0 108.117 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.84 124.03 2.9 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 110.101 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -153.53 164.5 38.12 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.594 0.712 . . . . 0.0 111.8 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.2 121.64 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.341 1.857 . . . . 0.0 106.968 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.68 139.28 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -134.84 153.35 52.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -60.84 116.41 4.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.368 1.467 . . . . 0.0 109.115 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.4 ptp -64.09 -9.01 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.26 -15.87 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.467 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.4 p -137.91 -29.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.94 1.246 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.66 62.55 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.217 1.389 . . . . 0.0 112.037 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -80.14 154.97 27.69 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.696 1.248 . . . . 0.0 109.094 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 m -56.04 123.58 14.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.857 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -76.88 -22.56 53.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.121 0.568 . . . . 0.0 111.692 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.73 -26.53 10.68 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 127.006 2.241 . . . . 0.0 112.619 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -103.06 168.09 9.41 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.764 1.225 . . . . 0.0 112.389 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.84 177.85 31.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.785 2.136 . . . . 0.0 109.307 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -138.79 155.42 48.18 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.031 0.932 . . . . 0.0 109.938 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.3 t -142.89 125.56 13.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.174 1.39 . . . . 0.0 108.405 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -112.92 142.15 45.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.16 163.07 22.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.65 -19.95 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.892 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.19 169.12 16.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.722 1.209 . . . . 0.0 111.607 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -77.81 -52.74 8.43 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.578 1.151 . . . . 0.0 110.808 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -49.61 -48.92 48.66 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.182 1.793 . . . . 0.0 111.096 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.86 -43.96 69.97 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.091 0.869 . . . . 0.0 110.124 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.42 -56.04 12.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.135 1.374 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.08 -48.33 64.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.333 1.453 . . . . 0.0 111.185 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -53.14 -46.0 68.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 109.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.88 -43.23 65.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.855 1.262 . . . . 0.0 110.18 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 95.5 mt -49.52 -44.54 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 120.8 1.636 . . . . 0.0 108.704 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.4 -70.87 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.14 -43.46 98.84 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 68.2 mmm -71.93 -22.59 61.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.594 1.543 . . . . 0.0 111.494 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.0 113.55 5.75 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 118.96 0.8 . . . . 0.0 111.834 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.22 60.29 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.325 -1.264 . . . . 0.0 113.119 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.6 169.05 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.964 1.382 . . . . 0.0 108.795 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -105.33 137.29 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 50.4 tp -124.79 127.88 47.87 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.78 -101.17 0.44 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 105.695 -2.962 . . . . 0.0 105.695 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.75 10.85 7.5 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 116.355 -2.358 . . . . 0.0 115.729 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.98 159.25 43.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.971 2.886 . . . . 0.0 112.969 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -72.37 153.97 41.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.17 151.97 27.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 123.409 0.684 . . . . 0.0 111.457 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -111.64 126.52 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.995 1.318 . . . . 0.0 108.387 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.9 p -113.54 141.58 46.98 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.238 1.415 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -167.45 177.12 6.16 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.086 1.755 . . . . 0.0 107.459 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -77.69 152.62 33.64 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.76 4.48 18.84 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.478 -0.764 . . . . 0.0 112.21 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.2 p -142.68 159.0 43.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 109.886 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -173.18 164.66 4.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.071 1.749 . . . . 0.0 109.849 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -82.53 141.39 45.2 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.09 159.12 54.46 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 121.702 1.601 . . . . 0.0 109.482 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.15 171.9 17.41 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.103 3.202 . . . . 0.0 111.746 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.79 147.62 62.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.802 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.07 100.6 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.311 2.674 . . . . 0.0 107.39 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -159.9 158.46 30.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.97 0.805 . . . . 0.0 112.436 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 p -160.91 -177.79 6.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.379 2.272 . . . . 0.0 107.517 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t 160.56 173.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.733 4.013 . . . . 0.0 107.557 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -163.81 -171.51 2.52 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.621 2.768 . . . . 0.0 108.226 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -163.6 152.4 13.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.331 2.253 . . . . 0.0 106.518 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 42.0 p -154.39 71.81 0.85 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.082 0.855 . . . . 0.0 110.671 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -76.31 79.34 3.07 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.819 -0.551 . . . . 0.0 110.59 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 21.9 p -60.2 -44.84 94.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.548 0.739 . . . . 0.0 109.92 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 35.1 tttm 49.78 20.73 0.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.962 2.105 . . . . 0.0 114.894 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -142.74 146.52 34.39 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.68 1.592 . . . . 0.0 106.919 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.4 p -77.95 -46.69 20.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.537 1.135 . . . . 0.0 108.856 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.33 174.83 40.65 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.562 2.03 . . . . 0.0 108.972 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.27 168.02 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.21 2.607 . . . . 0.0 110.981 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.4 p -147.84 117.01 6.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.2 p -150.68 91.18 1.7 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.792 0 C-N-CA 127.499 2.476 . . . . 0.0 106.971 -179.595 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.7 t -69.51 -23.33 63.59 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.263 -0.551 . . . . 0.0 111.954 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.7 p -147.07 176.02 10.25 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.044 0.938 . . . . 0.0 111.967 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.76 -173.11 14.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.787 2.613 . . . . 0.0 107.015 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -146.91 139.64 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -102.79 164.5 11.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.393 1.477 . . . . 0.0 112.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.74 -116.05 0.62 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.73 154.58 41.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 152.17 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 59.92 2.34 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.155 1.382 . . . . 0.0 113.889 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.54 131.13 45.44 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.388 1.449 . . . . 0.0 109.309 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.3 p -111.41 -1.44 15.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.21 1.004 . . . . 0.0 112.031 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -63.81 -4.99 3.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.973 1.709 . . . . 0.0 115.037 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -122.86 6.97 9.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.973 2.109 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -109.47 177.84 4.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.38 1.072 . . . . 0.0 111.327 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -113.52 139.56 48.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.468 ' CG ' ' HG ' ' A' ' 144' ' ' SER . 2.1 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.042 1.292 . . . . 0.0 110.214 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.08 154.36 28.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.668 2.387 . . . . 0.0 109.704 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -103.82 141.42 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.579 3.152 . . . . 0.0 108.709 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.61 140.33 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.44 178.86 24.78 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 119.652 1.114 . . . . 0.0 111.543 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t0 70.41 -1.69 2.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.762 2.825 . . . . 0.0 114.525 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 mt -47.78 139.01 7.91 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 127.283 2.233 . . . . 0.0 113.892 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.7 t -62.65 148.12 91.64 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.83 -18.1 58.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.161 1.908 . . . . 0.0 113.822 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -76.43 -25.49 54.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mm -57.84 124.11 11.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.448 1.499 . . . . 0.0 110.613 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -106.93 175.3 5.54 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.134 0.974 . . . . 0.0 109.03 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -56.73 -33.52 66.62 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.52 -0.737 . . . . 0.0 111.851 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.39 -42.56 78.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.133 1.773 . . . . 0.0 112.142 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.63 -51.54 65.08 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.326 1.05 . . . . 0.0 109.482 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.0 mt -60.12 -53.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.2 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -51.1 -44.77 61.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 117.885 -1.055 . . . . 0.0 112.092 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.09 81.88 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.948 0.78 . . . . 0.0 110.734 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.79 83.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.12 -5.76 59.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.402 1.081 . . . . 0.0 113.152 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -47.2 99.3 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.54 -3.9 12.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 CA-C-N 121.111 1.432 . . . . 0.0 112.388 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.95 -18.91 18.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.251 0.932 . . . . 0.0 110.719 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.4 168.19 25.0 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 118.887 0.767 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.85 130.72 40.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.2 mt -100.26 154.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.0 t -116.06 -72.65 0.68 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.12 139.97 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.815 1.646 . . . . 0.0 109.303 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.33 135.53 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -162.77 163.01 26.9 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.577 0.626 . . . . 0.0 110.703 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.6 t -102.59 123.28 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.66 138.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -132.15 151.5 51.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 107.739 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -60.01 123.23 16.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.356 1.462 . . . . 0.0 109.97 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.84 -12.9 27.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.835 0.854 . . . . 0.0 113.166 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.82 -10.77 18.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.8 p -141.93 -25.17 0.68 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.95 11.95 75.39 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.183 0.897 . . . . 0.0 110.907 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -82.31 143.92 30.95 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -55.46 125.8 22.46 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -73.07 -22.91 60.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.13 -18.28 42.84 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.936 1.255 . . . . 0.0 112.128 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.282 31.8 p90 -103.14 161.75 13.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.332 1.566 . . . . 0.0 109.573 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.38 175.03 28.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.938 1.256 . . . . 0.0 110.763 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.93 153.37 51.81 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.102 1.361 . . . . 0.0 108.96 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.65 131.22 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 126.254 1.822 . . . . 0.0 106.516 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.468 ' HG ' ' CG ' ' A' ' 98' ' ' HIS . 58.3 m -122.14 132.02 54.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.081 0.952 . . . . 0.0 109.368 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.96 156.29 26.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.189 1.396 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -72.59 -24.05 61.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.717 1.207 . . . . 0.0 112.959 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -131.18 156.25 45.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.23 0.923 . . . . 0.0 110.183 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -67.16 -48.39 68.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.852 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -47.72 -49.28 28.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.71 1.604 . . . . 0.0 112.881 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.77 -49.78 67.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.636 1.574 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.82 63.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.716 1.206 . . . . 0.0 112.018 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -51.38 -49.0 62.36 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.422 1.889 . . . . 0.0 109.867 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -54.23 -52.18 62.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.061 0.944 . . . . 0.0 110.54 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.22 89.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.363 -1.303 . . . . 0.0 111.755 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.4 mt -51.42 -48.05 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 121.739 2.063 . . . . 0.0 109.44 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.42 -60.17 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -68.57 -48.44 64.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.34 2.256 . . . . 0.0 115.516 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.41 -22.84 58.97 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.176 0.898 . . . . 0.0 111.807 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.87 97.84 0.17 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.496 1.046 . . . . 0.0 111.203 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 114.14 -7.72 23.17 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.246 -1.308 . . . . 0.0 113.857 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.27 174.54 9.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.754 1.277 . . . . 0.0 109.951 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -109.38 146.42 34.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.5 tp -139.58 128.37 23.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.994 2.118 . . . . 0.0 106.904 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 48.19 32.22 9.36 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.78 1.181 . . . . 0.0 114.818 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.65 -5.24 51.04 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 117.704 1.841 . . . . 0.0 117.704 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -141.76 157.58 44.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 122.037 2.919 . . . . 0.0 110.738 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.93 161.21 21.78 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.296 0.997 . . . . 0.0 110.658 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.82 155.96 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.541 1.136 . . . . 0.0 108.717 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.3 p -137.2 155.37 49.61 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.992 0.917 . . . . 0.0 110.174 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -176.24 165.05 2.77 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.742 1.217 . . . . 0.0 108.719 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -73.77 122.36 22.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.7 108.65 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.8 p -140.74 159.65 41.75 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.67 1.588 . . . . 0.0 108.894 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -160.93 -166.99 1.71 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.406 1.882 . . . . 0.0 107.658 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -139.09 157.64 70.9 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 124.221 1.009 . . . . 0.0 108.856 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.7 148.27 52.53 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.986 1.791 . . . . 0.0 109.624 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.81 166.85 28.38 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.524 2.15 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -138.77 153.68 72.31 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.993 0.917 . . . . 0.0 109.015 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.5 179.84 5.52 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.778 2.985 . . . . 0.0 112.912 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -94.01 137.22 33.46 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.288 1.435 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -86.42 -177.43 6.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.042 0.537 . . . . 0.0 110.158 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.4 p -146.42 162.22 38.72 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.47 1.108 . . . . 0.0 109.363 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -172.24 162.07 5.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.237 1.815 . . . . 0.0 107.975 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -171.25 140.74 1.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.39 2.676 . . . . 0.0 104.606 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 69.0 m -164.51 27.9 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.81 2.044 . . . . 0.0 111.422 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.93 140.74 56.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.069 1.304 . . . . 0.0 110.766 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.9 t -167.11 171.44 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.013 1.325 . . . . 0.0 107.613 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -154.55 150.46 27.78 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.035 -1.041 . . . . 0.0 109.834 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -143.46 177.83 8.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.009 2.524 . . . . 0.0 106.362 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p 160.71 141.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 128.678 2.791 . . . . 0.0 108.507 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.51 156.33 27.23 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.32 174.88 9.52 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.285 2.657 . . . . 0.0 110.68 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 10.5 t -156.96 152.68 26.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 t -166.15 166.06 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.877 1.671 . . . . 0.0 107.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.78 0 C-N-CA 128.055 2.74 . . . . 0.0 106.901 -179.714 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.46 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 m -145.59 -165.47 2.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.318 2.247 . . . . 0.0 107.36 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -8.99 46.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.755 1.222 . . . . 0.0 112.385 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.44 -69.52 1.07 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.973 -0.904 . . . . 0.0 113.8 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.14 107.96 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -61.96 -23.11 66.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.42 1.888 . . . . 0.0 111.204 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.36 158.97 31.5 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 128.24 2.828 . . . . 0.0 106.793 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -95.92 -28.74 14.54 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.209 1.404 . . . . 0.0 114.392 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -148.78 158.63 44.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.519 1.054 . . . . 0.0 110.418 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.02 -43.36 6.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.605 . . . . 0.0 108.981 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.64 19.07 9.05 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.745 1.618 . . . . 0.0 113.585 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.7 p 55.08 2.44 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.678 2.391 . . . . 0.0 116.224 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -53.8 -6.14 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.203 2.601 . . . . 0.0 117.408 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.4 21.41 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 121.294 1.861 . . . . 0.0 111.845 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -94.44 165.57 12.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.756 0.822 . . . . 0.0 109.996 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.74 112.4 25.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.57 148.75 22.05 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.812 0.695 . . . . 0.0 111.157 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.32 140.72 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 129.07 2.948 . . . . 0.0 109.166 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -92.03 141.14 28.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.845 2.858 . . . . 0.0 107.24 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.9 143.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 -176.21 23.59 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.88 14.12 9.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.35 2.26 . . . . 0.0 113.126 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.6 mt -62.98 137.18 58.19 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.164 1.785 . . . . 0.0 112.415 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.5 t -62.85 143.46 97.1 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.24 -14.37 33.7 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.806 2.337 . . . . 0.0 114.679 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.26 -23.96 37.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.314 0.961 . . . . 0.0 111.667 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.24 143.24 12.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.62 1.568 . . . . 0.0 110.231 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.5 t -121.75 179.29 4.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.859 1.314 . . . . 0.0 110.038 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 m -57.03 -39.37 74.69 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.591 1.956 . . . . 0.0 112.145 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.51 -37.48 80.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.251 1.82 . . . . 0.0 111.417 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.03 -49.71 76.29 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.4 mt -57.58 -52.29 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -54.11 -46.58 72.17 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.163 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.99 81.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.149 0.886 . . . . 0.0 111.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.27 -53.05 50.04 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.852 1.261 . . . . 0.0 113.67 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -84.46 -15.55 45.66 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.18 -48.75 93.37 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.875 1.27 . . . . 0.0 112.329 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.61 -5.16 8.13 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.548 1.498 . . . . 0.0 113.479 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -99.11 -14.89 19.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.413 1.006 . . . . 0.0 111.091 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 161.31 157.96 9.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.636 1.589 . . . . 0.0 110.528 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -73.39 107.21 5.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.086 1.354 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.3 140.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 126.507 1.923 . . . . 0.0 109.229 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 p -99.8 -71.44 0.7 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.24 142.86 32.8 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 128.319 2.647 . . . . 0.0 109.823 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -162.73 131.67 4.13 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.903 1.281 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -155.42 157.3 36.81 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.223 0.92 . . . . 0.0 111.948 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.3 t -106.26 119.19 55.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.61 139.08 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 121.716 -0.615 . . . . 0.0 109.361 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -133.65 150.39 51.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.326 1.05 . . . . 0.0 108.533 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.82 137.96 52.24 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.589 0.356 . . . . 0.0 111.875 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.2 ptm -71.61 -17.83 62.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.38 -11.93 31.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.378 1.445 . . . . 0.0 114.217 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 62.1 p -140.24 -16.15 0.96 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.17 74.15 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.79 148.79 25.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 118.323 1.061 . . . . 0.0 110.48 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 123.62 14.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.293 1.437 . . . . 0.0 111.156 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -71.45 -53.82 12.7 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.232 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 141.11 -28.08 2.39 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.131 2.301 . . . . 0.0 112.78 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -102.59 161.55 13.63 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.257 1.423 . . . . 0.0 112.704 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.66 168.99 26.67 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.643 1.116 . . . . 0.0 110.382 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -132.72 142.08 48.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.578 1.151 . . . . 0.0 108.789 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.6 t -133.51 143.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.302 1.441 . . . . 0.0 107.484 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.4 t -119.94 130.58 54.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.572 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -114.43 150.23 35.04 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.441 1.096 . . . . 0.0 113.677 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -70.81 -14.76 62.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.313 1.445 . . . . 0.0 114.134 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -138.89 159.75 41.38 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.963 1.711 . . . . 0.0 108.13 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -64.64 -53.16 51.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -29.07 68.65 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 126.145 1.778 . . . . 0.0 112.661 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -64.06 -43.15 96.36 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.32 -47.33 50.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.705 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -55.69 -47.15 77.26 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.176 0.898 . . . . 0.0 110.873 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -49.95 -51.36 41.84 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 126.08 1.752 . . . . 0.0 108.002 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.53 66.72 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 117.189 -1.386 . . . . 0.0 111.936 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 78.5 mt -49.55 -48.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 122.452 2.387 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -64.74 -59.9 3.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.834 1.653 . . . . 0.0 112.789 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -71.31 -44.61 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.907 1.683 . . . . 0.0 115.231 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.5 mmm -72.63 -21.41 61.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 110.27 2.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.16 62.36 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.869 -1.517 . . . . 0.0 113.903 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -69.73 166.45 19.2 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.518 1.659 . . . . 0.0 108.982 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -106.27 99.2 8.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.542 1.137 . . . . 0.0 109.642 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 23.3 tp -85.01 111.98 20.2 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.11 -129.87 38.19 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.93 87.81 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 115.826 -2.652 . . . . 0.0 117.497 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -147.41 157.21 43.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 123.209 3.505 . . . . 0.0 115.267 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.03 163.19 17.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.5 pt -134.92 165.8 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.013 0.911 . . . . 0.0 110.673 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -123.31 147.13 47.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.474 2.31 . . . . 0.0 105.462 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.6 p -138.22 148.35 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.44 1.096 . . . . 0.0 110.702 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -170.08 171.08 7.14 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -69.67 138.75 53.24 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.72 7.56 20.1 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 t -138.41 158.22 44.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.514 1.126 . . . . 0.0 108.492 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -162.32 153.22 17.51 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.014 2.526 . . . . 0.0 106.321 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -135.32 156.01 78.28 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 153.28 75.32 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.631 2.22 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.94 160.53 47.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.644 2.229 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.99 150.4 85.82 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.193 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.83 124.13 11.52 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.919 2.413 . . . . 0.0 106.133 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.82 116.41 10.17 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.741 -0.784 . . . . 0.0 108.907 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 p -130.06 163.41 26.58 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.931 1.292 . . . . 0.0 108.572 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -179.38 163.48 1.25 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.761 2.024 . . . . 0.0 107.691 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -112.37 86.02 2.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.322 1.449 . . . . 0.0 108.393 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.38 144.79 51.47 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.36 93.2 0.93 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.539 -0.726 . . . . 0.0 111.263 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -147.56 122.5 10.03 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.081 -1.012 . . . . 0.0 108.763 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.2 t -141.78 146.59 36.12 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -119.12 85.16 2.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -138.08 169.89 16.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.275 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.5 m 52.51 29.22 6.82 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.768 1.227 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.38 51.51 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.2 163.1 40.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.361 2.041 . . . . 0.0 110.308 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.3 m -162.61 173.63 13.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.155 2.182 . . . . 0.0 107.135 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.0 t -156.06 -178.93 7.67 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.861 1 C-N-CA 132.783 4.992 . . . . 0.0 103.608 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.891 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -132.51 169.53 16.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.789 1.636 . . . . 0.0 110.27 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -65.63 164.13 14.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.089 0.556 . . . . 0.0 111.922 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.33 0.26 65.87 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.013 0.816 . . . . 0.0 113.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 t -122.87 145.54 48.36 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 118.685 1.243 . . . . 0.0 107.879 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -133.72 105.66 6.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.249 1.82 . . . . 0.0 107.076 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.09 79.38 0.18 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -108.01 153.02 23.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.131 1.372 . . . . 0.0 110.235 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -143.18 113.33 7.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.46 1.504 . . . . 0.0 109.052 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -140.41 -177.61 5.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.499 2.32 . . . . 0.0 108.071 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -120.15 171.66 8.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.044 0.937 . . . . 0.0 110.084 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -91.64 16.15 11.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.597 1.959 . . . . 0.0 113.289 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.7 p -47.26 -26.69 1.28 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.17 61.06 1.36 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -124.29 172.08 9.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.566 1.546 . . . . 0.0 109.22 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.69 100.94 6.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.73 144.52 32.13 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.39 135.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.296 1.838 . . . . 0.0 107.853 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -85.92 136.43 33.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.047 2.139 . . . . 0.0 106.492 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.41 142.52 41.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.62 179.36 25.52 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.283 0.944 . . . . 0.0 111.168 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.91 15.45 9.14 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.073 2.549 . . . . 0.0 113.901 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.48 145.59 55.93 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.857 1.263 . . . . 0.0 111.333 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 t -68.46 149.79 97.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.46 -16.75 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.038 1.825 . . . . 0.0 113.5 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -78.46 -16.59 57.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.301 1.04 . . . . 0.0 112.777 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.82 121.49 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.5 1.12 . . . . 0.0 109.669 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 111' ' ' GLU . 4.7 t -99.78 -179.19 4.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.426 1.091 . . . . 0.0 109.923 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.3 m -62.93 -33.08 74.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.405 ' H ' HG22 ' A' ' 109' ' ' THR . 26.0 mt-10 -69.49 -41.81 75.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.786 0.834 . . . . 0.0 109.914 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -56.15 -49.96 72.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.745 0.818 . . . . 0.0 109.172 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.77 -54.51 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -51.91 -41.44 61.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 116.945 -1.502 . . . . 0.0 112.584 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.05 -45.97 79.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.345 0.975 . . . . 0.0 110.085 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.02 -5.99 54.57 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.02 99.74 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-O 117.471 -1.252 . . . . 0.0 114.164 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.34 -5.65 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 121.721 1.65 . . . . 0.0 112.131 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.06 -43.93 7.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 119.751 1.159 . . . . 0.0 108.806 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.84 164.27 36.32 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -80.8 118.47 22.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.43 157.99 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 126.035 1.734 . . . . 0.0 107.748 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.7 t -123.84 -69.45 0.81 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.38 130.16 47.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 107.817 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.2 137.84 9.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.051 1.296 . . . . 0.0 108.774 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.16 173.09 15.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 111.313 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.47 138.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.28 133.83 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -123.6 164.32 19.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.31 142.52 43.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.724 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.6 ptp -75.63 -29.68 59.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.788 -0.57 . . . . 0.0 109.892 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.84 -45.27 15.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -104.75 -18.36 14.29 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.94 12.26 74.93 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.978 -0.451 . . . . 0.0 113.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -85.46 155.06 21.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.481 1.112 . . . . 0.0 109.966 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 t -57.81 126.35 27.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.896 0.878 . . . . 0.0 108.849 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -70.08 -65.85 0.67 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.698 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 150.72 -18.82 0.99 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 128.152 2.786 . . . . 0.0 110.245 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -102.93 162.88 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.072 -1.252 . . . . 0.0 112.585 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.49 176.99 29.68 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.28 1.419 . . . . 0.0 110.613 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.33 151.29 46.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.603 0.761 . . . . 0.0 109.359 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 50.2 t -143.8 121.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.382 1.473 . . . . 0.0 109.072 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -107.0 125.37 50.91 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 109.317 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -105.47 159.65 15.77 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.288 1.035 . . . . 0.0 110.709 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.17 -30.0 65.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.196 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -132.02 158.78 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.773 1.17 . . . . 0.0 111.033 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -60.56 -53.94 51.43 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.03 1.332 . . . . 0.0 112.33 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -41.16 67.75 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.788 2.035 . . . . 0.0 112.619 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -58.31 -45.43 88.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.209 1.004 . . . . 0.0 109.301 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.53 -50.36 45.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.271 1.028 . . . . 0.0 110.687 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.47 -48.73 62.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.207 1.403 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -56.17 -34.93 66.65 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.53 -45.33 16.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 116.923 -1.513 . . . . 0.0 109.6 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 79.5 mt -49.03 -39.39 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 122.083 2.22 . . . . 0.0 109.747 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -68.69 -71.09 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.528 1.131 . . . . 0.0 111.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -64.18 -45.61 87.61 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 127.802 2.441 . . . . 0.0 116.14 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.8 mmm -76.65 -21.14 55.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.737 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.43 0.62 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 116.266 1.266 . . . . 0.0 116.266 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.93 -11.15 0.5 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.504 2.002 . . . . 0.0 112.231 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.04 167.38 11.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.174 0.987 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.25 123.04 47.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.38 118.18 32.51 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.273 1.429 . . . . 0.0 109.255 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.11 5.99 17.58 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.7 1.143 . . . . 0.0 113.686 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 124.6 -5.96 8.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 117.042 -1.977 . . . . 0.0 114.683 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -133.28 148.17 51.93 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.519 2.659 . . . . 0.0 112.018 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -64.49 154.78 34.85 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.496 0.718 . . . . 0.0 110.413 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 26.4 pt -128.58 163.45 33.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 110.698 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -124.84 141.37 52.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.7 p -139.52 141.78 37.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.484 1.038 . . . . 0.0 111.035 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -163.28 176.79 9.56 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.857 1.663 . . . . 0.0 108.166 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -70.38 152.9 43.59 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.149 -1.595 . . . . 0.0 109.031 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 9.72 5.5 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.6 t -136.28 168.69 18.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.422 1.489 . . . . 0.0 109.469 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -132.63 -170.78 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.659 2.384 . . . . 0.0 106.284 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -135.31 155.67 78.55 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 119.149 0.886 . . . . 0.0 110.23 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.78 162.33 39.98 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.142 1.895 . . . . 0.0 109.898 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.72 173.07 15.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.955 2.437 . . . . 0.0 111.703 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.42 149.81 55.76 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.33 -20.15 32.53 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.051 1.834 . . . . 0.0 111.596 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -54.25 119.53 5.27 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.178 1.391 . . . . 0.0 109.628 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.7 t -129.35 101.75 6.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.6 m -77.24 136.35 38.53 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.393 1.077 . . . . 0.0 108.402 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.76 173.92 9.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.943 0.497 . . . . 0.0 110.447 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.26 150.8 32.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.396 1.478 . . . . 0.0 107.19 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.4 p -167.57 174.75 7.55 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -150.37 130.59 13.63 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.766 1.226 . . . . 0.0 108.037 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.1 m -120.24 133.32 55.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.13 134.75 2.48 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.37 128.76 4.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 p -161.41 110.84 1.59 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.24 78.6 0.28 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.94 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.2 167.16 27.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.401 2.067 . . . . 0.0 110.334 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.4 p -149.15 163.95 36.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.417 1.087 . . . . 0.0 109.038 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.3 t -157.81 164.61 36.83 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.406 0 C-N-CA 128.207 2.813 . . . . 0.0 106.678 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 t -159.3 -164.44 1.38 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.578 2.351 . . . . 0.0 106.31 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 t -69.76 160.49 31.6 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.067 -1.02 . . . . 0.0 108.961 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.72 111.26 1.35 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.236 1.398 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -152.06 92.49 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.952 0.876 . . . . 0.0 109.082 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 p -121.36 -174.28 2.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 109.205 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.57 174.94 21.73 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.568 1.08 . . . . 0.0 112.231 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -77.25 166.25 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.29 0.636 . . . . 0.0 110.108 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.51 111.16 18.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 111.613 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -99.58 54.45 0.95 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.22 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.706 0.802 . . . . 0.0 111.007 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -138.66 -0.28 1.96 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.044 0.937 . . . . 0.0 112.973 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -56.58 -37.89 71.21 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.298 -1.501 . . . . 0.0 114.202 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -79.83 -8.58 59.37 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.305 -0.872 . . . . 0.0 112.13 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -84.93 167.41 15.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.256 0.934 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.07 100.16 7.04 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.957 1.303 . . . . 0.0 110.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.98 146.3 35.51 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.102 0.954 . . . . 0.0 111.545 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.2 t -129.2 141.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 129.524 3.13 . . . . 0.0 109.426 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -95.23 136.52 35.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.611 2.364 . . . . 0.0 107.578 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 t -132.33 135.3 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.68 -178.57 21.28 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 121.537 -0.727 . . . . 0.0 111.64 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.93 7.22 6.12 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.957 2.503 . . . . 0.0 113.268 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.6 mt -58.14 145.51 36.67 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.66 2.384 . . . . 0.0 111.36 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -67.14 148.0 98.91 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.36 -10.53 11.09 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.098 2.532 . . . . 0.0 114.4 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.18 -23.45 21.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.627 1.103 . . . . 0.0 113.002 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.8 mm -57.97 128.15 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.008 0.923 . . . . 0.0 109.395 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.5 t -107.76 177.9 4.68 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.893 1.33 . . . . 0.0 111.131 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 m -60.23 -31.42 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.428 1.091 . . . . 0.0 111.042 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.7 -36.52 65.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.054 0.942 . . . . 0.0 111.267 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -60.53 -49.62 76.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.3 mt -59.44 -54.2 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -51.79 -47.26 64.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.316 0.962 . . . . 0.0 111.38 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.68 83.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.531 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -39.54 63.03 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -88.85 -10.98 46.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.016 0.926 . . . . 0.0 112.608 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.83 97.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.936 1.294 . . . . 0.0 111.236 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.22 -3.82 6.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 CA-C-N 121.872 1.704 . . . . 0.0 113.906 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.92 -15.28 18.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.216 0.916 . . . . 0.0 112.003 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.48 177.72 30.85 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 122.407 1.004 . . . . 0.0 111.702 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -74.08 131.45 41.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.21 135.75 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -74.89 0.59 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -103.53 141.5 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.846 2.059 . . . . 0.0 108.655 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.22 127.48 2.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.932 1.242 . . . . 0.0 109.03 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -154.85 162.54 41.07 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.1 0.864 . . . . 0.0 111.601 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.01 120.08 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.82 135.43 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -131.7 151.16 51.84 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.77 144.4 56.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.88 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 tpt -83.0 -19.43 37.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.036 0.835 . . . . 0.0 111.701 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.85 -9.36 37.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.002 -1.061 . . . . 0.0 113.509 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.7 p -136.79 -25.36 1.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.355 0.979 . . . . 0.0 112.398 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.0 81.22 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -92.2 156.45 17.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.884 1.342 . . . . 0.0 109.559 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -54.16 126.15 21.8 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.382 1.073 . . . . 0.0 111.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -75.36 -32.78 60.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.828 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.22 -25.52 7.39 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.714 2.578 . . . . 0.0 111.259 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -102.57 161.2 13.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.527 1.163 . . . . 0.0 112.281 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.1 172.79 28.31 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.642 1.591 . . . . 0.0 109.317 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -135.03 155.02 51.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.51 1.124 . . . . 0.0 108.555 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.8 t -145.31 146.81 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.071 2.548 . . . . 0.0 104.509 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 t -145.2 112.76 6.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.755 1.616 . . . . 0.0 109.79 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -86.88 152.39 22.49 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.588 1.155 . . . . 0.0 112.131 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -70.27 -34.82 73.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.642 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -112.52 146.86 37.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.16 1.384 . . . . 0.0 108.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.55 -49.24 74.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.42 -33.47 59.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.52 1.128 . . . . 0.0 113.913 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -62.24 -46.79 87.29 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.14 -49.41 69.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 110.186 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.47 -45.13 76.96 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.162 0.585 . . . . 0.0 110.501 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.36 -50.59 67.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.144 0.577 . . . . 0.0 110.465 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.12 78.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.413 1.485 . . . . 0.0 111.285 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 89.0 mt -51.49 -47.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 121.815 2.098 . . . . 0.0 110.375 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 156' ' ' GLN . 7.1 mt-30 -67.77 -56.13 10.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 124.129 0.893 . . . . 0.0 112.109 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.05 -52.8 21.1 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.57 -17.62 64.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -75.99 79.91 1.12 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 123.793 0.711 . . . . 0.0 111.918 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 132.69 -5.75 5.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.795 2.14 . . . . 0.0 111.379 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -73.76 178.8 4.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.208 1.004 . . . . 0.0 108.77 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -118.85 150.47 39.79 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.9 tp -138.44 126.97 23.3 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.808 1.643 . . . . 0.0 106.64 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 -86.84 0.49 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.72 5.6 1.79 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.83 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -141.19 164.28 30.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.93 1.865 . . . . 0.0 112.98 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.0 160.86 31.16 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.581 1.152 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.3 pt -137.62 171.9 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.614 1.166 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.1 144.32 47.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.612 1.565 . . . . 0.0 108.026 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -136.83 137.27 39.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.843 0.747 . . . . 0.0 111.217 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.12 169.98 21.08 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -64.53 141.42 58.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.36 60.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.392 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.5 p -85.94 165.0 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.401 1.08 . . . . 0.0 108.916 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -152.88 171.82 17.71 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.011 1.325 . . . . 0.0 108.013 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.16 133.42 20.16 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.29 165.86 20.95 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.158 2.572 . . . . 0.0 112.995 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.54 177.36 8.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.806 2.337 . . . . 0.0 111.1 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -131.36 137.68 31.09 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.26 88.48 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.861 3.041 . . . . 0.0 112.302 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -159.85 129.03 5.15 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.879 -1.138 . . . . 0.0 109.077 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.7 p -150.69 -176.82 5.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.926 1.29 . . . . 0.0 108.047 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.5 t -131.55 -176.31 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 109.73 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -117.04 169.34 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.611 1.564 . . . . 0.0 108.17 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.07 -176.03 5.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.449 0.7 . . . . 0.0 110.048 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 m -135.29 16.45 3.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.668 0.787 . . . . 0.0 111.513 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.35 17.94 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.493 1.117 . . . . 0.0 112.117 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 12.8 p -71.29 58.88 0.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.115 2.566 . . . . 0.0 110.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -49.98 -55.39 14.83 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 126.546 1.938 . . . . 0.0 113.425 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -168.99 158.01 8.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 142.51 56.79 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.38 68.18 1.68 Allowed Glycine 0 CA--C 1.533 1.171 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.12 27.21 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.625 2.216 . . . . 0.0 113.003 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.3 p -144.26 158.41 43.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.328 1.451 . . . . 0.0 108.813 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.4 166.79 22.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.192 2.197 . . . . 0.0 106.396 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.413 0 N-CA-C 107.321 -2.311 . . . . 0.0 107.321 -179.422 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.779 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 p -86.46 -179.55 6.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.686 0.795 . . . . 0.0 110.566 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 t -117.96 -19.26 9.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.975 1.31 . . . . 0.0 110.4 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.04 86.42 1.7 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 105.291 -3.124 . . . . 0.0 105.291 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -130.65 46.67 2.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.321 1.448 . . . . 0.0 108.788 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.5 m -58.14 15.98 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.111 2.964 . . . . 0.0 116.641 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.37 -10.01 9.9 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.439 1.472 . . . . 0.0 114.195 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.32 139.81 35.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.024 1.912 . . . . 0.0 107.147 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -126.18 155.41 41.8 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -171.0 143.05 1.92 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.997 2.119 . . . . 0.0 106.337 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 38.58 36.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 129.082 2.953 . . . . 0.0 113.361 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p 55.21 14.02 0.96 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.885 1.674 . . . . 0.0 114.008 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -56.18 -16.01 4.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.45 1.9 . . . . 0.0 115.518 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -123.17 3.24 9.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.317 0.962 . . . . 0.0 111.411 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -78.01 171.58 14.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.087 0.955 . . . . 0.0 108.701 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.44 100.89 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.563 ' CE1' ' HG ' ' A' ' 144' ' ' SER . 22.5 m-70 -86.95 142.48 27.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.334 0.588 . . . . 0.0 112.235 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.66 143.18 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.81 2.444 . . . . 0.0 108.515 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -93.78 136.04 34.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.417 2.687 . . . . 0.0 108.014 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.6 140.71 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.495 -2.78 . . . . 0.0 103.495 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 175.98 29.65 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.84 16.96 10.49 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 124.618 1.167 . . . . 0.0 112.68 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.25 149.3 45.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 0.0 110.961 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -70.83 144.49 90.72 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.45 -3.74 6.97 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 114.929 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.5 -21.83 20.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.949 1.7 . . . . 0.0 111.662 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.64 134.48 30.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 127.891 2.476 . . . . 0.0 111.123 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -106.15 173.07 6.47 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.182 0.991 . . . . 0.0 108.792 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.5 m -60.24 -30.37 69.37 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.562 -1.336 . . . . 0.0 109.714 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -68.99 -32.42 71.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 110.343 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.43 -41.21 85.16 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.46 -48.42 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -55.22 -41.54 72.19 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.068 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -52.25 60.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.819 0.847 . . . . 0.0 110.928 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.89 77.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -94.93 -2.72 49.98 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.74 99.54 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.639 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.73 -2.93 9.39 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-N 121.792 1.676 . . . . 0.0 112.727 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.75 -19.55 18.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.139 0.881 . . . . 0.0 111.452 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.06 170.12 30.55 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 122.096 0.831 . . . . 0.0 112.394 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -78.14 101.94 7.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.61 1.195 . . . . 0.0 109.15 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mt -76.74 148.36 6.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 t -111.41 -73.26 0.68 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.39 136.39 41.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.943 1.697 . . . . 0.0 108.778 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -163.65 138.83 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.25 151.22 22.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.353 0.979 . . . . 0.0 111.485 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 t -99.26 117.36 44.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.99 145.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -131.51 151.26 51.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -61.66 115.88 4.32 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -58.0 -17.34 16.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.843 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.6 -7.07 28.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.4 p -139.81 -28.54 0.75 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.72 1.145 . . . . 0.0 111.869 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 13.02 71.52 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.859 1.218 . . . . 0.0 110.617 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.15 153.63 22.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.797 1.298 . . . . 0.0 108.387 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.3 t -55.8 128.44 34.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.721 0.691 . . . . 0.0 111.406 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -78.8 -17.43 55.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.03 -23.8 34.25 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.167 0.889 . . . . 0.0 112.931 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.265 27.0 p90 -102.64 159.61 15.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.366 1.583 . . . . 0.0 110.43 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.42 178.17 33.04 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.609 1.099 . . . . 0.0 110.768 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -142.49 159.84 41.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.94 151.36 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.675 1.99 . . . . 0.0 106.939 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.563 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 2.6 t -132.88 119.67 20.49 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.643 1.977 . . . . 0.0 108.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -103.69 149.59 24.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.723 1.609 . . . . 0.0 111.202 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -71.16 -35.83 71.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.196 0.998 . . . . 0.0 110.279 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -122.99 153.31 39.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.717 1.207 . . . . 0.0 111.562 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -61.44 -50.2 73.76 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 110.753 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.0 -44.4 20.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.797 2.039 . . . . 0.0 112.577 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.87 -50.12 73.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.787 1.235 . . . . 0.0 109.844 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.39 94.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.075 0.95 . . . . 0.0 110.576 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -59.4 -54.7 43.67 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.69 1.196 . . . . 0.0 109.678 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -53.92 -45.36 71.16 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.02 62.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.224 1.409 . . . . 0.0 111.803 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.33 -39.53 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.818 1.645 . . . . 0.0 110.511 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.02 -62.17 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -65.55 -52.16 54.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 116.406 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -71.67 -21.79 61.75 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.032 1.287 . . . . 0.0 112.746 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.15 121.92 25.64 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.859 0.743 . . . . 0.0 111.857 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.86 71.41 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 118.627 -1.096 . . . . 0.0 113.963 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.87 175.04 9.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.105 1.452 . . . . 0.0 108.68 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -105.23 157.96 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.69 120.44 9.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.18 -39.23 0.56 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.448 1.023 . . . . 0.0 115.178 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.79 -5.19 0.03 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.954 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -137.4 162.26 34.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.421 2.111 . . . . 0.0 109.413 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -70.83 159.37 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.101 0.56 . . . . 0.0 110.809 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 pt -130.54 165.81 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.782 1.233 . . . . 0.0 110.248 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -121.66 147.76 45.46 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 56.0 p -133.91 142.43 47.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 108.571 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -166.31 167.56 15.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.805 1.184 . . . . 0.0 109.138 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -68.46 126.85 30.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.97 -25.56 66.38 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.4 t -150.25 156.36 41.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 108.138 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -166.89 169.89 12.72 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.812 2.445 . . . . 0.0 108.482 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -143.98 133.18 11.42 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.45 150.83 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 108.739 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.07 166.1 26.06 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.821 2.348 . . . . 0.0 112.423 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -119.31 141.08 29.99 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 109.325 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.91 110.69 2.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.878 3.052 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -136.14 77.21 1.64 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.824 1.65 . . . . 0.0 108.396 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 t -66.02 113.54 4.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.0 t -77.66 162.88 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -152.39 134.37 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -137.89 -11.41 1.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.777 0.831 . . . . 0.0 112.215 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.6 87.72 0.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.668 1.987 . . . . 0.0 110.995 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -143.43 169.03 18.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.057 1.343 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -145.71 168.25 21.16 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.419 1.088 . . . . 0.0 109.391 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -166.3 118.54 1.04 Allowed 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 124.527 1.131 . . . . 0.0 108.431 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -136.06 145.15 45.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 m -159.29 170.93 20.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.948 1.299 . . . . 0.0 108.057 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -151.2 69.93 0.31 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.34 171.52 17.93 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.424 2.083 . . . . 0.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -152.11 176.29 11.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 106.832 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 21.6 m -150.63 177.96 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.895 1.678 . . . . 0.0 107.586 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 C-N-CA 127.625 2.536 . . . . 0.0 106.831 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p 51.17 19.86 0.79 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.507 1.923 . . . . 0.0 113.666 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.5 p -68.29 -21.44 64.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.211 2.205 . . . . 0.0 113.975 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.44 -56.81 3.33 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.586 1.089 . . . . 0.0 112.454 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -40.25 -55.11 2.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.369 2.668 . . . . 0.0 111.991 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 m -163.18 178.56 8.13 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.77 2.028 . . . . 0.0 108.167 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.73 55.42 3.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -51.98 167.04 0.13 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.59 2.756 . . . . 0.0 113.798 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 11.54 28.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -142.99 142.14 31.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.67 1.123 . . . . 0.0 107.98 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.22 164.52 13.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.176 0.988 . . . . 0.0 111.69 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -70.88 -0.72 9.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.459 2.304 . . . . 0.0 115.226 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 t -41.16 -30.59 0.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.635 2.374 . . . . 0.0 116.747 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -130.92 32.91 4.26 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.074 1.306 . . . . 0.0 110.961 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.09 175.11 5.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.05 0.94 . . . . 0.0 110.417 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -112.11 146.63 37.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.6 147.92 49.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.536 0.684 . . . . 0.0 111.524 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.21 138.17 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.7 2.0 . . . . 0.0 109.38 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -96.1 134.13 39.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.604 2.362 . . . . 0.0 106.036 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.37 142.2 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.59 -179.98 23.13 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.897 0.771 . . . . 0.0 111.961 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 62.0 18.76 10.2 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.701 2.0 . . . . 0.0 111.749 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.3 mt -62.42 132.61 53.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.245 1.418 . . . . 0.0 110.717 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.42 151.33 77.49 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -60.19 -24.05 75.84 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.94 2.427 . . . . 0.0 114.955 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.13 -22.52 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.08 -1.012 . . . . 0.0 113.061 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.3 mm -58.89 122.7 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.022 0.915 . . . . 0.0 111.226 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.5 t -110.66 176.11 5.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.516 1.526 . . . . 0.0 107.173 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.8 m -65.19 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 120.428 -1.42 . . . . 0.0 112.8 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -70.42 -33.49 71.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -48.25 79.55 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 110.33 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 mt -60.54 -50.33 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -55.36 -48.16 74.66 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.591 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.38 68.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.911 0.885 . . . . 0.0 110.398 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -44.28 96.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -89.94 -8.88 50.72 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.03 -46.88 99.83 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 117.1 -1.429 . . . . 0.0 114.122 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.11 -3.83 10.48 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.115 1.791 . . . . 0.0 112.775 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.4 -11.82 22.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.601 0.637 . . . . 0.0 111.967 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.98 164.99 14.19 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -72.32 124.75 25.76 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.58 147.73 5.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.27 -65.41 1.18 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -102.4 133.71 46.89 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.904 0.882 . . . . 0.0 110.893 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -157.56 136.34 11.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.586 0.755 . . . . 0.0 109.759 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -163.34 158.42 21.29 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.97 1.708 . . . . 0.0 110.642 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.72 130.44 50.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 138.15 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -132.79 158.28 42.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.484 0.714 . . . . 0.0 109.858 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -61.53 114.83 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.23 -20.33 26.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.216 1.371 . . . . 0.0 112.81 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.8 -21.13 23.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.7 p -135.71 -15.46 1.82 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.94 1.245 . . . . 0.0 114.051 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.3 86.31 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.936 1.255 . . . . 0.0 114.02 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.2 152.17 30.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.364 1.582 . . . . 0.0 109.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -54.77 126.84 25.78 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.792 0.837 . . . . 0.0 112.059 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -72.59 -52.38 15.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 143.75 -21.54 2.17 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.712 3.053 . . . . 0.0 110.449 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.269 7.1 p90 -103.13 168.59 9.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.652 1.581 . . . . 0.0 113.997 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.82 175.06 33.02 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.509 1.528 . . . . 0.0 111.005 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -135.91 147.17 48.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.48 1.112 . . . . 0.0 109.553 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.64 144.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.9 t -136.13 140.27 43.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.233 1.413 . . . . 0.0 107.438 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.11 150.77 46.52 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.443 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -67.58 -14.24 62.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.221 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -133.82 156.12 48.61 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 120.161 1.346 . . . . 0.0 110.234 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -71.37 -53.05 15.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -51.03 -34.94 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.419 2.288 . . . . 0.0 112.018 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -60.27 -54.54 44.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.011 0.924 . . . . 0.0 108.608 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.33 76.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -56.28 -48.77 75.96 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.357 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.91 -45.03 87.14 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.166 0.439 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.16 85.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.076 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 88.9 mt -54.26 -35.94 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.387 1.903 . . . . 0.0 110.312 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -76.63 -62.35 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.054 0.542 . . . . 0.0 111.656 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -63.85 -45.25 90.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.02 2.128 . . . . 0.0 114.032 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.31 -24.97 57.52 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.82 98.36 0.29 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.29 -9.41 11.03 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.878 1.228 . . . . 0.0 112.264 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -76.15 178.64 6.24 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.749 1.275 . . . . 0.0 108.469 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -121.01 158.84 26.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.25 1.42 . . . . 0.0 107.986 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 tp -154.92 130.69 10.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.45 -25.52 0.47 Allowed Glycine 0 N--CA 1.464 0.566 0 C-N-CA 125.208 1.385 . . . . 0.0 115.707 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.56 -2.24 0.47 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 117.791 -1.56 . . . . 0.0 113.605 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -136.81 157.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.474 2.137 . . . . 0.0 110.99 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -66.97 153.56 43.3 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.75 152.55 32.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.801 0.84 . . . . 0.0 111.008 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -106.52 145.42 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.817 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.0 p -139.04 123.32 18.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.634 1.106 . . . . 0.0 110.202 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -149.22 172.2 15.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.756 0.707 . . . . 0.0 109.603 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -66.98 130.5 43.33 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.83 46.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 p -135.2 93.21 2.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.604 1.562 . . . . 0.0 109.884 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -140.06 123.48 17.06 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 108.927 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -134.72 151.8 76.45 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 126.008 1.723 . . . . 0.0 108.969 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 159.02 43.28 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.679 2.253 . . . . 0.0 110.487 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.23 -173.46 1.45 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.111 3.208 . . . . 0.0 108.83 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.6 157.68 37.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.346 -1.472 . . . . 0.0 108.803 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.42 1.45 7.38 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.762 2.308 . . . . 0.0 112.72 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -152.94 153.33 32.76 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.9 2.08 . . . . 0.0 106.96 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -129.19 -166.06 1.6 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.35 1.86 . . . . 0.0 107.939 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 -151.77 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -154.08 172.51 17.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 120.229 1.377 . . . . 0.0 108.281 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -122.79 103.1 8.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.3 t -117.11 127.39 54.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.67 145.16 56.26 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -79.58 175.02 10.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.588 1.155 . . . . 0.0 110.289 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -153.15 133.7 13.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 120.933 -1.104 . . . . 0.0 108.329 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -75.07 158.19 33.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.6 m -139.29 164.91 28.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.335 1.854 . . . . 0.0 107.606 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.07 88.8 0.16 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.91 172.7 15.82 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.397 2.065 . . . . 0.0 110.048 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 63.1 m -158.95 171.89 19.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.7 t -154.86 163.25 40.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 C-N-CA 128.764 3.078 . . . . 0.0 106.423 -179.62 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 m -112.85 157.73 21.05 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.412 0.685 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.72 126.08 20.69 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.824 0.85 . . . . 0.0 111.817 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.85 -70.66 3.08 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 123.985 0.803 . . . . 0.0 113.263 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -74.45 79.93 1.92 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.931 1.292 . . . . 0.0 113.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 t -74.59 -68.18 0.56 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.81 -147.29 19.71 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -116.94 32.15 6.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.794 0.838 . . . . 0.0 112.729 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.0 110.28 8.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.9 31.06 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.943 1.697 . . . . 0.0 110.736 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' C ' ' HG1' ' A' ' 93' ' ' THR . 37.7 t0 -62.95 163.29 9.9 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.416 ' HG1' ' C ' ' A' ' 92' ' ' ASP . 39.9 p 56.35 21.83 5.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.946 1.299 . . . . 0.0 111.825 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.1 77.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.245 -1.534 . . . . 0.0 111.033 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.92 -13.94 61.36 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.446 0.699 . . . . 0.0 112.361 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -86.28 172.96 10.07 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.412 1.085 . . . . 0.0 108.431 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -125.45 107.07 10.29 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.005 1.322 . . . . 0.0 111.653 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -85.07 128.43 34.64 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 110.727 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.46 138.98 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.984 2.514 . . . . 0.0 106.908 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -93.53 142.18 27.63 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.659 1.983 . . . . 0.0 107.075 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.94 137.1 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.49 179.43 18.76 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.407 -0.808 . . . . 0.0 111.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.57 15.43 6.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.156 3.382 . . . . 0.0 115.007 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.69 149.26 22.32 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.732 1.613 . . . . 0.0 111.596 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.4 t -65.45 145.35 99.07 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.98 -8.3 7.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.089 2.526 . . . . 0.0 115.304 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -98.12 -16.41 19.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.806 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.5 mm -58.29 116.81 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 t -91.1 174.34 7.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.655 0.741 . . . . 0.0 109.273 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -64.15 -31.93 73.31 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.391 -1.443 . . . . 0.0 111.595 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.42 -24.96 57.17 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.554 -0.716 . . . . 0.0 111.237 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.1 -46.66 76.83 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.19 -51.41 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -53.65 -49.27 68.28 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 117.579 -1.2 . . . . 0.0 110.709 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.37 81.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.375 0.989 . . . . 0.0 111.77 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.49 92.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.67 -9.95 39.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -47.14 99.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.61 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.06 -5.83 11.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.267 1.845 . . . . 0.0 112.39 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.04 -11.24 23.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.707 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 160.21 165.8 17.79 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 120.071 1.305 . . . . 0.0 114.17 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -76.4 119.18 19.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.2 mt -94.9 149.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 t -114.38 -67.39 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.23 125.26 48.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.77 136.14 32.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -160.94 153.41 20.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 119.441 1.019 . . . . 0.0 111.873 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.6 t -106.98 115.06 47.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.7 139.1 17.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 125.182 1.393 . . . . 0.0 107.625 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -130.83 153.66 48.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.607 -0.683 . . . . 0.0 110.484 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.55 107.57 1.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.5 ptm -54.03 -13.97 0.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 -19.04 17.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.688 1.131 . . . . 0.0 112.816 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 p -130.24 -22.44 2.81 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.98 16.97 73.52 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.605 2.05 . . . . 0.0 112.716 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -84.77 155.22 21.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 1.435 . . . . 0.0 109.105 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.9 t -62.95 122.4 15.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.882 0.31 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -71.5 -25.4 62.25 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.34 38.48 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.003 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -103.79 165.95 10.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.256 2.028 . . . . 0.0 110.506 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.52 177.4 33.51 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.841 0.734 . . . . 0.0 111.819 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -135.5 148.24 49.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.09 1.356 . . . . 0.0 109.698 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.7 t -137.43 120.17 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.138 1.775 . . . . 0.0 107.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -105.27 114.23 28.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.259 1.823 . . . . 0.0 108.898 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.93 148.95 23.45 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.66 1.184 . . . . 0.0 109.12 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -67.88 -40.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.211 0.604 . . . . 0.0 110.243 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -110.91 145.54 38.14 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.03 0.932 . . . . 0.0 112.183 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.32 -46.94 86.45 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.012 0.925 . . . . 0.0 112.141 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -34.26 69.4 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.485 1.114 . . . . 0.0 112.966 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.05 -47.49 79.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.39 71.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.968 1.307 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.51 -47.91 78.32 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.504 0.721 . . . . 0.0 110.293 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -55.57 -49.3 73.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.63 72.56 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 81.4 mt -49.91 -44.42 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.633 1.561 . . . . 0.0 110.221 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -73.09 -58.24 3.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.193 0.997 . . . . 0.0 113.294 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -68.58 -51.06 46.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.403 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -67.69 -20.79 65.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.191 0.905 . . . . 0.0 112.749 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.98 90.29 0.58 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.86 -6.15 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.776 1.655 . . . . 0.0 111.752 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -86.84 172.85 9.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.946 0.873 . . . . 0.0 110.172 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -113.03 154.77 25.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.997 1.319 . . . . 0.0 109.199 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.0 tp -153.71 128.01 9.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.593 1.557 . . . . 0.0 107.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.92 22.96 67.13 Favored Glycine 0 N--CA 1.464 0.504 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.401 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 98.38 -2.75 59.35 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 115.956 -2.58 . . . . 0.0 115.836 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -140.4 160.91 38.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 121.525 2.663 . . . . 0.0 111.655 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.73 159.08 28.65 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.76 154.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.477 1.111 . . . . 0.0 109.112 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -115.99 129.76 56.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.5 p -116.7 153.61 32.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.248 1.419 . . . . 0.0 108.961 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -175.51 166.57 3.26 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.733 1.213 . . . . 0.0 108.928 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -70.12 126.13 28.79 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.06 -52.76 6.04 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.27 0.486 . . . . 0.0 110.75 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.7 t -51.34 -58.34 6.47 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -142.41 142.84 32.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.861 1.664 . . . . 0.0 111.229 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -78.26 133.86 63.75 Favored Pre-proline 0 C--O 1.238 0.463 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.02 154.06 71.28 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.753 1.635 . . . . 0.0 110.105 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.99 176.34 10.25 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.031 2.487 . . . . 0.0 110.412 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.94 142.66 97.52 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.79 95.57 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.832 2.355 . . . . 0.0 106.597 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -68.45 121.87 17.25 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.172 -0.955 . . . . 0.0 109.497 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.3 t -123.98 93.63 3.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 28.7 m -142.92 146.85 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.808 1.643 . . . . 0.0 107.055 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -83.88 81.41 8.78 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -153.76 140.34 18.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -85.64 163.05 18.53 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.692 0.758 . . . . 0.0 109.752 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.28 165.87 34.35 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 110.972 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.6 t -163.45 138.97 6.55 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.221 1.809 . . . . 0.0 106.622 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -177.31 129.56 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.208 1.403 . . . . 0.0 110.63 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -151.48 167.58 27.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -143.85 174.63 10.66 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.281 1.832 . . . . 0.0 107.311 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.27 81.4 0.07 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 120.074 1.307 . . . . 0.0 114.545 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.61 169.64 21.86 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.093 1.862 . . . . 0.0 108.948 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.4 m -143.08 -174.48 4.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 109.626 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 75.6 m -73.46 159.97 32.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.302 -2.388 . . . . 0.0 109.296 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.6 p -35.5 93.89 0.01 OUTLIER 'General case' 0 C--O 1.239 0.544 0 C-N-CA 127.885 2.474 . . . . 0.0 114.14 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 p -160.72 127.48 4.16 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.468 2.307 . . . . 0.0 106.173 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.0 138.58 8.96 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 m -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 t -128.23 -10.99 5.25 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.097 1.359 . . . . 0.0 110.713 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.37 148.58 37.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 124.158 0.885 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.53 -22.36 66.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.595 0.758 . . . . 0.0 113.004 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -134.36 -68.84 0.54 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.034 1.333 . . . . 0.0 111.52 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -149.48 125.88 10.86 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.446 0.698 . . . . 0.0 111.388 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -87.07 70.41 10.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -72.96 -1.3 16.47 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.248 -0.907 . . . . 0.0 112.745 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -52.55 0.32 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.139 3.376 . . . . 0.0 117.069 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.65 -3.14 0.47 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -73.01 156.11 39.14 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.616 0.767 . . . . 0.0 110.696 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -99.74 101.45 12.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.27 154.5 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.413 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 110.745 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.96 129.52 34.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.13 137.69 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.93 -176.98 21.15 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 61.84 18.89 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.627 1.971 . . . . 0.0 112.627 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 mt -69.86 151.24 45.92 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.473 -1.392 . . . . 0.0 110.909 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -67.63 146.41 98.53 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.44 -4.36 6.62 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.626 2.884 . . . . 0.0 113.682 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -96.81 -21.34 17.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.882 1.273 . . . . 0.0 111.156 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.3 132.38 23.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.309 1.044 . . . . 0.0 108.953 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -112.13 172.17 7.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.227 1.013 . . . . 0.0 108.809 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -56.3 -29.85 61.77 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.146 1.378 . . . . 0.0 110.776 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -73.03 -34.94 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.704 0.801 . . . . 0.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.47 -49.13 74.84 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mt -59.17 -49.57 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -54.92 -42.32 72.08 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.656 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.97 77.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.828 0.74 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.53 98.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -89.42 -14.52 35.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.349 0.66 . . . . 0.0 112.354 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.72 99.51 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.047 0.939 . . . . 0.0 113.405 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.72 -6.68 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 121.396 1.534 . . . . 0.0 112.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.89 -18.59 17.05 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.364 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 168.23 169.34 31.58 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 119.57 1.077 . . . . 0.0 112.04 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -74.41 124.01 25.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.7 mt -100.1 150.48 5.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.58 -61.55 1.6 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -101.41 140.5 35.61 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.7 5.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.421 1.088 . . . . 0.0 108.384 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -162.77 161.64 26.29 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.713 1.205 . . . . 0.0 110.74 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.47 134.66 53.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.46 144.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -133.9 162.88 30.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.556 1.143 . . . . 0.0 109.583 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -71.31 119.14 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.447 1.499 . . . . 0.0 107.589 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.4 ptp -59.18 -16.59 21.28 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.65 -13.92 20.09 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.2 p -137.6 -15.46 1.4 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.306 1.412 . . . . 0.0 113.975 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.64 14.34 81.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.57 1.081 . . . . 0.0 110.904 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.92 141.58 37.48 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.834 1.253 . . . . 0.0 108.567 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.29 123.36 14.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.094 0.957 . . . . 0.0 112.209 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.56 -42.68 64.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.22 -15.27 7.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.757 1.17 . . . . 0.0 112.621 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.027 1.413 . . . . 0.0 108.075 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.05 33.74 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.813 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -131.89 156.4 46.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.323 1.062 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.67 135.22 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.4 m -123.96 112.74 17.57 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.425 1.09 . . . . 0.0 108.16 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -97.53 155.6 16.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.24 0.962 . . . . 0.0 110.025 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.72 -41.51 62.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -103.1 147.44 26.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.004 0.522 . . . . 0.0 111.751 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.444 ' HE3' ' CH2' ' A' ' 172' ' ' TRP . 11.0 tptm -64.42 -46.69 82.14 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.989 0.916 . . . . 0.0 109.248 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -33.3 68.6 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.538 1.535 . . . . 0.0 113.606 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.61 -49.82 71.83 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.47 -51.74 67.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.183 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -51.67 -52.65 46.4 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.116 0.966 . . . . 0.0 111.615 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -55.07 -50.47 69.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.104 0.562 . . . . 0.0 110.283 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.98 86.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 117.281 -1.342 . . . . 0.0 110.399 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.75 -36.98 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 123.513 2.869 . . . . 0.0 110.968 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -76.27 -65.19 0.95 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -62.37 -49.49 75.32 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.638 1.975 . . . . 0.0 114.3 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 86.0 mmm -68.95 -28.8 66.96 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.79 78.26 0.2 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.69 1.138 . . . . 0.0 114.633 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.26 -15.24 2.09 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.567 2.032 . . . . 0.0 111.802 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -71.58 171.37 11.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.039 0.92 . . . . 0.0 109.792 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -109.45 143.45 39.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.31 121.37 24.6 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.55 -57.48 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.03 1.776 . . . . 0.0 111.488 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.48 2.06 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.809 -1.55 . . . . 0.0 115.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -143.84 157.86 44.08 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.66 2.73 . . . . 0.0 112.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -67.49 136.17 54.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.246 0.618 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.0 166.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.272 1.035 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.49 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.898 1.679 . . . . 0.0 107.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 39.2 p -137.18 134.84 36.76 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.27 170.78 21.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.444 ' CH2' ' HE3' ' A' ' 148' ' ' LYS . 22.2 m95 -62.18 128.2 34.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.002 0.819 . . . . 0.0 109.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.36 -56.2 18.33 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.9 p -68.3 170.95 7.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.926 0.869 . . . . 0.0 112.813 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -130.15 151.56 50.55 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -146.23 150.53 41.72 Favored Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.01 158.1 59.25 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.232 1.955 . . . . 0.0 111.206 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.53 179.86 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.818 3.012 . . . . 0.0 111.5 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.26 72.66 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.124 0.97 . . . . 0.0 108.729 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.46 167.58 23.63 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.629 2.219 . . . . 0.0 110.78 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -153.0 128.05 9.69 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.7 t -159.04 159.68 34.98 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.076 1.351 . . . . 0.0 107.827 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.3 t -150.34 176.49 10.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.54 1.136 . . . . 0.0 108.774 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -137.18 173.8 11.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.302 1.841 . . . . 0.0 109.596 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 187' ' ' ASN . 0.0 OUTLIER -150.32 159.99 44.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 128.305 2.642 . . . . 0.0 105.63 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 53.2 m -159.6 28.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.216 1.406 . . . . 0.0 113.264 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . 0.424 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 0.0 OUTLIER -61.04 -14.88 26.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 119.854 -1.779 . . . . 0.0 115.756 -178.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.6 m -25.89 118.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.128 2.971 . . . . 0.0 114.659 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 170.14 16.83 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.208 -0.932 . . . . 0.0 109.747 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.4 169.93 23.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.45 1.5 . . . . 0.0 108.375 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 18.2 t -176.24 161.17 2.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.625 2.77 . . . . 0.0 105.535 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 133.82 68.35 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.96 166.97 27.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 119.817 1.809 . . . . 0.0 109.107 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.7 m -155.57 169.19 24.87 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.774 -1.204 . . . . 0.0 108.78 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 m -78.71 173.43 12.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.211 1.005 . . . . 0.0 110.417 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.844 0 C-N-CA 128.72 3.057 . . . . 0.0 106.453 179.504 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 159.0 10.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.453 1.901 . . . . 0.0 111.044 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 t -161.75 149.99 15.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.41 148.1 26.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.0 m -148.65 -65.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.983 1.391 . . . . 0.0 109.047 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 m 30.7 66.43 0.14 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.172 2.189 . . . . 0.0 113.816 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.5 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -72.31 158.49 35.72 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.709 1.204 . . . . 0.0 111.953 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 169.2 18.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.701 2.001 . . . . 0.0 107.073 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.02 28.67 1.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.169 0.988 . . . . 0.0 108.397 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.05 27.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 129.913 3.285 . . . . 0.0 113.518 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.15 46.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.315 2.646 . . . . 0.0 114.2 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 m -64.55 161.25 17.79 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.99 -1.069 . . . . 0.0 109.481 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 61.75 -12.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.433 2.293 . . . . 0.0 114.799 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -89.12 149.24 23.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -105.56 143.25 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -109.84 153.5 24.33 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.077 0.551 . . . . 0.0 112.062 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.45 148.72 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.712 2.005 . . . . 0.0 110.39 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -100.22 139.78 35.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.349 2.66 . . . . 0.0 107.014 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.03 129.5 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.47 179.87 17.66 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 111.94 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 64.34 9.95 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.74 3.216 . . . . 0.0 113.784 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.4 146.3 16.17 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.953 1.301 . . . . 0.0 111.04 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.5 t -63.04 141.23 97.71 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.06 -15.55 18.03 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.937 2.425 . . . . 0.0 114.928 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.79 -17.95 39.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 113.054 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.9 mm -58.51 135.22 23.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.243 1.417 . . . . 0.0 110.724 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.3 t -116.53 176.33 5.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.985 0.898 . . . . 0.0 111.488 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 -35.25 72.64 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.082 -1.011 . . . . 0.0 111.458 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.97 -18.12 51.18 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.317 0.647 . . . . 0.0 111.329 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.94 -50.09 21.64 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 mt -57.96 -50.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -54.87 -47.71 73.9 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.539 -1.22 . . . . 0.0 110.903 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.6 -33.87 70.49 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.691 1.132 . . . . 0.0 111.898 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.22 -46.37 64.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.923 0.889 . . . . 0.0 112.246 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -92.51 -1.66 56.79 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.41 95.37 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.876 1.67 . . . . 0.0 112.334 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.65 -0.57 5.41 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 121.091 1.425 . . . . 0.0 113.75 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -98.64 -10.75 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.955 0.798 . . . . 0.0 111.156 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.19 175.57 19.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -70.56 137.95 50.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.172 -0.605 . . . . 0.0 110.017 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.95 138.41 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.5 t -100.47 -72.93 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -102.43 142.52 33.51 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.08 1.752 . . . . 0.0 110.235 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.68 129.1 2.56 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.064 0.847 . . . . 0.0 109.409 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -162.26 150.85 14.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.618 0.367 . . . . 0.0 111.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.06 136.99 23.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.11 146.78 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -139.53 145.8 39.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -67.43 129.65 40.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -65.59 -18.78 65.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.466 0.706 . . . . 0.0 111.465 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.41 -12.43 22.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -134.3 -18.9 1.97 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.358 0.981 . . . . 0.0 113.287 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.49 72.78 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.94 153.62 18.23 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -59.91 130.15 45.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -20.57 57.45 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.466 -0.778 . . . . 0.0 111.947 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.16 -30.2 10.88 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.98 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -101.89 163.86 12.03 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.527 1.164 . . . . 0.0 108.315 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.7 171.64 27.43 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.849 1.69 . . . . 0.0 109.091 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -136.02 146.66 47.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -133.61 158.69 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.856 1.663 . . . . 0.0 106.726 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.4 t -143.18 135.4 27.11 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.45 166.28 15.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.448 0.699 . . . . 0.0 111.12 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -79.66 -26.42 41.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 117.753 -1.117 . . . . 0.0 113.939 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.35 150.76 45.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.814 1.643 . . . . 0.0 110.714 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -62.25 -48.6 79.22 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.114 0.483 . . . . 0.0 110.153 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -29.66 67.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.973 1.309 . . . . 0.0 112.615 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.03 -54.65 38.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.83 -57.88 11.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.201 2.2 . . . . 0.0 111.838 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.23 -51.49 25.23 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.364 1.466 . . . . 0.0 111.387 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -55.06 -45.69 75.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.412 0.445 . . . . 0.0 111.257 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.96 78.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.559 -1.21 . . . . 0.0 110.85 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.5 mt -52.02 -44.42 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 120.634 1.561 . . . . 0.0 108.069 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -68.08 -61.45 1.85 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.186 1.394 . . . . 0.0 111.678 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.7 -60.04 4.06 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.92 2.088 . . . . 0.0 114.465 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.31 -20.35 66.03 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.29 1.036 . . . . 0.0 113.665 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.11 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.46 49.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.593 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -69.72 167.56 16.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.44 1.62 . . . . 0.0 108.218 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -108.81 141.95 40.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.7 tp -140.97 129.55 22.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 79.56 -53.87 4.3 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.668 1.127 . . . . 0.0 110.326 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.11 6.15 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.429 1.014 . . . . 0.0 113.809 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -136.31 159.02 43.02 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.867 1.834 . . . . 0.0 108.595 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -68.15 166.04 16.99 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.44 145.35 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 109.351 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 ptt-85 -108.41 136.53 47.88 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 p -122.6 153.37 39.39 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.023 1.329 . . . . 0.0 108.191 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -173.21 165.86 4.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.843 0.857 . . . . 0.0 109.124 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -66.64 120.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.26 77.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.326 0.512 . . . . 0.0 111.177 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.2 t -66.73 152.09 46.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.439 1.495 . . . . 0.0 110.089 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -126.89 166.68 17.03 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.701 1.201 . . . . 0.0 109.034 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.12 131.95 9.43 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.68 150.98 87.31 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.837 3.025 . . . . 0.0 114.267 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.13 164.3 35.8 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.756 2.304 . . . . 0.0 112.398 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -151.88 160.94 30.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.288 2.235 . . . . 0.0 108.604 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -83.58 162.13 14.57 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.87 3.047 . . . . 0.0 111.503 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.86 143.57 6.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.257 1.423 . . . . 0.0 109.375 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.0 t -172.47 105.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -143.53 123.21 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -164.88 171.62 13.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.249 2.22 . . . . 0.0 106.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -163.29 103.24 0.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.2 t -175.88 146.69 0.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.208 2.203 . . . . 0.0 105.991 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -154.84 160.24 41.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.0 p -142.61 170.67 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.468 0.707 . . . . 0.0 109.223 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.67 -58.02 0.36 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.21 167.4 22.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.905 2.082 . . . . 0.0 106.633 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.3 p -154.51 178.55 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.087 2.155 . . . . 0.0 106.499 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 40.01 62.57 1.45 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.183 1.373 . . . . 0.0 114.097 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.42 108.49 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.373 2.049 . . . . 0.0 110.6 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 10.0 t -144.04 147.07 33.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.2 p -162.38 175.89 11.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.162 1.385 . . . . 0.0 108.03 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.425 0 C-N-CA 127.975 2.702 . . . . 0.0 106.631 179.821 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.74 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.3 m -154.88 161.99 41.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.576 1.95 . . . . 0.0 107.441 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.0 t -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.868 0.758 . . . . 0.0 110.141 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.45 161.68 29.97 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 125.222 1.391 . . . . 0.0 110.133 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.9 m -89.0 -175.57 4.88 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.598 0.713 . . . . 0.0 110.613 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.6 p -118.5 177.08 4.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.163 2.185 . . . . 0.0 107.157 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.7 143.36 5.57 Favored Glycine 0 C--O 1.236 0.229 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -80.8 110.98 16.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -79.9 63.28 4.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -45.48 77.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.917 1.687 . . . . 0.0 110.827 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.88 127.37 32.37 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.1 p -72.81 4.25 4.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.607 1.563 . . . . 0.0 114.36 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -31.74 -56.74 0.29 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 118.743 2.868 . . . . 0.0 118.743 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.97 13.82 27.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.318 1.047 . . . . 0.0 112.552 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -73.44 168.58 18.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.42 100.34 8.24 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.35 131.4 36.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.05 141.72 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 128.102 2.561 . . . . 0.0 109.521 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -88.89 131.0 35.31 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 127.013 2.125 . . . . 0.0 105.671 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.33 139.33 51.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.39 -177.94 22.26 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.268 77.1 m-20 68.12 13.93 9.19 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.62 1.968 . . . . 0.0 113.251 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.7 mt -64.53 140.06 58.83 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 t -67.89 150.14 97.91 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -60.76 -4.05 3.23 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.809 3.006 . . . . 0.0 114.927 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.85 -17.12 17.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.016 1.326 . . . . 0.0 111.783 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.3 mm -61.85 136.9 24.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.03 1.332 . . . . 0.0 109.517 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -108.57 174.52 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.033 0.92 . . . . 0.0 108.715 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -64.67 -27.54 68.99 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.547 -1.345 . . . . 0.0 110.647 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.91 -32.66 67.61 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.86 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.32 -47.29 84.92 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mt -60.11 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -53.53 -47.63 69.8 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 120.329 -1.482 . . . . 0.0 111.97 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.51 93.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.755 0.822 . . . . 0.0 111.633 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.55 -45.87 88.03 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.711 1.204 . . . . 0.0 113.602 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -89.56 -10.77 44.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 113.035 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.05 -47.56 98.56 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 124.817 1.247 . . . . 0.0 112.192 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.91 -7.16 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 121.791 1.675 . . . . 0.0 113.184 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.64 -13.28 20.41 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.428 1.013 . . . . 0.0 112.003 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 159.19 174.09 28.46 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 120.541 1.519 . . . . 0.0 112.724 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -71.7 127.55 32.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.9 mt -102.16 139.51 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.8 p -99.29 -79.02 0.49 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.66 126.05 49.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.764 2.826 . . . . 0.0 110.793 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.05 140.31 23.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.664 1.186 . . . . 0.0 107.943 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -162.7 151.54 14.86 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 t -94.32 127.26 46.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.18 141.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -125.63 161.03 28.15 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.885 1.326 . . . . 0.0 110.22 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.29 130.37 40.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.633 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -7.97 55.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 -21.81 12.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.626 1.103 . . . . 0.0 112.208 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -131.68 -8.24 3.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 31.31 78.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.209 -0.773 . . . . 0.0 112.143 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -100.98 157.19 16.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.192 1.397 . . . . 0.0 108.235 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -62.08 125.9 25.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.215 0.916 . . . . 0.0 111.314 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -74.65 -21.05 59.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.49 -15.7 55.73 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.36 1.457 . . . . 0.0 113.027 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.256 49.5 p90 -103.02 163.36 12.26 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.277 1.539 . . . . 0.0 109.282 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.5 169.3 32.8 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.337 -0.852 . . . . 0.0 111.384 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -129.77 149.82 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.913 0.885 . . . . 0.0 109.111 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.43 138.81 47.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 131.81 53.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.81 155.75 31.97 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.172 0.989 . . . . 0.0 109.744 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -76.39 -20.02 57.56 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.094 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -129.45 151.14 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.865 1.211 . . . . 0.0 112.781 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.496 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 7.6 ttmt -68.95 -50.74 46.62 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 110.196 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -47.71 69.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.097 1.359 . . . . 0.0 113.271 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -60.61 -46.93 88.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.41 83.29 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.961 1.305 . . . . 0.0 109.981 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -57.09 -45.67 83.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.82 1.248 . . . . 0.0 110.448 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -53.62 -48.05 69.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.55 87.82 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.936 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.7 mt -55.21 -37.93 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 121.804 2.093 . . . . 0.0 110.274 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -72.71 -65.77 0.75 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.616 0.766 . . . . 0.0 111.427 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -67.07 -44.41 80.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.872 2.069 . . . . 0.0 116.547 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -77.79 -20.79 52.66 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.831 1.196 . . . . 0.0 112.872 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.21 112.35 4.64 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.31 -9.54 65.04 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -70.91 169.71 14.2 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 119.753 1.776 . . . . 0.0 109.842 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -104.65 132.11 51.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 108.941 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 21.9 tp -123.83 118.95 28.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 108.143 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.82 -6.51 1.4 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.273 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.0 3.61 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.232 1.516 . . . . 0.0 115.331 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.796 2.298 . . . . 0.0 110.342 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.37 163.03 11.33 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.448 0.468 . . . . 0.0 109.976 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.23 153.76 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.753 1.221 . . . . 0.0 109.756 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -113.74 142.86 45.52 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.4 p -136.89 135.99 38.31 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.552 0.741 . . . . 0.0 109.524 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.46 174.08 15.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.218 0.607 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.496 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 83.9 m95 -70.57 118.24 13.11 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.538 -1.352 . . . . 0.0 108.153 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.14 -44.88 95.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.78 0.718 . . . . 0.0 109.077 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.6 p -73.26 100.6 3.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -71.54 109.54 5.55 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.844 -1.16 . . . . 0.0 110.705 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.34 150.71 69.65 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 125.674 1.589 . . . . 0.0 108.953 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 159.02 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.828 1.686 . . . . 0.0 108.704 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.95 154.02 63.21 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 N-CA-C 107.669 -1.704 . . . . 0.0 107.669 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -153.24 151.93 26.79 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 118.389 0.54 . . . . 0.0 111.398 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.75 166.88 26.34 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.961 2.441 . . . . 0.0 110.543 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -143.97 125.67 15.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.783 2.433 . . . . 0.0 104.865 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.17 -60.25 3.32 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.984 0.914 . . . . 0.0 110.372 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 -178.96 7.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -66.8 0.9 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 128.034 2.534 . . . . 0.0 110.058 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -161.69 -174.97 4.46 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.589 0.755 . . . . 0.0 111.212 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 t -157.63 88.2 0.98 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.43 1.092 . . . . 0.0 109.163 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -155.38 133.32 11.42 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.625 -0.672 . . . . 0.0 109.35 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.1 p -66.45 153.38 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -53.86 128.6 30.65 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -130.67 178.38 6.68 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.7 p -156.61 172.51 18.44 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.945 2.098 . . . . 0.0 106.621 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -143.63 149.31 21.29 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.23 177.04 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.709 2.272 . . . . 0.0 109.982 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -141.28 140.29 33.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.9 t -160.24 163.71 33.29 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 107.083 -2.407 . . . . 0.0 107.083 -179.364 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -61.91 -27.91 69.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.297 0.549 . . . . 0.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.56 121.53 30.1 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -165.31 113.63 0.56 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.0 m -72.57 -42.74 64.28 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.2 p 58.25 -52.36 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.763 3.225 . . . . 0.0 116.51 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.85 158.55 50.0 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 119.154 0.888 . . . . 0.0 113.549 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -138.75 50.86 1.84 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.064 1.746 . . . . 0.0 107.936 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.02 156.64 27.44 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.984 -1.072 . . . . 0.0 109.946 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -120.34 -1.35 10.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.917 1.287 . . . . 0.0 112.178 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -113.26 -172.76 2.12 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.666 1.121 . . . . 0.0 109.049 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.9 p -123.11 41.39 3.48 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.519 1.527 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.7 p -70.5 134.12 47.43 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 59.75 13.45 3.51 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.272 1.829 . . . . 0.0 114.211 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -84.5 178.35 7.76 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.13 100.65 6.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 144' ' ' SER . 1.3 m80 -71.38 167.29 19.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.369 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.32 142.94 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 127.875 2.47 . . . . 0.0 106.561 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -103.65 137.06 42.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -132.72 140.25 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 -179.26 21.15 Favored Glycine 0 N--CA 1.454 -0.153 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.26 4.69 2.22 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.466 2.306 . . . . 0.0 113.258 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -51.2 139.09 19.26 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 110.527 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 t -62.59 145.26 95.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.49 -18.1 37.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.489 2.793 . . . . 0.0 115.136 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.62 -13.21 43.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.084 -1.01 . . . . 0.0 112.652 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.66 138.71 22.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.5 t -118.45 175.13 5.86 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.502 1.144 . . . . 0.0 109.117 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.3 m -58.92 -30.15 67.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.226 1.01 . . . . 0.0 111.748 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.75 -43.37 68.96 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 125.92 1.688 . . . . 0.0 110.878 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.74 -51.92 65.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.214 1.405 . . . . 0.0 109.28 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.67 -48.14 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.59 -45.24 69.95 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.814 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.27 -45.94 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.084 0.856 . . . . 0.0 110.796 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.67 -47.54 85.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 113.197 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -87.35 -10.89 50.95 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.39 -48.52 95.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.66 -3.3 6.47 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 CA-C-N 121.47 1.561 . . . . 0.0 112.959 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.88 -17.71 18.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.069 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.57 162.17 16.21 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.584 1.084 . . . . 0.0 111.503 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -73.65 120.53 19.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.62 153.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.5 t -117.31 -68.44 0.92 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -102.03 145.04 29.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.469 1.107 . . . . 0.0 108.891 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.04 129.85 2.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.2 158.16 32.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.473 0.654 . . . . 0.0 110.777 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.22 120.1 56.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.43 141.8 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -135.41 157.3 47.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.5 ptp -59.88 -20.47 57.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.59 -9.22 16.65 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -131.83 -19.55 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.048 1.295 . . . . 0.0 113.083 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.81 2.41 56.96 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.291 0.948 . . . . 0.0 112.865 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -80.05 148.55 31.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.8 m -63.78 134.79 55.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.507 1.146 . . . . 0.0 112.33 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -77.71 -13.7 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.534 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.9 55.23 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.016 -1.435 . . . . 0.0 113.464 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -102.52 165.1 11.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.019 1.41 . . . . 0.0 109.112 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.32 179.79 28.55 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.471 1.034 . . . . 0.0 111.966 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.28 154.04 51.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 109.089 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -145.83 149.3 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 37.9 t -142.48 115.49 8.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.005 1.722 . . . . 0.0 107.393 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.91 158.17 15.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.805 1.242 . . . . 0.0 111.391 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.1 -14.83 61.95 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.66 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -143.56 156.84 44.71 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.857 1.208 . . . . 0.0 110.195 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.8 tttt -68.49 -43.03 77.77 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.923 1.289 . . . . 0.0 111.93 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.51 -41.75 66.66 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 111.658 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -62.15 -48.98 77.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.901 1.28 . . . . 0.0 108.893 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.56 66.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.367 1.067 . . . . 0.0 110.311 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.37 -50.0 63.29 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.844 1.658 . . . . 0.0 109.753 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -55.41 -55.4 32.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.552 1.141 . . . . 0.0 109.16 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.48 91.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.748 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.52 -49.26 44.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 121.136 1.789 . . . . 0.0 108.411 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.31 -67.22 0.46 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.132 0.573 . . . . 0.0 111.991 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -58.93 -50.43 74.07 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 83.8 mmm -69.29 -17.75 63.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.346 0.975 . . . . 0.0 111.95 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.26 79.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.445 2.45 . . . . 0.0 113.37 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 126.78 -8.74 7.25 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.062 1.791 . . . . 0.0 112.627 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -70.99 170.32 13.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.033 1.417 . . . . 0.0 109.67 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -111.14 150.79 28.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.385 1.074 . . . . 0.0 109.991 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 47.0 tp -155.51 130.1 9.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.805 2.042 . . . . 0.0 106.505 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.1 27.3 71.22 Favored Glycine 0 N--CA 1.465 0.59 0 O-C-N 121.49 -0.756 . . . . 0.0 114.032 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.78 4.4 87.34 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.439 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -137.57 155.35 49.31 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.81 2.305 . . . . 0.0 110.899 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -71.55 160.44 32.7 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.57 169.96 15.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -123.63 152.24 42.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.9 p -141.83 150.21 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 107.575 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -175.52 171.12 2.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -67.17 111.36 3.88 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.582 -0.699 . . . . 0.0 109.817 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.65 -31.61 64.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.549 1.14 . . . . 0.0 110.843 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.9 p -79.48 -8.22 58.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.17 1.788 . . . . 0.0 113.644 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -156.14 81.37 0.99 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.536 1.062 . . . . 0.0 111.645 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -75.63 137.11 70.6 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.0 161.04 41.99 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.19 1.927 . . . . 0.0 109.693 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.0 151.44 81.44 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.534 2.156 . . . . 0.0 111.566 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.71 156.24 73.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.261 1.024 . . . . 0.0 111.407 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.89 161.5 41.28 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.886 1.724 . . . . 0.0 109.426 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.34 175.08 9.89 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.837 1.655 . . . . 0.0 109.433 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.8 t -83.94 131.61 34.84 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.343 1.857 . . . . 0.0 106.055 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 28.7 p -133.91 74.4 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -62.35 150.67 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.07 0.948 . . . . 0.0 108.681 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -136.48 156.15 49.0 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.511 1.124 . . . . 0.0 109.186 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.4 t -159.3 84.97 0.79 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -135.1 154.84 51.53 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 62.3 m -158.74 127.89 5.54 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -156.96 82.09 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.358 0.981 . . . . 0.0 110.88 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.57 162.84 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.7 p -160.56 176.78 11.2 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.933 1.693 . . . . 0.0 108.283 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.62 87.81 0.43 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 105.89 -2.884 . . . . 0.0 105.89 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.29 -7.59 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.114 2.543 . . . . 0.0 113.262 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.2 p -136.43 172.02 13.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.848 1.659 . . . . 0.0 109.559 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.4 t -77.67 1.08 20.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.685 0.794 . . . . 0.0 112.498 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.713 0 C-N-CA 129.352 3.358 . . . . 0.0 106.53 -179.679 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -53.89 139.77 32.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.717 0.758 . . . . 0.0 110.4 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 t 170.96 166.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.567 3.147 . . . . 0.0 105.627 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.38 -146.25 2.41 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -73.59 159.33 33.27 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.58 -0.953 . . . . 0.0 109.416 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -156.94 -176.18 5.84 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.343 1.457 . . . . 0.0 108.67 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.11 126.33 2.95 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.942 1.258 . . . . 0.0 110.781 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -128.69 -3.97 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.109 0.964 . . . . 0.0 112.219 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 153.43 44.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -68.42 -8.35 39.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.34 162.52 22.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.947 0.899 . . . . 0.0 109.481 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.9 p -114.92 92.85 4.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.1 p -111.12 -27.71 8.61 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -88.51 -14.62 37.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.72 0.808 . . . . 0.0 112.341 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -80.79 168.38 18.87 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.684 1.193 . . . . 0.0 112.335 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.6 99.23 7.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.0 127.4 32.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 113.338 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.55 148.21 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 126.788 2.035 . . . . 0.0 108.091 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -105.01 136.62 44.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 129.471 3.109 . . . . 0.0 106.95 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -129.27 142.83 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -149.84 -178.83 25.14 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.04 1.97 2.98 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.854 2.461 . . . . 0.0 114.382 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -50.19 149.26 2.97 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.829 2.452 . . . . 0.0 113.681 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 161.76 68.1 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.83 -29.44 15.46 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.145 1.23 . . . . 0.0 113.111 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.41 -16.94 61.84 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.851 1.66 . . . . 0.0 114.117 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -59.74 117.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.668 1.187 . . . . 0.0 110.116 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -100.3 171.03 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.3 m -55.1 -30.95 60.78 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 121.019 -1.05 . . . . 0.0 111.53 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.71 -33.75 64.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.122 0.969 . . . . 0.0 111.761 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -47.98 83.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.6 mt -61.22 -55.55 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -51.68 -47.93 63.65 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.501 1.046 . . . . 0.0 112.301 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.12 72.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.596 0.758 . . . . 0.0 112.14 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.08 -43.85 61.28 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.364 1.066 . . . . 0.0 112.014 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.26 -9.58 47.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.824 1.249 . . . . 0.0 112.851 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.3 99.54 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 126.6 1.96 . . . . 0.0 113.318 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.9 -0.84 9.04 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.501 1.572 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.66 -25.18 14.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.087 0.858 . . . . 0.0 110.967 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.44 34.7 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 121.137 -0.977 . . . . 0.0 111.201 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -77.78 117.45 19.18 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -88.4 145.3 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 p -100.54 -81.42 0.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -103.04 141.46 35.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.299 1.84 . . . . 0.0 111.196 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.13 141.85 5.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.106 2.163 . . . . 0.0 108.065 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.9 169.6 20.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.784 1.234 . . . . 0.0 109.136 178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.98 124.98 67.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.88 140.78 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.37 148.21 50.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 59.6 t0 -59.02 131.14 50.16 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.7 tpt -59.78 -30.41 68.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.366 0.53 . . . . 0.0 112.25 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.12 -41.05 9.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.3 p -95.85 -15.87 22.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.15 0.886 . . . . 0.0 112.943 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.92 12.52 57.46 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.283 0.944 . . . . 0.0 112.584 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.92 150.01 27.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.888 1.275 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 t -56.15 109.66 0.63 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.323 2.249 . . . . 0.0 109.142 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 131' ' ' ASP . 20.7 mttt -67.81 -23.4 65.18 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.47 -18.84 46.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.288 27.5 p90 -103.21 157.9 16.69 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.635 -1.509 . . . . 0.0 109.71 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.22 176.6 25.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.564 1.554 . . . . 0.0 111.077 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.77 152.0 44.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.02 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.0 t -147.25 130.65 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 108.027 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -118.77 127.81 53.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.744 2.018 . . . . 0.0 107.011 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.55 165.69 12.25 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.701 1.137 . . . . 0.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -74.43 -9.57 58.72 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.575 -0.703 . . . . 0.0 112.512 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -146.59 165.86 28.25 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.595 1.088 . . . . 0.0 112.09 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -73.85 -47.28 39.49 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.802 1.241 . . . . 0.0 111.543 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -39.06 76.9 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.702 0.801 . . . . 0.0 111.935 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.66 -48.42 77.64 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -54.89 15.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.322 1.849 . . . . 0.0 111.45 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -55.87 -44.15 77.83 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.176 0.99 . . . . 0.0 111.918 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.74 -45.26 86.07 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.74 79.62 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.684 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.69 -37.62 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 120.354 1.434 . . . . 0.0 110.399 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -73.07 -67.6 0.56 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.417 1.087 . . . . 0.0 110.632 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -58.69 -57.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.467 2.307 . . . . 0.0 114.295 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -65.34 -24.51 67.28 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.48 90.47 0.12 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.222 0.915 . . . . 0.0 111.971 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.49 -6.88 9.79 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.193 1.378 . . . . 0.0 113.308 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -74.97 174.3 9.51 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.093 1.446 . . . . 0.0 109.481 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -109.74 129.35 55.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 39.3 tp -125.25 124.22 41.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.901 1.68 . . . . 0.0 108.934 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.1 -59.21 1.84 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 125.005 1.288 . . . . 0.0 111.554 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.75 -3.04 0.03 OUTLIER Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.947 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -141.49 165.98 26.02 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.384 2.092 . . . . 0.0 111.5 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -67.57 161.67 25.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.351 0.66 . . . . 0.0 110.645 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.7 pt -138.71 157.64 29.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.533 1.133 . . . . 0.0 109.977 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -122.32 148.02 45.54 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.1 p -138.91 134.66 33.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.649 1.113 . . . . 0.0 110.409 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -157.02 176.92 12.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.571 1.148 . . . . 0.0 108.895 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -74.44 133.75 42.39 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.593 -1.317 . . . . 0.0 110.47 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.37 -52.35 9.3 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 p -65.82 125.66 26.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -133.95 -169.25 2.27 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.19 1.396 . . . . 0.0 111.298 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -136.37 158.12 74.07 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 125.204 1.402 . . . . 0.0 110.66 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.85 169.95 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.692 3.594 . . . . 0.0 111.569 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.84 174.82 10.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.181 3.254 . . . . 0.0 110.974 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.37 33.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 120.543 -1.348 . . . . 0.0 112.1 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.73 168.84 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.615 2.877 . . . . 0.0 109.635 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.48 134.21 25.16 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.292 -0.88 . . . . 0.0 109.761 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.2 t -163.58 112.8 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.2 1.4 . . . . 0.0 108.04 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.7 t -162.15 145.73 11.95 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -179.56 163.25 1.18 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.349 2.26 . . . . 0.0 108.402 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.51 148.61 1.21 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.965 2.906 . . . . 0.0 104.128 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 28.3 p -162.05 12.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.946 0.898 . . . . 0.0 111.554 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.13 152.14 41.34 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.878 1.217 . . . . 0.0 111.606 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.8 m -159.2 131.82 6.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -137.71 153.77 49.74 Favored 'General case' 0 C--N 1.335 -0.03 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -151.37 -176.86 5.75 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.113 1.765 . . . . 0.0 107.381 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.6 m -139.13 -16.5 1.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.965 1.706 . . . . 0.0 112.551 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 44.67 72.53 0.34 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.568 1.556 . . . . 0.0 113.776 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.98 -6.1 17.9 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.514 2.142 . . . . 0.0 113.96 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.4 t 71.69 -12.8 0.61 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.819 2.048 . . . . 0.0 112.894 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.2 p -78.46 -16.4 57.59 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.261 0.937 . . . . 0.0 109.374 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 1 C-N-CA 133.588 5.375 . . . . 0.0 104.65 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.4 m 51.77 18.87 0.81 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.803 2.441 . . . . 0.0 115.127 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -72.72 -17.6 61.6 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.671 1.188 . . . . 0.0 111.049 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.35 164.72 38.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.1 t -66.95 -46.08 75.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.611 1.564 . . . . 0.0 111.041 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.9 p -71.2 168.27 17.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.717 0.77 . . . . 0.0 112.022 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.83 112.75 0.54 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -49.03 135.2 16.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.085 0.942 . . . . 0.0 110.966 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -155.61 137.18 14.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.537 1.135 . . . . 0.0 110.56 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -17.36 34.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.332 1.02 . . . . 0.0 109.365 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.52 155.31 40.21 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.522 1.929 . . . . 0.0 108.385 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.6 p -128.07 18.52 6.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.527 1.131 . . . . 0.0 111.34 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -10.18 1.02 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.016 2.126 . . . . 0.0 115.978 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -136.9 13.08 3.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 111.296 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -86.39 -174.61 5.11 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.531 1.133 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.41 109.91 13.89 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -91.03 150.32 21.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.658 0.742 . . . . 0.0 111.733 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.2 t -129.39 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.126 1.77 . . . . 0.0 108.907 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -101.3 143.29 31.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.996 3.318 . . . . 0.0 106.753 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.78 146.39 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.89 173.91 26.04 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 119.031 0.832 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.5 t0 61.38 17.81 8.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.986 2.914 . . . . 0.0 114.211 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.31 135.68 57.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.343 1.457 . . . . 0.0 110.143 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 t -60.12 148.48 77.98 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.21 52.23 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.665 1.576 . . . . 0.0 113.364 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -76.48 -29.85 57.05 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.862 0.756 . . . . 0.0 110.591 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.31 115.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.517 1.527 . . . . 0.0 108.986 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 t -100.05 174.39 6.19 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.138 1.375 . . . . 0.0 109.714 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.4 m -57.76 -36.84 72.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.317 -0.864 . . . . 0.0 111.463 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.59 -44.36 78.31 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.08 1.352 . . . . 0.0 109.981 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.63 80.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.276 1.03 . . . . 0.0 109.666 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.14 -50.55 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -52.78 -48.05 67.12 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.259 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.14 -34.68 70.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.658 1.117 . . . . 0.0 111.675 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.74 -45.82 60.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.285 1.034 . . . . 0.0 111.503 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -87.69 -4.49 58.91 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.54 94.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.655 2.382 . . . . 0.0 114.664 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.21 -1.34 7.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 122.181 1.815 . . . . 0.0 112.516 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.4 -9.5 25.15 Favored 'General case' 0 N--CA 1.461 0.116 0 O-C-N 121.175 -0.953 . . . . 0.0 111.503 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.46 -155.83 26.54 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 111.832 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -100.27 131.24 46.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.384 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.18 133.63 43.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.726 1.61 . . . . 0.0 108.772 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.7 p -99.8 -73.03 0.65 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -103.47 148.99 25.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.288 1.835 . . . . 0.0 109.053 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.62 4.21 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.899 1.28 . . . . 0.0 108.967 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.8 ptm85 -161.01 147.67 15.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.44 0.564 . . . . 0.0 112.173 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.02 120.18 40.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.37 137.58 24.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -136.25 160.93 37.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.92 135.78 54.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -68.87 -14.37 62.99 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.773 -0.58 . . . . 0.0 110.015 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.5 17.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.079 1.752 . . . . 0.0 115.157 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 p -136.72 -23.32 1.21 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 112.254 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.8 4.54 62.26 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.345 -1.253 . . . . 0.0 110.839 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -81.82 150.9 27.63 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.93 1.865 . . . . 0.0 108.467 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 t -56.35 120.4 7.58 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -70.55 -35.3 73.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 127.89 -29.63 4.13 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.987 1.755 . . . . 0.0 110.404 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -102.15 166.51 10.56 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.601 1.16 . . . . 0.0 111.749 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.85 170.84 31.29 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.419 1.485 . . . . 0.0 110.173 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -129.38 150.15 50.86 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.091 1.356 . . . . 0.0 108.523 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.78 159.8 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 127.515 2.326 . . . . 0.0 105.028 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.9 t -142.63 130.75 21.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.806 2.042 . . . . 0.0 107.721 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.52 134.84 54.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.111 1.364 . . . . 0.0 109.368 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -64.31 -39.41 93.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.425 0.69 . . . . 0.0 109.639 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -111.11 145.64 38.22 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.04 1.336 . . . . 0.0 107.905 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.39 -45.11 81.13 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -38.66 55.75 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 112.882 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.83 -49.93 75.49 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.4 77.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.25 -51.31 67.03 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.115 0.566 . . . . 0.0 110.82 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.85 -48.82 74.84 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.34 70.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.995 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.24 -42.07 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 121.006 1.73 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -77.52 -36.94 51.95 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -87.93 -53.46 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.137 1.375 . . . . 0.0 112.044 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 72.7 mmm -68.28 -21.62 64.78 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.881 0.764 . . . . 0.0 112.329 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 109.03 1.96 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 124.478 1.037 . . . . 0.0 111.266 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.25 -6.35 66.01 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.155 -0.803 . . . . 0.0 113.611 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -73.05 179.15 3.92 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.34 1.07 . . . . 0.0 109.176 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.52 152.67 27.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.885 0.874 . . . . 0.0 109.041 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.1 tp -158.87 131.21 6.77 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.229 2.212 . . . . 0.0 105.66 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.9 30.23 77.1 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 119.085 0.857 . . . . 0.0 111.074 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.68 14.14 72.29 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.228 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -135.19 150.61 50.16 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.876 1.838 . . . . 0.0 109.339 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 21.1 pt -130.09 172.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.27 1.028 . . . . 0.0 108.989 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -131.62 154.4 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.982 1.713 . . . . 0.0 107.304 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.4 p -142.92 147.28 35.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.709 0.804 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -167.19 167.37 14.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -69.44 136.06 51.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.526 1.057 . . . . 0.0 108.322 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -88.32 152.22 22.08 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 29.7 p -136.12 147.98 48.03 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.426 0.631 . . . . 0.0 111.45 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -71.0 142.66 50.95 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -55.66 139.75 68.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.472 1.109 . . . . 0.0 111.064 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.34 160.6 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.775 1.65 . . . . 0.0 111.227 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.69 -176.85 3.38 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.364 3.376 . . . . 0.0 111.552 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.78 151.17 93.27 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.36 -45.14 15.86 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.991 1.794 . . . . 0.0 113.123 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -159.07 165.46 33.84 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.236 0.614 . . . . 0.0 109.882 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 m -83.11 160.58 21.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 36.5 p -61.6 157.16 18.06 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 119.707 1.14 . . . . 0.0 110.662 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.34 16.55 0.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.086 1.355 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.45 112.46 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.924 1.29 . . . . 0.0 108.805 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.0 t -153.84 169.55 23.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.63 0.729 . . . . 0.0 109.65 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 31.86 0.22 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.822 -0.549 . . . . 0.0 111.875 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 10.1 m -61.08 83.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.385 2.274 . . . . 0.0 112.422 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.5 166.12 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.771 2.828 . . . . 0.0 106.707 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -145.88 163.01 36.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.52 1.128 . . . . 0.0 108.15 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 t -171.89 -178.27 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.012 2.125 . . . . 0.0 107.245 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.94 78.89 0.7 Allowed Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.096 -1.391 . . . . 0.0 109.703 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.97 -50.33 9.19 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.525 2.15 . . . . 0.0 111.199 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m 64.08 -6.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.915 1.686 . . . . 0.0 114.925 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.0 p -75.91 -17.01 59.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.34 1.456 . . . . 0.0 111.129 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 C-N-CA 132.126 4.679 . . . . 0.0 105.226 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.641 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 m -83.68 -167.65 1.8 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.4 p -127.71 161.59 28.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.78 125.61 3.35 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 124.989 1.28 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -54.07 132.45 42.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.717 1.607 . . . . 0.0 110.529 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.9 m -65.59 -56.24 13.33 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.839 0.29 . . . . 0.0 111.143 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.96 106.42 0.15 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -76.12 69.9 2.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 109.375 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.1 173.19 10.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.945 1.298 . . . . 0.0 109.385 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.93 -52.39 65.71 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.808 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -61.19 136.02 57.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.6 p -68.46 38.39 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.685 2.794 . . . . 0.0 113.271 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.1 m -59.41 123.06 15.56 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.679 3.191 . . . . 0.0 108.765 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.4 t30 68.57 0.01 2.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.747 1.619 . . . . 0.0 113.936 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -73.6 173.27 9.97 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.169 0.988 . . . . 0.0 109.586 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.33 114.45 20.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.23 1.412 . . . . 0.0 107.246 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.573 ' CG ' ' HG ' ' A' ' 144' ' ' SER . 0.2 OUTLIER -89.21 132.7 34.74 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.337 1.055 . . . . 0.0 111.506 -178.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.87 144.97 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.501 2.32 . . . . 0.0 109.013 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.84 139.03 38.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 127.455 2.302 . . . . 0.0 106.552 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.94 143.9 36.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.71 173.54 26.89 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.582 1.083 . . . . 0.0 113.91 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 57.45 23.26 8.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 129.085 2.954 . . . . 0.0 115.289 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.5 mt -60.95 145.82 49.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.513 1.525 . . . . 0.0 109.467 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t -59.38 143.75 85.01 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.69 -15.5 31.89 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.595 2.197 . . . . 0.0 116.294 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.05 -28.9 29.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.932 1.693 . . . . 0.0 111.551 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -56.42 113.73 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.656 1.582 . . . . 0.0 110.57 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -97.52 179.43 4.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.135 0.969 . . . . 0.0 109.241 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 m -55.97 -33.08 64.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.632 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -69.3 -46.8 66.29 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 110.057 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.84 -44.49 73.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 110.186 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.67 -54.65 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -50.65 -51.05 52.72 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.871 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.92 69.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.089 1.356 . . . . 0.0 111.257 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.59 96.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -90.8 -7.78 51.43 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.29 94.61 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.806 1.642 . . . . 0.0 113.282 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.79 -0.96 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 121.251 1.482 . . . . 0.0 113.099 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.97 -34.56 10.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.403 1.001 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.13 177.9 47.2 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 122.991 1.328 . . . . 0.0 111.473 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -74.35 123.11 24.0 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.756 -1.222 . . . . 0.0 107.938 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.5 mt -101.17 154.71 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.2 t -125.73 -65.33 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -102.02 134.6 44.97 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.94 128.94 2.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -162.99 170.91 17.32 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.109 0.564 . . . . 0.0 111.724 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.93 130.26 51.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.536 1.534 . . . . 0.0 107.936 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 135.5 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -134.81 160.28 38.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.29 158.42 35.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.302 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.6 ptm -91.02 -16.22 28.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.792 1.237 . . . . 0.0 113.491 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.4 -26.64 11.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.872 1.214 . . . . 0.0 112.706 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.5 p -114.84 -19.75 10.87 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.87 50.36 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 121.655 0.586 . . . . 0.0 112.746 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.62 145.59 34.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -66.1 139.0 58.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.631 0.729 . . . . 0.0 112.274 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -81.75 -8.68 59.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.242 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.9 -12.91 65.96 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 124.43 1.014 . . . . 0.0 112.723 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.292 3.2 p90 -102.96 169.35 8.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.777 1.788 . . . . 0.0 109.876 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 178.44 30.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.356 0.503 . . . . 0.0 112.33 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.9 148.15 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.256 1.422 . . . . 0.0 108.117 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.99 124.83 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.035 1.734 . . . . 0.0 106.939 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.573 ' HG ' ' CG ' ' A' ' 98' ' ' HIS . 62.9 m -109.62 125.92 53.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.815 1.189 . . . . 0.0 108.69 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -109.98 148.52 31.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -69.63 -17.92 63.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.334 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -132.03 148.52 52.51 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.703 1.138 . . . . 0.0 109.124 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -63.62 -55.72 21.42 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.247 0.619 . . . . 0.0 109.497 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -39.53 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.687 1.595 . . . . 0.0 113.107 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.19 -48.25 80.87 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.66 74.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.772 0.829 . . . . 0.0 110.117 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.48 -47.3 69.93 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.172 1.389 . . . . 0.0 110.909 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -57.23 -43.62 83.05 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.31 84.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.851 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 89.0 mt -53.05 -52.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.997 1.726 . . . . 0.0 107.633 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -60.25 -66.46 0.52 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.38 1.472 . . . . 0.0 113.011 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.89 -49.74 69.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.736 2.014 . . . . 0.0 115.183 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -73.15 -19.61 61.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.696 1.135 . . . . 0.0 112.638 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.45 96.88 0.36 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.64 -11.05 11.24 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.607 1.099 . . . . 0.0 111.428 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -73.91 170.13 16.0 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.594 1.197 . . . . 0.0 107.836 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -113.38 136.51 52.69 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.449 1.1 . . . . 0.0 108.268 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.21 121.58 18.18 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.13 21.82 79.47 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.025 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.98 6.14 79.74 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.975 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -133.77 147.04 51.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.301 2.05 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.83 138.6 52.75 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -108.15 163.94 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.982 0.896 . . . . 0.0 109.849 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -124.49 149.48 46.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.901 1.281 . . . . 0.0 107.66 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.9 p -139.29 140.36 37.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.298 1.039 . . . . 0.0 109.628 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -163.3 173.03 13.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.157 1.383 . . . . 0.0 108.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -71.45 124.44 24.63 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.343 1.057 . . . . 0.0 110.957 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.48 -12.02 60.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.636 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.3 p -89.0 164.89 14.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.275 . . . . 0.0 109.139 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -142.57 148.73 38.02 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.102 -0.999 . . . . 0.0 108.77 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.9 pttp -69.29 150.49 97.2 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 161.85 42.89 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 108.116 -1.532 . . . . 0.0 108.116 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.4 168.71 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.198 1.932 . . . . 0.0 108.734 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -126.94 159.97 61.74 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 110.448 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.35 121.16 8.68 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.756 2.304 . . . . 0.0 110.745 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.98 124.35 28.62 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.7 t -83.69 153.04 24.42 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.5 p -156.98 127.87 6.72 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.542 1.937 . . . . 0.0 108.065 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.41 158.12 40.97 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -153.8 144.24 22.35 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 t -175.13 162.82 3.08 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.829 1.652 . . . . 0.0 107.607 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -161.24 161.93 30.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.47 1.108 . . . . 0.0 108.537 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.2 m -160.93 110.18 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 189' ' ' LYS . 0.3 OUTLIER -141.49 129.15 21.53 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.09 166.85 14.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.726 2.011 . . . . 0.0 107.991 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.2 t 176.34 -174.35 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.707 3.203 . . . . 0.0 106.041 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.25 44.44 1.08 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.584 -1.676 . . . . 0.0 115.45 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.88 156.9 47.94 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 121.151 2.476 . . . . 0.0 109.111 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 8.5 t -154.19 -177.11 6.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.936 1.295 . . . . 0.0 107.677 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.6 p -134.32 5.98 3.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.527 1.931 . . . . 0.0 111.07 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.75 0 C-N-CA 129.794 3.568 . . . . 0.0 106.702 179.76 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 m -60.0 118.15 5.94 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -146.55 148.0 31.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.23 170.26 30.88 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -50.69 127.51 18.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.045 1.338 . . . . 0.0 110.416 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -136.91 74.58 1.49 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.47 0.708 . . . . 0.0 109.166 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.17 91.96 0.96 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.664 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -59.32 -22.18 60.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.972 0.886 . . . . 0.0 110.521 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.35 81.07 1.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.681 1.992 . . . . 0.0 109.092 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 4.8 mmpt? -144.66 -177.34 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -51.99 122.32 8.22 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.562 1.145 . . . . 0.0 108.718 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 p -58.09 -1.28 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.589 2.756 . . . . 0.0 113.213 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 t -49.44 -27.31 4.05 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.402 2.681 . . . . 0.0 113.553 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -96.23 -11.54 25.88 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -81.15 157.9 25.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.803 0.729 . . . . 0.0 109.487 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.72 115.48 30.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.1 151.7 18.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.151 0.907 . . . . 0.0 110.91 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.95 136.97 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 126.899 2.079 . . . . 0.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -85.59 132.67 34.13 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.448 2.299 . . . . 0.0 105.646 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.73 135.02 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.4 -175.97 14.27 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.613 -0.679 . . . . 0.0 111.444 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 61.74 21.13 11.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.972 2.509 . . . . 0.0 114.25 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.32 153.5 43.63 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.884 -1.135 . . . . 0.0 111.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 t -71.39 157.32 90.26 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.63 -6.51 18.82 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.424 2.083 . . . . 0.0 114.173 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.29 -15.32 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 112.811 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -58.25 137.37 20.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 109.84 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -112.21 168.86 9.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.669 1.187 . . . . 0.0 108.284 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 m -60.37 -30.2 69.41 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.907 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.86 -34.23 62.24 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.77 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -48.07 80.66 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.7 mt -58.76 -52.4 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 126' ' ' ALA . 24.0 mtmt -52.77 -47.62 67.38 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 117.679 -1.153 . . . . 0.0 112.093 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.24 67.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.254 0.934 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.58 -50.12 68.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.122 1.369 . . . . 0.0 113.413 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 -11.34 47.11 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.44 90.58 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.423 1.489 . . . . 0.0 112.395 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.1 -10.76 21.94 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.752 1.661 . . . . 0.0 112.583 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -98.13 -10.51 24.08 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.501 1.046 . . . . 0.0 111.532 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.51 165.89 21.43 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 120.026 1.285 . . . . 0.0 111.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 68.3 mtt-85 -77.17 130.12 36.88 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.2 mt -101.99 132.42 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.2 1.0 . . . . 0.0 109.229 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.18 -66.21 0.92 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.05 133.56 46.69 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.314 0.645 . . . . 0.0 110.132 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.433 ' HB2' ' HE2' ' A' ' 114' ' ' LYS . . . -155.61 137.43 14.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -160.36 157.98 28.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.663 0.665 . . . . 0.0 111.626 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.21 119.56 50.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.9 t -66.09 133.09 31.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -129.88 151.64 50.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.06 128.55 36.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.8 ptp -66.89 -10.35 47.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.844 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.57 -17.03 26.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.296 1.039 . . . . 0.0 113.738 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.3 p -141.93 -34.08 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.09 14.48 51.54 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.558 -1.135 . . . . 0.0 111.053 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.94 149.56 24.71 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.539 1.67 . . . . 0.0 107.896 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.5 m -53.34 117.31 2.96 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.598 1.159 . . . . 0.0 112.345 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -64.24 -25.03 67.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.334 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.67 -30.81 4.78 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.442 1.972 . . . . 0.0 111.915 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -102.9 172.72 6.66 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.001 1.32 . . . . 0.0 113.501 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.99 175.95 34.36 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.938 2.208 . . . . 0.0 108.908 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.04 151.45 45.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.03 143.59 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.7 m -130.64 128.86 41.83 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.648 1.579 . . . . 0.0 107.708 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -110.75 163.3 13.91 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.544 1.138 . . . . 0.0 110.085 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.53 -28.8 52.08 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.589 0.756 . . . . 0.0 111.748 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -124.89 160.36 29.01 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.083 0.953 . . . . 0.0 111.957 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.542 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 20.1 tptm -65.32 -51.82 58.09 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.632 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -50.99 -45.79 61.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 125.579 1.552 . . . . 0.0 113.134 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -56.96 -43.88 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.963 0.79 . . . . 0.0 110.227 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -50.96 43.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.042 0.937 . . . . 0.0 110.307 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -54.08 -50.79 66.0 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.623 1.169 . . . . 0.0 110.668 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -51.51 -52.67 44.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.709 2.004 . . . . 0.0 108.847 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -47.46 79.54 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.333 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.01 -27.07 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 121.481 1.946 . . . . 0.0 111.342 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -84.77 -70.99 0.54 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.923 0.889 . . . . 0.0 109.932 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -56.62 -50.26 72.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.333 2.253 . . . . 0.0 113.588 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 66.4 mmm -78.01 -20.95 51.54 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.286 1.035 . . . . 0.0 113.659 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.11 75.74 0.25 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.731 1.157 . . . . 0.0 114.563 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.6 -5.15 2.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.049 1.785 . . . . 0.0 112.556 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -76.82 -177.02 4.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.226 1.41 . . . . 0.0 110.819 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -112.85 157.47 21.36 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.347 1.459 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.5 tp -151.35 126.28 9.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.366 1.466 . . . . 0.0 108.774 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.89 -67.8 0.13 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 126.555 2.026 . . . . 0.0 112.776 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.26 1.99 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.841 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -148.58 167.99 23.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.123 2.461 . . . . 0.0 111.947 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -72.95 147.77 44.92 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -115.6 169.29 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 110.776 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -127.59 146.84 50.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.804 2.041 . . . . 0.0 107.888 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.9 p -142.56 151.04 41.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.23 0.923 . . . . 0.0 109.913 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -173.75 172.73 3.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.148 2.179 . . . . 0.0 108.767 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.542 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 40.1 m95 -67.63 148.53 51.26 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.242 -1.536 . . . . 0.0 111.155 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.42 114.67 28.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.8 p 62.14 -15.81 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.452 3.101 . . . . 0.0 115.989 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.04 178.55 6.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.863 1.665 . . . . 0.0 113.64 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -146.71 152.79 45.69 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.704 2.002 . . . . 0.0 107.494 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.42 166.35 29.66 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.331 2.688 . . . . 0.0 110.417 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.14 163.93 36.79 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.381 2.054 . . . . 0.0 108.711 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.82 154.76 88.3 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.126 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.25 2.54 5.49 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.447 2.765 . . . . 0.0 113.505 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -145.99 82.16 1.61 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 104.16 -2.534 . . . . 0.0 104.16 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -153.83 176.76 11.77 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 109.75 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.94 149.13 29.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -170.59 154.68 4.64 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.992 1.717 . . . . 0.0 107.862 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -177.94 171.94 1.71 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.17 1.788 . . . . 0.0 107.555 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.9 t -159.41 153.27 23.14 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -129.67 80.56 1.97 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 108.278 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.9 t -147.65 144.6 28.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.2 155.48 8.01 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.919 1.688 . . . . 0.0 106.547 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -148.75 -179.01 6.67 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 p -172.15 111.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.84 135.76 2.54 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.166 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.91 -15.87 26.2 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.143 2.562 . . . . 0.0 113.06 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.5 t -58.82 142.01 51.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.009 1.324 . . . . 0.0 110.839 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.1 t -54.24 -36.54 63.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.054 1.342 . . . . 0.0 112.296 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.867 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.157 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 t -68.48 79.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 110.033 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.51 -179.58 6.64 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 128.293 2.637 . . . . 0.0 109.266 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.65 64.56 0.3 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 124.965 1.269 . . . . 0.0 111.564 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.3 t -79.4 67.61 5.19 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -145.14 95.08 2.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.45 166.31 20.72 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.3 148.83 16.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.064 1.746 . . . . 0.0 107.882 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.48 4.7 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 110.242 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -75.88 -77.85 0.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -55.68 163.66 1.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.63 2.372 . . . . 0.0 113.689 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.1 p -81.43 148.89 29.06 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 -37.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.092 -1.005 . . . . 0.0 112.016 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -141.25 15.86 2.23 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.63 1.572 . . . . 0.0 111.255 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -68.84 175.39 3.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 125.61 1.564 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.61 100.5 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.407 ' CE1' ' HG ' ' A' ' 144' ' ' SER . 14.4 m-70 -81.83 153.88 26.18 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.1 133.68 55.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 127.379 2.272 . . . . 0.0 109.735 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -84.83 142.81 29.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.99 135.61 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.61 27.64 Favored Glycine 0 C--O 1.228 -0.254 0 O-C-N 121.206 -0.934 . . . . 0.0 111.47 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.79 7.47 5.9 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.746 2.418 . . . . 0.0 113.749 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt -52.45 149.22 5.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.384 2.274 . . . . 0.0 112.4 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.53 150.71 93.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.63 -14.14 42.91 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.115 1.876 . . . . 0.0 114.632 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.3 -10.66 29.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.613 1.565 . . . . 0.0 112.433 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -61.5 143.26 15.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 119.587 1.085 . . . . 0.0 110.102 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.6 t -122.17 173.72 7.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.9 m -62.29 -31.66 72.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.937 0.895 . . . . 0.0 110.715 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -74.03 -34.1 63.98 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.95 -42.91 99.18 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.77 -54.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -50.36 -45.96 55.55 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.321 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.61 75.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.668 0.605 . . . . 0.0 111.544 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.9 85.8 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.01 -8.36 55.72 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.169 0.587 . . . . 0.0 111.13 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.15 97.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 116.956 -1.497 . . . . 0.0 113.523 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.08 -3.42 8.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 122.31 1.861 . . . . 0.0 112.467 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -99.46 -16.15 18.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.42 1.088 . . . . 0.0 109.803 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.48 171.66 20.89 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 122.495 1.053 . . . . 0.0 113.079 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -77.87 123.04 26.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.3 mt -94.48 163.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.97 -69.32 0.82 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.7 136.77 41.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.872 1.269 . . . . 0.0 110.255 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.06 139.27 4.94 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.637 1.108 . . . . 0.0 109.184 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -162.63 169.34 20.3 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.17 119.78 59.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.887 2.075 . . . . 0.0 105.698 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.3 t -67.24 141.55 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -132.8 155.42 48.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 110.188 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -57.03 117.96 4.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.07 -18.41 64.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 -13.53 18.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 -18.34 2.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.863 1.21 . . . . 0.0 113.997 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.24 87.8 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.213 0.911 . . . . 0.0 113.775 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.84 155.82 25.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.644 1.722 . . . . 0.0 109.408 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.0 t -60.19 126.47 27.64 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.866 0.866 . . . . 0.0 111.091 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -73.27 -48.43 34.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.59 -25.79 3.09 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -103.22 159.02 15.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.464 1.105 . . . . 0.0 111.495 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.9 176.39 29.46 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.932 1.729 . . . . 0.0 109.504 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.29 156.85 45.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.78 0.832 . . . . 0.0 109.348 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.3 t -138.57 154.9 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.407 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 8.2 t -144.07 125.68 15.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.34 156.65 24.03 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.677 1.191 . . . . 0.0 111.237 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.96 -23.07 61.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.975 1.31 . . . . 0.0 113.681 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -137.22 153.99 50.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.479 1.036 . . . . 0.0 109.972 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.49 -48.82 79.36 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -34.68 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.914 1.285 . . . . 0.0 112.874 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.24 -47.63 73.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.1 54.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.645 1.178 . . . . 0.0 111.538 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -53.32 -45.55 69.06 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.395 1.078 . . . . 0.0 111.85 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -53.86 -47.56 70.89 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.775 0.83 . . . . 0.0 108.876 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.73 -47.37 72.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.424 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.8 mt -51.74 -44.5 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.682 1.583 . . . . 0.0 110.154 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -69.89 -67.96 0.45 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.23 1.412 . . . . 0.0 112.925 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -66.68 -43.19 85.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.565 1.546 . . . . 0.0 115.053 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 74.0 mmm -75.97 -21.55 56.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.598 1.545 . . . . 0.0 112.332 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.31 4.87 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.95 -5.7 69.04 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.527 1.061 . . . . 0.0 112.898 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -73.61 171.21 13.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.467 1.634 . . . . 0.0 109.468 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -101.94 143.82 31.34 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.06 122.81 12.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.194 0.998 . . . . 0.0 109.434 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.59 3.66 2.39 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 118.073 -1.404 . . . . 0.0 115.896 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 133.65 -13.23 4.81 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-O 116.767 -2.129 . . . . 0.0 115.183 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -137.22 162.54 33.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 121.037 2.419 . . . . 0.0 110.019 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -72.85 162.86 28.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.979 0.354 . . . . 0.0 110.318 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.1 pt -136.94 163.44 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.517 1.127 . . . . 0.0 110.974 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -126.5 151.35 47.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.31 1.444 . . . . 0.0 108.464 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.8 p -141.83 156.74 45.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.671 1.188 . . . . 0.0 109.534 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 172' ' ' TRP . 3.5 t-20 -173.95 173.84 3.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 109.259 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.453 ' H ' ' ND2' ' A' ' 171' ' ' ASN . 50.4 m95 -67.51 116.19 7.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.49 61.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.691 0.796 . . . . 0.0 112.821 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.9 t -130.1 131.32 45.69 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.7 tpt85 -121.34 45.72 2.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -59.98 131.06 89.23 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.82 157.31 60.71 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.261 1.974 . . . . 0.0 112.195 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.47 -177.24 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.569 2.846 . . . . 0.0 109.307 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -145.12 147.97 36.48 Favored Pre-proline 0 C--O 1.236 0.358 0 C-N-CA 123.638 0.775 . . . . 0.0 108.987 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.56 62.76 7.82 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.0 3.133 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -125.25 147.52 49.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 20.4 t -134.23 -60.44 0.81 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.6 m 61.76 30.74 18.48 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.723 0.809 . . . . 0.0 110.5 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -67.13 163.76 19.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.912 0.885 . . . . 0.0 109.574 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.86 -177.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.101 1.76 . . . . 0.0 107.164 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.9 p -146.32 133.17 20.1 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.67 109.42 6.66 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.147 0.885 . . . . 0.0 109.862 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.1 m -73.2 46.98 0.19 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.26 1.824 . . . . 0.0 110.543 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -81.6 102.94 10.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.685 1.594 . . . . 0.0 111.515 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 139.24 58.4 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.1 m -70.31 136.12 49.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.325 0.584 . . . . 0.0 111.621 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.2 176.04 21.59 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.11 114.79 2.34 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.638 2.225 . . . . 0.0 109.62 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.72 30.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.545 0.738 . . . . 0.0 109.503 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 7.4 t -78.21 -177.58 5.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.632 0.729 . . . . 0.0 109.542 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.642 0 N-CA-C 104.599 -3.4 . . . . 0.0 104.599 179.665 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.324 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.4 p -100.01 171.56 7.76 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.9 m -137.94 162.53 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.0 110.216 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 125.0 -178.86 16.37 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.0 t -78.28 156.17 29.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.538 1.169 . . . . 0.0 108.784 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.8 m -71.38 169.62 14.93 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.03 177.14 34.89 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -69.97 164.74 23.24 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.149 0.976 . . . . 0.0 108.574 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -115.6 -35.81 4.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.412 1.485 . . . . 0.0 108.385 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -63.21 -31.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.546 1.138 . . . . 0.0 111.327 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.62 148.44 22.1 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.125 0.97 . . . . 0.0 113.362 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.9 p -119.97 13.42 12.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.765 1.626 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -53.54 -2.32 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.913 2.485 . . . . 0.0 117.254 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -150.84 16.16 0.76 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.485 1.514 . . . . 0.0 110.43 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.22 168.33 18.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.705 0.802 . . . . 0.0 111.068 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 101.19 8.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.53 146.99 24.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.025 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -123.93 142.83 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.253 1.821 . . . . 0.0 108.47 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -97.02 135.32 39.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 106.351 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.39 139.3 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 -178.33 22.28 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.53 12.63 4.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.722 2.009 . . . . 0.0 113.162 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -55.16 148.13 14.87 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.753 2.021 . . . . 0.0 111.645 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -64.26 142.61 98.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.3 -17.67 27.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.524 2.816 . . . . 0.0 116.315 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -98.62 -5.64 31.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.277 0.944 . . . . 0.0 113.042 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 142.72 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 119.569 1.077 . . . . 0.0 108.374 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.8 t -115.31 169.2 9.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 122.233 1.016 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -61.73 -35.32 77.73 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.766 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -66.29 -34.8 78.82 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.824 1.25 . . . . 0.0 109.998 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.58 -42.77 86.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 108.762 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.34 -43.5 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -54.52 -43.75 72.16 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.606 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.91 73.9 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.85 0.719 . . . . 0.0 111.519 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.35 -43.62 71.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -94.61 -9.39 35.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.756 -0.59 . . . . 0.0 112.295 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.67 93.98 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.94 1.296 . . . . 0.0 114.015 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.04 -7.16 14.53 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 121.87 1.703 . . . . 0.0 112.63 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.41 -12.95 19.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.307 0.958 . . . . 0.0 112.053 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 171.0 -173.7 44.7 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.475 1.489 . . . . 0.0 111.499 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -101.64 129.77 47.85 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.2 mt -100.33 160.8 3.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 126.437 1.895 . . . . 0.0 109.408 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 t -126.93 -69.24 0.77 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.578 1.551 . . . . 0.0 106.837 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.99 138.17 38.39 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.46 4.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.893 1.677 . . . . 0.0 107.435 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -160.74 156.04 24.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.55 1.068 . . . . 0.0 111.726 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.65 121.59 51.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.97 144.49 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -140.91 148.66 40.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.53 121.71 12.21 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.485 1.114 . . . . 0.0 108.165 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.1 ptm -58.49 -22.63 55.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.57 -9.8 18.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.4 p -131.99 -20.27 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.94 1.246 . . . . 0.0 113.02 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.78 6.56 82.04 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.375 0.988 . . . . 0.0 112.756 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -76.51 149.16 36.76 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 t -58.17 129.59 42.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -78.05 -12.79 60.02 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.51 -24.59 28.6 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-O 118.564 -1.131 . . . . 0.0 113.75 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -102.87 166.45 10.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.252 1.026 . . . . 0.0 109.311 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.63 174.14 33.68 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.215 1.388 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.16 157.01 46.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.489 0.716 . . . . 0.0 109.121 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -143.95 133.81 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.074 1.75 . . . . 0.0 106.775 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 t -115.95 129.75 56.53 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.749 2.02 . . . . 0.0 108.254 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.12 155.43 26.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.55 -23.29 61.73 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.528 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -135.81 156.47 48.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.507 1.503 . . . . 0.0 110.994 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.38 -46.11 74.26 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.573 0.749 . . . . 0.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -39.87 72.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.21 1.804 . . . . 0.0 111.177 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -57.44 -52.92 63.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.69 53.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.732 1.213 . . . . 0.0 111.122 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -50.29 -49.02 54.71 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.373 1.069 . . . . 0.0 111.221 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -52.23 -57.35 9.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.275 1.03 . . . . 0.0 110.211 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.17 94.7 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 116.779 -1.582 . . . . 0.0 113.523 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.0 mt -50.97 -34.74 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 121.581 1.991 . . . . 0.0 110.69 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -79.96 -63.42 1.42 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.33 0.652 . . . . 0.0 111.009 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.58 -49.91 69.32 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.7 mmm -68.29 -31.39 70.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.441 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.68 92.7 0.11 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.817 0.722 . . . . 0.0 111.31 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 138.56 -18.0 3.26 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.901 1.239 . . . . 0.0 111.786 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 167.72 20.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.402 1.101 . . . . 0.0 110.672 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -107.0 116.3 31.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.0 tp -116.3 127.3 54.58 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.753 1.221 . . . . 0.0 107.763 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 -63.28 4.18 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.31 5.9 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.208 -1.884 . . . . 0.0 112.808 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -136.13 154.49 50.97 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.213 2.007 . . . . 0.0 110.358 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -68.73 148.45 50.36 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.6 pt -116.88 160.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.454 1.102 . . . . 0.0 110.974 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -118.16 143.91 46.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.389 1.876 . . . . 0.0 105.985 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.6 p -138.89 123.09 18.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -149.94 174.36 12.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -69.07 155.22 40.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.72 3.15 50.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.029 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.9 p -74.39 145.76 43.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.177 -0.952 . . . . 0.0 111.162 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -80.29 124.51 28.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -152.88 133.11 7.51 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 119.938 1.245 . . . . 0.0 110.484 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.22 159.91 50.02 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.708 1.605 . . . . 0.0 110.238 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.12 156.46 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.917 1.744 . . . . 0.0 110.679 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.84 94.0 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.99 170.91 16.9 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.164 1.909 . . . . 0.0 112.173 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -152.82 151.65 30.68 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.652 1.181 . . . . 0.0 109.654 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -133.11 169.38 16.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.579 1.152 . . . . 0.0 108.541 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 12.7 t -143.9 165.45 27.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.698 0.799 . . . . 0.0 109.008 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -171.06 151.56 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.961 2.504 . . . . 0.0 105.961 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.28 151.37 51.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.4 m -165.24 169.26 16.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.654 1.182 . . . . 0.0 109.278 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -153.2 169.09 23.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.081 1.752 . . . . 0.0 107.049 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.5 t -149.14 179.92 7.52 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.411 ' O ' ' HE3' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -140.59 99.13 3.56 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.357 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 176.14 9.59 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 60.4 m -137.55 135.02 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.92 93.59 0.71 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.74 152.6 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 CA-C-N 119.754 1.777 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.2 m -77.43 166.51 23.02 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.1 t -141.87 11.36 2.02 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.468 1.507 . . . . 0.0 110.041 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 1 C-N-CA 130.909 4.099 . . . . 0.0 105.395 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.903 0 CA-C-O 119.417 -0.657 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.29 121.97 29.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.9 p -149.68 -170.43 3.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.555 1.542 . . . . 0.0 107.79 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.25 14.53 66.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.184 0.902 . . . . 0.0 112.52 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -50.13 97.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 129.103 2.961 . . . . 0.0 110.542 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t 58.16 13.93 2.53 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.078 1.351 . . . . 0.0 111.582 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.02 96.66 0.87 Allowed Glycine 0 C--N 1.341 0.831 0 C-N-CA 126.703 2.097 . . . . 0.0 113.862 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.46 166.47 23.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -141.17 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.502 0.721 . . . . 0.0 109.942 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -80.46 -14.88 57.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.198 0.999 . . . . 0.0 110.111 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -108.3 112.86 25.54 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.562 1.145 . . . . 0.0 110.117 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.8 p -63.39 99.57 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -120.76 -5.87 9.65 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -143.0 -7.66 0.82 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.898 1.279 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -72.57 166.95 21.7 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.539 1.935 . . . . 0.0 111.23 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -123.86 113.61 18.74 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.09 1.356 . . . . 0.0 108.086 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.77 151.65 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.76 0.79 . . . . 0.0 111.229 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.17 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 128.859 2.863 . . . . 0.0 107.875 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -95.45 133.06 39.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 106.172 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -127.31 138.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.07 179.63 19.83 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.706 -0.621 . . . . 0.0 111.835 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.284 7.2 t0 60.57 10.88 2.76 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 129.93 3.292 . . . . 0.0 114.982 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.2 mt -52.35 138.61 26.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.66 1.984 . . . . 0.0 110.462 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.83 151.35 64.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.96 -19.43 68.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.038 1.826 . . . . 0.0 114.239 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -82.73 -23.41 34.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.691 1.197 . . . . 0.0 113.598 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mm -56.89 130.61 19.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.283 1.033 . . . . 0.0 110.451 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -107.9 167.53 9.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.159 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.8 m -61.32 -21.61 64.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.056 -1.652 . . . . 0.0 111.969 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.76 -36.77 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.828 1.651 . . . . 0.0 109.96 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.91 -50.95 71.78 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.32 -52.62 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.271 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -53.55 -48.36 69.18 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.994 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.66 -45.87 90.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.623 0.769 . . . . 0.0 111.833 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.35 -49.13 78.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.67 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -84.48 -8.28 59.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.947 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.3 93.75 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 120.215 1.371 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.58 -6.07 15.72 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 122.1 1.786 . . . . 0.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.62 -18.21 17.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.73 0.812 . . . . 0.0 110.913 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 170.17 175.23 38.91 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 123.596 1.665 . . . . 0.0 114.651 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -86.03 117.68 25.03 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.5 mt -100.36 158.01 3.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.12 1.368 . . . . 0.0 107.818 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 t -134.95 -62.61 0.72 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.83 126.47 48.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.831 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.22 136.62 13.09 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -162.65 157.03 21.32 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.492 0.587 . . . . 0.0 112.004 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.91 122.65 58.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.49 141.8 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -130.85 155.69 46.3 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.747 0.784 . . . . 0.0 109.083 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.49 124.51 23.77 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.068 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.8 ptp -64.54 -20.2 66.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.87 10.47 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.826 1.194 . . . . 0.0 113.845 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 80.5 p -104.05 -19.25 14.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.017 1.327 . . . . 0.0 114.303 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.0 78.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.195 0.903 . . . . 0.0 112.607 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -83.6 157.27 22.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.06 1.344 . . . . 0.0 109.154 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 t -62.06 124.99 22.3 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.718 0.807 . . . . 0.0 111.221 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -71.4 -31.61 67.47 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.27 -29.96 5.98 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.081 1.324 . . . . 0.0 110.601 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -103.31 164.99 11.3 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.305 -1.115 . . . . 0.0 111.574 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.6 178.37 33.09 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.695 1.616 . . . . 0.0 110.015 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.38 153.87 51.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.399 1.079 . . . . 0.0 108.419 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.2 t -140.24 143.61 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 12.9 t -131.35 135.3 47.12 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.738 1.615 . . . . 0.0 107.234 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 148.58 43.37 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 124.529 1.143 . . . . 0.0 109.381 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.03 -48.12 59.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -92.33 143.1 26.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.652 0.781 . . . . 0.0 109.238 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.34 -45.32 84.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.527 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -36.71 63.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.976 1.711 . . . . 0.0 112.078 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.17 -47.05 87.95 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.25 -52.54 61.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.73 0.812 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.08 -54.75 14.62 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 110.511 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -51.15 -56.55 12.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.882 1.673 . . . . 0.0 111.537 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.45 91.89 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.079 -1.438 . . . . 0.0 112.111 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.8 mt -53.01 -45.77 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 122.06 2.209 . . . . 0.0 109.784 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.72 -64.76 0.79 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.049 1.34 . . . . 0.0 111.106 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.89 -57.62 10.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.247 1.819 . . . . 0.0 114.193 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.3 mmm -64.91 -21.96 66.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.361 1.437 . . . . 0.0 113.669 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.34 110.45 3.12 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 119.227 0.921 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.4 -5.71 70.99 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.752 1.168 . . . . 0.0 112.134 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -76.71 170.67 16.03 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 118.852 1.326 . . . . 0.0 107.605 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -102.01 142.67 32.92 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 22.7 tp -131.71 124.08 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.014 2.126 . . . . 0.0 106.214 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.39 -78.35 0.84 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.9 -2.27 0.15 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.069 -1.961 . . . . 0.0 114.544 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -129.22 163.72 25.0 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.16 2.48 . . . . 0.0 109.995 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -77.93 165.18 24.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.338 0.589 . . . . 0.0 109.581 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.14 159.08 38.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.675 0.79 . . . . 0.0 110.925 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -113.77 139.54 49.03 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 p -137.06 132.37 34.07 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.138 0.881 . . . . 0.0 109.448 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -157.1 167.43 30.45 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -61.08 132.87 55.16 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.1 69.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.134 0.425 . . . . 0.0 111.673 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 62.7 p -126.29 119.91 28.58 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.79 0.723 . . . . 0.0 109.611 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -141.64 160.53 39.98 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.483 1.913 . . . . 0.0 106.938 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -155.37 137.1 9.6 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.39 150.33 84.44 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.405 1.403 . . . . 0.0 109.057 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.32 165.55 31.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.225 1.95 . . . . 0.0 109.304 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -128.47 159.03 69.78 Favored Pre-proline 0 C--O 1.233 0.216 0 O-C-N 121.34 -0.85 . . . . 0.0 111.874 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.97 -6.91 19.84 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.514 2.809 . . . . 0.0 112.307 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -107.71 138.61 43.63 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.773 2.029 . . . . 0.0 108.27 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.8 t -136.77 -176.05 4.23 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.901 1.28 . . . . 0.0 108.568 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 p -90.26 138.55 31.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.658 1.183 . . . . 0.0 110.573 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.43 -11.02 8.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.822 1.649 . . . . 0.0 112.535 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.58 156.82 15.63 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.467 1.507 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 13.4 p -127.41 158.23 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.056 1.343 . . . . 0.0 108.145 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -158.03 173.57 16.55 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.2 t -87.36 -178.88 6.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.815 0.846 . . . . 0.0 109.298 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.05 159.89 29.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.409 1.484 . . . . 0.0 108.63 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.36 10.51 4.47 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.207 2.203 . . . . 0.0 108.666 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.8 m -143.03 179.79 6.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.066 2.546 . . . . 0.0 108.329 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.97 78.26 0.33 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.635 -1.092 . . . . 0.0 110.966 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.49 134.02 16.53 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.833 2.356 . . . . 0.0 108.451 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 61.3 m -138.02 164.87 27.98 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.234 1.014 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.7 t -144.9 -22.24 0.5 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.109 1.364 . . . . 0.0 110.525 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.328 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -179.723 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.886 0.374 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -105.39 102.59 12.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.317 1.847 . . . . 0.0 107.894 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 146.82 25.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.306 0.643 . . . . 0.0 110.568 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.61 138.18 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.344 1.858 . . . . 0.0 110.207 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -86.82 143.0 27.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.242 1.817 . . . . 0.0 106.686 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.13 137.37 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.5 -174.54 17.79 Favored Glycine 0 N--CA 1.463 0.498 0 O-C-N 120.865 -1.147 . . . . 0.0 111.164 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.7 8.94 4.8 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.067 2.147 . . . . 0.0 112.36 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -55.84 148.13 17.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.009 1.323 . . . . 0.0 111.519 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.11 162.32 69.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.14 -16.78 49.77 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.623 2.215 . . . . 0.0 114.632 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.87 -15.06 17.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.583 1.083 . . . . 0.0 112.288 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.417 HD11 ' HA3' ' A' ' 164' ' ' GLY . 28.3 mm -57.69 114.25 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 109.387 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 t -95.34 178.83 5.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 m -64.54 -30.91 71.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.928 -1.107 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -73.02 -30.12 63.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.315 1.046 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.04 -48.6 70.54 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -51.65 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -55.37 -38.65 69.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 120.904 -1.122 . . . . 0.0 112.34 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.17 64.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.672 0.608 . . . . 0.0 110.078 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.73 84.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.742 1.217 . . . . 0.0 113.547 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.47 -6.34 57.69 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.27 94.95 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.862 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.92 -5.96 14.7 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.529 1.486 . . . . 0.0 113.535 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -98.82 -20.97 16.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.775 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 169.33 175.16 38.36 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-O 122.943 1.301 . . . . 0.0 114.155 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.9 mtm105 -81.61 121.54 26.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.3 mt -100.79 153.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.377 1.071 . . . . 0.0 109.073 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 t -130.28 -61.07 0.99 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.77 132.89 45.95 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 134.71 6.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.198 0.999 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -162.84 163.38 26.53 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.957 0.798 . . . . 0.0 112.228 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 52.2 t -105.02 120.59 55.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.597 HG12 ' HG3' ' A' ' 138' ' ' LYS . 95.3 t -66.03 140.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -133.23 147.1 51.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.71 130.26 45.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.079 1.352 . . . . 0.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.6 ptm -76.02 -9.41 58.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.77 -24.29 16.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.864 1.211 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.5 p -128.48 -18.49 3.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.433 1.015 . . . . 0.0 113.043 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.52 19.11 78.47 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.592 1.091 . . . . 0.0 113.391 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -100.3 163.35 12.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.542 1.171 . . . . 0.0 109.867 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -46.27 126.21 7.55 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.885 1.274 . . . . 0.0 113.885 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.597 ' HG3' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -79.5 -22.5 43.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.699 178.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.93 -30.12 8.31 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.547 2.023 . . . . 0.0 110.644 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.503 ' CZ ' HG11 ' A' ' 129' ' ' VAL 0.264 29.9 p90 -102.88 169.37 8.63 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.422 1.089 . . . . 0.0 112.171 178.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.57 172.72 33.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.371 2.415 . . . . 0.0 108.379 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -140.37 149.95 43.33 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.54 155.75 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.662 1.985 . . . . 0.0 106.031 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.0 t -145.32 118.02 8.65 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.506 1.122 . . . . 0.0 108.354 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -99.46 152.12 20.35 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.17 1.388 . . . . 0.0 110.631 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -74.37 -24.41 59.15 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.394 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -125.44 151.27 46.44 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.782 1.233 . . . . 0.0 110.55 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.01 -49.24 73.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -31.46 17.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.456 1.903 . . . . 0.0 113.307 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.78 -55.28 10.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 108.347 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.71 76.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.971 1.708 . . . . 0.0 110.81 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.18 -50.01 70.42 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.583 1.153 . . . . 0.0 109.295 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -55.22 -50.91 68.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.752 0.421 . . . . 0.0 111.294 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.22 -55.12 37.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.033 1.733 . . . . 0.0 111.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.4 mt -46.68 -49.9 6.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 120.367 1.44 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -65.36 -60.78 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.288 0.992 . . . . 0.0 112.316 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -66.02 -58.07 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.2 mmm -58.19 -28.58 64.92 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.93 77.43 0.81 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 125.021 1.296 . . . . 0.0 110.123 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.17 -10.35 2.26 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 127.3 2.381 . . . . 0.0 111.838 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -80.18 165.52 22.34 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.879 1.34 . . . . 0.0 109.456 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -107.6 133.54 51.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.991 0.916 . . . . 0.0 108.853 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.88 130.48 46.91 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.565 1.946 . . . . 0.0 106.645 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 66.44 12.55 58.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.106 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.88 0.25 62.24 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.312 1.556 . . . . 0.0 112.564 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.26 157.06 46.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.427 1.614 . . . . 0.0 108.928 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.78 174.84 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.787 0.803 . . . . 0.0 109.308 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 pt -142.96 160.05 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.734 2.014 . . . . 0.0 108.025 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -123.51 140.6 52.84 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.4 p -138.93 149.23 44.56 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.957 0.903 . . . . 0.0 111.808 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -173.43 178.07 2.45 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.906 2.082 . . . . 0.0 109.352 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.12 126.65 30.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 112.855 -179.509 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -113.08 161.36 17.18 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -132.72 133.79 43.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.36 134.27 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 126.169 1.788 . . . . 0.0 109.571 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -85.59 136.1 33.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.52 HG12 HD21 ' A' ' 104' ' ' LEU . 15.8 t -131.71 133.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.02 -174.35 18.1 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 62.8 12.33 5.62 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.227 2.611 . . . . 0.0 111.951 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.52 HD21 HG12 ' A' ' 101' ' ' VAL . 53.8 mt -59.55 142.68 52.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.639 1.576 . . . . 0.0 111.322 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 t -59.87 143.81 86.89 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -59.95 -5.33 3.61 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 115.382 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.4 -14.38 18.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.285 2.234 . . . . 0.0 112.721 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.1 mm -58.05 136.2 21.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 119.316 0.962 . . . . 0.0 109.831 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -108.33 168.85 9.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.387 1.089 . . . . 0.0 108.843 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.0 m -60.82 -29.51 69.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.895 1.278 . . . . 0.0 109.381 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -70.24 -40.8 74.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 109.277 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.75 -47.54 85.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.738 0.815 . . . . 0.0 109.17 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 113' ' ' ILE . 27.9 mt -60.75 -49.53 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 22.8 mtmt -54.88 -48.53 72.86 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.762 -1.211 . . . . 0.0 110.99 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.33 -34.4 73.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.967 0.907 . . . . 0.0 112.614 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -75.31 -44.89 42.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.756 1.223 . . . . 0.0 113.842 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.04 -10.68 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.0 -50.37 86.82 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 126.481 1.913 . . . . 0.0 114.445 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -65.03 -4.17 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.464 1.443 . . . . 0.0 113.282 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -99.05 -9.63 23.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.47 15.1 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.094 1.316 . . . . 0.0 109.89 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -75.18 116.35 15.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.596 -0.943 . . . . 0.0 109.827 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -77.48 153.5 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 p -112.53 -73.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.011 1.724 . . . . 0.0 107.032 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.97 142.8 32.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.988 2.115 . . . . 0.0 108.117 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.416 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -161.84 124.03 2.9 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 110.101 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -153.53 164.5 38.12 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.594 0.712 . . . . 0.0 111.8 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.2 121.64 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.341 1.857 . . . . 0.0 106.968 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 140' ' ' TYR . 75.1 t -64.68 139.28 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -134.84 153.35 52.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -60.84 116.41 4.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.368 1.467 . . . . 0.0 109.115 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.4 ptp -64.09 -9.01 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.26 -15.87 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.467 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.4 p -137.91 -29.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.94 1.246 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.66 62.55 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.217 1.389 . . . . 0.0 112.037 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -80.14 154.97 27.69 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.696 1.248 . . . . 0.0 109.094 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 m -56.04 123.58 14.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.857 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -76.88 -22.56 53.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.121 0.568 . . . . 0.0 111.692 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.73 -26.53 10.68 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 127.006 2.241 . . . . 0.0 112.619 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CE2' HG11 ' A' ' 129' ' ' VAL . 7.3 p90 -103.06 168.09 9.41 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.764 1.225 . . . . 0.0 112.389 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.84 177.85 31.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.785 2.136 . . . . 0.0 109.307 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -138.79 155.42 48.18 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.031 0.932 . . . . 0.0 109.938 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.3 t -142.89 125.56 13.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.174 1.39 . . . . 0.0 108.405 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -112.92 142.15 45.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.16 163.07 22.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.65 -19.95 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.892 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.19 169.12 16.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.722 1.209 . . . . 0.0 111.607 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -77.81 -52.74 8.43 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.578 1.151 . . . . 0.0 110.808 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -49.61 -48.92 48.66 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.182 1.793 . . . . 0.0 111.096 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.86 -43.96 69.97 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.091 0.869 . . . . 0.0 110.124 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.42 -56.04 12.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.135 1.374 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.08 -48.33 64.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.333 1.453 . . . . 0.0 111.185 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -53.14 -46.0 68.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 109.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.88 -43.23 65.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.855 1.262 . . . . 0.0 110.18 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 95.5 mt -49.52 -44.54 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 120.8 1.636 . . . . 0.0 108.704 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.4 -70.87 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.14 -43.46 98.84 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 68.2 mmm -71.93 -22.59 61.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.594 1.543 . . . . 0.0 111.494 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.0 113.55 5.75 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 118.96 0.8 . . . . 0.0 111.834 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.22 60.29 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.325 -1.264 . . . . 0.0 113.119 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.6 169.05 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.964 1.382 . . . . 0.0 108.795 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -105.33 137.29 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 116' ' ' ALA . 50.4 tp -124.79 127.88 47.87 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.78 -101.17 0.44 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 105.695 -2.962 . . . . 0.0 105.695 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.75 10.85 7.5 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 116.355 -2.358 . . . . 0.0 115.729 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.98 159.25 43.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.971 2.886 . . . . 0.0 112.969 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -72.37 153.97 41.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.17 151.97 27.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 123.409 0.684 . . . . 0.0 111.457 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -111.64 126.52 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.995 1.318 . . . . 0.0 108.387 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.9 p -113.54 141.58 46.98 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.238 1.415 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -167.45 177.12 6.16 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.086 1.755 . . . . 0.0 107.459 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -77.69 152.62 33.64 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.416 0 O-C-N 121.478 -0.764 . . . . 0.0 112.21 179.471 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.095 0.474 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -113.52 139.56 48.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.042 1.292 . . . . 0.0 110.214 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.08 154.36 28.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.668 2.387 . . . . 0.0 109.704 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -103.82 141.42 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.579 3.152 . . . . 0.0 108.709 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.61 140.33 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.44 178.86 24.78 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 119.652 1.114 . . . . 0.0 111.543 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t0 70.41 -1.69 2.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.762 2.825 . . . . 0.0 114.525 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 mt -47.78 139.01 7.91 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 127.283 2.233 . . . . 0.0 113.892 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.7 t -62.65 148.12 91.64 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.83 -18.1 58.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.161 1.908 . . . . 0.0 113.822 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -76.43 -25.49 54.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mm -57.84 124.11 11.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.448 1.499 . . . . 0.0 110.613 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -106.93 175.3 5.54 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.134 0.974 . . . . 0.0 109.03 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -56.73 -33.52 66.62 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.52 -0.737 . . . . 0.0 111.851 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.39 -42.56 78.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.133 1.773 . . . . 0.0 112.142 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.63 -51.54 65.08 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.326 1.05 . . . . 0.0 109.482 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.0 mt -60.12 -53.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.2 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -51.1 -44.77 61.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 117.885 -1.055 . . . . 0.0 112.092 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.09 81.88 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.948 0.78 . . . . 0.0 110.734 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -57.51 -46.79 83.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.12 -5.76 59.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.402 1.081 . . . . 0.0 113.152 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -47.2 99.3 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.54 -3.9 12.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 CA-C-N 121.111 1.432 . . . . 0.0 112.388 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.95 -18.91 18.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.251 0.932 . . . . 0.0 110.719 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.4 168.19 25.0 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 118.887 0.767 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.85 130.72 40.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.2 mt -100.26 154.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.0 t -116.06 -72.65 0.68 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.12 139.97 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.815 1.646 . . . . 0.0 109.303 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.33 135.53 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -162.77 163.01 26.9 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.577 0.626 . . . . 0.0 110.703 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.6 t -102.59 123.28 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.66 138.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -132.15 151.5 51.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 107.739 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -60.01 123.23 16.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.356 1.462 . . . . 0.0 109.97 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.84 -12.9 27.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.835 0.854 . . . . 0.0 113.166 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.82 -10.77 18.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.8 p -141.93 -25.17 0.68 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.95 11.95 75.39 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.183 0.897 . . . . 0.0 110.907 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -82.31 143.92 30.95 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -55.46 125.8 22.46 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -73.07 -22.91 60.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.13 -18.28 42.84 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.936 1.255 . . . . 0.0 112.128 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.282 31.8 p90 -103.14 161.75 13.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.332 1.566 . . . . 0.0 109.573 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.38 175.03 28.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.938 1.256 . . . . 0.0 110.763 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.93 153.37 51.81 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.102 1.361 . . . . 0.0 108.96 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.65 131.22 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 126.254 1.822 . . . . 0.0 106.516 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.3 m -122.14 132.02 54.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.081 0.952 . . . . 0.0 109.368 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.96 156.29 26.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.189 1.396 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -72.59 -24.05 61.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.717 1.207 . . . . 0.0 112.959 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -131.18 156.25 45.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.23 0.923 . . . . 0.0 110.183 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -67.16 -48.39 68.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.852 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -47.72 -49.28 28.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.71 1.604 . . . . 0.0 112.881 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.77 -49.78 67.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.636 1.574 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.82 63.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.716 1.206 . . . . 0.0 112.018 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -51.38 -49.0 62.36 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.422 1.889 . . . . 0.0 109.867 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -54.23 -52.18 62.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.061 0.944 . . . . 0.0 110.54 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.22 89.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.363 -1.303 . . . . 0.0 111.755 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.4 mt -51.42 -48.05 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 121.739 2.063 . . . . 0.0 109.44 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -66.42 -60.17 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -68.57 -48.44 64.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.34 2.256 . . . . 0.0 115.516 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.41 -22.84 58.97 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.176 0.898 . . . . 0.0 111.807 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.87 97.84 0.17 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.496 1.046 . . . . 0.0 111.203 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 114.14 -7.72 23.17 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.246 -1.308 . . . . 0.0 113.857 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.27 174.54 9.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.754 1.277 . . . . 0.0 109.951 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 15.3 m95 -109.38 146.42 34.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' A' ' 116' ' ' ALA . 37.5 tp -139.58 128.37 23.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.994 2.118 . . . . 0.0 106.904 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 48.19 32.22 9.36 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.78 1.181 . . . . 0.0 114.818 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.65 -5.24 51.04 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 117.704 1.841 . . . . 0.0 117.704 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -141.76 157.58 44.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 122.037 2.919 . . . . 0.0 110.738 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 162' ' ' TRP . 39.6 mt-30 -65.93 161.21 21.78 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.296 0.997 . . . . 0.0 110.658 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.82 155.96 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.541 1.136 . . . . 0.0 108.717 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.3 p -137.2 155.37 49.61 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.992 0.917 . . . . 0.0 110.174 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -176.24 165.05 2.77 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.742 1.217 . . . . 0.0 108.719 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -73.77 122.36 22.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.222 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.339 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.8 m170 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.74 112.4 25.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.57 148.75 22.05 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.812 0.695 . . . . 0.0 111.157 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.32 140.72 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 129.07 2.948 . . . . 0.0 109.166 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -92.03 141.14 28.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.845 2.858 . . . . 0.0 107.24 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.9 143.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 -176.21 23.59 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.88 14.12 9.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.35 2.26 . . . . 0.0 113.126 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.6 mt -62.98 137.18 58.19 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.164 1.785 . . . . 0.0 112.415 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.5 t -62.85 143.46 97.1 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.24 -14.37 33.7 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.806 2.337 . . . . 0.0 114.679 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.26 -23.96 37.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.314 0.961 . . . . 0.0 111.667 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.24 143.24 12.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.62 1.568 . . . . 0.0 110.231 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.5 t -121.75 179.29 4.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.859 1.314 . . . . 0.0 110.038 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 m -57.03 -39.37 74.69 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.591 1.956 . . . . 0.0 112.145 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.51 -37.48 80.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.251 1.82 . . . . 0.0 111.417 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.03 -49.71 76.29 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.4 mt -57.58 -52.29 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -54.11 -46.58 72.17 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.163 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.99 81.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.149 0.886 . . . . 0.0 111.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -65.27 -53.05 50.04 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.852 1.261 . . . . 0.0 113.67 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -84.46 -15.55 45.66 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.18 -48.75 93.37 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.875 1.27 . . . . 0.0 112.329 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.61 -5.16 8.13 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.548 1.498 . . . . 0.0 113.479 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -99.11 -14.89 19.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.413 1.006 . . . . 0.0 111.091 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 161.31 157.96 9.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.636 1.589 . . . . 0.0 110.528 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -73.39 107.21 5.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.086 1.354 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.3 140.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 126.507 1.923 . . . . 0.0 109.229 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 p -99.8 -71.44 0.7 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.24 142.86 32.8 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 128.319 2.647 . . . . 0.0 109.823 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -162.73 131.67 4.13 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.903 1.281 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -155.42 157.3 36.81 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.223 0.92 . . . . 0.0 111.948 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.3 t -106.26 119.19 55.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.61 139.08 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 121.716 -0.615 . . . . 0.0 109.361 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -133.65 150.39 51.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.326 1.05 . . . . 0.0 108.533 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.82 137.96 52.24 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.589 0.356 . . . . 0.0 111.875 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.2 ptm -71.61 -17.83 62.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.38 -11.93 31.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.378 1.445 . . . . 0.0 114.217 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 62.1 p -140.24 -16.15 0.96 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.17 74.15 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.79 148.79 25.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 118.323 1.061 . . . . 0.0 110.48 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 123.62 14.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.293 1.437 . . . . 0.0 111.156 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -71.45 -53.82 12.7 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.232 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 141.11 -28.08 2.39 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.131 2.301 . . . . 0.0 112.78 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -102.59 161.55 13.63 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.257 1.423 . . . . 0.0 112.704 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.66 168.99 26.67 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.643 1.116 . . . . 0.0 110.382 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -132.72 142.08 48.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.578 1.151 . . . . 0.0 108.789 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.6 t -133.51 143.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.302 1.441 . . . . 0.0 107.484 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.4 t -119.94 130.58 54.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.572 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -114.43 150.23 35.04 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.441 1.096 . . . . 0.0 113.677 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -70.81 -14.76 62.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.313 1.445 . . . . 0.0 114.134 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -138.89 159.75 41.38 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.963 1.711 . . . . 0.0 108.13 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -64.64 -53.16 51.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -29.07 68.65 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 126.145 1.778 . . . . 0.0 112.661 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -64.06 -43.15 96.36 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.32 -47.33 50.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.705 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -55.69 -47.15 77.26 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.176 0.898 . . . . 0.0 110.873 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -49.95 -51.36 41.84 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 126.08 1.752 . . . . 0.0 108.002 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.53 66.72 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 117.189 -1.386 . . . . 0.0 111.936 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 78.5 mt -49.55 -48.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 122.452 2.387 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.74 -59.9 3.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.834 1.653 . . . . 0.0 112.789 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -71.31 -44.61 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.907 1.683 . . . . 0.0 115.231 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.5 mmm -72.63 -21.41 61.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 110.27 2.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.16 62.36 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.869 -1.517 . . . . 0.0 113.903 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -69.73 166.45 19.2 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.518 1.659 . . . . 0.0 108.982 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -106.27 99.2 8.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.542 1.137 . . . . 0.0 109.642 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 116' ' ' ALA . 23.3 tp -85.01 111.98 20.2 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.11 -129.87 38.19 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.93 87.81 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 115.826 -2.652 . . . . 0.0 117.497 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -147.41 157.21 43.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 123.209 3.505 . . . . 0.0 115.267 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.03 163.19 17.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.5 pt -134.92 165.8 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.013 0.911 . . . . 0.0 110.673 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -123.31 147.13 47.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.474 2.31 . . . . 0.0 105.462 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.6 p -138.22 148.35 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.44 1.096 . . . . 0.0 110.702 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -170.08 171.08 7.14 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -69.67 138.75 53.24 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 m170 . . . . . 0 C--O 1.237 0.395 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.69 100.94 6.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.73 144.52 32.13 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.39 135.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.296 1.838 . . . . 0.0 107.853 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -85.92 136.43 33.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.047 2.139 . . . . 0.0 106.492 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.41 142.52 41.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.62 179.36 25.52 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.283 0.944 . . . . 0.0 111.168 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.91 15.45 9.14 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.073 2.549 . . . . 0.0 113.901 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.48 145.59 55.93 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.857 1.263 . . . . 0.0 111.333 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 t -68.46 149.79 97.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.46 -16.75 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.038 1.825 . . . . 0.0 113.5 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -78.46 -16.59 57.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.301 1.04 . . . . 0.0 112.777 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.556 HD11 ' HA3' ' A' ' 164' ' ' GLY . 32.1 mm -70.82 121.49 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.5 1.12 . . . . 0.0 109.669 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 111' ' ' GLU . 4.7 t -99.78 -179.19 4.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.426 1.091 . . . . 0.0 109.923 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.3 m -62.93 -33.08 74.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.523 ' H ' HG23 ' A' ' 109' ' ' THR . 26.0 mt-10 -69.49 -41.81 75.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.786 0.834 . . . . 0.0 109.914 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -56.15 -49.96 72.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.745 0.818 . . . . 0.0 109.172 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.77 -54.51 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -51.91 -41.44 61.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 116.945 -1.502 . . . . 0.0 112.584 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.05 -45.97 79.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.345 0.975 . . . . 0.0 110.085 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.02 -5.99 54.57 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.02 99.74 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-O 117.471 -1.252 . . . . 0.0 114.164 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.34 -5.65 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 121.721 1.65 . . . . 0.0 112.131 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.06 -43.93 7.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 119.751 1.159 . . . . 0.0 108.806 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.84 164.27 36.32 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -80.8 118.47 22.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.43 157.99 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 126.035 1.734 . . . . 0.0 107.748 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.7 t -123.84 -69.45 0.81 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.38 130.16 47.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 107.817 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.2 137.84 9.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.051 1.296 . . . . 0.0 108.774 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.16 173.09 15.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 111.313 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.47 138.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.28 133.83 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -123.6 164.32 19.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.31 142.52 43.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.724 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.6 ptp -75.63 -29.68 59.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.788 -0.57 . . . . 0.0 109.892 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.84 -45.27 15.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -104.75 -18.36 14.29 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.94 12.26 74.93 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.978 -0.451 . . . . 0.0 113.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -85.46 155.06 21.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.481 1.112 . . . . 0.0 109.966 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 t -57.81 126.35 27.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.896 0.878 . . . . 0.0 108.849 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -70.08 -65.85 0.67 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.698 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 150.72 -18.82 0.99 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 128.152 2.786 . . . . 0.0 110.245 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -102.93 162.88 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.072 -1.252 . . . . 0.0 112.585 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.49 176.99 29.68 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.28 1.419 . . . . 0.0 110.613 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.33 151.29 46.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.603 0.761 . . . . 0.0 109.359 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 50.2 t -143.8 121.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.382 1.473 . . . . 0.0 109.072 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -107.0 125.37 50.91 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 109.317 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -105.47 159.65 15.77 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.288 1.035 . . . . 0.0 110.709 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.17 -30.0 65.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.196 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -132.02 158.78 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.773 1.17 . . . . 0.0 111.033 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -60.56 -53.94 51.43 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.03 1.332 . . . . 0.0 112.33 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -41.16 67.75 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.788 2.035 . . . . 0.0 112.619 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -58.31 -45.43 88.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.209 1.004 . . . . 0.0 109.301 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.53 -50.36 45.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.271 1.028 . . . . 0.0 110.687 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.47 -48.73 62.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.207 1.403 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -56.17 -34.93 66.65 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.53 -45.33 16.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 116.923 -1.513 . . . . 0.0 109.6 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 79.5 mt -49.03 -39.39 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 122.083 2.22 . . . . 0.0 109.747 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.69 -71.09 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.528 1.131 . . . . 0.0 111.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -64.18 -45.61 87.61 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 127.802 2.441 . . . . 0.0 116.14 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.8 mmm -76.65 -21.14 55.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.737 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.43 0.62 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 116.266 1.266 . . . . 0.0 116.266 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.93 -11.15 0.5 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.504 2.002 . . . . 0.0 112.231 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.04 167.38 11.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.174 0.987 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.25 123.04 47.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.38 118.18 32.51 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.273 1.429 . . . . 0.0 109.255 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.556 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 64.11 5.99 17.58 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.7 1.143 . . . . 0.0 113.686 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 124.6 -5.96 8.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 117.042 -1.977 . . . . 0.0 114.683 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -133.28 148.17 51.93 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.519 2.659 . . . . 0.0 112.018 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -64.49 154.78 34.85 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.496 0.718 . . . . 0.0 110.413 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 26.4 pt -128.58 163.45 33.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 110.698 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -124.84 141.37 52.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.7 p -139.52 141.78 37.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.484 1.038 . . . . 0.0 111.035 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -163.28 176.79 9.56 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.857 1.663 . . . . 0.0 108.166 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -70.38 152.9 43.59 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.149 -1.595 . . . . 0.0 109.031 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.751 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 C--O 1.238 0.459 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.07 100.16 7.04 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.957 1.303 . . . . 0.0 110.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.98 146.3 35.51 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.102 0.954 . . . . 0.0 111.545 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.2 t -129.2 141.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 129.524 3.13 . . . . 0.0 109.426 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -95.23 136.52 35.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.611 2.364 . . . . 0.0 107.578 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.444 HG12 HD21 ' A' ' 104' ' ' LEU . 7.1 t -132.33 135.3 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.68 -178.57 21.28 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 121.537 -0.727 . . . . 0.0 111.64 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.93 7.22 6.12 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.957 2.503 . . . . 0.0 113.268 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.444 HD21 HG12 ' A' ' 101' ' ' VAL . 24.6 mt -58.14 145.51 36.67 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.66 2.384 . . . . 0.0 111.36 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -67.14 148.0 98.91 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.36 -10.53 11.09 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.098 2.532 . . . . 0.0 114.4 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.18 -23.45 21.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.627 1.103 . . . . 0.0 113.002 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.8 mm -57.97 128.15 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.008 0.923 . . . . 0.0 109.395 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 111' ' ' GLU . 4.5 t -107.76 177.9 4.68 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.893 1.33 . . . . 0.0 111.131 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 m -60.23 -31.42 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.428 1.091 . . . . 0.0 111.042 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 109' ' ' THR . 5.4 mt-10 -73.7 -36.52 65.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.054 0.942 . . . . 0.0 111.267 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -60.53 -49.62 76.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.3 mt -59.44 -54.2 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -51.79 -47.26 64.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.316 0.962 . . . . 0.0 111.38 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.68 83.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.531 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -39.54 63.03 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -88.85 -10.98 46.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.016 0.926 . . . . 0.0 112.608 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.83 97.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.936 1.294 . . . . 0.0 111.236 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.22 -3.82 6.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 CA-C-N 121.872 1.704 . . . . 0.0 113.906 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.92 -15.28 18.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.216 0.916 . . . . 0.0 112.003 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.48 177.72 30.85 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 122.407 1.004 . . . . 0.0 111.702 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -74.08 131.45 41.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.21 135.75 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -74.89 0.59 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -103.53 141.5 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.846 2.059 . . . . 0.0 108.655 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.22 127.48 2.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.932 1.242 . . . . 0.0 109.03 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -154.85 162.54 41.07 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.1 0.864 . . . . 0.0 111.601 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.01 120.08 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.82 135.43 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -131.7 151.16 51.84 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.77 144.4 56.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.88 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 tpt -83.0 -19.43 37.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.036 0.835 . . . . 0.0 111.701 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.85 -9.36 37.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.002 -1.061 . . . . 0.0 113.509 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.7 p -136.79 -25.36 1.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.355 0.979 . . . . 0.0 112.398 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.0 81.22 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -92.2 156.45 17.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.884 1.342 . . . . 0.0 109.559 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -54.16 126.15 21.8 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.382 1.073 . . . . 0.0 111.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -75.36 -32.78 60.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.828 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.22 -25.52 7.39 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.714 2.578 . . . . 0.0 111.259 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -102.57 161.2 13.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.527 1.163 . . . . 0.0 112.281 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.1 172.79 28.31 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.642 1.591 . . . . 0.0 109.317 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -135.03 155.02 51.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.51 1.124 . . . . 0.0 108.555 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.8 t -145.31 146.81 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.071 2.548 . . . . 0.0 104.509 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 t -145.2 112.76 6.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.755 1.616 . . . . 0.0 109.79 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -86.88 152.39 22.49 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.588 1.155 . . . . 0.0 112.131 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -70.27 -34.82 73.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.642 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -112.52 146.86 37.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.16 1.384 . . . . 0.0 108.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.55 -49.24 74.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.42 -33.47 59.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.52 1.128 . . . . 0.0 113.913 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -62.24 -46.79 87.29 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.14 -49.41 69.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 110.186 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.47 -45.13 76.96 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.162 0.585 . . . . 0.0 110.501 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.36 -50.59 67.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.144 0.577 . . . . 0.0 110.465 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.12 78.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.413 1.485 . . . . 0.0 111.285 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 89.0 mt -51.49 -47.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 121.815 2.098 . . . . 0.0 110.375 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -67.77 -56.13 10.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 124.129 0.893 . . . . 0.0 112.109 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.05 -52.8 21.1 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.57 -17.62 64.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -75.99 79.91 1.12 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 123.793 0.711 . . . . 0.0 111.918 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 132.69 -5.75 5.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.795 2.14 . . . . 0.0 111.379 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -73.76 178.8 4.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.208 1.004 . . . . 0.0 108.77 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -118.85 150.47 39.79 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.9 tp -138.44 126.97 23.3 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.808 1.643 . . . . 0.0 106.64 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 -86.84 0.49 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.72 5.6 1.79 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.83 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -141.19 164.28 30.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.93 1.865 . . . . 0.0 112.98 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.0 160.86 31.16 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.581 1.152 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.3 pt -137.62 171.9 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.614 1.166 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.1 144.32 47.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.612 1.565 . . . . 0.0 108.026 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -136.83 137.27 39.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.843 0.747 . . . . 0.0 111.217 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -152.12 169.98 21.08 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -64.53 141.42 58.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.392 178.662 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 m170 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.44 100.89 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.428 ' CE1' ' HG ' ' A' ' 144' ' ' SER . 22.5 m-70 -86.95 142.48 27.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.334 0.588 . . . . 0.0 112.235 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.66 143.18 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.81 2.444 . . . . 0.0 108.515 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -93.78 136.04 34.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.417 2.687 . . . . 0.0 108.014 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.6 140.71 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.495 -2.78 . . . . 0.0 103.495 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 175.98 29.65 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.84 16.96 10.49 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 124.618 1.167 . . . . 0.0 112.68 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.25 149.3 45.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 0.0 110.961 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -70.83 144.49 90.72 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.45 -3.74 6.97 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 114.929 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.5 -21.83 20.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.949 1.7 . . . . 0.0 111.662 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.47 HD11 ' HA3' ' A' ' 164' ' ' GLY . 46.0 mm -67.64 134.48 30.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 127.891 2.476 . . . . 0.0 111.123 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -106.15 173.07 6.47 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.182 0.991 . . . . 0.0 108.792 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.5 m -60.24 -30.37 69.37 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.562 -1.336 . . . . 0.0 109.714 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -68.99 -32.42 71.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 110.343 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.43 -41.21 85.16 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.46 -48.42 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -55.22 -41.54 72.19 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.068 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -52.25 60.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.819 0.847 . . . . 0.0 110.928 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.89 77.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -94.93 -2.72 49.98 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.74 99.54 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.639 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.73 -2.93 9.39 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-N 121.792 1.676 . . . . 0.0 112.727 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.75 -19.55 18.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.139 0.881 . . . . 0.0 111.452 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.06 170.12 30.55 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 122.096 0.831 . . . . 0.0 112.394 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -78.14 101.94 7.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.61 1.195 . . . . 0.0 109.15 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mt -76.74 148.36 6.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 t -111.41 -73.26 0.68 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.39 136.39 41.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.943 1.697 . . . . 0.0 108.778 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -163.65 138.83 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.25 151.22 22.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.353 0.979 . . . . 0.0 111.485 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 t -99.26 117.36 44.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.99 145.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -131.51 151.26 51.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -61.66 115.88 4.32 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -58.0 -17.34 16.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.843 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.6 -7.07 28.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.4 p -139.81 -28.54 0.75 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.72 1.145 . . . . 0.0 111.869 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 13.02 71.52 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.859 1.218 . . . . 0.0 110.617 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.15 153.63 22.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.797 1.298 . . . . 0.0 108.387 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.3 t -55.8 128.44 34.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.721 0.691 . . . . 0.0 111.406 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -78.8 -17.43 55.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.03 -23.8 34.25 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.167 0.889 . . . . 0.0 112.931 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.265 27.0 p90 -102.64 159.61 15.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.366 1.583 . . . . 0.0 110.43 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.42 178.17 33.04 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.609 1.099 . . . . 0.0 110.768 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -142.49 159.84 41.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.94 151.36 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.675 1.99 . . . . 0.0 106.939 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.428 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 2.6 t -132.88 119.67 20.49 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.643 1.977 . . . . 0.0 108.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -103.69 149.59 24.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.723 1.609 . . . . 0.0 111.202 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -71.16 -35.83 71.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.196 0.998 . . . . 0.0 110.279 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -122.99 153.31 39.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.717 1.207 . . . . 0.0 111.562 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -61.44 -50.2 73.76 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 110.753 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.0 -44.4 20.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.797 2.039 . . . . 0.0 112.577 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.87 -50.12 73.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.787 1.235 . . . . 0.0 109.844 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.39 94.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.075 0.95 . . . . 0.0 110.576 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -59.4 -54.7 43.67 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.69 1.196 . . . . 0.0 109.678 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -53.92 -45.36 71.16 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.02 62.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.224 1.409 . . . . 0.0 111.803 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.33 -39.53 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.818 1.645 . . . . 0.0 110.511 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -70.02 -62.17 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -65.55 -52.16 54.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 116.406 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -71.67 -21.79 61.75 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.032 1.287 . . . . 0.0 112.746 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.15 121.92 25.64 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.859 0.743 . . . . 0.0 111.857 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.86 71.41 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 118.627 -1.096 . . . . 0.0 113.963 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.87 175.04 9.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.105 1.452 . . . . 0.0 108.68 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 8.5 m95 -105.23 157.96 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.69 120.44 9.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.47 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 71.18 -39.23 0.56 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.448 1.023 . . . . 0.0 115.178 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.79 -5.19 0.03 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.954 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -137.4 162.26 34.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.421 2.111 . . . . 0.0 109.413 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 162' ' ' TRP . 52.5 mt-30 -70.83 159.37 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.101 0.56 . . . . 0.0 110.809 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 pt -130.54 165.81 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.782 1.233 . . . . 0.0 110.248 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -121.66 147.76 45.46 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 56.0 p -133.91 142.43 47.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 108.571 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -166.31 167.56 15.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.805 1.184 . . . . 0.0 109.138 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -68.46 126.85 30.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.025 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.788 0.327 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -112.11 146.63 37.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.6 147.92 49.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.536 0.684 . . . . 0.0 111.524 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.21 138.17 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.7 2.0 . . . . 0.0 109.38 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -96.1 134.13 39.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.604 2.362 . . . . 0.0 106.036 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.37 142.2 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.59 -179.98 23.13 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.897 0.771 . . . . 0.0 111.961 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 62.0 18.76 10.2 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.701 2.0 . . . . 0.0 111.749 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.3 mt -62.42 132.61 53.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.245 1.418 . . . . 0.0 110.717 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.42 151.33 77.49 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -60.19 -24.05 75.84 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.94 2.427 . . . . 0.0 114.955 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.13 -22.52 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.08 -1.012 . . . . 0.0 113.061 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.636 HD11 ' HA3' ' A' ' 164' ' ' GLY . 44.3 mm -58.89 122.7 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.022 0.915 . . . . 0.0 111.226 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.5 t -110.66 176.11 5.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.516 1.526 . . . . 0.0 107.173 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.8 m -65.19 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 120.428 -1.42 . . . . 0.0 112.8 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -70.42 -33.49 71.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -48.25 79.55 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 110.33 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 mt -60.54 -50.33 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 26.9 mtmt -55.36 -48.16 74.66 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.591 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.38 68.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.911 0.885 . . . . 0.0 110.398 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -44.28 96.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -89.94 -8.88 50.72 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.03 -46.88 99.83 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 117.1 -1.429 . . . . 0.0 114.122 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.11 -3.83 10.48 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.115 1.791 . . . . 0.0 112.775 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.4 -11.82 22.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.601 0.637 . . . . 0.0 111.967 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.98 164.99 14.19 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -72.32 124.75 25.76 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.58 147.73 5.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.27 -65.41 1.18 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -102.4 133.71 46.89 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.904 0.882 . . . . 0.0 110.893 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.523 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -157.56 136.34 11.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.586 0.755 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -163.34 158.42 21.29 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.97 1.708 . . . . 0.0 110.642 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.72 130.44 50.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 138.15 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -132.79 158.28 42.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.484 0.714 . . . . 0.0 109.858 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -61.53 114.83 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.23 -20.33 26.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.216 1.371 . . . . 0.0 112.81 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.8 -21.13 23.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.7 p -135.71 -15.46 1.82 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.94 1.245 . . . . 0.0 114.051 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.3 86.31 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.936 1.255 . . . . 0.0 114.02 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.2 152.17 30.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.364 1.582 . . . . 0.0 109.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -54.77 126.84 25.78 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.792 0.837 . . . . 0.0 112.059 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -72.59 -52.38 15.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 143.75 -21.54 2.17 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.712 3.053 . . . . 0.0 110.449 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.269 7.1 p90 -103.13 168.59 9.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.652 1.581 . . . . 0.0 113.997 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.82 175.06 33.02 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.509 1.528 . . . . 0.0 111.005 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -135.91 147.17 48.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.48 1.112 . . . . 0.0 109.553 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.64 144.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.9 t -136.13 140.27 43.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.233 1.413 . . . . 0.0 107.438 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.11 150.77 46.52 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.443 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -67.58 -14.24 62.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.221 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -133.82 156.12 48.61 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 120.161 1.346 . . . . 0.0 110.234 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -71.37 -53.05 15.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -51.03 -34.94 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.419 2.288 . . . . 0.0 112.018 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -60.27 -54.54 44.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.011 0.924 . . . . 0.0 108.608 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.33 76.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -56.28 -48.77 75.96 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.357 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.91 -45.03 87.14 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.166 0.439 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.16 85.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.076 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 88.9 mt -54.26 -35.94 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.387 1.903 . . . . 0.0 110.312 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -76.63 -62.35 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.054 0.542 . . . . 0.0 111.656 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -63.85 -45.25 90.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.02 2.128 . . . . 0.0 114.032 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.31 -24.97 57.52 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.82 98.36 0.29 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.29 -9.41 11.03 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.878 1.228 . . . . 0.0 112.264 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -76.15 178.64 6.24 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.749 1.275 . . . . 0.0 108.469 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -121.01 158.84 26.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.25 1.42 . . . . 0.0 107.986 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 tp -154.92 130.69 10.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.636 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 70.45 -25.52 0.47 Allowed Glycine 0 N--CA 1.464 0.566 0 C-N-CA 125.208 1.385 . . . . 0.0 115.707 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.56 -2.24 0.47 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 117.791 -1.56 . . . . 0.0 113.605 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -136.81 157.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.474 2.137 . . . . 0.0 110.99 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -66.97 153.56 43.3 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.75 152.55 32.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.801 0.84 . . . . 0.0 111.008 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -106.52 145.42 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.817 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.0 p -139.04 123.32 18.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.634 1.106 . . . . 0.0 110.202 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -149.22 172.2 15.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.756 0.707 . . . . 0.0 109.603 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -66.98 130.5 43.33 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.715 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -125.45 107.07 10.29 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.005 1.322 . . . . 0.0 111.653 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -85.07 128.43 34.64 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 110.727 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.46 138.98 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.984 2.514 . . . . 0.0 106.908 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -93.53 142.18 27.63 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.659 1.983 . . . . 0.0 107.075 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.94 137.1 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.49 179.43 18.76 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.407 -0.808 . . . . 0.0 111.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.57 15.43 6.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.156 3.382 . . . . 0.0 115.007 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.69 149.26 22.32 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.732 1.613 . . . . 0.0 111.596 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.4 t -65.45 145.35 99.07 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.98 -8.3 7.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.089 2.526 . . . . 0.0 115.304 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -98.12 -16.41 19.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.806 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.663 HD11 ' HA3' ' A' ' 164' ' ' GLY . 23.5 mm -58.29 116.81 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 t -91.1 174.34 7.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.655 0.741 . . . . 0.0 109.273 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -64.15 -31.93 73.31 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.391 -1.443 . . . . 0.0 111.595 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.42 -24.96 57.17 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.554 -0.716 . . . . 0.0 111.237 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.1 -46.66 76.83 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.19 -51.41 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -53.65 -49.27 68.28 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 117.579 -1.2 . . . . 0.0 110.709 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.37 81.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.375 0.989 . . . . 0.0 111.77 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.49 92.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.67 -9.95 39.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -47.14 99.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.61 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.06 -5.83 11.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.267 1.845 . . . . 0.0 112.39 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.04 -11.24 23.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.707 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 160.21 165.8 17.79 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 120.071 1.305 . . . . 0.0 114.17 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -76.4 119.18 19.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.2 mt -94.9 149.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 t -114.38 -67.39 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.23 125.26 48.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.77 136.14 32.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -160.94 153.41 20.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 119.441 1.019 . . . . 0.0 111.873 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.6 t -106.98 115.06 47.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.7 139.1 17.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 125.182 1.393 . . . . 0.0 107.625 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -130.83 153.66 48.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.607 -0.683 . . . . 0.0 110.484 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.55 107.57 1.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.5 ptm -54.03 -13.97 0.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 -19.04 17.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.688 1.131 . . . . 0.0 112.816 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 p -130.24 -22.44 2.81 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.98 16.97 73.52 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.605 2.05 . . . . 0.0 112.716 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -84.77 155.22 21.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 1.435 . . . . 0.0 109.105 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.9 t -62.95 122.4 15.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.882 0.31 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -71.5 -25.4 62.25 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.34 38.48 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.003 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -103.79 165.95 10.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.256 2.028 . . . . 0.0 110.506 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.52 177.4 33.51 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.841 0.734 . . . . 0.0 111.819 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -135.5 148.24 49.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.09 1.356 . . . . 0.0 109.698 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.7 t -137.43 120.17 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.138 1.775 . . . . 0.0 107.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -105.27 114.23 28.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.259 1.823 . . . . 0.0 108.898 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.93 148.95 23.45 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.66 1.184 . . . . 0.0 109.12 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -67.88 -40.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.211 0.604 . . . . 0.0 110.243 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -110.91 145.54 38.14 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.03 0.932 . . . . 0.0 112.183 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.32 -46.94 86.45 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.012 0.925 . . . . 0.0 112.141 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -34.26 69.4 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.485 1.114 . . . . 0.0 112.966 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.05 -47.49 79.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.39 71.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.968 1.307 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.51 -47.91 78.32 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.504 0.721 . . . . 0.0 110.293 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -55.57 -49.3 73.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.63 72.56 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 81.4 mt -49.91 -44.42 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.633 1.561 . . . . 0.0 110.221 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -73.09 -58.24 3.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.193 0.997 . . . . 0.0 113.294 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -68.58 -51.06 46.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.403 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -67.69 -20.79 65.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.191 0.905 . . . . 0.0 112.749 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.98 90.29 0.58 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.86 -6.15 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.776 1.655 . . . . 0.0 111.752 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -86.84 172.85 9.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.946 0.873 . . . . 0.0 110.172 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -113.03 154.77 25.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.997 1.319 . . . . 0.0 109.199 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.0 tp -153.71 128.01 9.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.593 1.557 . . . . 0.0 107.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.663 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 63.92 22.96 67.13 Favored Glycine 0 N--CA 1.464 0.504 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.401 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 98.38 -2.75 59.35 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 115.956 -2.58 . . . . 0.0 115.836 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -140.4 160.91 38.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 121.525 2.663 . . . . 0.0 111.655 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.73 159.08 28.65 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.76 154.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.477 1.111 . . . . 0.0 109.112 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -115.99 129.76 56.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.5 p -116.7 153.61 32.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.248 1.419 . . . . 0.0 108.961 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -175.51 166.57 3.26 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.733 1.213 . . . . 0.0 108.928 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -70.12 126.13 28.79 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.221 0 CA-C-N 118.27 0.486 . . . . 0.0 110.75 179.402 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 . . . . . 0 C--O 1.237 0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -99.74 101.45 12.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.27 154.5 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.413 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 110.745 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.96 129.52 34.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.13 137.69 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.93 -176.98 21.15 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 61.84 18.89 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.627 1.971 . . . . 0.0 112.627 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 mt -69.86 151.24 45.92 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.473 -1.392 . . . . 0.0 110.909 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -67.63 146.41 98.53 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.44 -4.36 6.62 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.626 2.884 . . . . 0.0 113.682 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -96.81 -21.34 17.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.882 1.273 . . . . 0.0 111.156 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.3 132.38 23.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.309 1.044 . . . . 0.0 108.953 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -112.13 172.17 7.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.227 1.013 . . . . 0.0 108.809 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -56.3 -29.85 61.77 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.146 1.378 . . . . 0.0 110.776 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -73.03 -34.94 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.704 0.801 . . . . 0.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.47 -49.13 74.84 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mt -59.17 -49.57 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -54.92 -42.32 72.08 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.656 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.97 77.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.828 0.74 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.53 98.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -89.42 -14.52 35.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.349 0.66 . . . . 0.0 112.354 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.72 99.51 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.047 0.939 . . . . 0.0 113.405 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.72 -6.68 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 121.396 1.534 . . . . 0.0 112.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.89 -18.59 17.05 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.364 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 168.23 169.34 31.58 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 119.57 1.077 . . . . 0.0 112.04 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -74.41 124.01 25.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.7 mt -100.1 150.48 5.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.58 -61.55 1.6 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -101.41 140.5 35.61 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.7 5.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.421 1.088 . . . . 0.0 108.384 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -162.77 161.64 26.29 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.713 1.205 . . . . 0.0 110.74 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.47 134.66 53.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.46 144.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -133.9 162.88 30.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.556 1.143 . . . . 0.0 109.583 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -71.31 119.14 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.447 1.499 . . . . 0.0 107.589 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.4 ptp -59.18 -16.59 21.28 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.65 -13.92 20.09 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.2 p -137.6 -15.46 1.4 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.306 1.412 . . . . 0.0 113.975 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.64 14.34 81.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.57 1.081 . . . . 0.0 110.904 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.92 141.58 37.48 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.834 1.253 . . . . 0.0 108.567 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.29 123.36 14.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.094 0.957 . . . . 0.0 112.209 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.56 -42.68 64.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.22 -15.27 7.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.757 1.17 . . . . 0.0 112.621 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.027 1.413 . . . . 0.0 108.075 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.05 33.74 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.813 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -131.89 156.4 46.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.323 1.062 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.67 135.22 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.4 m -123.96 112.74 17.57 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.425 1.09 . . . . 0.0 108.16 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -97.53 155.6 16.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.24 0.962 . . . . 0.0 110.025 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.72 -41.51 62.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -103.1 147.44 26.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.004 0.522 . . . . 0.0 111.751 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.468 ' HE3' ' CH2' ' A' ' 172' ' ' TRP . 11.0 tptm -64.42 -46.69 82.14 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.989 0.916 . . . . 0.0 109.248 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -33.3 68.6 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.538 1.535 . . . . 0.0 113.606 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.61 -49.82 71.83 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.47 -51.74 67.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.183 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -51.67 -52.65 46.4 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.116 0.966 . . . . 0.0 111.615 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -55.07 -50.47 69.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.104 0.562 . . . . 0.0 110.283 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.98 86.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 117.281 -1.342 . . . . 0.0 110.399 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.75 -36.98 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 123.513 2.869 . . . . 0.0 110.968 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -76.27 -65.19 0.95 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -62.37 -49.49 75.32 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.638 1.975 . . . . 0.0 114.3 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 86.0 mmm -68.95 -28.8 66.96 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.79 78.26 0.2 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.69 1.138 . . . . 0.0 114.633 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.26 -15.24 2.09 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.567 2.032 . . . . 0.0 111.802 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -71.58 171.37 11.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.039 0.92 . . . . 0.0 109.792 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -109.45 143.45 39.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.31 121.37 24.6 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.55 -57.48 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.03 1.776 . . . . 0.0 111.488 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.48 2.06 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.809 -1.55 . . . . 0.0 115.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -143.84 157.86 44.08 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.66 2.73 . . . . 0.0 112.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -67.49 136.17 54.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.246 0.618 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.0 166.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.272 1.035 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.49 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.898 1.679 . . . . 0.0 107.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 39.2 p -137.18 134.84 36.76 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.27 170.78 21.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.468 ' CH2' ' HE3' ' A' ' 148' ' ' LYS . 22.2 m95 -62.18 128.2 34.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.002 0.819 . . . . 0.0 109.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.324 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.948 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.6 m170 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -105.56 143.25 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -109.84 153.5 24.33 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.077 0.551 . . . . 0.0 112.062 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.45 148.72 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.712 2.005 . . . . 0.0 110.39 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -100.22 139.78 35.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.349 2.66 . . . . 0.0 107.014 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.03 129.5 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.47 179.87 17.66 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 111.94 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 64.34 9.95 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.74 3.216 . . . . 0.0 113.784 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.4 146.3 16.17 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.953 1.301 . . . . 0.0 111.04 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.5 t -63.04 141.23 97.71 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.06 -15.55 18.03 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.937 2.425 . . . . 0.0 114.928 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.79 -17.95 39.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 113.054 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.64 HD11 ' HA3' ' A' ' 164' ' ' GLY . 27.9 mm -58.51 135.22 23.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.243 1.417 . . . . 0.0 110.724 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 111' ' ' GLU . 1.3 t -116.53 176.33 5.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.985 0.898 . . . . 0.0 111.488 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 -35.25 72.64 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.082 -1.011 . . . . 0.0 111.458 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' H ' HG23 ' A' ' 109' ' ' THR . 8.6 mt-10 -79.97 -18.12 51.18 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.317 0.647 . . . . 0.0 111.329 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.94 -50.09 21.64 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 mt -57.96 -50.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -54.87 -47.71 73.9 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.539 -1.22 . . . . 0.0 110.903 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.6 -33.87 70.49 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.691 1.132 . . . . 0.0 111.898 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.22 -46.37 64.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.923 0.889 . . . . 0.0 112.246 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -92.51 -1.66 56.79 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.41 95.37 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.876 1.67 . . . . 0.0 112.334 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.65 -0.57 5.41 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 121.091 1.425 . . . . 0.0 113.75 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -98.64 -10.75 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.955 0.798 . . . . 0.0 111.156 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.19 175.57 19.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 35.4 mtt180 -70.56 137.95 50.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.172 -0.605 . . . . 0.0 110.017 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.95 138.41 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.5 t -100.47 -72.93 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 144' ' ' SER . 6.9 t70 -102.43 142.52 33.51 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.08 1.752 . . . . 0.0 110.235 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.68 129.1 2.56 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.064 0.847 . . . . 0.0 109.409 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -162.26 150.85 14.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.618 0.367 . . . . 0.0 111.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.06 136.99 23.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.11 146.78 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -139.53 145.8 39.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -67.43 129.65 40.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -65.59 -18.78 65.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.466 0.706 . . . . 0.0 111.465 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.41 -12.43 22.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -134.3 -18.9 1.97 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.358 0.981 . . . . 0.0 113.287 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.49 72.78 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.94 153.62 18.23 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -59.91 130.15 45.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -20.57 57.45 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.466 -0.778 . . . . 0.0 111.947 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.16 -30.2 10.88 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.98 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -101.89 163.86 12.03 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.527 1.164 . . . . 0.0 108.315 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.7 171.64 27.43 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.849 1.69 . . . . 0.0 109.091 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -136.02 146.66 47.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -133.61 158.69 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.856 1.663 . . . . 0.0 106.726 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 125' ' ' ASP . 32.4 t -143.18 135.4 27.11 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.45 166.28 15.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.448 0.699 . . . . 0.0 111.12 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 122' ' ' ARG . 82.4 m-85 -79.66 -26.42 41.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 117.753 -1.117 . . . . 0.0 113.939 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.35 150.76 45.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.814 1.643 . . . . 0.0 110.714 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -62.25 -48.6 79.22 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.114 0.483 . . . . 0.0 110.153 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -29.66 67.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.973 1.309 . . . . 0.0 112.615 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.03 -54.65 38.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.83 -57.88 11.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.201 2.2 . . . . 0.0 111.838 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.23 -51.49 25.23 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.364 1.466 . . . . 0.0 111.387 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -55.06 -45.69 75.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.412 0.445 . . . . 0.0 111.257 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.96 78.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.559 -1.21 . . . . 0.0 110.85 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.5 mt -52.02 -44.42 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 120.634 1.561 . . . . 0.0 108.069 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -68.08 -61.45 1.85 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.186 1.394 . . . . 0.0 111.678 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.7 -60.04 4.06 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.92 2.088 . . . . 0.0 114.465 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.31 -20.35 66.03 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.29 1.036 . . . . 0.0 113.665 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.11 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.46 49.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.593 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -69.72 167.56 16.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.44 1.62 . . . . 0.0 108.218 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -108.81 141.95 40.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.7 tp -140.97 129.55 22.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.64 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 79.56 -53.87 4.3 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.668 1.127 . . . . 0.0 110.326 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.11 6.15 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.429 1.014 . . . . 0.0 113.809 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -136.31 159.02 43.02 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.867 1.834 . . . . 0.0 108.595 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -68.15 166.04 16.99 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.44 145.35 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 109.351 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 ptt-85 -108.41 136.53 47.88 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 p -122.6 153.37 39.39 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.023 1.329 . . . . 0.0 108.191 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -173.21 165.86 4.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.843 0.857 . . . . 0.0 109.124 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -66.64 120.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-N 118.326 0.512 . . . . 0.0 111.177 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m170 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.42 100.34 8.24 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.35 131.4 36.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.05 141.72 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 128.102 2.561 . . . . 0.0 109.521 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -88.89 131.0 35.31 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 127.013 2.125 . . . . 0.0 105.671 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.33 139.33 51.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.39 -177.94 22.26 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.268 77.1 m-20 68.12 13.93 9.19 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.62 1.968 . . . . 0.0 113.251 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.7 mt -64.53 140.06 58.83 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 t -67.89 150.14 97.91 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -60.76 -4.05 3.23 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.809 3.006 . . . . 0.0 114.927 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.85 -17.12 17.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.016 1.326 . . . . 0.0 111.783 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.3 mm -61.85 136.9 24.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.03 1.332 . . . . 0.0 109.517 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -108.57 174.52 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.033 0.92 . . . . 0.0 108.715 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -64.67 -27.54 68.99 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.547 -1.345 . . . . 0.0 110.647 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.91 -32.66 67.61 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.86 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.32 -47.29 84.92 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mt -60.11 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 22.0 mtmt -53.53 -47.63 69.8 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 120.329 -1.482 . . . . 0.0 111.97 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.51 93.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.755 0.822 . . . . 0.0 111.633 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -58.55 -45.87 88.03 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.711 1.204 . . . . 0.0 113.602 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -89.56 -10.77 44.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 113.035 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.05 -47.56 98.56 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 124.817 1.247 . . . . 0.0 112.192 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.91 -7.16 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 121.791 1.675 . . . . 0.0 113.184 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.64 -13.28 20.41 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.428 1.013 . . . . 0.0 112.003 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 159.19 174.09 28.46 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 120.541 1.519 . . . . 0.0 112.724 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -71.7 127.55 32.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.9 mt -102.16 139.51 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.8 p -99.29 -79.02 0.49 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.66 126.05 49.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.764 2.826 . . . . 0.0 110.793 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.411 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -149.05 140.31 23.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.664 1.186 . . . . 0.0 107.943 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -162.7 151.54 14.86 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 t -94.32 127.26 46.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.18 141.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -125.63 161.03 28.15 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.885 1.326 . . . . 0.0 110.22 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.29 130.37 40.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.633 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -7.97 55.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 -21.81 12.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.626 1.103 . . . . 0.0 112.208 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -131.68 -8.24 3.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 31.31 78.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.209 -0.773 . . . . 0.0 112.143 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -100.98 157.19 16.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.192 1.397 . . . . 0.0 108.235 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -62.08 125.9 25.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.215 0.916 . . . . 0.0 111.314 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -74.65 -21.05 59.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.49 -15.7 55.73 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.36 1.457 . . . . 0.0 113.027 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.256 49.5 p90 -103.02 163.36 12.26 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.277 1.539 . . . . 0.0 109.282 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.5 169.3 32.8 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.337 -0.852 . . . . 0.0 111.384 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -129.77 149.82 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.913 0.885 . . . . 0.0 109.111 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.43 138.81 47.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 131.81 53.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.81 155.75 31.97 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.172 0.989 . . . . 0.0 109.744 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -76.39 -20.02 57.56 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.094 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -129.45 151.14 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.865 1.211 . . . . 0.0 112.781 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.543 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 7.6 ttmt -68.95 -50.74 46.62 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 110.196 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -47.71 69.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.097 1.359 . . . . 0.0 113.271 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -60.61 -46.93 88.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.41 83.29 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.961 1.305 . . . . 0.0 109.981 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -57.09 -45.67 83.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.82 1.248 . . . . 0.0 110.448 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -53.62 -48.05 69.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.55 87.82 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.936 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.7 mt -55.21 -37.93 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 121.804 2.093 . . . . 0.0 110.274 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -72.71 -65.77 0.75 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.616 0.766 . . . . 0.0 111.427 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -67.07 -44.41 80.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.872 2.069 . . . . 0.0 116.547 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -77.79 -20.79 52.66 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.831 1.196 . . . . 0.0 112.872 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.21 112.35 4.64 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.31 -9.54 65.04 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -70.91 169.71 14.2 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 119.753 1.776 . . . . 0.0 109.842 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -104.65 132.11 51.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 108.941 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 116' ' ' ALA . 21.9 tp -123.83 118.95 28.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 108.143 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.82 -6.51 1.4 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.273 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.0 3.61 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.232 1.516 . . . . 0.0 115.331 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.796 2.298 . . . . 0.0 110.342 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.37 163.03 11.33 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.448 0.468 . . . . 0.0 109.976 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.23 153.76 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.753 1.221 . . . . 0.0 109.756 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -113.74 142.86 45.52 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.4 p -136.89 135.99 38.31 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.552 0.741 . . . . 0.0 109.524 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.46 174.08 15.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.218 0.607 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.543 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 83.9 m95 -70.57 118.24 13.11 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.538 -1.352 . . . . 0.0 108.153 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 118.78 0.718 . . . . 0.0 109.077 179.3 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--O 1.236 0.359 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.13 100.65 6.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 144' ' ' SER . 1.3 m80 -71.38 167.29 19.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.369 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.32 142.94 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 127.875 2.47 . . . . 0.0 106.561 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -103.65 137.06 42.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -132.72 140.25 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 -179.26 21.15 Favored Glycine 0 N--CA 1.454 -0.153 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.26 4.69 2.22 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.466 2.306 . . . . 0.0 113.258 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -51.2 139.09 19.26 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 110.527 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 t -62.59 145.26 95.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.49 -18.1 37.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.489 2.793 . . . . 0.0 115.136 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.62 -13.21 43.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.084 -1.01 . . . . 0.0 112.652 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.66 138.71 22.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.5 t -118.45 175.13 5.86 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.502 1.144 . . . . 0.0 109.117 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.3 m -58.92 -30.15 67.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.226 1.01 . . . . 0.0 111.748 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.75 -43.37 68.96 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 125.92 1.688 . . . . 0.0 110.878 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.74 -51.92 65.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.214 1.405 . . . . 0.0 109.28 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.67 -48.14 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.59 -45.24 69.95 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.814 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.27 -45.94 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.084 0.856 . . . . 0.0 110.796 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.67 -47.54 85.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 113.197 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -87.35 -10.89 50.95 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.39 -48.52 95.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.66 -3.3 6.47 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 CA-C-N 121.47 1.561 . . . . 0.0 112.959 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.88 -17.71 18.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.069 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.57 162.17 16.21 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.584 1.084 . . . . 0.0 111.503 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -73.65 120.53 19.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.62 153.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.5 t -117.31 -68.44 0.92 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -102.03 145.04 29.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.469 1.107 . . . . 0.0 108.891 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.04 129.85 2.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.2 158.16 32.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.473 0.654 . . . . 0.0 110.777 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.22 120.1 56.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.43 141.8 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 137' ' ' SER . 46.0 mttm -135.41 157.3 47.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.5 ptp -59.88 -20.47 57.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.59 -9.22 16.65 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -131.83 -19.55 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.048 1.295 . . . . 0.0 113.083 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.81 2.41 56.96 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.291 0.948 . . . . 0.0 112.865 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -80.05 148.55 31.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' A' ' 130' ' ' LYS . 17.8 m -63.78 134.79 55.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.507 1.146 . . . . 0.0 112.33 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -77.71 -13.7 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.534 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.9 55.23 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.016 -1.435 . . . . 0.0 113.464 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -102.52 165.1 11.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.019 1.41 . . . . 0.0 109.112 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.32 179.79 28.55 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.471 1.034 . . . . 0.0 111.966 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.28 154.04 51.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 109.089 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -145.83 149.3 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 37.9 t -142.48 115.49 8.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.005 1.722 . . . . 0.0 107.393 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.91 158.17 15.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.805 1.242 . . . . 0.0 111.391 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.1 -14.83 61.95 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.66 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -143.56 156.84 44.71 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.857 1.208 . . . . 0.0 110.195 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.8 tttt -68.49 -43.03 77.77 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.923 1.289 . . . . 0.0 111.93 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.51 -41.75 66.66 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 111.658 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -62.15 -48.98 77.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.901 1.28 . . . . 0.0 108.893 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.56 66.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.367 1.067 . . . . 0.0 110.311 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.37 -50.0 63.29 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.844 1.658 . . . . 0.0 109.753 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -55.41 -55.4 32.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.552 1.141 . . . . 0.0 109.16 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.48 91.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.748 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.52 -49.26 44.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 121.136 1.789 . . . . 0.0 108.411 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.31 -67.22 0.46 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.132 0.573 . . . . 0.0 111.991 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -58.93 -50.43 74.07 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 83.8 mmm -69.29 -17.75 63.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.346 0.975 . . . . 0.0 111.95 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.26 79.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.445 2.45 . . . . 0.0 113.37 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 126.78 -8.74 7.25 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.062 1.791 . . . . 0.0 112.627 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -70.99 170.32 13.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.033 1.417 . . . . 0.0 109.67 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -111.14 150.79 28.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.385 1.074 . . . . 0.0 109.991 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 47.0 tp -155.51 130.1 9.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.805 2.042 . . . . 0.0 106.505 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.1 27.3 71.22 Favored Glycine 0 N--CA 1.465 0.59 0 O-C-N 121.49 -0.756 . . . . 0.0 114.032 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.78 4.4 87.34 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.439 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -137.57 155.35 49.31 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.81 2.305 . . . . 0.0 110.899 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -71.55 160.44 32.7 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.57 169.96 15.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -123.63 152.24 42.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.9 p -141.83 150.21 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 107.575 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -175.52 171.12 2.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -67.17 111.36 3.88 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.582 -0.699 . . . . 0.0 109.817 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 C-N-CA 124.549 1.14 . . . . 0.0 110.843 179.427 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 m80 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.6 99.23 7.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.0 127.4 32.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 113.338 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.55 148.21 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 126.788 2.035 . . . . 0.0 108.091 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -105.01 136.62 44.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 129.471 3.109 . . . . 0.0 106.95 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -129.27 142.83 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -149.84 -178.83 25.14 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.04 1.97 2.98 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.854 2.461 . . . . 0.0 114.382 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -50.19 149.26 2.97 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.829 2.452 . . . . 0.0 113.681 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 161.76 68.1 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.83 -29.44 15.46 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.145 1.23 . . . . 0.0 113.111 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.41 -16.94 61.84 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.851 1.66 . . . . 0.0 114.117 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -59.74 117.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.668 1.187 . . . . 0.0 110.116 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -100.3 171.03 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 127' ' ' ARG . 85.3 m -55.1 -30.95 60.78 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 121.019 -1.05 . . . . 0.0 111.53 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.71 -33.75 64.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.122 0.969 . . . . 0.0 111.761 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -47.98 83.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.6 mt -61.22 -55.55 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.426 ' HE3' HG22 ' A' ' 110' ' ' THR . 22.5 mtmt -51.68 -47.93 63.65 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.501 1.046 . . . . 0.0 112.301 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.12 72.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.596 0.758 . . . . 0.0 112.14 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.409 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -73.08 -43.85 61.28 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.364 1.066 . . . . 0.0 112.014 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.26 -9.58 47.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.824 1.249 . . . . 0.0 112.851 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.3 99.54 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 126.6 1.96 . . . . 0.0 113.318 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.9 -0.84 9.04 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.501 1.572 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.66 -25.18 14.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.087 0.858 . . . . 0.0 110.967 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.44 34.7 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 121.137 -0.977 . . . . 0.0 111.201 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -77.78 117.45 19.18 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -88.4 145.3 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 p -100.54 -81.42 0.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -103.04 141.46 35.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.299 1.84 . . . . 0.0 111.196 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.13 141.85 5.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.106 2.163 . . . . 0.0 108.065 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.485 ' HA ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -161.9 169.6 20.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.784 1.234 . . . . 0.0 109.136 178.403 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.98 124.98 67.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.443 HG21 ' CD2' ' A' ' 140' ' ' TYR . 47.9 t -64.88 140.78 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.37 148.21 50.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 59.6 t0 -59.02 131.14 50.16 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.7 tpt -59.78 -30.41 68.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.366 0.53 . . . . 0.0 112.25 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.12 -41.05 9.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.3 p -95.85 -15.87 22.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.15 0.886 . . . . 0.0 112.943 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.92 12.52 57.46 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.283 0.944 . . . . 0.0 112.584 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.92 150.01 27.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.888 1.275 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 t -56.15 109.66 0.63 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.323 2.249 . . . . 0.0 109.142 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 131' ' ' ASP . 20.7 mttt -67.81 -23.4 65.18 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.47 -18.84 46.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.443 ' CD2' HG21 ' A' ' 129' ' ' VAL 0.288 27.5 p90 -103.21 157.9 16.69 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.635 -1.509 . . . . 0.0 109.71 176.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.22 176.6 25.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.564 1.554 . . . . 0.0 111.077 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.77 152.0 44.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.02 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.0 t -147.25 130.65 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 108.027 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -118.77 127.81 53.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.744 2.018 . . . . 0.0 107.011 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.55 165.69 12.25 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.701 1.137 . . . . 0.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -74.43 -9.57 58.72 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.575 -0.703 . . . . 0.0 112.512 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -146.59 165.86 28.25 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.595 1.088 . . . . 0.0 112.09 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -73.85 -47.28 39.49 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.802 1.241 . . . . 0.0 111.543 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -39.06 76.9 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.702 0.801 . . . . 0.0 111.935 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.66 -48.42 77.64 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -54.89 15.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.322 1.849 . . . . 0.0 111.45 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -55.87 -44.15 77.83 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.176 0.99 . . . . 0.0 111.918 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.74 -45.26 86.07 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.74 79.62 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.684 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.69 -37.62 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 120.354 1.434 . . . . 0.0 110.399 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -73.07 -67.6 0.56 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.417 1.087 . . . . 0.0 110.632 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -58.69 -57.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.467 2.307 . . . . 0.0 114.295 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -65.34 -24.51 67.28 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.48 90.47 0.12 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.222 0.915 . . . . 0.0 111.971 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.49 -6.88 9.79 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.193 1.378 . . . . 0.0 113.308 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -74.97 174.3 9.51 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.093 1.446 . . . . 0.0 109.481 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -109.74 129.35 55.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' A' ' 116' ' ' ALA . 39.3 tp -125.25 124.22 41.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.901 1.68 . . . . 0.0 108.934 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.1 -59.21 1.84 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 125.005 1.288 . . . . 0.0 111.554 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.75 -3.04 0.03 OUTLIER Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.947 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -141.49 165.98 26.02 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.384 2.092 . . . . 0.0 111.5 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -67.57 161.67 25.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.351 0.66 . . . . 0.0 110.645 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.7 pt -138.71 157.64 29.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.533 1.133 . . . . 0.0 109.977 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -122.32 148.02 45.54 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.1 p -138.91 134.66 33.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.649 1.113 . . . . 0.0 110.409 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -157.02 176.92 12.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.571 1.148 . . . . 0.0 108.895 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -74.44 133.75 42.39 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.593 -1.317 . . . . 0.0 110.47 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.174 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m170 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.41 109.91 13.89 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -91.03 150.32 21.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.658 0.742 . . . . 0.0 111.733 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.2 t -129.39 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.126 1.77 . . . . 0.0 108.907 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -101.3 143.29 31.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.996 3.318 . . . . 0.0 106.753 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.78 146.39 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.89 173.91 26.04 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 119.031 0.832 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.5 t0 61.38 17.81 8.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.986 2.914 . . . . 0.0 114.211 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.451 HD13 HD11 ' A' ' 113' ' ' ILE . 12.9 mt -59.31 135.68 57.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.343 1.457 . . . . 0.0 110.143 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 t -60.12 148.48 77.98 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.21 52.23 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.665 1.576 . . . . 0.0 113.364 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -76.48 -29.85 57.05 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.862 0.756 . . . . 0.0 110.591 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.31 115.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.517 1.527 . . . . 0.0 108.986 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 t -100.05 174.39 6.19 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.138 1.375 . . . . 0.0 109.714 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.4 m -57.76 -36.84 72.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.317 -0.864 . . . . 0.0 111.463 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.59 -44.36 78.31 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.08 1.352 . . . . 0.0 109.981 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.63 80.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.276 1.03 . . . . 0.0 109.666 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 104' ' ' LEU . 10.9 mt -60.14 -50.55 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -52.78 -48.05 67.12 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.259 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.14 -34.68 70.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.658 1.117 . . . . 0.0 111.675 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.74 -45.82 60.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.285 1.034 . . . . 0.0 111.503 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -87.69 -4.49 58.91 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.54 94.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.655 2.382 . . . . 0.0 114.664 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.21 -1.34 7.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 122.181 1.815 . . . . 0.0 112.516 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.4 -9.5 25.15 Favored 'General case' 0 N--CA 1.461 0.116 0 O-C-N 121.175 -0.953 . . . . 0.0 111.503 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.46 -155.83 26.54 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 111.832 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -100.27 131.24 46.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.384 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.18 133.63 43.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.726 1.61 . . . . 0.0 108.772 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.7 p -99.8 -73.03 0.65 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -103.47 148.99 25.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.288 1.835 . . . . 0.0 109.053 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.62 4.21 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.899 1.28 . . . . 0.0 108.967 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.8 ptm85 -161.01 147.67 15.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.44 0.564 . . . . 0.0 112.173 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.02 120.18 40.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.37 137.58 24.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -136.25 160.93 37.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.92 135.78 54.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -68.87 -14.37 62.99 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.773 -0.58 . . . . 0.0 110.015 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.5 17.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.079 1.752 . . . . 0.0 115.157 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 p -136.72 -23.32 1.21 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 112.254 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.8 4.54 62.26 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.345 -1.253 . . . . 0.0 110.839 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -81.82 150.9 27.63 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.93 1.865 . . . . 0.0 108.467 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 t -56.35 120.4 7.58 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -70.55 -35.3 73.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 127.89 -29.63 4.13 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.987 1.755 . . . . 0.0 110.404 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -102.15 166.51 10.56 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.601 1.16 . . . . 0.0 111.749 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.85 170.84 31.29 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.419 1.485 . . . . 0.0 110.173 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -129.38 150.15 50.86 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.091 1.356 . . . . 0.0 108.523 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.78 159.8 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 127.515 2.326 . . . . 0.0 105.028 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.9 t -142.63 130.75 21.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.806 2.042 . . . . 0.0 107.721 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.52 134.84 54.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.111 1.364 . . . . 0.0 109.368 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -64.31 -39.41 93.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.425 0.69 . . . . 0.0 109.639 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -111.11 145.64 38.22 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.04 1.336 . . . . 0.0 107.905 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.39 -45.11 81.13 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -38.66 55.75 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 112.882 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.83 -49.93 75.49 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.4 77.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.25 -51.31 67.03 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.115 0.566 . . . . 0.0 110.82 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.85 -48.82 74.84 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.34 70.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.995 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.24 -42.07 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 121.006 1.73 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -77.52 -36.94 51.95 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -87.93 -53.46 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.137 1.375 . . . . 0.0 112.044 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 72.7 mmm -68.28 -21.62 64.78 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.881 0.764 . . . . 0.0 112.329 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 109.03 1.96 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 124.478 1.037 . . . . 0.0 111.266 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.25 -6.35 66.01 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.155 -0.803 . . . . 0.0 113.611 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -73.05 179.15 3.92 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.34 1.07 . . . . 0.0 109.176 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.52 152.67 27.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.885 0.874 . . . . 0.0 109.041 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.1 tp -158.87 131.21 6.77 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.229 2.212 . . . . 0.0 105.66 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.9 30.23 77.1 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 119.085 0.857 . . . . 0.0 111.074 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.68 14.14 72.29 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.228 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -135.19 150.61 50.16 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.876 1.838 . . . . 0.0 109.339 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 21.1 pt -130.09 172.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.27 1.028 . . . . 0.0 108.989 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -131.62 154.4 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.982 1.713 . . . . 0.0 107.304 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.4 p -142.92 147.28 35.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.709 0.804 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -167.19 167.37 14.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -69.44 136.06 51.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.526 1.057 . . . . 0.0 108.322 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.9 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.33 114.45 20.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.23 1.412 . . . . 0.0 107.246 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 132.7 34.74 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.337 1.055 . . . . 0.0 111.506 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.87 144.97 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.501 2.32 . . . . 0.0 109.013 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.84 139.03 38.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 127.455 2.302 . . . . 0.0 106.552 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.423 HG12 HD21 ' A' ' 104' ' ' LEU . 2.5 t -134.94 143.9 36.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.71 173.54 26.89 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.582 1.083 . . . . 0.0 113.91 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 57.45 23.26 8.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 129.085 2.954 . . . . 0.0 115.289 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.423 HD21 HG12 ' A' ' 101' ' ' VAL . 27.5 mt -60.95 145.82 49.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.513 1.525 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t -59.38 143.75 85.01 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.69 -15.5 31.89 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.595 2.197 . . . . 0.0 116.294 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.05 -28.9 29.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.932 1.693 . . . . 0.0 111.551 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -56.42 113.73 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.656 1.582 . . . . 0.0 110.57 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -97.52 179.43 4.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.135 0.969 . . . . 0.0 109.241 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 127' ' ' ARG . 23.8 m -55.97 -33.08 64.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.632 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -69.3 -46.8 66.29 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 110.057 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.84 -44.49 73.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 110.186 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.67 -54.65 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -50.65 -51.05 52.72 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.871 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.92 69.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.089 1.356 . . . . 0.0 111.257 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.59 96.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -90.8 -7.78 51.43 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.29 94.61 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.806 1.642 . . . . 0.0 113.282 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.79 -0.96 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 121.251 1.482 . . . . 0.0 113.099 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.97 -34.56 10.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.403 1.001 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.13 177.9 47.2 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 122.991 1.328 . . . . 0.0 111.473 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 87.2 mtt180 -74.35 123.11 24.0 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.756 -1.222 . . . . 0.0 107.938 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 126' ' ' ALA . 60.5 mt -101.17 154.71 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.2 t -125.73 -65.33 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -102.02 134.6 44.97 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 123' ' ' ILE . . . -164.94 128.94 2.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' HA ' HG23 ' A' ' 110' ' ' THR . 14.4 ptt180 -162.99 170.91 17.32 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.109 0.564 . . . . 0.0 111.724 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.93 130.26 51.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.536 1.534 . . . . 0.0 107.936 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 135.5 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -134.81 160.28 38.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.29 158.42 35.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.302 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.6 ptm -91.02 -16.22 28.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.792 1.237 . . . . 0.0 113.491 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.4 -26.64 11.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.872 1.214 . . . . 0.0 112.706 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.5 p -114.84 -19.75 10.87 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.87 50.36 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 121.655 0.586 . . . . 0.0 112.746 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.62 145.59 34.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -66.1 139.0 58.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.631 0.729 . . . . 0.0 112.274 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -81.75 -8.68 59.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.242 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.9 -12.91 65.96 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 124.43 1.014 . . . . 0.0 112.723 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.292 3.2 p90 -102.96 169.35 8.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.777 1.788 . . . . 0.0 109.876 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 178.44 30.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.356 0.503 . . . . 0.0 112.33 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.9 148.15 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.256 1.422 . . . . 0.0 108.117 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.99 124.83 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.035 1.734 . . . . 0.0 106.939 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.9 m -109.62 125.92 53.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.815 1.189 . . . . 0.0 108.69 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -109.98 148.52 31.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 122' ' ' ARG . 62.9 m-85 -69.63 -17.92 63.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.334 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -132.03 148.52 52.51 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.703 1.138 . . . . 0.0 109.124 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -63.62 -55.72 21.42 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.247 0.619 . . . . 0.0 109.497 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -39.53 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.687 1.595 . . . . 0.0 113.107 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.19 -48.25 80.87 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.66 74.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.772 0.829 . . . . 0.0 110.117 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 155' ' ' ILE . 5.2 mm-40 -53.48 -47.3 69.93 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.172 1.389 . . . . 0.0 110.909 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -57.23 -43.62 83.05 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.31 84.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.851 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 152' ' ' GLU . 89.0 mt -53.05 -52.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.997 1.726 . . . . 0.0 107.633 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -60.25 -66.46 0.52 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.38 1.472 . . . . 0.0 113.011 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.89 -49.74 69.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.736 2.014 . . . . 0.0 115.183 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -73.15 -19.61 61.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.696 1.135 . . . . 0.0 112.638 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.45 96.88 0.36 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.64 -11.05 11.24 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.607 1.099 . . . . 0.0 111.428 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -73.91 170.13 16.0 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.594 1.197 . . . . 0.0 107.836 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -113.38 136.51 52.69 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.449 1.1 . . . . 0.0 108.268 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.21 121.58 18.18 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.13 21.82 79.47 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.025 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.98 6.14 79.74 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.975 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -133.77 147.04 51.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.301 2.05 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.83 138.6 52.75 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -108.15 163.94 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.982 0.896 . . . . 0.0 109.849 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -124.49 149.48 46.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.901 1.281 . . . . 0.0 107.66 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.9 p -139.29 140.36 37.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.298 1.039 . . . . 0.0 109.628 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -163.3 173.03 13.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.157 1.383 . . . . 0.0 108.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -71.45 124.44 24.63 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.343 1.057 . . . . 0.0 110.957 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.636 178.904 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m170 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.72 115.48 30.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.1 151.7 18.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.151 0.907 . . . . 0.0 110.91 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.95 136.97 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 126.899 2.079 . . . . 0.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -85.59 132.67 34.13 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.448 2.299 . . . . 0.0 105.646 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.73 135.02 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.4 -175.97 14.27 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.613 -0.679 . . . . 0.0 111.444 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 61.74 21.13 11.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.972 2.509 . . . . 0.0 114.25 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.32 153.5 43.63 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.884 -1.135 . . . . 0.0 111.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 t -71.39 157.32 90.26 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.63 -6.51 18.82 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.424 2.083 . . . . 0.0 114.173 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.29 -15.32 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 112.811 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -58.25 137.37 20.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 109.84 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -112.21 168.86 9.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.669 1.187 . . . . 0.0 108.284 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 m -60.37 -30.2 69.41 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.907 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.86 -34.23 62.24 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.77 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -48.07 80.66 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.7 mt -58.76 -52.4 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 24.0 mtmt -52.77 -47.62 67.38 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 117.679 -1.153 . . . . 0.0 112.093 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.24 67.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.254 0.934 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -64.58 -50.12 68.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.122 1.369 . . . . 0.0 113.413 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 -11.34 47.11 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.44 90.58 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.423 1.489 . . . . 0.0 112.395 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.1 -10.76 21.94 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.752 1.661 . . . . 0.0 112.583 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -98.13 -10.51 24.08 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.501 1.046 . . . . 0.0 111.532 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.51 165.89 21.43 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 120.026 1.285 . . . . 0.0 111.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 68.3 mtt-85 -77.17 130.12 36.88 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.2 mt -101.99 132.42 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.2 1.0 . . . . 0.0 109.229 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.18 -66.21 0.92 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.05 133.56 46.69 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.314 0.645 . . . . 0.0 110.132 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -155.61 137.43 14.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -160.36 157.98 28.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.663 0.665 . . . . 0.0 111.626 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.21 119.56 50.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.9 t -66.09 133.09 31.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -129.88 151.64 50.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.06 128.55 36.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.8 ptp -66.89 -10.35 47.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.844 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.57 -17.03 26.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.296 1.039 . . . . 0.0 113.738 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.3 p -141.93 -34.08 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.09 14.48 51.54 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.558 -1.135 . . . . 0.0 111.053 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.94 149.56 24.71 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.539 1.67 . . . . 0.0 107.896 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.5 m -53.34 117.31 2.96 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.598 1.159 . . . . 0.0 112.345 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -64.24 -25.03 67.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.334 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.67 -30.81 4.78 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.442 1.972 . . . . 0.0 111.915 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -102.9 172.72 6.66 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.001 1.32 . . . . 0.0 113.501 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.99 175.95 34.36 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.938 2.208 . . . . 0.0 108.908 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.04 151.45 45.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.03 143.59 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.7 m -130.64 128.86 41.83 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.648 1.579 . . . . 0.0 107.708 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -110.75 163.3 13.91 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.544 1.138 . . . . 0.0 110.085 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.53 -28.8 52.08 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.589 0.756 . . . . 0.0 111.748 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -124.89 160.36 29.01 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.083 0.953 . . . . 0.0 111.957 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.566 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 20.1 tptm -65.32 -51.82 58.09 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.632 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -50.99 -45.79 61.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 125.579 1.552 . . . . 0.0 113.134 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -56.96 -43.88 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.963 0.79 . . . . 0.0 110.227 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -50.96 43.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.042 0.937 . . . . 0.0 110.307 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -54.08 -50.79 66.0 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.623 1.169 . . . . 0.0 110.668 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -51.51 -52.67 44.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.709 2.004 . . . . 0.0 108.847 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -47.46 79.54 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.333 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.01 -27.07 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 121.481 1.946 . . . . 0.0 111.342 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -84.77 -70.99 0.54 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.923 0.889 . . . . 0.0 109.932 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -56.62 -50.26 72.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.333 2.253 . . . . 0.0 113.588 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 66.4 mmm -78.01 -20.95 51.54 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.286 1.035 . . . . 0.0 113.659 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.11 75.74 0.25 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.731 1.157 . . . . 0.0 114.563 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.6 -5.15 2.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.049 1.785 . . . . 0.0 112.556 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -76.82 -177.02 4.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.226 1.41 . . . . 0.0 110.819 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -112.85 157.47 21.36 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.347 1.459 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 116' ' ' ALA . 65.5 tp -151.35 126.28 9.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.366 1.466 . . . . 0.0 108.774 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.89 -67.8 0.13 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 126.555 2.026 . . . . 0.0 112.776 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.26 1.99 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.841 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -148.58 167.99 23.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.123 2.461 . . . . 0.0 111.947 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -72.95 147.77 44.92 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -115.6 169.29 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 110.776 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -127.59 146.84 50.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.804 2.041 . . . . 0.0 107.888 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.9 p -142.56 151.04 41.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.23 0.923 . . . . 0.0 109.913 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -173.75 172.73 3.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.148 2.179 . . . . 0.0 108.767 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.566 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 40.1 m95 -67.63 148.53 51.26 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.242 -1.536 . . . . 0.0 111.155 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 178.052 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.0 m170 . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.889 0.376 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.61 100.5 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -81.83 153.88 26.18 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.1 133.68 55.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 127.379 2.272 . . . . 0.0 109.735 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -84.83 142.81 29.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.99 135.61 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.61 27.64 Favored Glycine 0 C--O 1.228 -0.254 0 O-C-N 121.206 -0.934 . . . . 0.0 111.47 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.79 7.47 5.9 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.746 2.418 . . . . 0.0 113.749 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt -52.45 149.22 5.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.384 2.274 . . . . 0.0 112.4 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.53 150.71 93.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.63 -14.14 42.91 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.115 1.876 . . . . 0.0 114.632 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.3 -10.66 29.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.613 1.565 . . . . 0.0 112.433 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -61.5 143.26 15.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 119.587 1.085 . . . . 0.0 110.102 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.6 t -122.17 173.72 7.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 127' ' ' ARG . 52.9 m -62.29 -31.66 72.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.937 0.895 . . . . 0.0 110.715 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -74.03 -34.1 63.98 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.95 -42.91 99.18 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.77 -54.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -50.36 -45.96 55.55 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.321 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.61 75.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.668 0.605 . . . . 0.0 111.544 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.9 85.8 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.01 -8.36 55.72 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.169 0.587 . . . . 0.0 111.13 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.15 97.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 116.956 -1.497 . . . . 0.0 113.523 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.08 -3.42 8.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 122.31 1.861 . . . . 0.0 112.467 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -99.46 -16.15 18.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.42 1.088 . . . . 0.0 109.803 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.48 171.66 20.89 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 122.495 1.053 . . . . 0.0 113.079 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -77.87 123.04 26.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.3 mt -94.48 163.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.97 -69.32 0.82 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.7 136.77 41.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.872 1.269 . . . . 0.0 110.255 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.06 139.27 4.94 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.637 1.108 . . . . 0.0 109.184 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HA ' HG23 ' A' ' 110' ' ' THR . 2.4 ptm180 -162.63 169.34 20.3 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.17 119.78 59.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.887 2.075 . . . . 0.0 105.698 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.3 t -67.24 141.55 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -132.8 155.42 48.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 110.188 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -57.03 117.96 4.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.07 -18.41 64.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 -13.53 18.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 -18.34 2.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.863 1.21 . . . . 0.0 113.997 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.24 87.8 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.213 0.911 . . . . 0.0 113.775 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.84 155.82 25.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.644 1.722 . . . . 0.0 109.408 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.0 t -60.19 126.47 27.64 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.866 0.866 . . . . 0.0 111.091 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -73.27 -48.43 34.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.59 -25.79 3.09 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -103.22 159.02 15.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.464 1.105 . . . . 0.0 111.495 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.9 176.39 29.46 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.932 1.729 . . . . 0.0 109.504 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.29 156.85 45.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.78 0.832 . . . . 0.0 109.348 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.3 t -138.57 154.9 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.2 t -144.07 125.68 15.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.34 156.65 24.03 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.677 1.191 . . . . 0.0 111.237 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.96 -23.07 61.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.975 1.31 . . . . 0.0 113.681 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -137.22 153.99 50.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.479 1.036 . . . . 0.0 109.972 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.49 -48.82 79.36 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -34.68 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.914 1.285 . . . . 0.0 112.874 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.24 -47.63 73.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.1 54.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.645 1.178 . . . . 0.0 111.538 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 155' ' ' ILE . 44.4 mt-10 -53.32 -45.55 69.06 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.395 1.078 . . . . 0.0 111.85 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -53.86 -47.56 70.89 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.775 0.83 . . . . 0.0 108.876 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.73 -47.37 72.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.424 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 152' ' ' GLU . 63.8 mt -51.74 -44.5 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.682 1.583 . . . . 0.0 110.154 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -69.89 -67.96 0.45 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.23 1.412 . . . . 0.0 112.925 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -66.68 -43.19 85.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.565 1.546 . . . . 0.0 115.053 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 74.0 mmm -75.97 -21.55 56.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.598 1.545 . . . . 0.0 112.332 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.31 4.87 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.95 -5.7 69.04 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.527 1.061 . . . . 0.0 112.898 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -73.61 171.21 13.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.467 1.634 . . . . 0.0 109.468 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.405 ' CD1' ' HG2' ' A' ' 167' ' ' GLN . 20.5 m95 -101.94 143.82 31.34 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.06 122.81 12.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.194 0.998 . . . . 0.0 109.434 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.59 3.66 2.39 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 118.073 -1.404 . . . . 0.0 115.896 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 133.65 -13.23 4.81 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-O 116.767 -2.129 . . . . 0.0 115.183 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -137.22 162.54 33.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 121.037 2.419 . . . . 0.0 110.019 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.405 ' HG2' ' CD1' ' A' ' 162' ' ' TRP . 44.1 mt-30 -72.85 162.86 28.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.979 0.354 . . . . 0.0 110.318 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.1 pt -136.94 163.44 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.517 1.127 . . . . 0.0 110.974 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -126.5 151.35 47.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.31 1.444 . . . . 0.0 108.464 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.8 p -141.83 156.74 45.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.671 1.188 . . . . 0.0 109.534 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -173.95 173.84 3.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 109.259 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -67.51 116.19 7.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 123.691 0.796 . . . . 0.0 112.821 -179.781 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m170 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.381 0.61 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 101.19 8.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.53 146.99 24.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.025 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -123.93 142.83 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.253 1.821 . . . . 0.0 108.47 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -97.02 135.32 39.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 106.351 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.39 139.3 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 -178.33 22.28 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.53 12.63 4.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.722 2.009 . . . . 0.0 113.162 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -55.16 148.13 14.87 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.753 2.021 . . . . 0.0 111.645 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -64.26 142.61 98.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.3 -17.67 27.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.524 2.816 . . . . 0.0 116.315 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -98.62 -5.64 31.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.277 0.944 . . . . 0.0 113.042 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 142.72 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 119.569 1.077 . . . . 0.0 108.374 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.8 t -115.31 169.2 9.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 122.233 1.016 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -61.73 -35.32 77.73 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.766 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -66.29 -34.8 78.82 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.824 1.25 . . . . 0.0 109.998 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.58 -42.77 86.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 108.762 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.34 -43.5 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -54.52 -43.75 72.16 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.606 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.91 73.9 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.85 0.719 . . . . 0.0 111.519 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.35 -43.62 71.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -94.61 -9.39 35.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.756 -0.59 . . . . 0.0 112.295 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.67 93.98 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.94 1.296 . . . . 0.0 114.015 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.04 -7.16 14.53 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 121.87 1.703 . . . . 0.0 112.63 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.41 -12.95 19.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.307 0.958 . . . . 0.0 112.053 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 171.0 -173.7 44.7 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.475 1.489 . . . . 0.0 111.499 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -101.64 129.77 47.85 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.2 mt -100.33 160.8 3.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 126.437 1.895 . . . . 0.0 109.408 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 t -126.93 -69.24 0.77 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.578 1.551 . . . . 0.0 106.837 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.99 138.17 38.39 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.46 4.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.893 1.677 . . . . 0.0 107.435 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -160.74 156.04 24.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.55 1.068 . . . . 0.0 111.726 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.65 121.59 51.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.97 144.49 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -140.91 148.66 40.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.53 121.71 12.21 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.485 1.114 . . . . 0.0 108.165 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.1 ptm -58.49 -22.63 55.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.57 -9.8 18.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.4 p -131.99 -20.27 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.94 1.246 . . . . 0.0 113.02 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.78 6.56 82.04 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.375 0.988 . . . . 0.0 112.756 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -76.51 149.16 36.76 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 t -58.17 129.59 42.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -78.05 -12.79 60.02 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.51 -24.59 28.6 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-O 118.564 -1.131 . . . . 0.0 113.75 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -102.87 166.45 10.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.252 1.026 . . . . 0.0 109.311 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.63 174.14 33.68 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.215 1.388 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.16 157.01 46.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.489 0.716 . . . . 0.0 109.121 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -143.95 133.81 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.074 1.75 . . . . 0.0 106.775 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 t -115.95 129.75 56.53 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.749 2.02 . . . . 0.0 108.254 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.12 155.43 26.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.55 -23.29 61.73 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.528 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -135.81 156.47 48.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.507 1.503 . . . . 0.0 110.994 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.38 -46.11 74.26 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.573 0.749 . . . . 0.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -39.87 72.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.21 1.804 . . . . 0.0 111.177 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -57.44 -52.92 63.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.69 53.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.732 1.213 . . . . 0.0 111.122 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -50.29 -49.02 54.71 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.373 1.069 . . . . 0.0 111.221 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -52.23 -57.35 9.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.275 1.03 . . . . 0.0 110.211 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.17 94.7 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 116.779 -1.582 . . . . 0.0 113.523 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.0 mt -50.97 -34.74 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 121.581 1.991 . . . . 0.0 110.69 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -79.96 -63.42 1.42 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.33 0.652 . . . . 0.0 111.009 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.58 -49.91 69.32 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.7 mmm -68.29 -31.39 70.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.441 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.68 92.7 0.11 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.817 0.722 . . . . 0.0 111.31 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 138.56 -18.0 3.26 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.901 1.239 . . . . 0.0 111.786 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 167.72 20.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.402 1.101 . . . . 0.0 110.672 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -107.0 116.3 31.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.0 tp -116.3 127.3 54.58 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.753 1.221 . . . . 0.0 107.763 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 -63.28 4.18 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.31 5.9 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.208 -1.884 . . . . 0.0 112.808 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -136.13 154.49 50.97 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.213 2.007 . . . . 0.0 110.358 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -68.73 148.45 50.36 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.6 pt -116.88 160.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.454 1.102 . . . . 0.0 110.974 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -118.16 143.91 46.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.389 1.876 . . . . 0.0 105.985 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.6 p -138.89 123.09 18.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -149.94 174.36 12.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -69.07 155.22 40.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.029 179.688 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -123.86 113.61 18.74 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.09 1.356 . . . . 0.0 108.086 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.77 151.65 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.76 0.79 . . . . 0.0 111.229 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.17 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 128.859 2.863 . . . . 0.0 107.875 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -95.45 133.06 39.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 106.172 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -127.31 138.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.07 179.63 19.83 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.706 -0.621 . . . . 0.0 111.835 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.284 7.2 t0 60.57 10.88 2.76 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 129.93 3.292 . . . . 0.0 114.982 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.2 mt -52.35 138.61 26.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.66 1.984 . . . . 0.0 110.462 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.83 151.35 64.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.96 -19.43 68.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.038 1.826 . . . . 0.0 114.239 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -82.73 -23.41 34.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.691 1.197 . . . . 0.0 113.598 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mm -56.89 130.61 19.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.283 1.033 . . . . 0.0 110.451 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -107.9 167.53 9.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.159 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.8 m -61.32 -21.61 64.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.056 -1.652 . . . . 0.0 111.969 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.76 -36.77 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.828 1.651 . . . . 0.0 109.96 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.91 -50.95 71.78 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.32 -52.62 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.271 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -53.55 -48.36 69.18 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.994 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.66 -45.87 90.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.623 0.769 . . . . 0.0 111.833 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -60.35 -49.13 78.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.67 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -84.48 -8.28 59.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.947 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.3 93.75 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 120.215 1.371 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.58 -6.07 15.72 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 122.1 1.786 . . . . 0.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.62 -18.21 17.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.73 0.812 . . . . 0.0 110.913 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 170.17 175.23 38.91 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 123.596 1.665 . . . . 0.0 114.651 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -86.03 117.68 25.03 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.5 mt -100.36 158.01 3.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.12 1.368 . . . . 0.0 107.818 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 t -134.95 -62.61 0.72 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.83 126.47 48.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.831 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.22 136.62 13.09 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -162.65 157.03 21.32 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.492 0.587 . . . . 0.0 112.004 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.91 122.65 58.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.49 141.8 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -130.85 155.69 46.3 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.747 0.784 . . . . 0.0 109.083 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.49 124.51 23.77 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.068 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.8 ptp -64.54 -20.2 66.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.87 10.47 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.826 1.194 . . . . 0.0 113.845 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 80.5 p -104.05 -19.25 14.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.017 1.327 . . . . 0.0 114.303 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.0 78.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.195 0.903 . . . . 0.0 112.607 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -83.6 157.27 22.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.06 1.344 . . . . 0.0 109.154 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 t -62.06 124.99 22.3 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.718 0.807 . . . . 0.0 111.221 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -71.4 -31.61 67.47 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.27 -29.96 5.98 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.081 1.324 . . . . 0.0 110.601 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -103.31 164.99 11.3 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.305 -1.115 . . . . 0.0 111.574 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.6 178.37 33.09 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.695 1.616 . . . . 0.0 110.015 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.38 153.87 51.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.399 1.079 . . . . 0.0 108.419 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.2 t -140.24 143.61 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 12.9 t -131.35 135.3 47.12 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.738 1.615 . . . . 0.0 107.234 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 148.58 43.37 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 124.529 1.143 . . . . 0.0 109.381 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.03 -48.12 59.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -92.33 143.1 26.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.652 0.781 . . . . 0.0 109.238 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.34 -45.32 84.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.527 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -36.71 63.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.976 1.711 . . . . 0.0 112.078 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.17 -47.05 87.95 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.25 -52.54 61.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.73 0.812 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.08 -54.75 14.62 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 110.511 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -51.15 -56.55 12.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.882 1.673 . . . . 0.0 111.537 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.45 91.89 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.079 -1.438 . . . . 0.0 112.111 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.8 mt -53.01 -45.77 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 122.06 2.209 . . . . 0.0 109.784 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.72 -64.76 0.79 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.049 1.34 . . . . 0.0 111.106 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -62.89 -57.62 10.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.247 1.819 . . . . 0.0 114.193 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.3 mmm -64.91 -21.96 66.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.361 1.437 . . . . 0.0 113.669 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.34 110.45 3.12 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 119.227 0.921 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.4 -5.71 70.99 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.752 1.168 . . . . 0.0 112.134 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -76.71 170.67 16.03 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 118.852 1.326 . . . . 0.0 107.605 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -102.01 142.67 32.92 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 116' ' ' ALA . 22.7 tp -131.71 124.08 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.014 2.126 . . . . 0.0 106.214 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.39 -78.35 0.84 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.9 -2.27 0.15 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.069 -1.961 . . . . 0.0 114.544 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -129.22 163.72 25.0 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.16 2.48 . . . . 0.0 109.995 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -77.93 165.18 24.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.338 0.589 . . . . 0.0 109.581 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.14 159.08 38.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.675 0.79 . . . . 0.0 110.925 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -113.77 139.54 49.03 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 p -137.06 132.37 34.07 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.138 0.881 . . . . 0.0 109.448 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -157.1 167.43 30.45 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -61.08 132.87 55.16 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.19 0 CA-C-N 118.134 0.425 . . . . 0.0 111.673 -179.785 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.432 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 126.33 26.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.608 0.763 . . . . 0.0 109.744 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.4 m -71.76 178.44 3.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.75 1.22 . . . . 0.0 110.825 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.48 102.03 2.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.7 m -79.71 157.38 27.2 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.939 0.869 . . . . 0.0 109.949 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 m -63.2 -50.66 69.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.447 0.699 . . . . 0.0 112.294 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 91.48 0.1 Allowed Glycine 0 C--N 1.336 0.537 0 O-C-N 121.384 -0.822 . . . . 0.0 112.206 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -84.42 1.29 46.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.027 0.931 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -110.99 127.32 55.48 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 119.831 -1.793 . . . . 0.0 108.014 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -29.11 69.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.191 0.45 . . . . 0.0 110.722 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.99 141.42 38.94 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.25 . . . . 0.0 111.621 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -93.18 76.77 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.791 1.637 . . . . 0.0 108.127 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.8 m -109.87 -43.12 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -89.11 21.89 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.551 0.741 . . . . 0.0 110.129 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -113.38 159.01 19.89 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.106 -0.996 . . . . 0.0 110.715 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -105.39 102.59 12.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.317 1.847 . . . . 0.0 107.894 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 146.82 25.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.306 0.643 . . . . 0.0 110.568 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.61 138.18 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.344 1.858 . . . . 0.0 110.207 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -86.82 143.0 27.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.242 1.817 . . . . 0.0 106.686 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.13 137.37 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.5 -174.54 17.79 Favored Glycine 0 N--CA 1.463 0.498 0 O-C-N 120.865 -1.147 . . . . 0.0 111.164 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.7 8.94 4.8 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.067 2.147 . . . . 0.0 112.36 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -55.84 148.13 17.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.009 1.323 . . . . 0.0 111.519 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.11 162.32 69.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.14 -16.78 49.77 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.623 2.215 . . . . 0.0 114.632 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.87 -15.06 17.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.583 1.083 . . . . 0.0 112.288 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.417 HD11 ' HA3' ' A' ' 164' ' ' GLY . 28.3 mm -57.69 114.25 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 109.387 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 t -95.34 178.83 5.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 m -64.54 -30.91 71.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.928 -1.107 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -73.02 -30.12 63.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.315 1.046 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.04 -48.6 70.54 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -51.65 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -55.37 -38.65 69.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 120.904 -1.122 . . . . 0.0 112.34 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.17 64.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.672 0.608 . . . . 0.0 110.078 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.73 84.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.742 1.217 . . . . 0.0 113.547 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.47 -6.34 57.69 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.27 94.95 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.862 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.92 -5.96 14.7 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.529 1.486 . . . . 0.0 113.535 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -98.82 -20.97 16.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.775 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 169.33 175.16 38.36 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-O 122.943 1.301 . . . . 0.0 114.155 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.9 mtm105 -81.61 121.54 26.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.3 mt -100.79 153.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.377 1.071 . . . . 0.0 109.073 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 t -130.28 -61.07 0.99 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.77 132.89 45.95 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 134.71 6.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.198 0.999 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -162.84 163.38 26.53 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.957 0.798 . . . . 0.0 112.228 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 52.2 t -105.02 120.59 55.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.597 HG12 ' HG3' ' A' ' 138' ' ' LYS . 95.3 t -66.03 140.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -133.23 147.1 51.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.71 130.26 45.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.079 1.352 . . . . 0.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.6 ptm -76.02 -9.41 58.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.77 -24.29 16.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.864 1.211 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.5 p -128.48 -18.49 3.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.433 1.015 . . . . 0.0 113.043 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.52 19.11 78.47 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.592 1.091 . . . . 0.0 113.391 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -100.3 163.35 12.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.542 1.171 . . . . 0.0 109.867 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -46.27 126.21 7.55 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.885 1.274 . . . . 0.0 113.885 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.597 ' HG3' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -79.5 -22.5 43.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.699 178.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.93 -30.12 8.31 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.547 2.023 . . . . 0.0 110.644 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.503 ' CZ ' HG11 ' A' ' 129' ' ' VAL 0.264 29.9 p90 -102.88 169.37 8.63 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.422 1.089 . . . . 0.0 112.171 178.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.57 172.72 33.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.371 2.415 . . . . 0.0 108.379 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -140.37 149.95 43.33 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.54 155.75 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.662 1.985 . . . . 0.0 106.031 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.0 t -145.32 118.02 8.65 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.506 1.122 . . . . 0.0 108.354 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -99.46 152.12 20.35 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.17 1.388 . . . . 0.0 110.631 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -74.37 -24.41 59.15 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.394 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -125.44 151.27 46.44 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.782 1.233 . . . . 0.0 110.55 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.01 -49.24 73.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -31.46 17.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.456 1.903 . . . . 0.0 113.307 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.78 -55.28 10.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 108.347 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.71 76.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.971 1.708 . . . . 0.0 110.81 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.18 -50.01 70.42 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.583 1.153 . . . . 0.0 109.295 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -55.22 -50.91 68.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.752 0.421 . . . . 0.0 111.294 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.22 -55.12 37.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.033 1.733 . . . . 0.0 111.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.4 mt -46.68 -49.9 6.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 120.367 1.44 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -65.36 -60.78 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.288 0.992 . . . . 0.0 112.316 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -66.02 -58.07 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.2 mmm -58.19 -28.58 64.92 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.93 77.43 0.81 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 125.021 1.296 . . . . 0.0 110.123 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.17 -10.35 2.26 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 127.3 2.381 . . . . 0.0 111.838 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -80.18 165.52 22.34 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.879 1.34 . . . . 0.0 109.456 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -107.6 133.54 51.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.991 0.916 . . . . 0.0 108.853 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.88 130.48 46.91 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.565 1.946 . . . . 0.0 106.645 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 66.44 12.55 58.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.106 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.88 0.25 62.24 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.312 1.556 . . . . 0.0 112.564 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.26 157.06 46.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.427 1.614 . . . . 0.0 108.928 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.78 174.84 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.787 0.803 . . . . 0.0 109.308 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 pt -142.96 160.05 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.734 2.014 . . . . 0.0 108.025 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -123.51 140.6 52.84 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.4 p -138.93 149.23 44.56 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.957 0.903 . . . . 0.0 111.808 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -173.43 178.07 2.45 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.906 2.082 . . . . 0.0 109.352 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.12 126.65 30.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.55 -37.21 77.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 112.855 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.9 t -148.36 139.89 23.58 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -141.24 -178.0 5.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.553 1.541 . . . . 0.0 108.276 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -138.63 135.47 17.99 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.147 1.379 . . . . 0.0 108.062 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.13 148.39 56.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.223 2.615 . . . . 0.0 111.984 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.04 167.36 27.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.532 2.822 . . . . 0.0 111.957 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.72 156.28 77.77 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.36 -66.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.36 2.04 . . . . 0.0 112.172 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 182' ' ' SER . 13.9 tttm -150.93 171.77 16.73 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.968 0.907 . . . . 0.0 109.443 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.414 ' H ' ' HG2' ' A' ' 181' ' ' LYS . 7.2 t -137.47 152.05 49.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.471 1.109 . . . . 0.0 109.05 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.14 -176.72 5.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.708 2.003 . . . . 0.0 107.649 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -137.42 158.59 44.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.83 174.99 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.774 0.829 . . . . 0.0 109.817 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 p -144.6 8.39 1.32 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.614 1.565 . . . . 0.0 111.463 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -53.05 -38.89 62.85 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.965 2.106 . . . . 0.0 113.772 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.1 m -69.76 56.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.465 1.906 . . . . 0.0 113.689 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -91.72 161.71 14.78 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.519 -1.363 . . . . 0.0 108.485 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 174.94 13.92 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 127.483 2.313 . . . . 0.0 108.618 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.8 t -137.31 -80.81 0.37 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.93 65.39 1.55 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.149 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.05 89.88 0.77 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.788 2.326 . . . . 0.0 107.916 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.46 169.04 25.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 109.278 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.4 p -153.75 179.18 9.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.742 1.617 . . . . 0.0 108.221 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.838 0 C-N-CA 128.25 2.833 . . . . 0.0 106.882 179.554 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.1 p -62.95 169.44 3.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.602 1.201 . . . . 0.0 112.221 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 p -59.34 129.09 40.37 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.245 1.418 . . . . 0.0 109.419 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.11 -170.59 54.76 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.3 t -141.25 132.11 25.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.04 1.32 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.888 2.875 . . . . 0.0 117.956 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.36 -153.54 21.4 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.924 1.693 . . . . 0.0 111.267 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -52.16 91.68 0.01 OUTLIER 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.785 2.434 . . . . 0.0 113.197 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -130.37 160.64 33.37 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.1 0.96 . . . . 0.0 111.361 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -164.6 162.76 21.75 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.847 2.459 . . . . 0.0 107.159 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -135.64 73.53 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.3 p 48.8 19.37 0.25 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.32 2.248 . . . . 0.0 115.373 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -49.47 -24.41 2.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.361 2.664 . . . . 0.0 117.273 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -133.82 11.85 4.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.741 1.155 . . . . 0.0 110.305 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -90.17 167.3 12.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.723 0.809 . . . . 0.0 109.405 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -113.08 161.36 17.18 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -132.72 133.79 43.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.36 134.27 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 126.169 1.788 . . . . 0.0 109.571 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -85.59 136.1 33.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.52 HG12 HD21 ' A' ' 104' ' ' LEU . 15.8 t -131.71 133.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.02 -174.35 18.1 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 62.8 12.33 5.62 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.227 2.611 . . . . 0.0 111.951 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.52 HD21 HG12 ' A' ' 101' ' ' VAL . 53.8 mt -59.55 142.68 52.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.639 1.576 . . . . 0.0 111.322 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 t -59.87 143.81 86.89 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -59.95 -5.33 3.61 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 115.382 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.4 -14.38 18.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.285 2.234 . . . . 0.0 112.721 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.1 mm -58.05 136.2 21.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 119.316 0.962 . . . . 0.0 109.831 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -108.33 168.85 9.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.387 1.089 . . . . 0.0 108.843 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.0 m -60.82 -29.51 69.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.895 1.278 . . . . 0.0 109.381 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -70.24 -40.8 74.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 109.277 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.75 -47.54 85.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.738 0.815 . . . . 0.0 109.17 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 113' ' ' ILE . 27.9 mt -60.75 -49.53 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 22.8 mtmt -54.88 -48.53 72.86 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.762 -1.211 . . . . 0.0 110.99 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.33 -34.4 73.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.967 0.907 . . . . 0.0 112.614 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -75.31 -44.89 42.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.756 1.223 . . . . 0.0 113.842 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.04 -10.68 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.0 -50.37 86.82 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 126.481 1.913 . . . . 0.0 114.445 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -65.03 -4.17 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.464 1.443 . . . . 0.0 113.282 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -99.05 -9.63 23.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.47 15.1 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.094 1.316 . . . . 0.0 109.89 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -75.18 116.35 15.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.596 -0.943 . . . . 0.0 109.827 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -77.48 153.5 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 p -112.53 -73.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.011 1.724 . . . . 0.0 107.032 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.97 142.8 32.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.988 2.115 . . . . 0.0 108.117 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.416 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -161.84 124.03 2.9 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 110.101 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -153.53 164.5 38.12 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.594 0.712 . . . . 0.0 111.8 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.2 121.64 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.341 1.857 . . . . 0.0 106.968 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 140' ' ' TYR . 75.1 t -64.68 139.28 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -134.84 153.35 52.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -60.84 116.41 4.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.368 1.467 . . . . 0.0 109.115 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.4 ptp -64.09 -9.01 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.26 -15.87 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.467 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.4 p -137.91 -29.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.94 1.246 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.66 62.55 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.217 1.389 . . . . 0.0 112.037 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -80.14 154.97 27.69 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.696 1.248 . . . . 0.0 109.094 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 m -56.04 123.58 14.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.857 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -76.88 -22.56 53.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.121 0.568 . . . . 0.0 111.692 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.73 -26.53 10.68 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 127.006 2.241 . . . . 0.0 112.619 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CE2' HG11 ' A' ' 129' ' ' VAL . 7.3 p90 -103.06 168.09 9.41 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.764 1.225 . . . . 0.0 112.389 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.84 177.85 31.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.785 2.136 . . . . 0.0 109.307 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -138.79 155.42 48.18 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.031 0.932 . . . . 0.0 109.938 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.3 t -142.89 125.56 13.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.174 1.39 . . . . 0.0 108.405 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -112.92 142.15 45.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.16 163.07 22.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.65 -19.95 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.892 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.19 169.12 16.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.722 1.209 . . . . 0.0 111.607 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -77.81 -52.74 8.43 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.578 1.151 . . . . 0.0 110.808 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -49.61 -48.92 48.66 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.182 1.793 . . . . 0.0 111.096 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.86 -43.96 69.97 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.091 0.869 . . . . 0.0 110.124 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.42 -56.04 12.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.135 1.374 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.08 -48.33 64.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.333 1.453 . . . . 0.0 111.185 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -53.14 -46.0 68.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 109.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.88 -43.23 65.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.855 1.262 . . . . 0.0 110.18 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 95.5 mt -49.52 -44.54 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 120.8 1.636 . . . . 0.0 108.704 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.4 -70.87 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.14 -43.46 98.84 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 68.2 mmm -71.93 -22.59 61.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.594 1.543 . . . . 0.0 111.494 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.0 113.55 5.75 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 118.96 0.8 . . . . 0.0 111.834 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.22 60.29 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.325 -1.264 . . . . 0.0 113.119 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.6 169.05 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.964 1.382 . . . . 0.0 108.795 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -105.33 137.29 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 116' ' ' ALA . 50.4 tp -124.79 127.88 47.87 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.78 -101.17 0.44 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 105.695 -2.962 . . . . 0.0 105.695 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.75 10.85 7.5 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 116.355 -2.358 . . . . 0.0 115.729 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.98 159.25 43.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.971 2.886 . . . . 0.0 112.969 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -72.37 153.97 41.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.17 151.97 27.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 123.409 0.684 . . . . 0.0 111.457 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -111.64 126.52 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.995 1.318 . . . . 0.0 108.387 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.9 p -113.54 141.58 46.98 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.238 1.415 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -167.45 177.12 6.16 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.086 1.755 . . . . 0.0 107.459 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -77.69 152.62 33.64 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.76 4.48 18.84 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.478 -0.764 . . . . 0.0 112.21 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.2 p -142.68 159.0 43.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 109.886 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -173.18 164.66 4.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.071 1.749 . . . . 0.0 109.849 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -82.53 141.39 45.2 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.09 159.12 54.46 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 121.702 1.601 . . . . 0.0 109.482 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.15 171.9 17.41 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.103 3.202 . . . . 0.0 111.746 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.79 147.62 62.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.802 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.07 100.6 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.311 2.674 . . . . 0.0 107.39 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -159.9 158.46 30.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.97 0.805 . . . . 0.0 112.436 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 p -160.91 -177.79 6.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.379 2.272 . . . . 0.0 107.517 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t 160.56 173.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.733 4.013 . . . . 0.0 107.557 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -163.81 -171.51 2.52 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.621 2.768 . . . . 0.0 108.226 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -163.6 152.4 13.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.331 2.253 . . . . 0.0 106.518 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 42.0 p -154.39 71.81 0.85 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.082 0.855 . . . . 0.0 110.671 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -76.31 79.34 3.07 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.819 -0.551 . . . . 0.0 110.59 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 21.9 p -60.2 -44.84 94.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.548 0.739 . . . . 0.0 109.92 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 35.1 tttm 49.78 20.73 0.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.962 2.105 . . . . 0.0 114.894 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -142.74 146.52 34.39 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.68 1.592 . . . . 0.0 106.919 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.4 p -77.95 -46.69 20.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.537 1.135 . . . . 0.0 108.856 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.33 174.83 40.65 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.562 2.03 . . . . 0.0 108.972 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.27 168.02 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.21 2.607 . . . . 0.0 110.981 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.4 p -147.84 117.01 6.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.2 p -150.68 91.18 1.7 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.792 0 C-N-CA 127.499 2.476 . . . . 0.0 106.971 -179.595 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.7 t -69.51 -23.33 63.59 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.263 -0.551 . . . . 0.0 111.954 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.7 p -147.07 176.02 10.25 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.044 0.938 . . . . 0.0 111.967 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.76 -173.11 14.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.787 2.613 . . . . 0.0 107.015 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -146.91 139.64 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -102.79 164.5 11.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.393 1.477 . . . . 0.0 112.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.74 -116.05 0.62 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.73 154.58 41.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 152.17 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 59.92 2.34 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.155 1.382 . . . . 0.0 113.889 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.54 131.13 45.44 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.388 1.449 . . . . 0.0 109.309 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.3 p -111.41 -1.44 15.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.21 1.004 . . . . 0.0 112.031 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -63.81 -4.99 3.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.973 1.709 . . . . 0.0 115.037 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -122.86 6.97 9.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.973 2.109 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -109.47 177.84 4.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.38 1.072 . . . . 0.0 111.327 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -113.52 139.56 48.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.042 1.292 . . . . 0.0 110.214 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.08 154.36 28.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.668 2.387 . . . . 0.0 109.704 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -103.82 141.42 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.579 3.152 . . . . 0.0 108.709 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.61 140.33 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.44 178.86 24.78 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 119.652 1.114 . . . . 0.0 111.543 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t0 70.41 -1.69 2.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.762 2.825 . . . . 0.0 114.525 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 mt -47.78 139.01 7.91 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 127.283 2.233 . . . . 0.0 113.892 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.7 t -62.65 148.12 91.64 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.83 -18.1 58.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.161 1.908 . . . . 0.0 113.822 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -76.43 -25.49 54.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mm -57.84 124.11 11.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.448 1.499 . . . . 0.0 110.613 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -106.93 175.3 5.54 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.134 0.974 . . . . 0.0 109.03 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -56.73 -33.52 66.62 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.52 -0.737 . . . . 0.0 111.851 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.39 -42.56 78.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.133 1.773 . . . . 0.0 112.142 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.63 -51.54 65.08 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.326 1.05 . . . . 0.0 109.482 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.0 mt -60.12 -53.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.2 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -51.1 -44.77 61.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 117.885 -1.055 . . . . 0.0 112.092 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.09 81.88 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.948 0.78 . . . . 0.0 110.734 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -57.51 -46.79 83.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.12 -5.76 59.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.402 1.081 . . . . 0.0 113.152 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -47.2 99.3 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.54 -3.9 12.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 CA-C-N 121.111 1.432 . . . . 0.0 112.388 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.95 -18.91 18.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.251 0.932 . . . . 0.0 110.719 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.4 168.19 25.0 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 118.887 0.767 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.85 130.72 40.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.2 mt -100.26 154.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.0 t -116.06 -72.65 0.68 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.12 139.97 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.815 1.646 . . . . 0.0 109.303 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.33 135.53 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -162.77 163.01 26.9 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.577 0.626 . . . . 0.0 110.703 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.6 t -102.59 123.28 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.66 138.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -132.15 151.5 51.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 107.739 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -60.01 123.23 16.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.356 1.462 . . . . 0.0 109.97 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.84 -12.9 27.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.835 0.854 . . . . 0.0 113.166 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.82 -10.77 18.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.8 p -141.93 -25.17 0.68 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.95 11.95 75.39 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.183 0.897 . . . . 0.0 110.907 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -82.31 143.92 30.95 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -55.46 125.8 22.46 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -73.07 -22.91 60.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.13 -18.28 42.84 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.936 1.255 . . . . 0.0 112.128 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.282 31.8 p90 -103.14 161.75 13.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.332 1.566 . . . . 0.0 109.573 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.38 175.03 28.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.938 1.256 . . . . 0.0 110.763 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.93 153.37 51.81 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.102 1.361 . . . . 0.0 108.96 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.65 131.22 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 126.254 1.822 . . . . 0.0 106.516 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.3 m -122.14 132.02 54.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.081 0.952 . . . . 0.0 109.368 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.96 156.29 26.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.189 1.396 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -72.59 -24.05 61.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.717 1.207 . . . . 0.0 112.959 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -131.18 156.25 45.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.23 0.923 . . . . 0.0 110.183 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -67.16 -48.39 68.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.852 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -47.72 -49.28 28.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.71 1.604 . . . . 0.0 112.881 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.77 -49.78 67.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.636 1.574 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.82 63.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.716 1.206 . . . . 0.0 112.018 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -51.38 -49.0 62.36 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.422 1.889 . . . . 0.0 109.867 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -54.23 -52.18 62.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.061 0.944 . . . . 0.0 110.54 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.22 89.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.363 -1.303 . . . . 0.0 111.755 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.4 mt -51.42 -48.05 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 121.739 2.063 . . . . 0.0 109.44 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -66.42 -60.17 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -68.57 -48.44 64.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.34 2.256 . . . . 0.0 115.516 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.41 -22.84 58.97 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.176 0.898 . . . . 0.0 111.807 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.87 97.84 0.17 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.496 1.046 . . . . 0.0 111.203 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 114.14 -7.72 23.17 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.246 -1.308 . . . . 0.0 113.857 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.27 174.54 9.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.754 1.277 . . . . 0.0 109.951 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 15.3 m95 -109.38 146.42 34.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' A' ' 116' ' ' ALA . 37.5 tp -139.58 128.37 23.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.994 2.118 . . . . 0.0 106.904 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 48.19 32.22 9.36 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.78 1.181 . . . . 0.0 114.818 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.65 -5.24 51.04 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 117.704 1.841 . . . . 0.0 117.704 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -141.76 157.58 44.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 122.037 2.919 . . . . 0.0 110.738 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 162' ' ' TRP . 39.6 mt-30 -65.93 161.21 21.78 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.296 0.997 . . . . 0.0 110.658 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.82 155.96 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.541 1.136 . . . . 0.0 108.717 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.3 p -137.2 155.37 49.61 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.992 0.917 . . . . 0.0 110.174 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -176.24 165.05 2.77 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.742 1.217 . . . . 0.0 108.719 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -73.77 122.36 22.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.7 108.65 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.8 p -140.74 159.65 41.75 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.67 1.588 . . . . 0.0 108.894 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -160.93 -166.99 1.71 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.406 1.882 . . . . 0.0 107.658 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -139.09 157.64 70.9 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 124.221 1.009 . . . . 0.0 108.856 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.7 148.27 52.53 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.986 1.791 . . . . 0.0 109.624 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.81 166.85 28.38 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.524 2.15 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -138.77 153.68 72.31 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.993 0.917 . . . . 0.0 109.015 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.5 179.84 5.52 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.778 2.985 . . . . 0.0 112.912 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -94.01 137.22 33.46 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.288 1.435 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -86.42 -177.43 6.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.042 0.537 . . . . 0.0 110.158 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.4 p -146.42 162.22 38.72 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.47 1.108 . . . . 0.0 109.363 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -172.24 162.07 5.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.237 1.815 . . . . 0.0 107.975 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -171.25 140.74 1.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.39 2.676 . . . . 0.0 104.606 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 69.0 m -164.51 27.9 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.81 2.044 . . . . 0.0 111.422 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.93 140.74 56.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.069 1.304 . . . . 0.0 110.766 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.9 t -167.11 171.44 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.013 1.325 . . . . 0.0 107.613 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -154.55 150.46 27.78 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.035 -1.041 . . . . 0.0 109.834 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -143.46 177.83 8.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.009 2.524 . . . . 0.0 106.362 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p 160.71 141.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 128.678 2.791 . . . . 0.0 108.507 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.51 156.33 27.23 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.32 174.88 9.52 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.285 2.657 . . . . 0.0 110.68 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 10.5 t -156.96 152.68 26.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 t -166.15 166.06 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.877 1.671 . . . . 0.0 107.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.78 0 C-N-CA 128.055 2.74 . . . . 0.0 106.901 -179.714 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.46 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 m -145.59 -165.47 2.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.318 2.247 . . . . 0.0 107.36 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -8.99 46.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.755 1.222 . . . . 0.0 112.385 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.44 -69.52 1.07 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.973 -0.904 . . . . 0.0 113.8 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.14 107.96 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -61.96 -23.11 66.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.42 1.888 . . . . 0.0 111.204 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.36 158.97 31.5 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 128.24 2.828 . . . . 0.0 106.793 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -95.92 -28.74 14.54 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.209 1.404 . . . . 0.0 114.392 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -148.78 158.63 44.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.519 1.054 . . . . 0.0 110.418 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.02 -43.36 6.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.605 . . . . 0.0 108.981 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.64 19.07 9.05 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.745 1.618 . . . . 0.0 113.585 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.7 p 55.08 2.44 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.678 2.391 . . . . 0.0 116.224 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -53.8 -6.14 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.203 2.601 . . . . 0.0 117.408 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.4 21.41 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 121.294 1.861 . . . . 0.0 111.845 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -94.44 165.57 12.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.756 0.822 . . . . 0.0 109.996 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.74 112.4 25.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.57 148.75 22.05 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.812 0.695 . . . . 0.0 111.157 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.32 140.72 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 129.07 2.948 . . . . 0.0 109.166 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -92.03 141.14 28.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.845 2.858 . . . . 0.0 107.24 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.9 143.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 -176.21 23.59 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.88 14.12 9.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.35 2.26 . . . . 0.0 113.126 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.6 mt -62.98 137.18 58.19 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.164 1.785 . . . . 0.0 112.415 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.5 t -62.85 143.46 97.1 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.24 -14.37 33.7 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.806 2.337 . . . . 0.0 114.679 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.26 -23.96 37.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.314 0.961 . . . . 0.0 111.667 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.24 143.24 12.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.62 1.568 . . . . 0.0 110.231 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.5 t -121.75 179.29 4.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.859 1.314 . . . . 0.0 110.038 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 m -57.03 -39.37 74.69 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.591 1.956 . . . . 0.0 112.145 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.51 -37.48 80.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.251 1.82 . . . . 0.0 111.417 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.03 -49.71 76.29 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.4 mt -57.58 -52.29 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -54.11 -46.58 72.17 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.163 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.99 81.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.149 0.886 . . . . 0.0 111.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -65.27 -53.05 50.04 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.852 1.261 . . . . 0.0 113.67 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -84.46 -15.55 45.66 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.18 -48.75 93.37 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.875 1.27 . . . . 0.0 112.329 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.61 -5.16 8.13 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.548 1.498 . . . . 0.0 113.479 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -99.11 -14.89 19.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.413 1.006 . . . . 0.0 111.091 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 161.31 157.96 9.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.636 1.589 . . . . 0.0 110.528 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -73.39 107.21 5.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.086 1.354 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.3 140.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 126.507 1.923 . . . . 0.0 109.229 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 p -99.8 -71.44 0.7 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.24 142.86 32.8 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 128.319 2.647 . . . . 0.0 109.823 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -162.73 131.67 4.13 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.903 1.281 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -155.42 157.3 36.81 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.223 0.92 . . . . 0.0 111.948 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.3 t -106.26 119.19 55.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.61 139.08 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 121.716 -0.615 . . . . 0.0 109.361 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -133.65 150.39 51.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.326 1.05 . . . . 0.0 108.533 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.82 137.96 52.24 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.589 0.356 . . . . 0.0 111.875 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.2 ptm -71.61 -17.83 62.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.38 -11.93 31.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.378 1.445 . . . . 0.0 114.217 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 62.1 p -140.24 -16.15 0.96 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.17 74.15 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.79 148.79 25.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 118.323 1.061 . . . . 0.0 110.48 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 123.62 14.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.293 1.437 . . . . 0.0 111.156 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -71.45 -53.82 12.7 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.232 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 141.11 -28.08 2.39 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.131 2.301 . . . . 0.0 112.78 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -102.59 161.55 13.63 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.257 1.423 . . . . 0.0 112.704 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.66 168.99 26.67 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.643 1.116 . . . . 0.0 110.382 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -132.72 142.08 48.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.578 1.151 . . . . 0.0 108.789 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.6 t -133.51 143.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.302 1.441 . . . . 0.0 107.484 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.4 t -119.94 130.58 54.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.572 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -114.43 150.23 35.04 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.441 1.096 . . . . 0.0 113.677 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -70.81 -14.76 62.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.313 1.445 . . . . 0.0 114.134 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -138.89 159.75 41.38 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.963 1.711 . . . . 0.0 108.13 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -64.64 -53.16 51.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -29.07 68.65 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 126.145 1.778 . . . . 0.0 112.661 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -64.06 -43.15 96.36 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.32 -47.33 50.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.705 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -55.69 -47.15 77.26 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.176 0.898 . . . . 0.0 110.873 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -49.95 -51.36 41.84 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 126.08 1.752 . . . . 0.0 108.002 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.53 66.72 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 117.189 -1.386 . . . . 0.0 111.936 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 78.5 mt -49.55 -48.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 122.452 2.387 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.74 -59.9 3.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.834 1.653 . . . . 0.0 112.789 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -71.31 -44.61 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.907 1.683 . . . . 0.0 115.231 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.5 mmm -72.63 -21.41 61.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 110.27 2.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.16 62.36 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.869 -1.517 . . . . 0.0 113.903 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -69.73 166.45 19.2 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.518 1.659 . . . . 0.0 108.982 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -106.27 99.2 8.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.542 1.137 . . . . 0.0 109.642 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 116' ' ' ALA . 23.3 tp -85.01 111.98 20.2 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.11 -129.87 38.19 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.93 87.81 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 115.826 -2.652 . . . . 0.0 117.497 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -147.41 157.21 43.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 123.209 3.505 . . . . 0.0 115.267 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.03 163.19 17.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.5 pt -134.92 165.8 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.013 0.911 . . . . 0.0 110.673 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -123.31 147.13 47.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.474 2.31 . . . . 0.0 105.462 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.6 p -138.22 148.35 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.44 1.096 . . . . 0.0 110.702 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -170.08 171.08 7.14 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -69.67 138.75 53.24 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.72 7.56 20.1 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 t -138.41 158.22 44.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.514 1.126 . . . . 0.0 108.492 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -162.32 153.22 17.51 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.014 2.526 . . . . 0.0 106.321 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -135.32 156.01 78.28 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 153.28 75.32 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.631 2.22 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.94 160.53 47.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.644 2.229 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.99 150.4 85.82 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.193 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.83 124.13 11.52 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.919 2.413 . . . . 0.0 106.133 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.82 116.41 10.17 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.741 -0.784 . . . . 0.0 108.907 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 p -130.06 163.41 26.58 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.931 1.292 . . . . 0.0 108.572 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -179.38 163.48 1.25 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.761 2.024 . . . . 0.0 107.691 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -112.37 86.02 2.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.322 1.449 . . . . 0.0 108.393 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.38 144.79 51.47 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.36 93.2 0.93 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.539 -0.726 . . . . 0.0 111.263 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -147.56 122.5 10.03 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.081 -1.012 . . . . 0.0 108.763 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.2 t -141.78 146.59 36.12 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -119.12 85.16 2.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -138.08 169.89 16.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.275 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.5 m 52.51 29.22 6.82 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.768 1.227 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.38 51.51 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.2 163.1 40.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.361 2.041 . . . . 0.0 110.308 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.3 m -162.61 173.63 13.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.155 2.182 . . . . 0.0 107.135 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.0 t -156.06 -178.93 7.67 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.861 1 C-N-CA 132.783 4.992 . . . . 0.0 103.608 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.891 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -132.51 169.53 16.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.789 1.636 . . . . 0.0 110.27 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -65.63 164.13 14.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.089 0.556 . . . . 0.0 111.922 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.33 0.26 65.87 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.013 0.816 . . . . 0.0 113.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 t -122.87 145.54 48.36 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 118.685 1.243 . . . . 0.0 107.879 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -133.72 105.66 6.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.249 1.82 . . . . 0.0 107.076 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.09 79.38 0.18 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -108.01 153.02 23.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.131 1.372 . . . . 0.0 110.235 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -143.18 113.33 7.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.46 1.504 . . . . 0.0 109.052 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -140.41 -177.61 5.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.499 2.32 . . . . 0.0 108.071 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -120.15 171.66 8.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.044 0.937 . . . . 0.0 110.084 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -91.64 16.15 11.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.597 1.959 . . . . 0.0 113.289 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.7 p -47.26 -26.69 1.28 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.17 61.06 1.36 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -124.29 172.08 9.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.566 1.546 . . . . 0.0 109.22 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.69 100.94 6.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.73 144.52 32.13 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.39 135.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.296 1.838 . . . . 0.0 107.853 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -85.92 136.43 33.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.047 2.139 . . . . 0.0 106.492 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.41 142.52 41.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.62 179.36 25.52 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.283 0.944 . . . . 0.0 111.168 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.91 15.45 9.14 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.073 2.549 . . . . 0.0 113.901 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.48 145.59 55.93 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.857 1.263 . . . . 0.0 111.333 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 t -68.46 149.79 97.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.46 -16.75 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.038 1.825 . . . . 0.0 113.5 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -78.46 -16.59 57.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.301 1.04 . . . . 0.0 112.777 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.556 HD11 ' HA3' ' A' ' 164' ' ' GLY . 32.1 mm -70.82 121.49 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.5 1.12 . . . . 0.0 109.669 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 111' ' ' GLU . 4.7 t -99.78 -179.19 4.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.426 1.091 . . . . 0.0 109.923 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.3 m -62.93 -33.08 74.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.523 ' H ' HG23 ' A' ' 109' ' ' THR . 26.0 mt-10 -69.49 -41.81 75.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.786 0.834 . . . . 0.0 109.914 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -56.15 -49.96 72.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.745 0.818 . . . . 0.0 109.172 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.77 -54.51 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -51.91 -41.44 61.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 116.945 -1.502 . . . . 0.0 112.584 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.05 -45.97 79.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.345 0.975 . . . . 0.0 110.085 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.02 -5.99 54.57 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.02 99.74 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-O 117.471 -1.252 . . . . 0.0 114.164 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.34 -5.65 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 121.721 1.65 . . . . 0.0 112.131 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.06 -43.93 7.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 119.751 1.159 . . . . 0.0 108.806 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.84 164.27 36.32 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -80.8 118.47 22.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.43 157.99 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 126.035 1.734 . . . . 0.0 107.748 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.7 t -123.84 -69.45 0.81 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.38 130.16 47.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 107.817 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.2 137.84 9.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.051 1.296 . . . . 0.0 108.774 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.16 173.09 15.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 111.313 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.47 138.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.28 133.83 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -123.6 164.32 19.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.31 142.52 43.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.724 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.6 ptp -75.63 -29.68 59.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.788 -0.57 . . . . 0.0 109.892 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.84 -45.27 15.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -104.75 -18.36 14.29 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.94 12.26 74.93 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.978 -0.451 . . . . 0.0 113.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -85.46 155.06 21.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.481 1.112 . . . . 0.0 109.966 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 t -57.81 126.35 27.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.896 0.878 . . . . 0.0 108.849 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -70.08 -65.85 0.67 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.698 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 150.72 -18.82 0.99 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 128.152 2.786 . . . . 0.0 110.245 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -102.93 162.88 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.072 -1.252 . . . . 0.0 112.585 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.49 176.99 29.68 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.28 1.419 . . . . 0.0 110.613 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.33 151.29 46.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.603 0.761 . . . . 0.0 109.359 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 50.2 t -143.8 121.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.382 1.473 . . . . 0.0 109.072 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -107.0 125.37 50.91 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 109.317 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -105.47 159.65 15.77 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.288 1.035 . . . . 0.0 110.709 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.17 -30.0 65.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.196 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -132.02 158.78 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.773 1.17 . . . . 0.0 111.033 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -60.56 -53.94 51.43 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.03 1.332 . . . . 0.0 112.33 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -41.16 67.75 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.788 2.035 . . . . 0.0 112.619 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -58.31 -45.43 88.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.209 1.004 . . . . 0.0 109.301 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.53 -50.36 45.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.271 1.028 . . . . 0.0 110.687 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.47 -48.73 62.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.207 1.403 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -56.17 -34.93 66.65 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.53 -45.33 16.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 116.923 -1.513 . . . . 0.0 109.6 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 79.5 mt -49.03 -39.39 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 122.083 2.22 . . . . 0.0 109.747 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.69 -71.09 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.528 1.131 . . . . 0.0 111.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -64.18 -45.61 87.61 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 127.802 2.441 . . . . 0.0 116.14 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.8 mmm -76.65 -21.14 55.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.737 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.43 0.62 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 116.266 1.266 . . . . 0.0 116.266 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.93 -11.15 0.5 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.504 2.002 . . . . 0.0 112.231 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.04 167.38 11.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.174 0.987 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.25 123.04 47.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.38 118.18 32.51 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.273 1.429 . . . . 0.0 109.255 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.556 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 64.11 5.99 17.58 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.7 1.143 . . . . 0.0 113.686 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 124.6 -5.96 8.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 117.042 -1.977 . . . . 0.0 114.683 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -133.28 148.17 51.93 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.519 2.659 . . . . 0.0 112.018 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -64.49 154.78 34.85 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.496 0.718 . . . . 0.0 110.413 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 26.4 pt -128.58 163.45 33.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 110.698 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -124.84 141.37 52.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.7 p -139.52 141.78 37.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.484 1.038 . . . . 0.0 111.035 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -163.28 176.79 9.56 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.857 1.663 . . . . 0.0 108.166 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -70.38 152.9 43.59 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.149 -1.595 . . . . 0.0 109.031 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 9.72 5.5 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.6 t -136.28 168.69 18.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.422 1.489 . . . . 0.0 109.469 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -132.63 -170.78 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.659 2.384 . . . . 0.0 106.284 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -135.31 155.67 78.55 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 119.149 0.886 . . . . 0.0 110.23 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.78 162.33 39.98 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.142 1.895 . . . . 0.0 109.898 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.72 173.07 15.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.955 2.437 . . . . 0.0 111.703 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.42 149.81 55.76 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.33 -20.15 32.53 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.051 1.834 . . . . 0.0 111.596 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -54.25 119.53 5.27 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.178 1.391 . . . . 0.0 109.628 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.7 t -129.35 101.75 6.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.6 m -77.24 136.35 38.53 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.393 1.077 . . . . 0.0 108.402 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.76 173.92 9.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.943 0.497 . . . . 0.0 110.447 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.26 150.8 32.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.396 1.478 . . . . 0.0 107.19 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.4 p -167.57 174.75 7.55 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -150.37 130.59 13.63 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.766 1.226 . . . . 0.0 108.037 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.1 m -120.24 133.32 55.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.13 134.75 2.48 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.37 128.76 4.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 p -161.41 110.84 1.59 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.24 78.6 0.28 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.94 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.2 167.16 27.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.401 2.067 . . . . 0.0 110.334 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.4 p -149.15 163.95 36.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.417 1.087 . . . . 0.0 109.038 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.3 t -157.81 164.61 36.83 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.406 0 C-N-CA 128.207 2.813 . . . . 0.0 106.678 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 t -159.3 -164.44 1.38 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.578 2.351 . . . . 0.0 106.31 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 t -69.76 160.49 31.6 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.067 -1.02 . . . . 0.0 108.961 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.72 111.26 1.35 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.236 1.398 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -152.06 92.49 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.952 0.876 . . . . 0.0 109.082 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 p -121.36 -174.28 2.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 109.205 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.57 174.94 21.73 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.568 1.08 . . . . 0.0 112.231 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -77.25 166.25 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.29 0.636 . . . . 0.0 110.108 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.51 111.16 18.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 111.613 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -99.58 54.45 0.95 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.22 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.706 0.802 . . . . 0.0 111.007 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -138.66 -0.28 1.96 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.044 0.937 . . . . 0.0 112.973 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -56.58 -37.89 71.21 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.298 -1.501 . . . . 0.0 114.202 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -79.83 -8.58 59.37 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.305 -0.872 . . . . 0.0 112.13 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -84.93 167.41 15.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.256 0.934 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.07 100.16 7.04 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.957 1.303 . . . . 0.0 110.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.98 146.3 35.51 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.102 0.954 . . . . 0.0 111.545 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.2 t -129.2 141.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 129.524 3.13 . . . . 0.0 109.426 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -95.23 136.52 35.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.611 2.364 . . . . 0.0 107.578 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.444 HG12 HD21 ' A' ' 104' ' ' LEU . 7.1 t -132.33 135.3 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.68 -178.57 21.28 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 121.537 -0.727 . . . . 0.0 111.64 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.93 7.22 6.12 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.957 2.503 . . . . 0.0 113.268 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD21 HG12 ' A' ' 101' ' ' VAL . 24.6 mt -58.14 145.51 36.67 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.66 2.384 . . . . 0.0 111.36 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -67.14 148.0 98.91 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.36 -10.53 11.09 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.098 2.532 . . . . 0.0 114.4 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.18 -23.45 21.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.627 1.103 . . . . 0.0 113.002 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.8 mm -57.97 128.15 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.008 0.923 . . . . 0.0 109.395 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 111' ' ' GLU . 4.5 t -107.76 177.9 4.68 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.893 1.33 . . . . 0.0 111.131 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 m -60.23 -31.42 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.428 1.091 . . . . 0.0 111.042 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 109' ' ' THR . 5.4 mt-10 -73.7 -36.52 65.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.054 0.942 . . . . 0.0 111.267 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -60.53 -49.62 76.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.3 mt -59.44 -54.2 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -51.79 -47.26 64.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.316 0.962 . . . . 0.0 111.38 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.68 83.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.531 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -39.54 63.03 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -88.85 -10.98 46.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.016 0.926 . . . . 0.0 112.608 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.83 97.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.936 1.294 . . . . 0.0 111.236 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.22 -3.82 6.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 CA-C-N 121.872 1.704 . . . . 0.0 113.906 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.92 -15.28 18.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.216 0.916 . . . . 0.0 112.003 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.48 177.72 30.85 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 122.407 1.004 . . . . 0.0 111.702 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -74.08 131.45 41.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.21 135.75 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -74.89 0.59 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -103.53 141.5 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.846 2.059 . . . . 0.0 108.655 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.22 127.48 2.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.932 1.242 . . . . 0.0 109.03 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -154.85 162.54 41.07 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.1 0.864 . . . . 0.0 111.601 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.01 120.08 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.82 135.43 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -131.7 151.16 51.84 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.77 144.4 56.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.88 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 tpt -83.0 -19.43 37.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.036 0.835 . . . . 0.0 111.701 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.85 -9.36 37.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.002 -1.061 . . . . 0.0 113.509 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.7 p -136.79 -25.36 1.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.355 0.979 . . . . 0.0 112.398 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.0 81.22 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -92.2 156.45 17.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.884 1.342 . . . . 0.0 109.559 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -54.16 126.15 21.8 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.382 1.073 . . . . 0.0 111.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -75.36 -32.78 60.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.828 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.22 -25.52 7.39 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.714 2.578 . . . . 0.0 111.259 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -102.57 161.2 13.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.527 1.163 . . . . 0.0 112.281 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.1 172.79 28.31 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.642 1.591 . . . . 0.0 109.317 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -135.03 155.02 51.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.51 1.124 . . . . 0.0 108.555 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.8 t -145.31 146.81 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.071 2.548 . . . . 0.0 104.509 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 t -145.2 112.76 6.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.755 1.616 . . . . 0.0 109.79 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -86.88 152.39 22.49 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.588 1.155 . . . . 0.0 112.131 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -70.27 -34.82 73.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.642 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -112.52 146.86 37.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.16 1.384 . . . . 0.0 108.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.55 -49.24 74.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.42 -33.47 59.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.52 1.128 . . . . 0.0 113.913 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -62.24 -46.79 87.29 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.14 -49.41 69.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 110.186 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.47 -45.13 76.96 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.162 0.585 . . . . 0.0 110.501 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.36 -50.59 67.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.144 0.577 . . . . 0.0 110.465 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.12 78.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.413 1.485 . . . . 0.0 111.285 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 89.0 mt -51.49 -47.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 121.815 2.098 . . . . 0.0 110.375 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -67.77 -56.13 10.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 124.129 0.893 . . . . 0.0 112.109 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.05 -52.8 21.1 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.57 -17.62 64.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -75.99 79.91 1.12 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 123.793 0.711 . . . . 0.0 111.918 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 132.69 -5.75 5.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.795 2.14 . . . . 0.0 111.379 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -73.76 178.8 4.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.208 1.004 . . . . 0.0 108.77 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -118.85 150.47 39.79 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.9 tp -138.44 126.97 23.3 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.808 1.643 . . . . 0.0 106.64 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 -86.84 0.49 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.72 5.6 1.79 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.83 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -141.19 164.28 30.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.93 1.865 . . . . 0.0 112.98 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.0 160.86 31.16 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.581 1.152 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.3 pt -137.62 171.9 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.614 1.166 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.1 144.32 47.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.612 1.565 . . . . 0.0 108.026 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -136.83 137.27 39.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.843 0.747 . . . . 0.0 111.217 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -152.12 169.98 21.08 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -64.53 141.42 58.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.36 60.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.392 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.5 p -85.94 165.0 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.401 1.08 . . . . 0.0 108.916 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -152.88 171.82 17.71 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.011 1.325 . . . . 0.0 108.013 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.16 133.42 20.16 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.29 165.86 20.95 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.158 2.572 . . . . 0.0 112.995 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.54 177.36 8.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.806 2.337 . . . . 0.0 111.1 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -131.36 137.68 31.09 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.26 88.48 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.861 3.041 . . . . 0.0 112.302 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -159.85 129.03 5.15 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.879 -1.138 . . . . 0.0 109.077 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.7 p -150.69 -176.82 5.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.926 1.29 . . . . 0.0 108.047 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.5 t -131.55 -176.31 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 109.73 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -117.04 169.34 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.611 1.564 . . . . 0.0 108.17 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.07 -176.03 5.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.449 0.7 . . . . 0.0 110.048 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 m -135.29 16.45 3.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.668 0.787 . . . . 0.0 111.513 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.35 17.94 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.493 1.117 . . . . 0.0 112.117 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 12.8 p -71.29 58.88 0.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.115 2.566 . . . . 0.0 110.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -49.98 -55.39 14.83 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 126.546 1.938 . . . . 0.0 113.425 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -168.99 158.01 8.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 142.51 56.79 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.38 68.18 1.68 Allowed Glycine 0 CA--C 1.533 1.171 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.12 27.21 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.625 2.216 . . . . 0.0 113.003 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.3 p -144.26 158.41 43.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.328 1.451 . . . . 0.0 108.813 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.4 166.79 22.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.192 2.197 . . . . 0.0 106.396 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.413 0 N-CA-C 107.321 -2.311 . . . . 0.0 107.321 -179.422 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.779 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 p -86.46 -179.55 6.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.686 0.795 . . . . 0.0 110.566 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 t -117.96 -19.26 9.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.975 1.31 . . . . 0.0 110.4 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.04 86.42 1.7 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 105.291 -3.124 . . . . 0.0 105.291 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -130.65 46.67 2.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.321 1.448 . . . . 0.0 108.788 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.5 m -58.14 15.98 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.111 2.964 . . . . 0.0 116.641 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.37 -10.01 9.9 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.439 1.472 . . . . 0.0 114.195 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.32 139.81 35.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.024 1.912 . . . . 0.0 107.147 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -126.18 155.41 41.8 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -171.0 143.05 1.92 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.997 2.119 . . . . 0.0 106.337 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 38.58 36.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 129.082 2.953 . . . . 0.0 113.361 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p 55.21 14.02 0.96 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.885 1.674 . . . . 0.0 114.008 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -56.18 -16.01 4.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.45 1.9 . . . . 0.0 115.518 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -123.17 3.24 9.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.317 0.962 . . . . 0.0 111.411 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -78.01 171.58 14.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.087 0.955 . . . . 0.0 108.701 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.44 100.89 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.428 ' CE1' ' HG ' ' A' ' 144' ' ' SER . 22.5 m-70 -86.95 142.48 27.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.334 0.588 . . . . 0.0 112.235 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.66 143.18 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.81 2.444 . . . . 0.0 108.515 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -93.78 136.04 34.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.417 2.687 . . . . 0.0 108.014 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.6 140.71 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.495 -2.78 . . . . 0.0 103.495 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 175.98 29.65 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.84 16.96 10.49 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 124.618 1.167 . . . . 0.0 112.68 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.25 149.3 45.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 0.0 110.961 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -70.83 144.49 90.72 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.45 -3.74 6.97 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 114.929 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.5 -21.83 20.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.949 1.7 . . . . 0.0 111.662 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.47 HD11 ' HA3' ' A' ' 164' ' ' GLY . 46.0 mm -67.64 134.48 30.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 127.891 2.476 . . . . 0.0 111.123 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -106.15 173.07 6.47 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.182 0.991 . . . . 0.0 108.792 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.5 m -60.24 -30.37 69.37 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.562 -1.336 . . . . 0.0 109.714 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -68.99 -32.42 71.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 110.343 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.43 -41.21 85.16 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.46 -48.42 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -55.22 -41.54 72.19 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.068 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -52.25 60.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.819 0.847 . . . . 0.0 110.928 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.89 77.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -94.93 -2.72 49.98 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.74 99.54 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.639 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.73 -2.93 9.39 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-N 121.792 1.676 . . . . 0.0 112.727 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.75 -19.55 18.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.139 0.881 . . . . 0.0 111.452 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.06 170.12 30.55 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 122.096 0.831 . . . . 0.0 112.394 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -78.14 101.94 7.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.61 1.195 . . . . 0.0 109.15 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mt -76.74 148.36 6.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 t -111.41 -73.26 0.68 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.39 136.39 41.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.943 1.697 . . . . 0.0 108.778 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -163.65 138.83 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.25 151.22 22.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.353 0.979 . . . . 0.0 111.485 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 t -99.26 117.36 44.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.99 145.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -131.51 151.26 51.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -61.66 115.88 4.32 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -58.0 -17.34 16.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.843 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.6 -7.07 28.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.4 p -139.81 -28.54 0.75 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.72 1.145 . . . . 0.0 111.869 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 13.02 71.52 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.859 1.218 . . . . 0.0 110.617 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.15 153.63 22.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.797 1.298 . . . . 0.0 108.387 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.3 t -55.8 128.44 34.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.721 0.691 . . . . 0.0 111.406 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -78.8 -17.43 55.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.03 -23.8 34.25 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.167 0.889 . . . . 0.0 112.931 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.265 27.0 p90 -102.64 159.61 15.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.366 1.583 . . . . 0.0 110.43 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.42 178.17 33.04 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.609 1.099 . . . . 0.0 110.768 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -142.49 159.84 41.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.94 151.36 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.675 1.99 . . . . 0.0 106.939 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.428 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 2.6 t -132.88 119.67 20.49 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.643 1.977 . . . . 0.0 108.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -103.69 149.59 24.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.723 1.609 . . . . 0.0 111.202 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -71.16 -35.83 71.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.196 0.998 . . . . 0.0 110.279 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -122.99 153.31 39.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.717 1.207 . . . . 0.0 111.562 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -61.44 -50.2 73.76 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 110.753 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.0 -44.4 20.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.797 2.039 . . . . 0.0 112.577 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.87 -50.12 73.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.787 1.235 . . . . 0.0 109.844 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.39 94.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.075 0.95 . . . . 0.0 110.576 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -59.4 -54.7 43.67 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.69 1.196 . . . . 0.0 109.678 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -53.92 -45.36 71.16 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.02 62.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.224 1.409 . . . . 0.0 111.803 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.33 -39.53 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.818 1.645 . . . . 0.0 110.511 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -70.02 -62.17 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -65.55 -52.16 54.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 116.406 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -71.67 -21.79 61.75 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.032 1.287 . . . . 0.0 112.746 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.15 121.92 25.64 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.859 0.743 . . . . 0.0 111.857 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.86 71.41 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 118.627 -1.096 . . . . 0.0 113.963 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.87 175.04 9.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.105 1.452 . . . . 0.0 108.68 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 8.5 m95 -105.23 157.96 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.69 120.44 9.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.47 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 71.18 -39.23 0.56 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.448 1.023 . . . . 0.0 115.178 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.79 -5.19 0.03 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.954 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -137.4 162.26 34.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.421 2.111 . . . . 0.0 109.413 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 162' ' ' TRP . 52.5 mt-30 -70.83 159.37 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.101 0.56 . . . . 0.0 110.809 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 pt -130.54 165.81 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.782 1.233 . . . . 0.0 110.248 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -121.66 147.76 45.46 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 56.0 p -133.91 142.43 47.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 108.571 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -166.31 167.56 15.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.805 1.184 . . . . 0.0 109.138 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -68.46 126.85 30.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.97 -25.56 66.38 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.4 t -150.25 156.36 41.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 108.138 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -166.89 169.89 12.72 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.812 2.445 . . . . 0.0 108.482 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -143.98 133.18 11.42 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.45 150.83 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 108.739 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.07 166.1 26.06 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.821 2.348 . . . . 0.0 112.423 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -119.31 141.08 29.99 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 109.325 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.91 110.69 2.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.878 3.052 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -136.14 77.21 1.64 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.824 1.65 . . . . 0.0 108.396 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 t -66.02 113.54 4.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.0 t -77.66 162.88 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -152.39 134.37 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -137.89 -11.41 1.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.777 0.831 . . . . 0.0 112.215 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.6 87.72 0.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.668 1.987 . . . . 0.0 110.995 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -143.43 169.03 18.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.057 1.343 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -145.71 168.25 21.16 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.419 1.088 . . . . 0.0 109.391 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -166.3 118.54 1.04 Allowed 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 124.527 1.131 . . . . 0.0 108.431 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -136.06 145.15 45.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 m -159.29 170.93 20.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.948 1.299 . . . . 0.0 108.057 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -151.2 69.93 0.31 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.34 171.52 17.93 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.424 2.083 . . . . 0.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -152.11 176.29 11.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 106.832 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 21.6 m -150.63 177.96 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.895 1.678 . . . . 0.0 107.586 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 C-N-CA 127.625 2.536 . . . . 0.0 106.831 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p 51.17 19.86 0.79 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.507 1.923 . . . . 0.0 113.666 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.5 p -68.29 -21.44 64.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.211 2.205 . . . . 0.0 113.975 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.44 -56.81 3.33 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.586 1.089 . . . . 0.0 112.454 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -40.25 -55.11 2.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.369 2.668 . . . . 0.0 111.991 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 m -163.18 178.56 8.13 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.77 2.028 . . . . 0.0 108.167 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.73 55.42 3.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -51.98 167.04 0.13 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.59 2.756 . . . . 0.0 113.798 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 11.54 28.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -142.99 142.14 31.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.67 1.123 . . . . 0.0 107.98 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.22 164.52 13.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.176 0.988 . . . . 0.0 111.69 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -70.88 -0.72 9.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.459 2.304 . . . . 0.0 115.226 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 t -41.16 -30.59 0.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.635 2.374 . . . . 0.0 116.747 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -130.92 32.91 4.26 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.074 1.306 . . . . 0.0 110.961 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.09 175.11 5.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.05 0.94 . . . . 0.0 110.417 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -112.11 146.63 37.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.6 147.92 49.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.536 0.684 . . . . 0.0 111.524 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.21 138.17 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.7 2.0 . . . . 0.0 109.38 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -96.1 134.13 39.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.604 2.362 . . . . 0.0 106.036 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.37 142.2 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.59 -179.98 23.13 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.897 0.771 . . . . 0.0 111.961 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 62.0 18.76 10.2 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.701 2.0 . . . . 0.0 111.749 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.3 mt -62.42 132.61 53.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.245 1.418 . . . . 0.0 110.717 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.42 151.33 77.49 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -60.19 -24.05 75.84 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.94 2.427 . . . . 0.0 114.955 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.13 -22.52 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.08 -1.012 . . . . 0.0 113.061 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.636 HD11 ' HA3' ' A' ' 164' ' ' GLY . 44.3 mm -58.89 122.7 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.022 0.915 . . . . 0.0 111.226 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.5 t -110.66 176.11 5.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.516 1.526 . . . . 0.0 107.173 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.8 m -65.19 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 120.428 -1.42 . . . . 0.0 112.8 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -70.42 -33.49 71.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -48.25 79.55 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 110.33 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 mt -60.54 -50.33 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 26.9 mtmt -55.36 -48.16 74.66 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.591 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.38 68.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.911 0.885 . . . . 0.0 110.398 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -44.28 96.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -89.94 -8.88 50.72 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.03 -46.88 99.83 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 117.1 -1.429 . . . . 0.0 114.122 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.11 -3.83 10.48 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.115 1.791 . . . . 0.0 112.775 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.4 -11.82 22.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.601 0.637 . . . . 0.0 111.967 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.98 164.99 14.19 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -72.32 124.75 25.76 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.58 147.73 5.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.27 -65.41 1.18 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -102.4 133.71 46.89 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.904 0.882 . . . . 0.0 110.893 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.523 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -157.56 136.34 11.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.586 0.755 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -163.34 158.42 21.29 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.97 1.708 . . . . 0.0 110.642 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.72 130.44 50.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 138.15 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -132.79 158.28 42.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.484 0.714 . . . . 0.0 109.858 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -61.53 114.83 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.23 -20.33 26.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.216 1.371 . . . . 0.0 112.81 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.8 -21.13 23.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.7 p -135.71 -15.46 1.82 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.94 1.245 . . . . 0.0 114.051 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.3 86.31 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.936 1.255 . . . . 0.0 114.02 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.2 152.17 30.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.364 1.582 . . . . 0.0 109.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -54.77 126.84 25.78 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.792 0.837 . . . . 0.0 112.059 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -72.59 -52.38 15.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 143.75 -21.54 2.17 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.712 3.053 . . . . 0.0 110.449 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.269 7.1 p90 -103.13 168.59 9.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.652 1.581 . . . . 0.0 113.997 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.82 175.06 33.02 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.509 1.528 . . . . 0.0 111.005 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -135.91 147.17 48.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.48 1.112 . . . . 0.0 109.553 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.64 144.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.9 t -136.13 140.27 43.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.233 1.413 . . . . 0.0 107.438 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.11 150.77 46.52 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.443 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -67.58 -14.24 62.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.221 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -133.82 156.12 48.61 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 120.161 1.346 . . . . 0.0 110.234 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -71.37 -53.05 15.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -51.03 -34.94 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.419 2.288 . . . . 0.0 112.018 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -60.27 -54.54 44.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.011 0.924 . . . . 0.0 108.608 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.33 76.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -56.28 -48.77 75.96 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.357 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.91 -45.03 87.14 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.166 0.439 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.16 85.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.076 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 88.9 mt -54.26 -35.94 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.387 1.903 . . . . 0.0 110.312 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -76.63 -62.35 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.054 0.542 . . . . 0.0 111.656 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -63.85 -45.25 90.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.02 2.128 . . . . 0.0 114.032 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.31 -24.97 57.52 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.82 98.36 0.29 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.29 -9.41 11.03 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.878 1.228 . . . . 0.0 112.264 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -76.15 178.64 6.24 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.749 1.275 . . . . 0.0 108.469 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -121.01 158.84 26.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.25 1.42 . . . . 0.0 107.986 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 tp -154.92 130.69 10.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.636 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 70.45 -25.52 0.47 Allowed Glycine 0 N--CA 1.464 0.566 0 C-N-CA 125.208 1.385 . . . . 0.0 115.707 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.56 -2.24 0.47 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 117.791 -1.56 . . . . 0.0 113.605 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -136.81 157.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.474 2.137 . . . . 0.0 110.99 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -66.97 153.56 43.3 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.75 152.55 32.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.801 0.84 . . . . 0.0 111.008 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -106.52 145.42 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.817 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.0 p -139.04 123.32 18.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.634 1.106 . . . . 0.0 110.202 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -149.22 172.2 15.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.756 0.707 . . . . 0.0 109.603 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -66.98 130.5 43.33 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.83 46.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 p -135.2 93.21 2.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.604 1.562 . . . . 0.0 109.884 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -140.06 123.48 17.06 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 108.927 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -134.72 151.8 76.45 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 126.008 1.723 . . . . 0.0 108.969 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 159.02 43.28 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.679 2.253 . . . . 0.0 110.487 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.23 -173.46 1.45 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.111 3.208 . . . . 0.0 108.83 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.6 157.68 37.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.346 -1.472 . . . . 0.0 108.803 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.42 1.45 7.38 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.762 2.308 . . . . 0.0 112.72 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -152.94 153.33 32.76 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.9 2.08 . . . . 0.0 106.96 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -129.19 -166.06 1.6 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.35 1.86 . . . . 0.0 107.939 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 -151.77 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -154.08 172.51 17.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 120.229 1.377 . . . . 0.0 108.281 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -122.79 103.1 8.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.3 t -117.11 127.39 54.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.67 145.16 56.26 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -79.58 175.02 10.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.588 1.155 . . . . 0.0 110.289 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -153.15 133.7 13.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 120.933 -1.104 . . . . 0.0 108.329 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -75.07 158.19 33.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.6 m -139.29 164.91 28.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.335 1.854 . . . . 0.0 107.606 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.07 88.8 0.16 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.91 172.7 15.82 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.397 2.065 . . . . 0.0 110.048 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 63.1 m -158.95 171.89 19.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.7 t -154.86 163.25 40.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 C-N-CA 128.764 3.078 . . . . 0.0 106.423 -179.62 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 m -112.85 157.73 21.05 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.412 0.685 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.72 126.08 20.69 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.824 0.85 . . . . 0.0 111.817 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.85 -70.66 3.08 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 123.985 0.803 . . . . 0.0 113.263 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -74.45 79.93 1.92 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.931 1.292 . . . . 0.0 113.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 t -74.59 -68.18 0.56 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.81 -147.29 19.71 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -116.94 32.15 6.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.794 0.838 . . . . 0.0 112.729 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.0 110.28 8.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.9 31.06 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.943 1.697 . . . . 0.0 110.736 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -62.95 163.29 9.9 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.9 p 56.35 21.83 5.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.946 1.299 . . . . 0.0 111.825 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.1 77.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.245 -1.534 . . . . 0.0 111.033 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.92 -13.94 61.36 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.446 0.699 . . . . 0.0 112.361 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -86.28 172.96 10.07 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.412 1.085 . . . . 0.0 108.431 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -125.45 107.07 10.29 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.005 1.322 . . . . 0.0 111.653 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -85.07 128.43 34.64 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 110.727 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.46 138.98 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.984 2.514 . . . . 0.0 106.908 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -93.53 142.18 27.63 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.659 1.983 . . . . 0.0 107.075 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.94 137.1 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.49 179.43 18.76 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.407 -0.808 . . . . 0.0 111.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.57 15.43 6.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.156 3.382 . . . . 0.0 115.007 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.69 149.26 22.32 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.732 1.613 . . . . 0.0 111.596 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.4 t -65.45 145.35 99.07 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.98 -8.3 7.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.089 2.526 . . . . 0.0 115.304 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -98.12 -16.41 19.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.806 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.663 HD11 ' HA3' ' A' ' 164' ' ' GLY . 23.5 mm -58.29 116.81 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 t -91.1 174.34 7.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.655 0.741 . . . . 0.0 109.273 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -64.15 -31.93 73.31 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.391 -1.443 . . . . 0.0 111.595 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.42 -24.96 57.17 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.554 -0.716 . . . . 0.0 111.237 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.1 -46.66 76.83 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.19 -51.41 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -53.65 -49.27 68.28 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 117.579 -1.2 . . . . 0.0 110.709 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.37 81.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.375 0.989 . . . . 0.0 111.77 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.49 92.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.67 -9.95 39.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -47.14 99.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.61 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.06 -5.83 11.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.267 1.845 . . . . 0.0 112.39 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.04 -11.24 23.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.707 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 160.21 165.8 17.79 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 120.071 1.305 . . . . 0.0 114.17 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -76.4 119.18 19.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.2 mt -94.9 149.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 t -114.38 -67.39 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.23 125.26 48.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.77 136.14 32.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -160.94 153.41 20.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 119.441 1.019 . . . . 0.0 111.873 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.6 t -106.98 115.06 47.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.7 139.1 17.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 125.182 1.393 . . . . 0.0 107.625 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -130.83 153.66 48.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.607 -0.683 . . . . 0.0 110.484 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.55 107.57 1.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.5 ptm -54.03 -13.97 0.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 -19.04 17.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.688 1.131 . . . . 0.0 112.816 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 p -130.24 -22.44 2.81 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.98 16.97 73.52 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.605 2.05 . . . . 0.0 112.716 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -84.77 155.22 21.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 1.435 . . . . 0.0 109.105 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.9 t -62.95 122.4 15.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.882 0.31 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -71.5 -25.4 62.25 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.34 38.48 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.003 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -103.79 165.95 10.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.256 2.028 . . . . 0.0 110.506 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.52 177.4 33.51 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.841 0.734 . . . . 0.0 111.819 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -135.5 148.24 49.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.09 1.356 . . . . 0.0 109.698 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.7 t -137.43 120.17 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.138 1.775 . . . . 0.0 107.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -105.27 114.23 28.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.259 1.823 . . . . 0.0 108.898 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.93 148.95 23.45 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.66 1.184 . . . . 0.0 109.12 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -67.88 -40.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.211 0.604 . . . . 0.0 110.243 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -110.91 145.54 38.14 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.03 0.932 . . . . 0.0 112.183 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.32 -46.94 86.45 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.012 0.925 . . . . 0.0 112.141 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -34.26 69.4 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.485 1.114 . . . . 0.0 112.966 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.05 -47.49 79.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.39 71.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.968 1.307 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.51 -47.91 78.32 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.504 0.721 . . . . 0.0 110.293 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -55.57 -49.3 73.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.63 72.56 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 81.4 mt -49.91 -44.42 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.633 1.561 . . . . 0.0 110.221 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -73.09 -58.24 3.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.193 0.997 . . . . 0.0 113.294 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -68.58 -51.06 46.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.403 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -67.69 -20.79 65.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.191 0.905 . . . . 0.0 112.749 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.98 90.29 0.58 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.86 -6.15 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.776 1.655 . . . . 0.0 111.752 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -86.84 172.85 9.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.946 0.873 . . . . 0.0 110.172 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -113.03 154.77 25.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.997 1.319 . . . . 0.0 109.199 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.0 tp -153.71 128.01 9.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.593 1.557 . . . . 0.0 107.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.663 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 63.92 22.96 67.13 Favored Glycine 0 N--CA 1.464 0.504 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.401 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 98.38 -2.75 59.35 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 115.956 -2.58 . . . . 0.0 115.836 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -140.4 160.91 38.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 121.525 2.663 . . . . 0.0 111.655 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.73 159.08 28.65 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.76 154.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.477 1.111 . . . . 0.0 109.112 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -115.99 129.76 56.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.5 p -116.7 153.61 32.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.248 1.419 . . . . 0.0 108.961 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -175.51 166.57 3.26 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.733 1.213 . . . . 0.0 108.928 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -70.12 126.13 28.79 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.06 -52.76 6.04 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.27 0.486 . . . . 0.0 110.75 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.7 t -51.34 -58.34 6.47 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -142.41 142.84 32.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.861 1.664 . . . . 0.0 111.229 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -78.26 133.86 63.75 Favored Pre-proline 0 C--O 1.238 0.463 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.02 154.06 71.28 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.753 1.635 . . . . 0.0 110.105 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.99 176.34 10.25 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.031 2.487 . . . . 0.0 110.412 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.94 142.66 97.52 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.79 95.57 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.832 2.355 . . . . 0.0 106.597 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -68.45 121.87 17.25 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.172 -0.955 . . . . 0.0 109.497 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.3 t -123.98 93.63 3.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 28.7 m -142.92 146.85 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.808 1.643 . . . . 0.0 107.055 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -83.88 81.41 8.78 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -153.76 140.34 18.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -85.64 163.05 18.53 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.692 0.758 . . . . 0.0 109.752 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.28 165.87 34.35 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 110.972 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.6 t -163.45 138.97 6.55 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.221 1.809 . . . . 0.0 106.622 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -177.31 129.56 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.208 1.403 . . . . 0.0 110.63 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -151.48 167.58 27.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -143.85 174.63 10.66 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.281 1.832 . . . . 0.0 107.311 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.27 81.4 0.07 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 120.074 1.307 . . . . 0.0 114.545 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.61 169.64 21.86 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.093 1.862 . . . . 0.0 108.948 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.4 m -143.08 -174.48 4.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 109.626 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 75.6 m -73.46 159.97 32.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.302 -2.388 . . . . 0.0 109.296 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.6 p -35.5 93.89 0.01 OUTLIER 'General case' 0 C--O 1.239 0.544 0 C-N-CA 127.885 2.474 . . . . 0.0 114.14 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 p -160.72 127.48 4.16 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.468 2.307 . . . . 0.0 106.173 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.0 138.58 8.96 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 m -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 t -128.23 -10.99 5.25 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.097 1.359 . . . . 0.0 110.713 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.37 148.58 37.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 124.158 0.885 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.53 -22.36 66.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.595 0.758 . . . . 0.0 113.004 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -134.36 -68.84 0.54 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.034 1.333 . . . . 0.0 111.52 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -149.48 125.88 10.86 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.446 0.698 . . . . 0.0 111.388 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -87.07 70.41 10.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -72.96 -1.3 16.47 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.248 -0.907 . . . . 0.0 112.745 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -52.55 0.32 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.139 3.376 . . . . 0.0 117.069 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.65 -3.14 0.47 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -73.01 156.11 39.14 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.616 0.767 . . . . 0.0 110.696 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -99.74 101.45 12.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.27 154.5 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.413 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 110.745 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.96 129.52 34.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.13 137.69 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.93 -176.98 21.15 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 61.84 18.89 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.627 1.971 . . . . 0.0 112.627 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 mt -69.86 151.24 45.92 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.473 -1.392 . . . . 0.0 110.909 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -67.63 146.41 98.53 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.44 -4.36 6.62 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.626 2.884 . . . . 0.0 113.682 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -96.81 -21.34 17.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.882 1.273 . . . . 0.0 111.156 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.3 132.38 23.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.309 1.044 . . . . 0.0 108.953 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -112.13 172.17 7.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.227 1.013 . . . . 0.0 108.809 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -56.3 -29.85 61.77 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.146 1.378 . . . . 0.0 110.776 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -73.03 -34.94 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.704 0.801 . . . . 0.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.47 -49.13 74.84 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mt -59.17 -49.57 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -54.92 -42.32 72.08 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.656 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.97 77.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.828 0.74 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.53 98.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -89.42 -14.52 35.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.349 0.66 . . . . 0.0 112.354 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.72 99.51 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.047 0.939 . . . . 0.0 113.405 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.72 -6.68 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 121.396 1.534 . . . . 0.0 112.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.89 -18.59 17.05 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.364 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 168.23 169.34 31.58 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 119.57 1.077 . . . . 0.0 112.04 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -74.41 124.01 25.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.7 mt -100.1 150.48 5.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.58 -61.55 1.6 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -101.41 140.5 35.61 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.7 5.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.421 1.088 . . . . 0.0 108.384 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -162.77 161.64 26.29 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.713 1.205 . . . . 0.0 110.74 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.47 134.66 53.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.46 144.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -133.9 162.88 30.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.556 1.143 . . . . 0.0 109.583 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -71.31 119.14 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.447 1.499 . . . . 0.0 107.589 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.4 ptp -59.18 -16.59 21.28 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.65 -13.92 20.09 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.2 p -137.6 -15.46 1.4 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.306 1.412 . . . . 0.0 113.975 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.64 14.34 81.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.57 1.081 . . . . 0.0 110.904 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.92 141.58 37.48 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.834 1.253 . . . . 0.0 108.567 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.29 123.36 14.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.094 0.957 . . . . 0.0 112.209 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.56 -42.68 64.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.22 -15.27 7.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.757 1.17 . . . . 0.0 112.621 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.027 1.413 . . . . 0.0 108.075 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.05 33.74 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.813 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -131.89 156.4 46.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.323 1.062 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.67 135.22 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.4 m -123.96 112.74 17.57 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.425 1.09 . . . . 0.0 108.16 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -97.53 155.6 16.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.24 0.962 . . . . 0.0 110.025 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.72 -41.51 62.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -103.1 147.44 26.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.004 0.522 . . . . 0.0 111.751 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' HE3' ' CH2' ' A' ' 172' ' ' TRP . 11.0 tptm -64.42 -46.69 82.14 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.989 0.916 . . . . 0.0 109.248 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -33.3 68.6 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.538 1.535 . . . . 0.0 113.606 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.61 -49.82 71.83 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.47 -51.74 67.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.183 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -51.67 -52.65 46.4 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.116 0.966 . . . . 0.0 111.615 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -55.07 -50.47 69.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.104 0.562 . . . . 0.0 110.283 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.98 86.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 117.281 -1.342 . . . . 0.0 110.399 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.75 -36.98 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 123.513 2.869 . . . . 0.0 110.968 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -76.27 -65.19 0.95 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -62.37 -49.49 75.32 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.638 1.975 . . . . 0.0 114.3 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 86.0 mmm -68.95 -28.8 66.96 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.79 78.26 0.2 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.69 1.138 . . . . 0.0 114.633 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.26 -15.24 2.09 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.567 2.032 . . . . 0.0 111.802 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -71.58 171.37 11.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.039 0.92 . . . . 0.0 109.792 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -109.45 143.45 39.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.31 121.37 24.6 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.55 -57.48 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.03 1.776 . . . . 0.0 111.488 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.48 2.06 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.809 -1.55 . . . . 0.0 115.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -143.84 157.86 44.08 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.66 2.73 . . . . 0.0 112.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -67.49 136.17 54.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.246 0.618 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.0 166.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.272 1.035 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.49 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.898 1.679 . . . . 0.0 107.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 39.2 p -137.18 134.84 36.76 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.27 170.78 21.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.468 ' CH2' ' HE3' ' A' ' 148' ' ' LYS . 22.2 m95 -62.18 128.2 34.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.002 0.819 . . . . 0.0 109.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.36 -56.2 18.33 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.9 p -68.3 170.95 7.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.926 0.869 . . . . 0.0 112.813 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -130.15 151.56 50.55 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -146.23 150.53 41.72 Favored Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.01 158.1 59.25 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.232 1.955 . . . . 0.0 111.206 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.53 179.86 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.818 3.012 . . . . 0.0 111.5 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.26 72.66 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.124 0.97 . . . . 0.0 108.729 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.46 167.58 23.63 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.629 2.219 . . . . 0.0 110.78 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -153.0 128.05 9.69 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.7 t -159.04 159.68 34.98 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.076 1.351 . . . . 0.0 107.827 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.3 t -150.34 176.49 10.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.54 1.136 . . . . 0.0 108.774 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -137.18 173.8 11.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.302 1.841 . . . . 0.0 109.596 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 187' ' ' ASN . 0.0 OUTLIER -150.32 159.99 44.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 128.305 2.642 . . . . 0.0 105.63 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 53.2 m -159.6 28.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.216 1.406 . . . . 0.0 113.264 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.415 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 0.0 OUTLIER -61.04 -14.88 26.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 119.854 -1.779 . . . . 0.0 115.756 -178.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.6 m -25.89 118.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.128 2.971 . . . . 0.0 114.659 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 170.14 16.83 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.208 -0.932 . . . . 0.0 109.747 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.4 169.93 23.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.45 1.5 . . . . 0.0 108.375 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 18.2 t -176.24 161.17 2.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.625 2.77 . . . . 0.0 105.535 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 133.82 68.35 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.96 166.97 27.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 119.817 1.809 . . . . 0.0 109.107 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.7 m -155.57 169.19 24.87 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.774 -1.204 . . . . 0.0 108.78 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 m -78.71 173.43 12.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.211 1.005 . . . . 0.0 110.417 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.844 0 C-N-CA 128.72 3.057 . . . . 0.0 106.453 179.504 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 159.0 10.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.453 1.901 . . . . 0.0 111.044 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 t -161.75 149.99 15.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.41 148.1 26.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.0 m -148.65 -65.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.983 1.391 . . . . 0.0 109.047 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 m 30.7 66.43 0.14 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.172 2.189 . . . . 0.0 113.816 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.5 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -72.31 158.49 35.72 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.709 1.204 . . . . 0.0 111.953 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 169.2 18.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.701 2.001 . . . . 0.0 107.073 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.02 28.67 1.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.169 0.988 . . . . 0.0 108.397 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.05 27.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 129.913 3.285 . . . . 0.0 113.518 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.15 46.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.315 2.646 . . . . 0.0 114.2 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 m -64.55 161.25 17.79 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.99 -1.069 . . . . 0.0 109.481 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 61.75 -12.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.433 2.293 . . . . 0.0 114.799 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -89.12 149.24 23.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -105.56 143.25 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -109.84 153.5 24.33 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.077 0.551 . . . . 0.0 112.062 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.45 148.72 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.712 2.005 . . . . 0.0 110.39 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -100.22 139.78 35.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.349 2.66 . . . . 0.0 107.014 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.03 129.5 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.47 179.87 17.66 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 111.94 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 64.34 9.95 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.74 3.216 . . . . 0.0 113.784 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.4 146.3 16.17 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.953 1.301 . . . . 0.0 111.04 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.5 t -63.04 141.23 97.71 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.06 -15.55 18.03 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.937 2.425 . . . . 0.0 114.928 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.79 -17.95 39.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 113.054 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.64 HD11 ' HA3' ' A' ' 164' ' ' GLY . 27.9 mm -58.51 135.22 23.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.243 1.417 . . . . 0.0 110.724 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 111' ' ' GLU . 1.3 t -116.53 176.33 5.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.985 0.898 . . . . 0.0 111.488 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 -35.25 72.64 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.082 -1.011 . . . . 0.0 111.458 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' H ' HG23 ' A' ' 109' ' ' THR . 8.6 mt-10 -79.97 -18.12 51.18 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.317 0.647 . . . . 0.0 111.329 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.94 -50.09 21.64 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 mt -57.96 -50.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -54.87 -47.71 73.9 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.539 -1.22 . . . . 0.0 110.903 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.6 -33.87 70.49 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.691 1.132 . . . . 0.0 111.898 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.22 -46.37 64.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.923 0.889 . . . . 0.0 112.246 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -92.51 -1.66 56.79 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.41 95.37 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.876 1.67 . . . . 0.0 112.334 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.65 -0.57 5.41 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 121.091 1.425 . . . . 0.0 113.75 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -98.64 -10.75 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.955 0.798 . . . . 0.0 111.156 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.19 175.57 19.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 35.4 mtt180 -70.56 137.95 50.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.172 -0.605 . . . . 0.0 110.017 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.95 138.41 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.5 t -100.47 -72.93 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 144' ' ' SER . 6.9 t70 -102.43 142.52 33.51 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.08 1.752 . . . . 0.0 110.235 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.68 129.1 2.56 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.064 0.847 . . . . 0.0 109.409 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -162.26 150.85 14.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.618 0.367 . . . . 0.0 111.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.06 136.99 23.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.11 146.78 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -139.53 145.8 39.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -67.43 129.65 40.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -65.59 -18.78 65.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.466 0.706 . . . . 0.0 111.465 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.41 -12.43 22.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -134.3 -18.9 1.97 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.358 0.981 . . . . 0.0 113.287 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.49 72.78 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.94 153.62 18.23 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -59.91 130.15 45.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -20.57 57.45 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.466 -0.778 . . . . 0.0 111.947 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.16 -30.2 10.88 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.98 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -101.89 163.86 12.03 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.527 1.164 . . . . 0.0 108.315 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.7 171.64 27.43 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.849 1.69 . . . . 0.0 109.091 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -136.02 146.66 47.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -133.61 158.69 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.856 1.663 . . . . 0.0 106.726 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 125' ' ' ASP . 32.4 t -143.18 135.4 27.11 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.45 166.28 15.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.448 0.699 . . . . 0.0 111.12 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 122' ' ' ARG . 82.4 m-85 -79.66 -26.42 41.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 117.753 -1.117 . . . . 0.0 113.939 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.35 150.76 45.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.814 1.643 . . . . 0.0 110.714 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -62.25 -48.6 79.22 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.114 0.483 . . . . 0.0 110.153 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -29.66 67.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.973 1.309 . . . . 0.0 112.615 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.03 -54.65 38.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.83 -57.88 11.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.201 2.2 . . . . 0.0 111.838 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.23 -51.49 25.23 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.364 1.466 . . . . 0.0 111.387 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -55.06 -45.69 75.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.412 0.445 . . . . 0.0 111.257 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.96 78.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.559 -1.21 . . . . 0.0 110.85 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.5 mt -52.02 -44.42 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 120.634 1.561 . . . . 0.0 108.069 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -68.08 -61.45 1.85 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.186 1.394 . . . . 0.0 111.678 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.7 -60.04 4.06 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.92 2.088 . . . . 0.0 114.465 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.31 -20.35 66.03 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.29 1.036 . . . . 0.0 113.665 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.11 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.46 49.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.593 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -69.72 167.56 16.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.44 1.62 . . . . 0.0 108.218 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -108.81 141.95 40.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.7 tp -140.97 129.55 22.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.64 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 79.56 -53.87 4.3 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.668 1.127 . . . . 0.0 110.326 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.11 6.15 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.429 1.014 . . . . 0.0 113.809 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -136.31 159.02 43.02 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.867 1.834 . . . . 0.0 108.595 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -68.15 166.04 16.99 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.44 145.35 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 109.351 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 ptt-85 -108.41 136.53 47.88 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 p -122.6 153.37 39.39 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.023 1.329 . . . . 0.0 108.191 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -173.21 165.86 4.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.843 0.857 . . . . 0.0 109.124 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -66.64 120.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.26 77.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.326 0.512 . . . . 0.0 111.177 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.2 t -66.73 152.09 46.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.439 1.495 . . . . 0.0 110.089 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -126.89 166.68 17.03 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.701 1.201 . . . . 0.0 109.034 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 176' ' ' LYS . 0.7 OUTLIER -146.12 131.95 9.43 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.68 150.98 87.31 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.837 3.025 . . . . 0.0 114.267 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.13 164.3 35.8 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.756 2.304 . . . . 0.0 112.398 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -151.88 160.94 30.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.288 2.235 . . . . 0.0 108.604 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -83.58 162.13 14.57 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.87 3.047 . . . . 0.0 111.503 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.86 143.57 6.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.257 1.423 . . . . 0.0 109.375 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.0 t -172.47 105.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -143.53 123.21 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -164.88 171.62 13.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.249 2.22 . . . . 0.0 106.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -163.29 103.24 0.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.2 t -175.88 146.69 0.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.208 2.203 . . . . 0.0 105.991 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -154.84 160.24 41.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.0 p -142.61 170.67 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.468 0.707 . . . . 0.0 109.223 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.67 -58.02 0.36 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.21 167.4 22.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.905 2.082 . . . . 0.0 106.633 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.3 p -154.51 178.55 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.087 2.155 . . . . 0.0 106.499 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 40.01 62.57 1.45 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.183 1.373 . . . . 0.0 114.097 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.42 108.49 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.373 2.049 . . . . 0.0 110.6 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 10.0 t -144.04 147.07 33.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.2 p -162.38 175.89 11.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.162 1.385 . . . . 0.0 108.03 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.425 0 C-N-CA 127.975 2.702 . . . . 0.0 106.631 179.821 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.74 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.3 m -154.88 161.99 41.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.576 1.95 . . . . 0.0 107.441 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.0 t -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.868 0.758 . . . . 0.0 110.141 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.45 161.68 29.97 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 125.222 1.391 . . . . 0.0 110.133 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.9 m -89.0 -175.57 4.88 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.598 0.713 . . . . 0.0 110.613 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.6 p -118.5 177.08 4.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.163 2.185 . . . . 0.0 107.157 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.7 143.36 5.57 Favored Glycine 0 C--O 1.236 0.229 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -80.8 110.98 16.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -79.9 63.28 4.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -45.48 77.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.917 1.687 . . . . 0.0 110.827 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.88 127.37 32.37 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.1 p -72.81 4.25 4.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.607 1.563 . . . . 0.0 114.36 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -31.74 -56.74 0.29 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 118.743 2.868 . . . . 0.0 118.743 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.97 13.82 27.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.318 1.047 . . . . 0.0 112.552 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -73.44 168.58 18.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.42 100.34 8.24 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.35 131.4 36.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.05 141.72 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 128.102 2.561 . . . . 0.0 109.521 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -88.89 131.0 35.31 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 127.013 2.125 . . . . 0.0 105.671 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.33 139.33 51.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.39 -177.94 22.26 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.268 77.1 m-20 68.12 13.93 9.19 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.62 1.968 . . . . 0.0 113.251 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.7 mt -64.53 140.06 58.83 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 t -67.89 150.14 97.91 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -60.76 -4.05 3.23 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.809 3.006 . . . . 0.0 114.927 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.85 -17.12 17.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.016 1.326 . . . . 0.0 111.783 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.3 mm -61.85 136.9 24.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.03 1.332 . . . . 0.0 109.517 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -108.57 174.52 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.033 0.92 . . . . 0.0 108.715 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -64.67 -27.54 68.99 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.547 -1.345 . . . . 0.0 110.647 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.91 -32.66 67.61 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.86 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.32 -47.29 84.92 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mt -60.11 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 22.0 mtmt -53.53 -47.63 69.8 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 120.329 -1.482 . . . . 0.0 111.97 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.51 93.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.755 0.822 . . . . 0.0 111.633 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -58.55 -45.87 88.03 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.711 1.204 . . . . 0.0 113.602 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -89.56 -10.77 44.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 113.035 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.05 -47.56 98.56 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 124.817 1.247 . . . . 0.0 112.192 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.91 -7.16 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 121.791 1.675 . . . . 0.0 113.184 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.64 -13.28 20.41 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.428 1.013 . . . . 0.0 112.003 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 159.19 174.09 28.46 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 120.541 1.519 . . . . 0.0 112.724 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -71.7 127.55 32.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.9 mt -102.16 139.51 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.8 p -99.29 -79.02 0.49 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.66 126.05 49.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.764 2.826 . . . . 0.0 110.793 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.411 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -149.05 140.31 23.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.664 1.186 . . . . 0.0 107.943 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -162.7 151.54 14.86 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 t -94.32 127.26 46.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.18 141.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -125.63 161.03 28.15 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.885 1.326 . . . . 0.0 110.22 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.29 130.37 40.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.633 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -7.97 55.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 -21.81 12.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.626 1.103 . . . . 0.0 112.208 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -131.68 -8.24 3.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 31.31 78.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.209 -0.773 . . . . 0.0 112.143 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -100.98 157.19 16.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.192 1.397 . . . . 0.0 108.235 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -62.08 125.9 25.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.215 0.916 . . . . 0.0 111.314 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -74.65 -21.05 59.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.49 -15.7 55.73 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.36 1.457 . . . . 0.0 113.027 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.256 49.5 p90 -103.02 163.36 12.26 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.277 1.539 . . . . 0.0 109.282 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.5 169.3 32.8 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.337 -0.852 . . . . 0.0 111.384 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -129.77 149.82 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.913 0.885 . . . . 0.0 109.111 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.43 138.81 47.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 131.81 53.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.81 155.75 31.97 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.172 0.989 . . . . 0.0 109.744 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -76.39 -20.02 57.56 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.094 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -129.45 151.14 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.865 1.211 . . . . 0.0 112.781 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.543 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 7.6 ttmt -68.95 -50.74 46.62 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 110.196 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -47.71 69.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.097 1.359 . . . . 0.0 113.271 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -60.61 -46.93 88.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.41 83.29 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.961 1.305 . . . . 0.0 109.981 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -57.09 -45.67 83.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.82 1.248 . . . . 0.0 110.448 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -53.62 -48.05 69.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.55 87.82 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.936 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.7 mt -55.21 -37.93 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 121.804 2.093 . . . . 0.0 110.274 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -72.71 -65.77 0.75 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.616 0.766 . . . . 0.0 111.427 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -67.07 -44.41 80.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.872 2.069 . . . . 0.0 116.547 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -77.79 -20.79 52.66 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.831 1.196 . . . . 0.0 112.872 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.21 112.35 4.64 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.31 -9.54 65.04 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -70.91 169.71 14.2 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 119.753 1.776 . . . . 0.0 109.842 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -104.65 132.11 51.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 108.941 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 116' ' ' ALA . 21.9 tp -123.83 118.95 28.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 108.143 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.82 -6.51 1.4 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.273 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.0 3.61 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.232 1.516 . . . . 0.0 115.331 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.796 2.298 . . . . 0.0 110.342 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.37 163.03 11.33 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.448 0.468 . . . . 0.0 109.976 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.23 153.76 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.753 1.221 . . . . 0.0 109.756 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -113.74 142.86 45.52 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.4 p -136.89 135.99 38.31 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.552 0.741 . . . . 0.0 109.524 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.46 174.08 15.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.218 0.607 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.543 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 83.9 m95 -70.57 118.24 13.11 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.538 -1.352 . . . . 0.0 108.153 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.14 -44.88 95.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.78 0.718 . . . . 0.0 109.077 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.6 p -73.26 100.6 3.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -71.54 109.54 5.55 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.844 -1.16 . . . . 0.0 110.705 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.34 150.71 69.65 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 125.674 1.589 . . . . 0.0 108.953 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 159.02 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.828 1.686 . . . . 0.0 108.704 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.95 154.02 63.21 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 N-CA-C 107.669 -1.704 . . . . 0.0 107.669 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -153.24 151.93 26.79 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 118.389 0.54 . . . . 0.0 111.398 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.75 166.88 26.34 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.961 2.441 . . . . 0.0 110.543 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -143.97 125.67 15.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.783 2.433 . . . . 0.0 104.865 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.17 -60.25 3.32 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.984 0.914 . . . . 0.0 110.372 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 -178.96 7.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -66.8 0.9 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 128.034 2.534 . . . . 0.0 110.058 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -161.69 -174.97 4.46 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.589 0.755 . . . . 0.0 111.212 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 t -157.63 88.2 0.98 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.43 1.092 . . . . 0.0 109.163 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -155.38 133.32 11.42 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.625 -0.672 . . . . 0.0 109.35 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.1 p -66.45 153.38 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -53.86 128.6 30.65 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -130.67 178.38 6.68 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.7 p -156.61 172.51 18.44 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.945 2.098 . . . . 0.0 106.621 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -143.63 149.31 21.29 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.23 177.04 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.709 2.272 . . . . 0.0 109.982 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -141.28 140.29 33.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.9 t -160.24 163.71 33.29 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 107.083 -2.407 . . . . 0.0 107.083 -179.364 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -61.91 -27.91 69.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.297 0.549 . . . . 0.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.56 121.53 30.1 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -165.31 113.63 0.56 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.0 m -72.57 -42.74 64.28 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.2 p 58.25 -52.36 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.763 3.225 . . . . 0.0 116.51 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.85 158.55 50.0 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 119.154 0.888 . . . . 0.0 113.549 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -138.75 50.86 1.84 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.064 1.746 . . . . 0.0 107.936 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.02 156.64 27.44 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.984 -1.072 . . . . 0.0 109.946 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -120.34 -1.35 10.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.917 1.287 . . . . 0.0 112.178 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -113.26 -172.76 2.12 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.666 1.121 . . . . 0.0 109.049 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.9 p -123.11 41.39 3.48 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.519 1.527 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.7 p -70.5 134.12 47.43 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 59.75 13.45 3.51 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.272 1.829 . . . . 0.0 114.211 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -84.5 178.35 7.76 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.13 100.65 6.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 144' ' ' SER . 1.3 m80 -71.38 167.29 19.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.369 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.32 142.94 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 127.875 2.47 . . . . 0.0 106.561 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -103.65 137.06 42.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -132.72 140.25 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 -179.26 21.15 Favored Glycine 0 N--CA 1.454 -0.153 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.26 4.69 2.22 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.466 2.306 . . . . 0.0 113.258 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -51.2 139.09 19.26 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 110.527 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 t -62.59 145.26 95.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.49 -18.1 37.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.489 2.793 . . . . 0.0 115.136 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.62 -13.21 43.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.084 -1.01 . . . . 0.0 112.652 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.66 138.71 22.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.5 t -118.45 175.13 5.86 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.502 1.144 . . . . 0.0 109.117 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.3 m -58.92 -30.15 67.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.226 1.01 . . . . 0.0 111.748 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.75 -43.37 68.96 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 125.92 1.688 . . . . 0.0 110.878 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.74 -51.92 65.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.214 1.405 . . . . 0.0 109.28 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.67 -48.14 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.59 -45.24 69.95 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.814 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.27 -45.94 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.084 0.856 . . . . 0.0 110.796 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.67 -47.54 85.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 113.197 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -87.35 -10.89 50.95 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.39 -48.52 95.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.66 -3.3 6.47 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 CA-C-N 121.47 1.561 . . . . 0.0 112.959 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.88 -17.71 18.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.069 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.57 162.17 16.21 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.584 1.084 . . . . 0.0 111.503 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -73.65 120.53 19.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.62 153.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.5 t -117.31 -68.44 0.92 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -102.03 145.04 29.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.469 1.107 . . . . 0.0 108.891 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.04 129.85 2.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.2 158.16 32.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.473 0.654 . . . . 0.0 110.777 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.22 120.1 56.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.43 141.8 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 137' ' ' SER . 46.0 mttm -135.41 157.3 47.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.5 ptp -59.88 -20.47 57.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.59 -9.22 16.65 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -131.83 -19.55 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.048 1.295 . . . . 0.0 113.083 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.81 2.41 56.96 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.291 0.948 . . . . 0.0 112.865 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -80.05 148.55 31.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' A' ' 130' ' ' LYS . 17.8 m -63.78 134.79 55.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.507 1.146 . . . . 0.0 112.33 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -77.71 -13.7 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.534 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.9 55.23 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.016 -1.435 . . . . 0.0 113.464 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -102.52 165.1 11.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.019 1.41 . . . . 0.0 109.112 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.32 179.79 28.55 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.471 1.034 . . . . 0.0 111.966 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.28 154.04 51.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 109.089 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -145.83 149.3 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 37.9 t -142.48 115.49 8.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.005 1.722 . . . . 0.0 107.393 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.91 158.17 15.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.805 1.242 . . . . 0.0 111.391 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.1 -14.83 61.95 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.66 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -143.56 156.84 44.71 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.857 1.208 . . . . 0.0 110.195 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.8 tttt -68.49 -43.03 77.77 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.923 1.289 . . . . 0.0 111.93 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.51 -41.75 66.66 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 111.658 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -62.15 -48.98 77.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.901 1.28 . . . . 0.0 108.893 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.56 66.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.367 1.067 . . . . 0.0 110.311 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.37 -50.0 63.29 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.844 1.658 . . . . 0.0 109.753 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -55.41 -55.4 32.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.552 1.141 . . . . 0.0 109.16 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.48 91.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.748 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.52 -49.26 44.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 121.136 1.789 . . . . 0.0 108.411 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.31 -67.22 0.46 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.132 0.573 . . . . 0.0 111.991 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -58.93 -50.43 74.07 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 83.8 mmm -69.29 -17.75 63.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.346 0.975 . . . . 0.0 111.95 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.26 79.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.445 2.45 . . . . 0.0 113.37 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 126.78 -8.74 7.25 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.062 1.791 . . . . 0.0 112.627 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -70.99 170.32 13.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.033 1.417 . . . . 0.0 109.67 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -111.14 150.79 28.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.385 1.074 . . . . 0.0 109.991 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 47.0 tp -155.51 130.1 9.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.805 2.042 . . . . 0.0 106.505 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.1 27.3 71.22 Favored Glycine 0 N--CA 1.465 0.59 0 O-C-N 121.49 -0.756 . . . . 0.0 114.032 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.78 4.4 87.34 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.439 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -137.57 155.35 49.31 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.81 2.305 . . . . 0.0 110.899 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -71.55 160.44 32.7 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.57 169.96 15.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -123.63 152.24 42.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.9 p -141.83 150.21 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 107.575 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -175.52 171.12 2.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -67.17 111.36 3.88 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.582 -0.699 . . . . 0.0 109.817 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.65 -31.61 64.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.549 1.14 . . . . 0.0 110.843 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.9 p -79.48 -8.22 58.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.17 1.788 . . . . 0.0 113.644 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -156.14 81.37 0.99 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.536 1.062 . . . . 0.0 111.645 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -75.63 137.11 70.6 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.0 161.04 41.99 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.19 1.927 . . . . 0.0 109.693 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.0 151.44 81.44 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.534 2.156 . . . . 0.0 111.566 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.71 156.24 73.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.261 1.024 . . . . 0.0 111.407 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.89 161.5 41.28 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.886 1.724 . . . . 0.0 109.426 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.34 175.08 9.89 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.837 1.655 . . . . 0.0 109.433 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.8 t -83.94 131.61 34.84 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.343 1.857 . . . . 0.0 106.055 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 28.7 p -133.91 74.4 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -62.35 150.67 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.07 0.948 . . . . 0.0 108.681 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -136.48 156.15 49.0 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.511 1.124 . . . . 0.0 109.186 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.4 t -159.3 84.97 0.79 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -135.1 154.84 51.53 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 62.3 m -158.74 127.89 5.54 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -156.96 82.09 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.358 0.981 . . . . 0.0 110.88 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.57 162.84 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.7 p -160.56 176.78 11.2 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.933 1.693 . . . . 0.0 108.283 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.62 87.81 0.43 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 105.89 -2.884 . . . . 0.0 105.89 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.29 -7.59 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.114 2.543 . . . . 0.0 113.262 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.2 p -136.43 172.02 13.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.848 1.659 . . . . 0.0 109.559 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.4 t -77.67 1.08 20.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.685 0.794 . . . . 0.0 112.498 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.713 0 C-N-CA 129.352 3.358 . . . . 0.0 106.53 -179.679 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -53.89 139.77 32.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.717 0.758 . . . . 0.0 110.4 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 t 170.96 166.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.567 3.147 . . . . 0.0 105.627 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.38 -146.25 2.41 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -73.59 159.33 33.27 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.58 -0.953 . . . . 0.0 109.416 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -156.94 -176.18 5.84 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.343 1.457 . . . . 0.0 108.67 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.11 126.33 2.95 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.942 1.258 . . . . 0.0 110.781 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -128.69 -3.97 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.109 0.964 . . . . 0.0 112.219 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 153.43 44.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -68.42 -8.35 39.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.34 162.52 22.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.947 0.899 . . . . 0.0 109.481 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.9 p -114.92 92.85 4.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.1 p -111.12 -27.71 8.61 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -88.51 -14.62 37.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.72 0.808 . . . . 0.0 112.341 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -80.79 168.38 18.87 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.684 1.193 . . . . 0.0 112.335 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.6 99.23 7.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.0 127.4 32.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 113.338 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.55 148.21 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 126.788 2.035 . . . . 0.0 108.091 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -105.01 136.62 44.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 129.471 3.109 . . . . 0.0 106.95 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -129.27 142.83 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -149.84 -178.83 25.14 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.04 1.97 2.98 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.854 2.461 . . . . 0.0 114.382 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -50.19 149.26 2.97 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.829 2.452 . . . . 0.0 113.681 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 161.76 68.1 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.83 -29.44 15.46 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.145 1.23 . . . . 0.0 113.111 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.41 -16.94 61.84 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.851 1.66 . . . . 0.0 114.117 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -59.74 117.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.668 1.187 . . . . 0.0 110.116 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -100.3 171.03 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 127' ' ' ARG . 85.3 m -55.1 -30.95 60.78 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 121.019 -1.05 . . . . 0.0 111.53 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.71 -33.75 64.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.122 0.969 . . . . 0.0 111.761 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -47.98 83.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.6 mt -61.22 -55.55 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.426 ' HE3' HG22 ' A' ' 110' ' ' THR . 22.5 mtmt -51.68 -47.93 63.65 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.501 1.046 . . . . 0.0 112.301 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.12 72.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.596 0.758 . . . . 0.0 112.14 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.409 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -73.08 -43.85 61.28 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.364 1.066 . . . . 0.0 112.014 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.26 -9.58 47.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.824 1.249 . . . . 0.0 112.851 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.3 99.54 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 126.6 1.96 . . . . 0.0 113.318 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.9 -0.84 9.04 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.501 1.572 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.66 -25.18 14.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.087 0.858 . . . . 0.0 110.967 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.44 34.7 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 121.137 -0.977 . . . . 0.0 111.201 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -77.78 117.45 19.18 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -88.4 145.3 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 p -100.54 -81.42 0.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -103.04 141.46 35.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.299 1.84 . . . . 0.0 111.196 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.13 141.85 5.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.106 2.163 . . . . 0.0 108.065 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.485 ' HA ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -161.9 169.6 20.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.784 1.234 . . . . 0.0 109.136 178.403 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.98 124.98 67.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.443 HG21 ' CD2' ' A' ' 140' ' ' TYR . 47.9 t -64.88 140.78 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.37 148.21 50.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 59.6 t0 -59.02 131.14 50.16 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.7 tpt -59.78 -30.41 68.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.366 0.53 . . . . 0.0 112.25 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.12 -41.05 9.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.3 p -95.85 -15.87 22.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.15 0.886 . . . . 0.0 112.943 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.92 12.52 57.46 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.283 0.944 . . . . 0.0 112.584 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.92 150.01 27.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.888 1.275 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 t -56.15 109.66 0.63 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.323 2.249 . . . . 0.0 109.142 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 131' ' ' ASP . 20.7 mttt -67.81 -23.4 65.18 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.47 -18.84 46.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.443 ' CD2' HG21 ' A' ' 129' ' ' VAL 0.288 27.5 p90 -103.21 157.9 16.69 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.635 -1.509 . . . . 0.0 109.71 176.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.22 176.6 25.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.564 1.554 . . . . 0.0 111.077 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.77 152.0 44.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.02 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.0 t -147.25 130.65 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 108.027 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -118.77 127.81 53.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.744 2.018 . . . . 0.0 107.011 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.55 165.69 12.25 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.701 1.137 . . . . 0.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -74.43 -9.57 58.72 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.575 -0.703 . . . . 0.0 112.512 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -146.59 165.86 28.25 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.595 1.088 . . . . 0.0 112.09 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -73.85 -47.28 39.49 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.802 1.241 . . . . 0.0 111.543 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -39.06 76.9 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.702 0.801 . . . . 0.0 111.935 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.66 -48.42 77.64 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -54.89 15.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.322 1.849 . . . . 0.0 111.45 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -55.87 -44.15 77.83 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.176 0.99 . . . . 0.0 111.918 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.74 -45.26 86.07 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.74 79.62 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.684 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.69 -37.62 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 120.354 1.434 . . . . 0.0 110.399 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -73.07 -67.6 0.56 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.417 1.087 . . . . 0.0 110.632 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -58.69 -57.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.467 2.307 . . . . 0.0 114.295 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -65.34 -24.51 67.28 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.48 90.47 0.12 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.222 0.915 . . . . 0.0 111.971 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.49 -6.88 9.79 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.193 1.378 . . . . 0.0 113.308 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -74.97 174.3 9.51 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.093 1.446 . . . . 0.0 109.481 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -109.74 129.35 55.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' A' ' 116' ' ' ALA . 39.3 tp -125.25 124.22 41.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.901 1.68 . . . . 0.0 108.934 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.1 -59.21 1.84 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 125.005 1.288 . . . . 0.0 111.554 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.75 -3.04 0.03 OUTLIER Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.947 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -141.49 165.98 26.02 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.384 2.092 . . . . 0.0 111.5 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -67.57 161.67 25.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.351 0.66 . . . . 0.0 110.645 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.7 pt -138.71 157.64 29.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.533 1.133 . . . . 0.0 109.977 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -122.32 148.02 45.54 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.1 p -138.91 134.66 33.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.649 1.113 . . . . 0.0 110.409 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -157.02 176.92 12.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.571 1.148 . . . . 0.0 108.895 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -74.44 133.75 42.39 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.593 -1.317 . . . . 0.0 110.47 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.37 -52.35 9.3 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 p -65.82 125.66 26.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -133.95 -169.25 2.27 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.19 1.396 . . . . 0.0 111.298 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -136.37 158.12 74.07 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 125.204 1.402 . . . . 0.0 110.66 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.85 169.95 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.692 3.594 . . . . 0.0 111.569 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.84 174.82 10.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.181 3.254 . . . . 0.0 110.974 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.37 33.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 120.543 -1.348 . . . . 0.0 112.1 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.73 168.84 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.615 2.877 . . . . 0.0 109.635 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.48 134.21 25.16 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.292 -0.88 . . . . 0.0 109.761 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.2 t -163.58 112.8 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.2 1.4 . . . . 0.0 108.04 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.7 t -162.15 145.73 11.95 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -179.56 163.25 1.18 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.349 2.26 . . . . 0.0 108.402 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.51 148.61 1.21 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.965 2.906 . . . . 0.0 104.128 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 28.3 p -162.05 12.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.946 0.898 . . . . 0.0 111.554 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.13 152.14 41.34 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.878 1.217 . . . . 0.0 111.606 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.8 m -159.2 131.82 6.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -137.71 153.77 49.74 Favored 'General case' 0 C--N 1.335 -0.03 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -151.37 -176.86 5.75 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.113 1.765 . . . . 0.0 107.381 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.6 m -139.13 -16.5 1.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.965 1.706 . . . . 0.0 112.551 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 44.67 72.53 0.34 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.568 1.556 . . . . 0.0 113.776 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.98 -6.1 17.9 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.514 2.142 . . . . 0.0 113.96 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.4 t 71.69 -12.8 0.61 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.819 2.048 . . . . 0.0 112.894 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.2 p -78.46 -16.4 57.59 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.261 0.937 . . . . 0.0 109.374 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 1 C-N-CA 133.588 5.375 . . . . 0.0 104.65 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.4 m 51.77 18.87 0.81 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.803 2.441 . . . . 0.0 115.127 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -72.72 -17.6 61.6 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.671 1.188 . . . . 0.0 111.049 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.35 164.72 38.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.1 t -66.95 -46.08 75.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.611 1.564 . . . . 0.0 111.041 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.9 p -71.2 168.27 17.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.717 0.77 . . . . 0.0 112.022 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.83 112.75 0.54 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -49.03 135.2 16.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.085 0.942 . . . . 0.0 110.966 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -155.61 137.18 14.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.537 1.135 . . . . 0.0 110.56 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -17.36 34.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.332 1.02 . . . . 0.0 109.365 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.52 155.31 40.21 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.522 1.929 . . . . 0.0 108.385 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.439 HG21 ' HB2' ' A' ' 125' ' ' ASP . 70.6 p -128.07 18.52 6.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.527 1.131 . . . . 0.0 111.34 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -10.18 1.02 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.016 2.126 . . . . 0.0 115.978 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -136.9 13.08 3.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 111.296 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -86.39 -174.61 5.11 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.531 1.133 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.41 109.91 13.89 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -91.03 150.32 21.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.658 0.742 . . . . 0.0 111.733 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.2 t -129.39 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.126 1.77 . . . . 0.0 108.907 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -101.3 143.29 31.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.996 3.318 . . . . 0.0 106.753 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.78 146.39 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.89 173.91 26.04 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 119.031 0.832 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.5 t0 61.38 17.81 8.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.986 2.914 . . . . 0.0 114.211 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.451 HD13 HD11 ' A' ' 113' ' ' ILE . 12.9 mt -59.31 135.68 57.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.343 1.457 . . . . 0.0 110.143 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 t -60.12 148.48 77.98 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.21 52.23 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.665 1.576 . . . . 0.0 113.364 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -76.48 -29.85 57.05 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.862 0.756 . . . . 0.0 110.591 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.31 115.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.517 1.527 . . . . 0.0 108.986 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 t -100.05 174.39 6.19 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.138 1.375 . . . . 0.0 109.714 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.4 m -57.76 -36.84 72.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.317 -0.864 . . . . 0.0 111.463 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.59 -44.36 78.31 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.08 1.352 . . . . 0.0 109.981 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.63 80.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.276 1.03 . . . . 0.0 109.666 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 104' ' ' LEU . 10.9 mt -60.14 -50.55 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -52.78 -48.05 67.12 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.259 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.14 -34.68 70.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.658 1.117 . . . . 0.0 111.675 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.74 -45.82 60.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.285 1.034 . . . . 0.0 111.503 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -87.69 -4.49 58.91 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.54 94.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.655 2.382 . . . . 0.0 114.664 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.21 -1.34 7.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 122.181 1.815 . . . . 0.0 112.516 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.4 -9.5 25.15 Favored 'General case' 0 N--CA 1.461 0.116 0 O-C-N 121.175 -0.953 . . . . 0.0 111.503 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.46 -155.83 26.54 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 111.832 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -100.27 131.24 46.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.384 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.18 133.63 43.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.726 1.61 . . . . 0.0 108.772 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.7 p -99.8 -73.03 0.65 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.439 ' HB2' HG21 ' A' ' 93' ' ' THR . 45.8 t0 -103.47 148.99 25.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.288 1.835 . . . . 0.0 109.053 177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.62 4.21 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.899 1.28 . . . . 0.0 108.967 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.8 ptm85 -161.01 147.67 15.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.44 0.564 . . . . 0.0 112.173 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.02 120.18 40.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.37 137.58 24.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -136.25 160.93 37.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.92 135.78 54.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -68.87 -14.37 62.99 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.773 -0.58 . . . . 0.0 110.015 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.5 17.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.079 1.752 . . . . 0.0 115.157 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 p -136.72 -23.32 1.21 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 112.254 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.8 4.54 62.26 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.345 -1.253 . . . . 0.0 110.839 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -81.82 150.9 27.63 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.93 1.865 . . . . 0.0 108.467 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 t -56.35 120.4 7.58 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -70.55 -35.3 73.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 127.89 -29.63 4.13 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.987 1.755 . . . . 0.0 110.404 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -102.15 166.51 10.56 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.601 1.16 . . . . 0.0 111.749 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.85 170.84 31.29 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.419 1.485 . . . . 0.0 110.173 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -129.38 150.15 50.86 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.091 1.356 . . . . 0.0 108.523 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.78 159.8 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 127.515 2.326 . . . . 0.0 105.028 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.9 t -142.63 130.75 21.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.806 2.042 . . . . 0.0 107.721 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.52 134.84 54.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.111 1.364 . . . . 0.0 109.368 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -64.31 -39.41 93.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.425 0.69 . . . . 0.0 109.639 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -111.11 145.64 38.22 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.04 1.336 . . . . 0.0 107.905 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.39 -45.11 81.13 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -38.66 55.75 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 112.882 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.83 -49.93 75.49 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.4 77.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.25 -51.31 67.03 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.115 0.566 . . . . 0.0 110.82 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.85 -48.82 74.84 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.34 70.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.995 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.24 -42.07 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 121.006 1.73 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -77.52 -36.94 51.95 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -87.93 -53.46 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.137 1.375 . . . . 0.0 112.044 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 72.7 mmm -68.28 -21.62 64.78 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.881 0.764 . . . . 0.0 112.329 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 109.03 1.96 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 124.478 1.037 . . . . 0.0 111.266 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.25 -6.35 66.01 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.155 -0.803 . . . . 0.0 113.611 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -73.05 179.15 3.92 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.34 1.07 . . . . 0.0 109.176 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.52 152.67 27.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.885 0.874 . . . . 0.0 109.041 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.1 tp -158.87 131.21 6.77 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.229 2.212 . . . . 0.0 105.66 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.9 30.23 77.1 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 119.085 0.857 . . . . 0.0 111.074 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.68 14.14 72.29 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.228 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -135.19 150.61 50.16 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.876 1.838 . . . . 0.0 109.339 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 21.1 pt -130.09 172.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.27 1.028 . . . . 0.0 108.989 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -131.62 154.4 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.982 1.713 . . . . 0.0 107.304 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.4 p -142.92 147.28 35.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.709 0.804 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -167.19 167.37 14.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -69.44 136.06 51.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.526 1.057 . . . . 0.0 108.322 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -88.32 152.22 22.08 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 29.7 p -136.12 147.98 48.03 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.426 0.631 . . . . 0.0 111.45 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -71.0 142.66 50.95 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -55.66 139.75 68.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.472 1.109 . . . . 0.0 111.064 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.34 160.6 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.775 1.65 . . . . 0.0 111.227 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.69 -176.85 3.38 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.364 3.376 . . . . 0.0 111.552 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.78 151.17 93.27 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.36 -45.14 15.86 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.991 1.794 . . . . 0.0 113.123 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -159.07 165.46 33.84 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.236 0.614 . . . . 0.0 109.882 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 m -83.11 160.58 21.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 36.5 p -61.6 157.16 18.06 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 119.707 1.14 . . . . 0.0 110.662 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.34 16.55 0.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.086 1.355 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.45 112.46 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.924 1.29 . . . . 0.0 108.805 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.0 t -153.84 169.55 23.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.63 0.729 . . . . 0.0 109.65 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 31.86 0.22 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.822 -0.549 . . . . 0.0 111.875 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 10.1 m -61.08 83.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.385 2.274 . . . . 0.0 112.422 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.5 166.12 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.771 2.828 . . . . 0.0 106.707 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -145.88 163.01 36.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.52 1.128 . . . . 0.0 108.15 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 t -171.89 -178.27 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.012 2.125 . . . . 0.0 107.245 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.94 78.89 0.7 Allowed Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.096 -1.391 . . . . 0.0 109.703 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.97 -50.33 9.19 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.525 2.15 . . . . 0.0 111.199 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m 64.08 -6.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.915 1.686 . . . . 0.0 114.925 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.0 p -75.91 -17.01 59.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.34 1.456 . . . . 0.0 111.129 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 C-N-CA 132.126 4.679 . . . . 0.0 105.226 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.641 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 m -83.68 -167.65 1.8 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.4 p -127.71 161.59 28.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.78 125.61 3.35 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 124.989 1.28 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -54.07 132.45 42.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.717 1.607 . . . . 0.0 110.529 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.9 m -65.59 -56.24 13.33 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.839 0.29 . . . . 0.0 111.143 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.96 106.42 0.15 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -76.12 69.9 2.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 109.375 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.1 173.19 10.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.945 1.298 . . . . 0.0 109.385 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.93 -52.39 65.71 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.808 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -61.19 136.02 57.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.6 p -68.46 38.39 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.685 2.794 . . . . 0.0 113.271 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.1 m -59.41 123.06 15.56 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.679 3.191 . . . . 0.0 108.765 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.4 t30 68.57 0.01 2.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.747 1.619 . . . . 0.0 113.936 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -73.6 173.27 9.97 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.169 0.988 . . . . 0.0 109.586 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.33 114.45 20.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.23 1.412 . . . . 0.0 107.246 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 132.7 34.74 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.337 1.055 . . . . 0.0 111.506 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.87 144.97 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.501 2.32 . . . . 0.0 109.013 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.84 139.03 38.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 127.455 2.302 . . . . 0.0 106.552 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.423 HG12 HD21 ' A' ' 104' ' ' LEU . 2.5 t -134.94 143.9 36.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.71 173.54 26.89 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.582 1.083 . . . . 0.0 113.91 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 57.45 23.26 8.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 129.085 2.954 . . . . 0.0 115.289 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.423 HD21 HG12 ' A' ' 101' ' ' VAL . 27.5 mt -60.95 145.82 49.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.513 1.525 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t -59.38 143.75 85.01 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.69 -15.5 31.89 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.595 2.197 . . . . 0.0 116.294 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.05 -28.9 29.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.932 1.693 . . . . 0.0 111.551 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -56.42 113.73 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.656 1.582 . . . . 0.0 110.57 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -97.52 179.43 4.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.135 0.969 . . . . 0.0 109.241 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 127' ' ' ARG . 23.8 m -55.97 -33.08 64.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.632 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -69.3 -46.8 66.29 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 110.057 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.84 -44.49 73.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 110.186 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.67 -54.65 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -50.65 -51.05 52.72 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.871 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.92 69.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.089 1.356 . . . . 0.0 111.257 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.59 96.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -90.8 -7.78 51.43 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.29 94.61 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.806 1.642 . . . . 0.0 113.282 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.79 -0.96 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 121.251 1.482 . . . . 0.0 113.099 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.97 -34.56 10.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.403 1.001 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.13 177.9 47.2 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 122.991 1.328 . . . . 0.0 111.473 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 87.2 mtt180 -74.35 123.11 24.0 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.756 -1.222 . . . . 0.0 107.938 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 126' ' ' ALA . 60.5 mt -101.17 154.71 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.2 t -125.73 -65.33 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -102.02 134.6 44.97 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 123' ' ' ILE . . . -164.94 128.94 2.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' HA ' HG23 ' A' ' 110' ' ' THR . 14.4 ptt180 -162.99 170.91 17.32 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.109 0.564 . . . . 0.0 111.724 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.93 130.26 51.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.536 1.534 . . . . 0.0 107.936 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 135.5 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -134.81 160.28 38.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.29 158.42 35.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.302 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.6 ptm -91.02 -16.22 28.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.792 1.237 . . . . 0.0 113.491 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.4 -26.64 11.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.872 1.214 . . . . 0.0 112.706 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.5 p -114.84 -19.75 10.87 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.87 50.36 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 121.655 0.586 . . . . 0.0 112.746 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.62 145.59 34.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -66.1 139.0 58.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.631 0.729 . . . . 0.0 112.274 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -81.75 -8.68 59.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.242 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.9 -12.91 65.96 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 124.43 1.014 . . . . 0.0 112.723 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.292 3.2 p90 -102.96 169.35 8.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.777 1.788 . . . . 0.0 109.876 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 178.44 30.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.356 0.503 . . . . 0.0 112.33 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.9 148.15 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.256 1.422 . . . . 0.0 108.117 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.99 124.83 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.035 1.734 . . . . 0.0 106.939 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.9 m -109.62 125.92 53.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.815 1.189 . . . . 0.0 108.69 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -109.98 148.52 31.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 122' ' ' ARG . 62.9 m-85 -69.63 -17.92 63.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.334 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -132.03 148.52 52.51 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.703 1.138 . . . . 0.0 109.124 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -63.62 -55.72 21.42 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.247 0.619 . . . . 0.0 109.497 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -39.53 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.687 1.595 . . . . 0.0 113.107 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.19 -48.25 80.87 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.66 74.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.772 0.829 . . . . 0.0 110.117 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 155' ' ' ILE . 5.2 mm-40 -53.48 -47.3 69.93 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.172 1.389 . . . . 0.0 110.909 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -57.23 -43.62 83.05 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.31 84.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.851 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 152' ' ' GLU . 89.0 mt -53.05 -52.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.997 1.726 . . . . 0.0 107.633 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -60.25 -66.46 0.52 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.38 1.472 . . . . 0.0 113.011 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.89 -49.74 69.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.736 2.014 . . . . 0.0 115.183 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -73.15 -19.61 61.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.696 1.135 . . . . 0.0 112.638 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.45 96.88 0.36 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.64 -11.05 11.24 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.607 1.099 . . . . 0.0 111.428 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -73.91 170.13 16.0 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.594 1.197 . . . . 0.0 107.836 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -113.38 136.51 52.69 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.449 1.1 . . . . 0.0 108.268 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.21 121.58 18.18 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.13 21.82 79.47 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.025 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.98 6.14 79.74 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.975 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -133.77 147.04 51.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.301 2.05 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.83 138.6 52.75 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -108.15 163.94 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.982 0.896 . . . . 0.0 109.849 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -124.49 149.48 46.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.901 1.281 . . . . 0.0 107.66 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.9 p -139.29 140.36 37.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.298 1.039 . . . . 0.0 109.628 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -163.3 173.03 13.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.157 1.383 . . . . 0.0 108.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -71.45 124.44 24.63 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.343 1.057 . . . . 0.0 110.957 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.48 -12.02 60.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.636 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.3 p -89.0 164.89 14.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.275 . . . . 0.0 109.139 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -142.57 148.73 38.02 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.102 -0.999 . . . . 0.0 108.77 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.9 pttp -69.29 150.49 97.2 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 161.85 42.89 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 108.116 -1.532 . . . . 0.0 108.116 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.4 168.71 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.198 1.932 . . . . 0.0 108.734 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -126.94 159.97 61.74 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 110.448 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.35 121.16 8.68 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.756 2.304 . . . . 0.0 110.745 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.98 124.35 28.62 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.7 t -83.69 153.04 24.42 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.5 p -156.98 127.87 6.72 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.542 1.937 . . . . 0.0 108.065 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.41 158.12 40.97 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -153.8 144.24 22.35 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 t -175.13 162.82 3.08 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.829 1.652 . . . . 0.0 107.607 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -161.24 161.93 30.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.47 1.108 . . . . 0.0 108.537 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.2 m -160.93 110.18 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 189' ' ' LYS . 0.3 OUTLIER -141.49 129.15 21.53 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.09 166.85 14.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.726 2.011 . . . . 0.0 107.991 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.2 t 176.34 -174.35 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.707 3.203 . . . . 0.0 106.041 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.25 44.44 1.08 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.584 -1.676 . . . . 0.0 115.45 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.88 156.9 47.94 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 121.151 2.476 . . . . 0.0 109.111 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 8.5 t -154.19 -177.11 6.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.936 1.295 . . . . 0.0 107.677 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.6 p -134.32 5.98 3.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.527 1.931 . . . . 0.0 111.07 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.75 0 C-N-CA 129.794 3.568 . . . . 0.0 106.702 179.76 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 m -60.0 118.15 5.94 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -146.55 148.0 31.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.23 170.26 30.88 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -50.69 127.51 18.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.045 1.338 . . . . 0.0 110.416 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -136.91 74.58 1.49 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.47 0.708 . . . . 0.0 109.166 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.17 91.96 0.96 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.664 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -59.32 -22.18 60.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.972 0.886 . . . . 0.0 110.521 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.35 81.07 1.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.681 1.992 . . . . 0.0 109.092 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 4.8 mmpt? -144.66 -177.34 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -51.99 122.32 8.22 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.562 1.145 . . . . 0.0 108.718 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 p -58.09 -1.28 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.589 2.756 . . . . 0.0 113.213 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 t -49.44 -27.31 4.05 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.402 2.681 . . . . 0.0 113.553 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -96.23 -11.54 25.88 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -81.15 157.9 25.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.803 0.729 . . . . 0.0 109.487 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.72 115.48 30.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.1 151.7 18.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.151 0.907 . . . . 0.0 110.91 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.95 136.97 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 126.899 2.079 . . . . 0.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -85.59 132.67 34.13 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.448 2.299 . . . . 0.0 105.646 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.73 135.02 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.4 -175.97 14.27 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.613 -0.679 . . . . 0.0 111.444 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 61.74 21.13 11.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.972 2.509 . . . . 0.0 114.25 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.32 153.5 43.63 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.884 -1.135 . . . . 0.0 111.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 t -71.39 157.32 90.26 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.63 -6.51 18.82 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.424 2.083 . . . . 0.0 114.173 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.29 -15.32 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 112.811 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -58.25 137.37 20.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 109.84 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -112.21 168.86 9.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.669 1.187 . . . . 0.0 108.284 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 m -60.37 -30.2 69.41 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.907 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.86 -34.23 62.24 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.77 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -48.07 80.66 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.7 mt -58.76 -52.4 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 24.0 mtmt -52.77 -47.62 67.38 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 117.679 -1.153 . . . . 0.0 112.093 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.24 67.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.254 0.934 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -64.58 -50.12 68.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.122 1.369 . . . . 0.0 113.413 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 -11.34 47.11 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.44 90.58 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.423 1.489 . . . . 0.0 112.395 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.1 -10.76 21.94 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.752 1.661 . . . . 0.0 112.583 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -98.13 -10.51 24.08 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.501 1.046 . . . . 0.0 111.532 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.51 165.89 21.43 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 120.026 1.285 . . . . 0.0 111.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 68.3 mtt-85 -77.17 130.12 36.88 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.2 mt -101.99 132.42 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.2 1.0 . . . . 0.0 109.229 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.18 -66.21 0.92 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.05 133.56 46.69 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.314 0.645 . . . . 0.0 110.132 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -155.61 137.43 14.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -160.36 157.98 28.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.663 0.665 . . . . 0.0 111.626 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.21 119.56 50.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.9 t -66.09 133.09 31.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -129.88 151.64 50.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.06 128.55 36.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.8 ptp -66.89 -10.35 47.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.844 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.57 -17.03 26.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.296 1.039 . . . . 0.0 113.738 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.3 p -141.93 -34.08 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.09 14.48 51.54 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.558 -1.135 . . . . 0.0 111.053 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.94 149.56 24.71 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.539 1.67 . . . . 0.0 107.896 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.5 m -53.34 117.31 2.96 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.598 1.159 . . . . 0.0 112.345 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -64.24 -25.03 67.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.334 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.67 -30.81 4.78 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.442 1.972 . . . . 0.0 111.915 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -102.9 172.72 6.66 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.001 1.32 . . . . 0.0 113.501 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.99 175.95 34.36 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.938 2.208 . . . . 0.0 108.908 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.04 151.45 45.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.03 143.59 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.7 m -130.64 128.86 41.83 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.648 1.579 . . . . 0.0 107.708 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -110.75 163.3 13.91 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.544 1.138 . . . . 0.0 110.085 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.53 -28.8 52.08 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.589 0.756 . . . . 0.0 111.748 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -124.89 160.36 29.01 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.083 0.953 . . . . 0.0 111.957 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.566 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 20.1 tptm -65.32 -51.82 58.09 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.632 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -50.99 -45.79 61.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 125.579 1.552 . . . . 0.0 113.134 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -56.96 -43.88 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.963 0.79 . . . . 0.0 110.227 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -50.96 43.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.042 0.937 . . . . 0.0 110.307 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -54.08 -50.79 66.0 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.623 1.169 . . . . 0.0 110.668 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -51.51 -52.67 44.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.709 2.004 . . . . 0.0 108.847 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -47.46 79.54 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.333 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.01 -27.07 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 121.481 1.946 . . . . 0.0 111.342 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -84.77 -70.99 0.54 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.923 0.889 . . . . 0.0 109.932 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -56.62 -50.26 72.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.333 2.253 . . . . 0.0 113.588 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 66.4 mmm -78.01 -20.95 51.54 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.286 1.035 . . . . 0.0 113.659 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.11 75.74 0.25 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.731 1.157 . . . . 0.0 114.563 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.6 -5.15 2.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.049 1.785 . . . . 0.0 112.556 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -76.82 -177.02 4.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.226 1.41 . . . . 0.0 110.819 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -112.85 157.47 21.36 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.347 1.459 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 116' ' ' ALA . 65.5 tp -151.35 126.28 9.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.366 1.466 . . . . 0.0 108.774 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.89 -67.8 0.13 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 126.555 2.026 . . . . 0.0 112.776 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.26 1.99 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.841 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -148.58 167.99 23.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.123 2.461 . . . . 0.0 111.947 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -72.95 147.77 44.92 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -115.6 169.29 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 110.776 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -127.59 146.84 50.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.804 2.041 . . . . 0.0 107.888 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.9 p -142.56 151.04 41.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.23 0.923 . . . . 0.0 109.913 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -173.75 172.73 3.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.148 2.179 . . . . 0.0 108.767 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.566 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 40.1 m95 -67.63 148.53 51.26 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.242 -1.536 . . . . 0.0 111.155 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.42 114.67 28.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.8 p 62.14 -15.81 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.452 3.101 . . . . 0.0 115.989 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.04 178.55 6.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.863 1.665 . . . . 0.0 113.64 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.401 ' HE3' ' HD2' ' A' ' 177' ' ' PRO . 26.9 mmmt -146.71 152.79 45.69 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.704 2.002 . . . . 0.0 107.494 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.401 ' HD2' ' HE3' ' A' ' 176' ' ' LYS . 90.2 Cg_endo -74.42 166.35 29.66 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.331 2.688 . . . . 0.0 110.417 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.14 163.93 36.79 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.381 2.054 . . . . 0.0 108.711 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.82 154.76 88.3 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.126 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.25 2.54 5.49 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.447 2.765 . . . . 0.0 113.505 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -145.99 82.16 1.61 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 104.16 -2.534 . . . . 0.0 104.16 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -153.83 176.76 11.77 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 109.75 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.94 149.13 29.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -170.59 154.68 4.64 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.992 1.717 . . . . 0.0 107.862 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -177.94 171.94 1.71 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.17 1.788 . . . . 0.0 107.555 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.9 t -159.41 153.27 23.14 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -129.67 80.56 1.97 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 108.278 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.9 t -147.65 144.6 28.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.2 155.48 8.01 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.919 1.688 . . . . 0.0 106.547 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -148.75 -179.01 6.67 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 p -172.15 111.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.84 135.76 2.54 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.166 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.91 -15.87 26.2 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.143 2.562 . . . . 0.0 113.06 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.5 t -58.82 142.01 51.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.009 1.324 . . . . 0.0 110.839 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.1 t -54.24 -36.54 63.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.054 1.342 . . . . 0.0 112.296 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.867 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.157 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 t -68.48 79.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 110.033 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.51 -179.58 6.64 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 128.293 2.637 . . . . 0.0 109.266 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.65 64.56 0.3 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 124.965 1.269 . . . . 0.0 111.564 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.3 t -79.4 67.61 5.19 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -145.14 95.08 2.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.45 166.31 20.72 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.3 148.83 16.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.064 1.746 . . . . 0.0 107.882 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.48 4.7 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 110.242 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -75.88 -77.85 0.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -55.68 163.66 1.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.63 2.372 . . . . 0.0 113.689 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.1 p -81.43 148.89 29.06 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 -37.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.092 -1.005 . . . . 0.0 112.016 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -141.25 15.86 2.23 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.63 1.572 . . . . 0.0 111.255 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -68.84 175.39 3.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 125.61 1.564 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.61 100.5 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -81.83 153.88 26.18 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.1 133.68 55.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 127.379 2.272 . . . . 0.0 109.735 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -84.83 142.81 29.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.99 135.61 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.61 27.64 Favored Glycine 0 C--O 1.228 -0.254 0 O-C-N 121.206 -0.934 . . . . 0.0 111.47 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.79 7.47 5.9 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.746 2.418 . . . . 0.0 113.749 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt -52.45 149.22 5.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.384 2.274 . . . . 0.0 112.4 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.53 150.71 93.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.63 -14.14 42.91 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.115 1.876 . . . . 0.0 114.632 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.3 -10.66 29.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.613 1.565 . . . . 0.0 112.433 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -61.5 143.26 15.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 119.587 1.085 . . . . 0.0 110.102 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.6 t -122.17 173.72 7.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 127' ' ' ARG . 52.9 m -62.29 -31.66 72.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.937 0.895 . . . . 0.0 110.715 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -74.03 -34.1 63.98 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.95 -42.91 99.18 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.77 -54.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -50.36 -45.96 55.55 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.321 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.61 75.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.668 0.605 . . . . 0.0 111.544 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.9 85.8 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.01 -8.36 55.72 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.169 0.587 . . . . 0.0 111.13 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.15 97.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 116.956 -1.497 . . . . 0.0 113.523 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.08 -3.42 8.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 122.31 1.861 . . . . 0.0 112.467 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -99.46 -16.15 18.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.42 1.088 . . . . 0.0 109.803 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.48 171.66 20.89 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 122.495 1.053 . . . . 0.0 113.079 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -77.87 123.04 26.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.3 mt -94.48 163.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.97 -69.32 0.82 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.7 136.77 41.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.872 1.269 . . . . 0.0 110.255 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.06 139.27 4.94 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.637 1.108 . . . . 0.0 109.184 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HA ' HG23 ' A' ' 110' ' ' THR . 2.4 ptm180 -162.63 169.34 20.3 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.17 119.78 59.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.887 2.075 . . . . 0.0 105.698 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.3 t -67.24 141.55 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -132.8 155.42 48.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 110.188 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -57.03 117.96 4.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.07 -18.41 64.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 -13.53 18.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 -18.34 2.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.863 1.21 . . . . 0.0 113.997 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.24 87.8 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.213 0.911 . . . . 0.0 113.775 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.84 155.82 25.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.644 1.722 . . . . 0.0 109.408 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.0 t -60.19 126.47 27.64 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.866 0.866 . . . . 0.0 111.091 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -73.27 -48.43 34.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.59 -25.79 3.09 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -103.22 159.02 15.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.464 1.105 . . . . 0.0 111.495 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.9 176.39 29.46 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.932 1.729 . . . . 0.0 109.504 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.29 156.85 45.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.78 0.832 . . . . 0.0 109.348 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.3 t -138.57 154.9 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.2 t -144.07 125.68 15.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.34 156.65 24.03 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.677 1.191 . . . . 0.0 111.237 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.96 -23.07 61.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.975 1.31 . . . . 0.0 113.681 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -137.22 153.99 50.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.479 1.036 . . . . 0.0 109.972 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.49 -48.82 79.36 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -34.68 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.914 1.285 . . . . 0.0 112.874 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.24 -47.63 73.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.1 54.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.645 1.178 . . . . 0.0 111.538 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 155' ' ' ILE . 44.4 mt-10 -53.32 -45.55 69.06 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.395 1.078 . . . . 0.0 111.85 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -53.86 -47.56 70.89 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.775 0.83 . . . . 0.0 108.876 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.73 -47.37 72.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.424 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 152' ' ' GLU . 63.8 mt -51.74 -44.5 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.682 1.583 . . . . 0.0 110.154 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -69.89 -67.96 0.45 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.23 1.412 . . . . 0.0 112.925 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -66.68 -43.19 85.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.565 1.546 . . . . 0.0 115.053 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 74.0 mmm -75.97 -21.55 56.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.598 1.545 . . . . 0.0 112.332 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.31 4.87 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.95 -5.7 69.04 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.527 1.061 . . . . 0.0 112.898 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -73.61 171.21 13.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.467 1.634 . . . . 0.0 109.468 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.405 ' CD1' ' HG2' ' A' ' 167' ' ' GLN . 20.5 m95 -101.94 143.82 31.34 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.06 122.81 12.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.194 0.998 . . . . 0.0 109.434 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.59 3.66 2.39 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 118.073 -1.404 . . . . 0.0 115.896 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 133.65 -13.23 4.81 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-O 116.767 -2.129 . . . . 0.0 115.183 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -137.22 162.54 33.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 121.037 2.419 . . . . 0.0 110.019 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.405 ' HG2' ' CD1' ' A' ' 162' ' ' TRP . 44.1 mt-30 -72.85 162.86 28.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.979 0.354 . . . . 0.0 110.318 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.1 pt -136.94 163.44 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.517 1.127 . . . . 0.0 110.974 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -126.5 151.35 47.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.31 1.444 . . . . 0.0 108.464 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.8 p -141.83 156.74 45.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.671 1.188 . . . . 0.0 109.534 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -173.95 173.84 3.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 109.259 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -67.51 116.19 7.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.49 61.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.691 0.796 . . . . 0.0 112.821 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.9 t -130.1 131.32 45.69 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.7 tpt85 -121.34 45.72 2.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -59.98 131.06 89.23 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.82 157.31 60.71 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.261 1.974 . . . . 0.0 112.195 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.47 -177.24 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.569 2.846 . . . . 0.0 109.307 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -145.12 147.97 36.48 Favored Pre-proline 0 C--O 1.236 0.358 0 C-N-CA 123.638 0.775 . . . . 0.0 108.987 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.56 62.76 7.82 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.0 3.133 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -125.25 147.52 49.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 20.4 t -134.23 -60.44 0.81 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.6 m 61.76 30.74 18.48 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.723 0.809 . . . . 0.0 110.5 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -67.13 163.76 19.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.912 0.885 . . . . 0.0 109.574 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.86 -177.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.101 1.76 . . . . 0.0 107.164 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.9 p -146.32 133.17 20.1 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.67 109.42 6.66 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.147 0.885 . . . . 0.0 109.862 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.1 m -73.2 46.98 0.19 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.26 1.824 . . . . 0.0 110.543 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -81.6 102.94 10.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.685 1.594 . . . . 0.0 111.515 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 139.24 58.4 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.1 m -70.31 136.12 49.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.325 0.584 . . . . 0.0 111.621 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.2 176.04 21.59 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.11 114.79 2.34 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.638 2.225 . . . . 0.0 109.62 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.72 30.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.545 0.738 . . . . 0.0 109.503 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 7.4 t -78.21 -177.58 5.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.632 0.729 . . . . 0.0 109.542 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.642 0 N-CA-C 104.599 -3.4 . . . . 0.0 104.599 179.665 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.324 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.4 p -100.01 171.56 7.76 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.9 m -137.94 162.53 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.0 110.216 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 125.0 -178.86 16.37 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.0 t -78.28 156.17 29.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.538 1.169 . . . . 0.0 108.784 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.8 m -71.38 169.62 14.93 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.03 177.14 34.89 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -69.97 164.74 23.24 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.149 0.976 . . . . 0.0 108.574 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -115.6 -35.81 4.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.412 1.485 . . . . 0.0 108.385 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -63.21 -31.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.546 1.138 . . . . 0.0 111.327 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.62 148.44 22.1 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.125 0.97 . . . . 0.0 113.362 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.9 p -119.97 13.42 12.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.765 1.626 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -53.54 -2.32 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.913 2.485 . . . . 0.0 117.254 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -150.84 16.16 0.76 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.485 1.514 . . . . 0.0 110.43 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.22 168.33 18.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.705 0.802 . . . . 0.0 111.068 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 101.19 8.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.53 146.99 24.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.025 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -123.93 142.83 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.253 1.821 . . . . 0.0 108.47 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -97.02 135.32 39.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 106.351 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.39 139.3 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 -178.33 22.28 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.53 12.63 4.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.722 2.009 . . . . 0.0 113.162 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -55.16 148.13 14.87 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.753 2.021 . . . . 0.0 111.645 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -64.26 142.61 98.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.3 -17.67 27.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.524 2.816 . . . . 0.0 116.315 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -98.62 -5.64 31.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.277 0.944 . . . . 0.0 113.042 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 142.72 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 119.569 1.077 . . . . 0.0 108.374 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.8 t -115.31 169.2 9.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 122.233 1.016 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -61.73 -35.32 77.73 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.766 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -66.29 -34.8 78.82 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.824 1.25 . . . . 0.0 109.998 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.58 -42.77 86.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 108.762 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.34 -43.5 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -54.52 -43.75 72.16 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.606 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.91 73.9 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.85 0.719 . . . . 0.0 111.519 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.35 -43.62 71.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -94.61 -9.39 35.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.756 -0.59 . . . . 0.0 112.295 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.67 93.98 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.94 1.296 . . . . 0.0 114.015 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.04 -7.16 14.53 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 121.87 1.703 . . . . 0.0 112.63 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.41 -12.95 19.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.307 0.958 . . . . 0.0 112.053 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 171.0 -173.7 44.7 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.475 1.489 . . . . 0.0 111.499 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -101.64 129.77 47.85 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.2 mt -100.33 160.8 3.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 126.437 1.895 . . . . 0.0 109.408 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 t -126.93 -69.24 0.77 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.578 1.551 . . . . 0.0 106.837 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.99 138.17 38.39 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.46 4.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.893 1.677 . . . . 0.0 107.435 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -160.74 156.04 24.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.55 1.068 . . . . 0.0 111.726 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.65 121.59 51.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.97 144.49 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -140.91 148.66 40.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.53 121.71 12.21 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.485 1.114 . . . . 0.0 108.165 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.1 ptm -58.49 -22.63 55.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.57 -9.8 18.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.4 p -131.99 -20.27 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.94 1.246 . . . . 0.0 113.02 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.78 6.56 82.04 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.375 0.988 . . . . 0.0 112.756 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -76.51 149.16 36.76 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 t -58.17 129.59 42.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -78.05 -12.79 60.02 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.51 -24.59 28.6 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-O 118.564 -1.131 . . . . 0.0 113.75 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -102.87 166.45 10.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.252 1.026 . . . . 0.0 109.311 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.63 174.14 33.68 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.215 1.388 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.16 157.01 46.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.489 0.716 . . . . 0.0 109.121 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -143.95 133.81 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.074 1.75 . . . . 0.0 106.775 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 t -115.95 129.75 56.53 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.749 2.02 . . . . 0.0 108.254 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.12 155.43 26.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.55 -23.29 61.73 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.528 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -135.81 156.47 48.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.507 1.503 . . . . 0.0 110.994 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.38 -46.11 74.26 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.573 0.749 . . . . 0.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -39.87 72.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.21 1.804 . . . . 0.0 111.177 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -57.44 -52.92 63.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.69 53.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.732 1.213 . . . . 0.0 111.122 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -50.29 -49.02 54.71 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.373 1.069 . . . . 0.0 111.221 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -52.23 -57.35 9.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.275 1.03 . . . . 0.0 110.211 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.17 94.7 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 116.779 -1.582 . . . . 0.0 113.523 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.0 mt -50.97 -34.74 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 121.581 1.991 . . . . 0.0 110.69 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -79.96 -63.42 1.42 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.33 0.652 . . . . 0.0 111.009 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.58 -49.91 69.32 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.7 mmm -68.29 -31.39 70.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.441 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.68 92.7 0.11 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.817 0.722 . . . . 0.0 111.31 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 138.56 -18.0 3.26 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.901 1.239 . . . . 0.0 111.786 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 167.72 20.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.402 1.101 . . . . 0.0 110.672 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -107.0 116.3 31.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.0 tp -116.3 127.3 54.58 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.753 1.221 . . . . 0.0 107.763 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 -63.28 4.18 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.31 5.9 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.208 -1.884 . . . . 0.0 112.808 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -136.13 154.49 50.97 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.213 2.007 . . . . 0.0 110.358 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -68.73 148.45 50.36 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.6 pt -116.88 160.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.454 1.102 . . . . 0.0 110.974 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -118.16 143.91 46.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.389 1.876 . . . . 0.0 105.985 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.6 p -138.89 123.09 18.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -149.94 174.36 12.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -69.07 155.22 40.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.72 3.15 50.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.029 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.9 p -74.39 145.76 43.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.177 -0.952 . . . . 0.0 111.162 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -80.29 124.51 28.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -152.88 133.11 7.51 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 119.938 1.245 . . . . 0.0 110.484 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.22 159.91 50.02 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.708 1.605 . . . . 0.0 110.238 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.12 156.46 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.917 1.744 . . . . 0.0 110.679 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.84 94.0 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.99 170.91 16.9 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.164 1.909 . . . . 0.0 112.173 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -152.82 151.65 30.68 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.652 1.181 . . . . 0.0 109.654 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -133.11 169.38 16.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.579 1.152 . . . . 0.0 108.541 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 12.7 t -143.9 165.45 27.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.698 0.799 . . . . 0.0 109.008 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -171.06 151.56 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.961 2.504 . . . . 0.0 105.961 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.28 151.37 51.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.4 m -165.24 169.26 16.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.654 1.182 . . . . 0.0 109.278 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -153.2 169.09 23.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.081 1.752 . . . . 0.0 107.049 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.5 t -149.14 179.92 7.52 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -140.59 99.13 3.56 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.357 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 176.14 9.59 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 60.4 m -137.55 135.02 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.92 93.59 0.71 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.74 152.6 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 CA-C-N 119.754 1.777 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.2 m -77.43 166.51 23.02 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.1 t -141.87 11.36 2.02 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.468 1.507 . . . . 0.0 110.041 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 1 C-N-CA 130.909 4.099 . . . . 0.0 105.395 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.903 0 CA-C-O 119.417 -0.657 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.29 121.97 29.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.9 p -149.68 -170.43 3.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.555 1.542 . . . . 0.0 107.79 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.25 14.53 66.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.184 0.902 . . . . 0.0 112.52 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -50.13 97.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 129.103 2.961 . . . . 0.0 110.542 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t 58.16 13.93 2.53 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.078 1.351 . . . . 0.0 111.582 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.02 96.66 0.87 Allowed Glycine 0 C--N 1.341 0.831 0 C-N-CA 126.703 2.097 . . . . 0.0 113.862 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.46 166.47 23.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -141.17 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.502 0.721 . . . . 0.0 109.942 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -80.46 -14.88 57.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.198 0.999 . . . . 0.0 110.111 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -108.3 112.86 25.54 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.562 1.145 . . . . 0.0 110.117 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.8 p -63.39 99.57 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -120.76 -5.87 9.65 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -143.0 -7.66 0.82 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.898 1.279 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -72.57 166.95 21.7 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.539 1.935 . . . . 0.0 111.23 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -123.86 113.61 18.74 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.09 1.356 . . . . 0.0 108.086 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.77 151.65 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.76 0.79 . . . . 0.0 111.229 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.17 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 128.859 2.863 . . . . 0.0 107.875 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -95.45 133.06 39.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 106.172 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -127.31 138.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.07 179.63 19.83 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.706 -0.621 . . . . 0.0 111.835 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.284 7.2 t0 60.57 10.88 2.76 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 129.93 3.292 . . . . 0.0 114.982 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.2 mt -52.35 138.61 26.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.66 1.984 . . . . 0.0 110.462 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.83 151.35 64.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.96 -19.43 68.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.038 1.826 . . . . 0.0 114.239 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -82.73 -23.41 34.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.691 1.197 . . . . 0.0 113.598 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mm -56.89 130.61 19.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.283 1.033 . . . . 0.0 110.451 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -107.9 167.53 9.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.159 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.8 m -61.32 -21.61 64.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.056 -1.652 . . . . 0.0 111.969 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.76 -36.77 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.828 1.651 . . . . 0.0 109.96 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.91 -50.95 71.78 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.32 -52.62 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.271 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -53.55 -48.36 69.18 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.994 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.66 -45.87 90.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.623 0.769 . . . . 0.0 111.833 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -60.35 -49.13 78.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.67 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -84.48 -8.28 59.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.947 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.3 93.75 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 120.215 1.371 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.58 -6.07 15.72 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 122.1 1.786 . . . . 0.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.62 -18.21 17.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.73 0.812 . . . . 0.0 110.913 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 170.17 175.23 38.91 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 123.596 1.665 . . . . 0.0 114.651 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -86.03 117.68 25.03 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.5 mt -100.36 158.01 3.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.12 1.368 . . . . 0.0 107.818 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 t -134.95 -62.61 0.72 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.83 126.47 48.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.831 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.22 136.62 13.09 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -162.65 157.03 21.32 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.492 0.587 . . . . 0.0 112.004 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.91 122.65 58.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.49 141.8 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -130.85 155.69 46.3 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.747 0.784 . . . . 0.0 109.083 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.49 124.51 23.77 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.068 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.8 ptp -64.54 -20.2 66.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.87 10.47 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.826 1.194 . . . . 0.0 113.845 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 80.5 p -104.05 -19.25 14.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.017 1.327 . . . . 0.0 114.303 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.0 78.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.195 0.903 . . . . 0.0 112.607 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -83.6 157.27 22.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.06 1.344 . . . . 0.0 109.154 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 t -62.06 124.99 22.3 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.718 0.807 . . . . 0.0 111.221 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -71.4 -31.61 67.47 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.27 -29.96 5.98 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.081 1.324 . . . . 0.0 110.601 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -103.31 164.99 11.3 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.305 -1.115 . . . . 0.0 111.574 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.6 178.37 33.09 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.695 1.616 . . . . 0.0 110.015 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.38 153.87 51.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.399 1.079 . . . . 0.0 108.419 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.2 t -140.24 143.61 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 12.9 t -131.35 135.3 47.12 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.738 1.615 . . . . 0.0 107.234 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 148.58 43.37 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 124.529 1.143 . . . . 0.0 109.381 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.03 -48.12 59.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -92.33 143.1 26.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.652 0.781 . . . . 0.0 109.238 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.34 -45.32 84.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.527 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -36.71 63.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.976 1.711 . . . . 0.0 112.078 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.17 -47.05 87.95 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.25 -52.54 61.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.73 0.812 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.08 -54.75 14.62 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 110.511 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -51.15 -56.55 12.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.882 1.673 . . . . 0.0 111.537 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.45 91.89 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.079 -1.438 . . . . 0.0 112.111 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.8 mt -53.01 -45.77 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 122.06 2.209 . . . . 0.0 109.784 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.72 -64.76 0.79 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.049 1.34 . . . . 0.0 111.106 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -62.89 -57.62 10.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.247 1.819 . . . . 0.0 114.193 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.3 mmm -64.91 -21.96 66.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.361 1.437 . . . . 0.0 113.669 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.34 110.45 3.12 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 119.227 0.921 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.4 -5.71 70.99 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.752 1.168 . . . . 0.0 112.134 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -76.71 170.67 16.03 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 118.852 1.326 . . . . 0.0 107.605 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -102.01 142.67 32.92 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 116' ' ' ALA . 22.7 tp -131.71 124.08 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.014 2.126 . . . . 0.0 106.214 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.39 -78.35 0.84 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.9 -2.27 0.15 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.069 -1.961 . . . . 0.0 114.544 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -129.22 163.72 25.0 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.16 2.48 . . . . 0.0 109.995 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -77.93 165.18 24.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.338 0.589 . . . . 0.0 109.581 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.14 159.08 38.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.675 0.79 . . . . 0.0 110.925 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -113.77 139.54 49.03 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 p -137.06 132.37 34.07 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.138 0.881 . . . . 0.0 109.448 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -157.1 167.43 30.45 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -61.08 132.87 55.16 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.1 69.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.134 0.425 . . . . 0.0 111.673 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 62.7 p -126.29 119.91 28.58 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.79 0.723 . . . . 0.0 109.611 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -141.64 160.53 39.98 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.483 1.913 . . . . 0.0 106.938 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -155.37 137.1 9.6 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.39 150.33 84.44 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.405 1.403 . . . . 0.0 109.057 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.32 165.55 31.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.225 1.95 . . . . 0.0 109.304 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -128.47 159.03 69.78 Favored Pre-proline 0 C--O 1.233 0.216 0 O-C-N 121.34 -0.85 . . . . 0.0 111.874 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.97 -6.91 19.84 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.514 2.809 . . . . 0.0 112.307 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -107.71 138.61 43.63 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.773 2.029 . . . . 0.0 108.27 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.8 t -136.77 -176.05 4.23 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.901 1.28 . . . . 0.0 108.568 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 p -90.26 138.55 31.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.658 1.183 . . . . 0.0 110.573 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.43 -11.02 8.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.822 1.649 . . . . 0.0 112.535 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.58 156.82 15.63 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.467 1.507 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 13.4 p -127.41 158.23 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.056 1.343 . . . . 0.0 108.145 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -158.03 173.57 16.55 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.2 t -87.36 -178.88 6.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.815 0.846 . . . . 0.0 109.298 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.05 159.89 29.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.409 1.484 . . . . 0.0 108.63 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.36 10.51 4.47 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.207 2.203 . . . . 0.0 108.666 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.8 m -143.03 179.79 6.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.066 2.546 . . . . 0.0 108.329 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.97 78.26 0.33 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.635 -1.092 . . . . 0.0 110.966 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.49 134.02 16.53 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.833 2.356 . . . . 0.0 108.451 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 61.3 m -138.02 164.87 27.98 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.234 1.014 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.7 t -144.9 -22.24 0.5 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.109 1.364 . . . . 0.0 110.525 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.328 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -179.723 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.886 0.374 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -105.39 102.59 12.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.317 1.847 . . . . 0.0 107.894 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 146.82 25.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.306 0.643 . . . . 0.0 110.568 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.61 138.18 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.344 1.858 . . . . 0.0 110.207 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -86.82 143.0 27.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.242 1.817 . . . . 0.0 106.686 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.13 137.37 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.5 -174.54 17.79 Favored Glycine 0 N--CA 1.463 0.498 0 O-C-N 120.865 -1.147 . . . . 0.0 111.164 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.7 8.94 4.8 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.067 2.147 . . . . 0.0 112.36 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -55.84 148.13 17.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.009 1.323 . . . . 0.0 111.519 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.11 162.32 69.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.14 -16.78 49.77 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.623 2.215 . . . . 0.0 114.632 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.87 -15.06 17.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.583 1.083 . . . . 0.0 112.288 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.417 HD11 ' HA3' ' A' ' 164' ' ' GLY . 28.3 mm -57.69 114.25 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 109.387 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 t -95.34 178.83 5.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 m -64.54 -30.91 71.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.928 -1.107 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -73.02 -30.12 63.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.315 1.046 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.04 -48.6 70.54 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -51.65 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -55.37 -38.65 69.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 120.904 -1.122 . . . . 0.0 112.34 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.17 64.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.672 0.608 . . . . 0.0 110.078 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.73 84.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.742 1.217 . . . . 0.0 113.547 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.47 -6.34 57.69 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.27 94.95 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.862 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.92 -5.96 14.7 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.529 1.486 . . . . 0.0 113.535 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -98.82 -20.97 16.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.775 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 169.33 175.16 38.36 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-O 122.943 1.301 . . . . 0.0 114.155 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.9 mtm105 -81.61 121.54 26.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.3 mt -100.79 153.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.377 1.071 . . . . 0.0 109.073 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 t -130.28 -61.07 0.99 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.77 132.89 45.95 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 134.71 6.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.198 0.999 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -162.84 163.38 26.53 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.957 0.798 . . . . 0.0 112.228 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 52.2 t -105.02 120.59 55.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.597 HG12 ' HG3' ' A' ' 138' ' ' LYS . 95.3 t -66.03 140.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -133.23 147.1 51.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.71 130.26 45.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.079 1.352 . . . . 0.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.6 ptm -76.02 -9.41 58.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.77 -24.29 16.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.864 1.211 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.5 p -128.48 -18.49 3.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.433 1.015 . . . . 0.0 113.043 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.52 19.11 78.47 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.592 1.091 . . . . 0.0 113.391 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -100.3 163.35 12.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.542 1.171 . . . . 0.0 109.867 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -46.27 126.21 7.55 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.885 1.274 . . . . 0.0 113.885 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.597 ' HG3' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -79.5 -22.5 43.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.699 178.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.93 -30.12 8.31 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.547 2.023 . . . . 0.0 110.644 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.503 ' CZ ' HG11 ' A' ' 129' ' ' VAL 0.264 29.9 p90 -102.88 169.37 8.63 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.422 1.089 . . . . 0.0 112.171 178.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.57 172.72 33.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.371 2.415 . . . . 0.0 108.379 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -140.37 149.95 43.33 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.54 155.75 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.662 1.985 . . . . 0.0 106.031 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.0 t -145.32 118.02 8.65 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.506 1.122 . . . . 0.0 108.354 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -99.46 152.12 20.35 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.17 1.388 . . . . 0.0 110.631 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -74.37 -24.41 59.15 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.394 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -125.44 151.27 46.44 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.782 1.233 . . . . 0.0 110.55 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.01 -49.24 73.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -31.46 17.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.456 1.903 . . . . 0.0 113.307 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.78 -55.28 10.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 108.347 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.71 76.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.971 1.708 . . . . 0.0 110.81 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.18 -50.01 70.42 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.583 1.153 . . . . 0.0 109.295 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -55.22 -50.91 68.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.752 0.421 . . . . 0.0 111.294 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.22 -55.12 37.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.033 1.733 . . . . 0.0 111.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.4 mt -46.68 -49.9 6.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 120.367 1.44 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.36 -60.78 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.288 0.992 . . . . 0.0 112.316 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -66.02 -58.07 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.2 mmm -58.19 -28.58 64.92 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.93 77.43 0.81 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 125.021 1.296 . . . . 0.0 110.123 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.17 -10.35 2.26 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 127.3 2.381 . . . . 0.0 111.838 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -80.18 165.52 22.34 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.879 1.34 . . . . 0.0 109.456 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -107.6 133.54 51.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.991 0.916 . . . . 0.0 108.853 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.88 130.48 46.91 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.565 1.946 . . . . 0.0 106.645 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 66.44 12.55 58.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.106 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.88 0.25 62.24 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.312 1.556 . . . . 0.0 112.564 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.26 157.06 46.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.427 1.614 . . . . 0.0 108.928 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.78 174.84 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.787 0.803 . . . . 0.0 109.308 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 pt -142.96 160.05 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.734 2.014 . . . . 0.0 108.025 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -123.51 140.6 52.84 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.4 p -138.93 149.23 44.56 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.957 0.903 . . . . 0.0 111.808 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -173.43 178.07 2.45 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.906 2.082 . . . . 0.0 109.352 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.12 126.65 30.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 112.855 -179.509 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -113.08 161.36 17.18 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -132.72 133.79 43.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.36 134.27 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 126.169 1.788 . . . . 0.0 109.571 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -85.59 136.1 33.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.52 HG12 HD21 ' A' ' 104' ' ' LEU . 15.8 t -131.71 133.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.02 -174.35 18.1 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 62.8 12.33 5.62 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.227 2.611 . . . . 0.0 111.951 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.52 HD21 HG12 ' A' ' 101' ' ' VAL . 53.8 mt -59.55 142.68 52.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.639 1.576 . . . . 0.0 111.322 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 t -59.87 143.81 86.89 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -59.95 -5.33 3.61 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 115.382 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.4 -14.38 18.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.285 2.234 . . . . 0.0 112.721 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.1 mm -58.05 136.2 21.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 119.316 0.962 . . . . 0.0 109.831 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -108.33 168.85 9.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.387 1.089 . . . . 0.0 108.843 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.0 m -60.82 -29.51 69.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.895 1.278 . . . . 0.0 109.381 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -70.24 -40.8 74.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 109.277 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.75 -47.54 85.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.738 0.815 . . . . 0.0 109.17 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 113' ' ' ILE . 27.9 mt -60.75 -49.53 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 22.8 mtmt -54.88 -48.53 72.86 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.762 -1.211 . . . . 0.0 110.99 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.33 -34.4 73.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.967 0.907 . . . . 0.0 112.614 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -75.31 -44.89 42.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.756 1.223 . . . . 0.0 113.842 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.04 -10.68 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.0 -50.37 86.82 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 126.481 1.913 . . . . 0.0 114.445 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -65.03 -4.17 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.464 1.443 . . . . 0.0 113.282 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -99.05 -9.63 23.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.47 15.1 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.094 1.316 . . . . 0.0 109.89 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -75.18 116.35 15.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.596 -0.943 . . . . 0.0 109.827 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -77.48 153.5 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 p -112.53 -73.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.011 1.724 . . . . 0.0 107.032 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.97 142.8 32.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.988 2.115 . . . . 0.0 108.117 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.416 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -161.84 124.03 2.9 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 110.101 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -153.53 164.5 38.12 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.594 0.712 . . . . 0.0 111.8 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.2 121.64 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.341 1.857 . . . . 0.0 106.968 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 140' ' ' TYR . 75.1 t -64.68 139.28 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -134.84 153.35 52.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -60.84 116.41 4.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.368 1.467 . . . . 0.0 109.115 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.4 ptp -64.09 -9.01 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.26 -15.87 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.467 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.4 p -137.91 -29.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.94 1.246 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.66 62.55 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.217 1.389 . . . . 0.0 112.037 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -80.14 154.97 27.69 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.696 1.248 . . . . 0.0 109.094 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 m -56.04 123.58 14.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.857 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -76.88 -22.56 53.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.121 0.568 . . . . 0.0 111.692 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.73 -26.53 10.68 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 127.006 2.241 . . . . 0.0 112.619 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CE2' HG11 ' A' ' 129' ' ' VAL . 7.3 p90 -103.06 168.09 9.41 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.764 1.225 . . . . 0.0 112.389 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.84 177.85 31.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.785 2.136 . . . . 0.0 109.307 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -138.79 155.42 48.18 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.031 0.932 . . . . 0.0 109.938 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.3 t -142.89 125.56 13.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.174 1.39 . . . . 0.0 108.405 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -112.92 142.15 45.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.16 163.07 22.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.65 -19.95 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.892 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.19 169.12 16.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.722 1.209 . . . . 0.0 111.607 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -77.81 -52.74 8.43 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.578 1.151 . . . . 0.0 110.808 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -49.61 -48.92 48.66 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.182 1.793 . . . . 0.0 111.096 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.86 -43.96 69.97 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.091 0.869 . . . . 0.0 110.124 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.42 -56.04 12.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.135 1.374 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.08 -48.33 64.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.333 1.453 . . . . 0.0 111.185 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -53.14 -46.0 68.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 109.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.88 -43.23 65.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.855 1.262 . . . . 0.0 110.18 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 95.5 mt -49.52 -44.54 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 120.8 1.636 . . . . 0.0 108.704 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.4 -70.87 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.14 -43.46 98.84 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 68.2 mmm -71.93 -22.59 61.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.594 1.543 . . . . 0.0 111.494 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.0 113.55 5.75 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 118.96 0.8 . . . . 0.0 111.834 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.22 60.29 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.325 -1.264 . . . . 0.0 113.119 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.6 169.05 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.964 1.382 . . . . 0.0 108.795 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -105.33 137.29 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 116' ' ' ALA . 50.4 tp -124.79 127.88 47.87 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.78 -101.17 0.44 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 105.695 -2.962 . . . . 0.0 105.695 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.75 10.85 7.5 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 116.355 -2.358 . . . . 0.0 115.729 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.98 159.25 43.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.971 2.886 . . . . 0.0 112.969 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -72.37 153.97 41.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.17 151.97 27.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 123.409 0.684 . . . . 0.0 111.457 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -111.64 126.52 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.995 1.318 . . . . 0.0 108.387 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.9 p -113.54 141.58 46.98 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.238 1.415 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -167.45 177.12 6.16 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.086 1.755 . . . . 0.0 107.459 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -77.69 152.62 33.64 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.416 0 O-C-N 121.478 -0.764 . . . . 0.0 112.21 179.471 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 121.095 0.474 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -113.52 139.56 48.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.042 1.292 . . . . 0.0 110.214 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.08 154.36 28.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.668 2.387 . . . . 0.0 109.704 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -103.82 141.42 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.579 3.152 . . . . 0.0 108.709 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.61 140.33 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.44 178.86 24.78 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 119.652 1.114 . . . . 0.0 111.543 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t0 70.41 -1.69 2.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.762 2.825 . . . . 0.0 114.525 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 mt -47.78 139.01 7.91 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 127.283 2.233 . . . . 0.0 113.892 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.7 t -62.65 148.12 91.64 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.83 -18.1 58.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.161 1.908 . . . . 0.0 113.822 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -76.43 -25.49 54.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mm -57.84 124.11 11.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.448 1.499 . . . . 0.0 110.613 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -106.93 175.3 5.54 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.134 0.974 . . . . 0.0 109.03 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -56.73 -33.52 66.62 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.52 -0.737 . . . . 0.0 111.851 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.39 -42.56 78.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.133 1.773 . . . . 0.0 112.142 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.63 -51.54 65.08 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.326 1.05 . . . . 0.0 109.482 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.0 mt -60.12 -53.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.2 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -51.1 -44.77 61.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 117.885 -1.055 . . . . 0.0 112.092 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.09 81.88 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.948 0.78 . . . . 0.0 110.734 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -57.51 -46.79 83.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.12 -5.76 59.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.402 1.081 . . . . 0.0 113.152 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -47.2 99.3 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.54 -3.9 12.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 CA-C-N 121.111 1.432 . . . . 0.0 112.388 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.95 -18.91 18.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.251 0.932 . . . . 0.0 110.719 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.4 168.19 25.0 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 118.887 0.767 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.85 130.72 40.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.2 mt -100.26 154.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.0 t -116.06 -72.65 0.68 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.12 139.97 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.815 1.646 . . . . 0.0 109.303 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.33 135.53 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -162.77 163.01 26.9 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.577 0.626 . . . . 0.0 110.703 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.6 t -102.59 123.28 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.66 138.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -132.15 151.5 51.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 107.739 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -60.01 123.23 16.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.356 1.462 . . . . 0.0 109.97 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.84 -12.9 27.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.835 0.854 . . . . 0.0 113.166 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.82 -10.77 18.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.8 p -141.93 -25.17 0.68 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.95 11.95 75.39 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.183 0.897 . . . . 0.0 110.907 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -82.31 143.92 30.95 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -55.46 125.8 22.46 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -73.07 -22.91 60.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.13 -18.28 42.84 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.936 1.255 . . . . 0.0 112.128 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.282 31.8 p90 -103.14 161.75 13.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.332 1.566 . . . . 0.0 109.573 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.38 175.03 28.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.938 1.256 . . . . 0.0 110.763 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.93 153.37 51.81 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.102 1.361 . . . . 0.0 108.96 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.65 131.22 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 126.254 1.822 . . . . 0.0 106.516 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.3 m -122.14 132.02 54.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.081 0.952 . . . . 0.0 109.368 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.96 156.29 26.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.189 1.396 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -72.59 -24.05 61.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.717 1.207 . . . . 0.0 112.959 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -131.18 156.25 45.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.23 0.923 . . . . 0.0 110.183 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -67.16 -48.39 68.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.852 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -47.72 -49.28 28.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.71 1.604 . . . . 0.0 112.881 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.77 -49.78 67.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.636 1.574 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.82 63.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.716 1.206 . . . . 0.0 112.018 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -51.38 -49.0 62.36 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.422 1.889 . . . . 0.0 109.867 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -54.23 -52.18 62.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.061 0.944 . . . . 0.0 110.54 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.22 89.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.363 -1.303 . . . . 0.0 111.755 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.4 mt -51.42 -48.05 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 121.739 2.063 . . . . 0.0 109.44 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.42 -60.17 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -68.57 -48.44 64.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.34 2.256 . . . . 0.0 115.516 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.41 -22.84 58.97 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.176 0.898 . . . . 0.0 111.807 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.87 97.84 0.17 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.496 1.046 . . . . 0.0 111.203 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 114.14 -7.72 23.17 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.246 -1.308 . . . . 0.0 113.857 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.27 174.54 9.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.754 1.277 . . . . 0.0 109.951 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 15.3 m95 -109.38 146.42 34.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' A' ' 116' ' ' ALA . 37.5 tp -139.58 128.37 23.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.994 2.118 . . . . 0.0 106.904 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 48.19 32.22 9.36 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.78 1.181 . . . . 0.0 114.818 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.65 -5.24 51.04 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 117.704 1.841 . . . . 0.0 117.704 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -141.76 157.58 44.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 122.037 2.919 . . . . 0.0 110.738 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 162' ' ' TRP . 39.6 mt-30 -65.93 161.21 21.78 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.296 0.997 . . . . 0.0 110.658 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.82 155.96 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.541 1.136 . . . . 0.0 108.717 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.3 p -137.2 155.37 49.61 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.992 0.917 . . . . 0.0 110.174 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -176.24 165.05 2.77 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.742 1.217 . . . . 0.0 108.719 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -73.77 122.36 22.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.222 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.339 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.8 m170 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.74 112.4 25.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.57 148.75 22.05 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.812 0.695 . . . . 0.0 111.157 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.32 140.72 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 129.07 2.948 . . . . 0.0 109.166 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -92.03 141.14 28.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.845 2.858 . . . . 0.0 107.24 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.9 143.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 -176.21 23.59 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.88 14.12 9.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.35 2.26 . . . . 0.0 113.126 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.6 mt -62.98 137.18 58.19 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.164 1.785 . . . . 0.0 112.415 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.5 t -62.85 143.46 97.1 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.24 -14.37 33.7 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.806 2.337 . . . . 0.0 114.679 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.26 -23.96 37.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.314 0.961 . . . . 0.0 111.667 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.24 143.24 12.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.62 1.568 . . . . 0.0 110.231 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.5 t -121.75 179.29 4.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.859 1.314 . . . . 0.0 110.038 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 m -57.03 -39.37 74.69 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.591 1.956 . . . . 0.0 112.145 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.51 -37.48 80.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.251 1.82 . . . . 0.0 111.417 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.03 -49.71 76.29 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.4 mt -57.58 -52.29 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -54.11 -46.58 72.17 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.163 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.99 81.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.149 0.886 . . . . 0.0 111.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -65.27 -53.05 50.04 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.852 1.261 . . . . 0.0 113.67 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -84.46 -15.55 45.66 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.18 -48.75 93.37 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.875 1.27 . . . . 0.0 112.329 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.61 -5.16 8.13 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.548 1.498 . . . . 0.0 113.479 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -99.11 -14.89 19.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.413 1.006 . . . . 0.0 111.091 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 161.31 157.96 9.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.636 1.589 . . . . 0.0 110.528 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -73.39 107.21 5.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.086 1.354 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.3 140.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 126.507 1.923 . . . . 0.0 109.229 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 p -99.8 -71.44 0.7 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.24 142.86 32.8 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 128.319 2.647 . . . . 0.0 109.823 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -162.73 131.67 4.13 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.903 1.281 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -155.42 157.3 36.81 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.223 0.92 . . . . 0.0 111.948 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.3 t -106.26 119.19 55.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.61 139.08 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 121.716 -0.615 . . . . 0.0 109.361 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -133.65 150.39 51.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.326 1.05 . . . . 0.0 108.533 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.82 137.96 52.24 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.589 0.356 . . . . 0.0 111.875 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.2 ptm -71.61 -17.83 62.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.38 -11.93 31.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.378 1.445 . . . . 0.0 114.217 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 62.1 p -140.24 -16.15 0.96 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.17 74.15 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.79 148.79 25.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 118.323 1.061 . . . . 0.0 110.48 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 123.62 14.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.293 1.437 . . . . 0.0 111.156 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -71.45 -53.82 12.7 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.232 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 141.11 -28.08 2.39 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.131 2.301 . . . . 0.0 112.78 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -102.59 161.55 13.63 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.257 1.423 . . . . 0.0 112.704 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.66 168.99 26.67 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.643 1.116 . . . . 0.0 110.382 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -132.72 142.08 48.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.578 1.151 . . . . 0.0 108.789 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.6 t -133.51 143.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.302 1.441 . . . . 0.0 107.484 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.4 t -119.94 130.58 54.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.572 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -114.43 150.23 35.04 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.441 1.096 . . . . 0.0 113.677 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -70.81 -14.76 62.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.313 1.445 . . . . 0.0 114.134 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -138.89 159.75 41.38 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.963 1.711 . . . . 0.0 108.13 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -64.64 -53.16 51.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -29.07 68.65 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 126.145 1.778 . . . . 0.0 112.661 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -64.06 -43.15 96.36 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.32 -47.33 50.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.705 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -55.69 -47.15 77.26 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.176 0.898 . . . . 0.0 110.873 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -49.95 -51.36 41.84 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 126.08 1.752 . . . . 0.0 108.002 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.53 66.72 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 117.189 -1.386 . . . . 0.0 111.936 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 78.5 mt -49.55 -48.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 122.452 2.387 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -64.74 -59.9 3.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.834 1.653 . . . . 0.0 112.789 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -71.31 -44.61 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.907 1.683 . . . . 0.0 115.231 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.5 mmm -72.63 -21.41 61.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 110.27 2.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.16 62.36 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.869 -1.517 . . . . 0.0 113.903 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -69.73 166.45 19.2 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.518 1.659 . . . . 0.0 108.982 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -106.27 99.2 8.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.542 1.137 . . . . 0.0 109.642 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 116' ' ' ALA . 23.3 tp -85.01 111.98 20.2 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.11 -129.87 38.19 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.93 87.81 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 115.826 -2.652 . . . . 0.0 117.497 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -147.41 157.21 43.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 123.209 3.505 . . . . 0.0 115.267 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.03 163.19 17.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.5 pt -134.92 165.8 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.013 0.911 . . . . 0.0 110.673 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -123.31 147.13 47.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.474 2.31 . . . . 0.0 105.462 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.6 p -138.22 148.35 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.44 1.096 . . . . 0.0 110.702 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -170.08 171.08 7.14 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -69.67 138.75 53.24 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 m170 . . . . . 0 C--O 1.237 0.395 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.69 100.94 6.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.73 144.52 32.13 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.39 135.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.296 1.838 . . . . 0.0 107.853 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -85.92 136.43 33.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.047 2.139 . . . . 0.0 106.492 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.41 142.52 41.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.62 179.36 25.52 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.283 0.944 . . . . 0.0 111.168 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.91 15.45 9.14 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.073 2.549 . . . . 0.0 113.901 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.48 145.59 55.93 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.857 1.263 . . . . 0.0 111.333 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 t -68.46 149.79 97.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.46 -16.75 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.038 1.825 . . . . 0.0 113.5 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -78.46 -16.59 57.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.301 1.04 . . . . 0.0 112.777 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.556 HD11 ' HA3' ' A' ' 164' ' ' GLY . 32.1 mm -70.82 121.49 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.5 1.12 . . . . 0.0 109.669 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 111' ' ' GLU . 4.7 t -99.78 -179.19 4.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.426 1.091 . . . . 0.0 109.923 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.3 m -62.93 -33.08 74.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.523 ' H ' HG23 ' A' ' 109' ' ' THR . 26.0 mt-10 -69.49 -41.81 75.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.786 0.834 . . . . 0.0 109.914 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -56.15 -49.96 72.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.745 0.818 . . . . 0.0 109.172 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.77 -54.51 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -51.91 -41.44 61.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 116.945 -1.502 . . . . 0.0 112.584 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.05 -45.97 79.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.345 0.975 . . . . 0.0 110.085 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.02 -5.99 54.57 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.02 99.74 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-O 117.471 -1.252 . . . . 0.0 114.164 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.34 -5.65 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 121.721 1.65 . . . . 0.0 112.131 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.06 -43.93 7.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 119.751 1.159 . . . . 0.0 108.806 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.84 164.27 36.32 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -80.8 118.47 22.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.43 157.99 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 126.035 1.734 . . . . 0.0 107.748 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.7 t -123.84 -69.45 0.81 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.38 130.16 47.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 107.817 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.2 137.84 9.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.051 1.296 . . . . 0.0 108.774 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.16 173.09 15.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 111.313 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.47 138.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.28 133.83 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -123.6 164.32 19.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.31 142.52 43.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.724 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.6 ptp -75.63 -29.68 59.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.788 -0.57 . . . . 0.0 109.892 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.84 -45.27 15.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -104.75 -18.36 14.29 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.94 12.26 74.93 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.978 -0.451 . . . . 0.0 113.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -85.46 155.06 21.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.481 1.112 . . . . 0.0 109.966 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 t -57.81 126.35 27.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.896 0.878 . . . . 0.0 108.849 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -70.08 -65.85 0.67 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.698 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 150.72 -18.82 0.99 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 128.152 2.786 . . . . 0.0 110.245 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -102.93 162.88 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.072 -1.252 . . . . 0.0 112.585 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.49 176.99 29.68 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.28 1.419 . . . . 0.0 110.613 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.33 151.29 46.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.603 0.761 . . . . 0.0 109.359 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 50.2 t -143.8 121.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.382 1.473 . . . . 0.0 109.072 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -107.0 125.37 50.91 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 109.317 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -105.47 159.65 15.77 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.288 1.035 . . . . 0.0 110.709 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.17 -30.0 65.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.196 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -132.02 158.78 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.773 1.17 . . . . 0.0 111.033 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -60.56 -53.94 51.43 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.03 1.332 . . . . 0.0 112.33 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -41.16 67.75 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.788 2.035 . . . . 0.0 112.619 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -58.31 -45.43 88.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.209 1.004 . . . . 0.0 109.301 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.53 -50.36 45.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.271 1.028 . . . . 0.0 110.687 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.47 -48.73 62.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.207 1.403 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -56.17 -34.93 66.65 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.53 -45.33 16.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 116.923 -1.513 . . . . 0.0 109.6 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 79.5 mt -49.03 -39.39 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 122.083 2.22 . . . . 0.0 109.747 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -68.69 -71.09 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.528 1.131 . . . . 0.0 111.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -64.18 -45.61 87.61 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 127.802 2.441 . . . . 0.0 116.14 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.8 mmm -76.65 -21.14 55.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.737 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.43 0.62 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 116.266 1.266 . . . . 0.0 116.266 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.93 -11.15 0.5 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.504 2.002 . . . . 0.0 112.231 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.04 167.38 11.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.174 0.987 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.25 123.04 47.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.38 118.18 32.51 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.273 1.429 . . . . 0.0 109.255 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.556 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 64.11 5.99 17.58 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.7 1.143 . . . . 0.0 113.686 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 124.6 -5.96 8.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 117.042 -1.977 . . . . 0.0 114.683 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -133.28 148.17 51.93 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.519 2.659 . . . . 0.0 112.018 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -64.49 154.78 34.85 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.496 0.718 . . . . 0.0 110.413 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 26.4 pt -128.58 163.45 33.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 110.698 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -124.84 141.37 52.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.7 p -139.52 141.78 37.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.484 1.038 . . . . 0.0 111.035 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -163.28 176.79 9.56 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.857 1.663 . . . . 0.0 108.166 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -70.38 152.9 43.59 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.149 -1.595 . . . . 0.0 109.031 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.648 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.751 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.8 m170 . . . . . 0 C--O 1.238 0.459 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.07 100.16 7.04 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.957 1.303 . . . . 0.0 110.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.98 146.3 35.51 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.102 0.954 . . . . 0.0 111.545 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.2 t -129.2 141.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 129.524 3.13 . . . . 0.0 109.426 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -95.23 136.52 35.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.611 2.364 . . . . 0.0 107.578 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.444 HG12 HD21 ' A' ' 104' ' ' LEU . 7.1 t -132.33 135.3 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.68 -178.57 21.28 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 121.537 -0.727 . . . . 0.0 111.64 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.93 7.22 6.12 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.957 2.503 . . . . 0.0 113.268 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.444 HD21 HG12 ' A' ' 101' ' ' VAL . 24.6 mt -58.14 145.51 36.67 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.66 2.384 . . . . 0.0 111.36 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -67.14 148.0 98.91 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.36 -10.53 11.09 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.098 2.532 . . . . 0.0 114.4 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.18 -23.45 21.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.627 1.103 . . . . 0.0 113.002 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.8 mm -57.97 128.15 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.008 0.923 . . . . 0.0 109.395 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 111' ' ' GLU . 4.5 t -107.76 177.9 4.68 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.893 1.33 . . . . 0.0 111.131 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 m -60.23 -31.42 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.428 1.091 . . . . 0.0 111.042 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 109' ' ' THR . 5.4 mt-10 -73.7 -36.52 65.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.054 0.942 . . . . 0.0 111.267 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -60.53 -49.62 76.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.3 mt -59.44 -54.2 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -51.79 -47.26 64.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.316 0.962 . . . . 0.0 111.38 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.68 83.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.531 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -39.54 63.03 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -88.85 -10.98 46.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.016 0.926 . . . . 0.0 112.608 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.83 97.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.936 1.294 . . . . 0.0 111.236 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.22 -3.82 6.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 CA-C-N 121.872 1.704 . . . . 0.0 113.906 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.92 -15.28 18.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.216 0.916 . . . . 0.0 112.003 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.48 177.72 30.85 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 122.407 1.004 . . . . 0.0 111.702 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -74.08 131.45 41.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.21 135.75 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -74.89 0.59 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -103.53 141.5 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.846 2.059 . . . . 0.0 108.655 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.22 127.48 2.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.932 1.242 . . . . 0.0 109.03 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -154.85 162.54 41.07 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.1 0.864 . . . . 0.0 111.601 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.01 120.08 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.82 135.43 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -131.7 151.16 51.84 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.77 144.4 56.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.88 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 tpt -83.0 -19.43 37.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.036 0.835 . . . . 0.0 111.701 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.85 -9.36 37.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.002 -1.061 . . . . 0.0 113.509 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.7 p -136.79 -25.36 1.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.355 0.979 . . . . 0.0 112.398 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.0 81.22 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -92.2 156.45 17.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.884 1.342 . . . . 0.0 109.559 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -54.16 126.15 21.8 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.382 1.073 . . . . 0.0 111.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -75.36 -32.78 60.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.828 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.22 -25.52 7.39 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.714 2.578 . . . . 0.0 111.259 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -102.57 161.2 13.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.527 1.163 . . . . 0.0 112.281 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.1 172.79 28.31 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.642 1.591 . . . . 0.0 109.317 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -135.03 155.02 51.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.51 1.124 . . . . 0.0 108.555 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.8 t -145.31 146.81 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.071 2.548 . . . . 0.0 104.509 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 t -145.2 112.76 6.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.755 1.616 . . . . 0.0 109.79 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -86.88 152.39 22.49 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.588 1.155 . . . . 0.0 112.131 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -70.27 -34.82 73.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.642 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -112.52 146.86 37.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.16 1.384 . . . . 0.0 108.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.55 -49.24 74.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.42 -33.47 59.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.52 1.128 . . . . 0.0 113.913 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -62.24 -46.79 87.29 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.14 -49.41 69.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 110.186 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.47 -45.13 76.96 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.162 0.585 . . . . 0.0 110.501 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.36 -50.59 67.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.144 0.577 . . . . 0.0 110.465 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.12 78.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.413 1.485 . . . . 0.0 111.285 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 89.0 mt -51.49 -47.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 121.815 2.098 . . . . 0.0 110.375 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -67.77 -56.13 10.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 124.129 0.893 . . . . 0.0 112.109 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.05 -52.8 21.1 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.57 -17.62 64.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -75.99 79.91 1.12 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 123.793 0.711 . . . . 0.0 111.918 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 132.69 -5.75 5.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.795 2.14 . . . . 0.0 111.379 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -73.76 178.8 4.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.208 1.004 . . . . 0.0 108.77 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -118.85 150.47 39.79 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.9 tp -138.44 126.97 23.3 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.808 1.643 . . . . 0.0 106.64 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 -86.84 0.49 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.72 5.6 1.79 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.83 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -141.19 164.28 30.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.93 1.865 . . . . 0.0 112.98 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.0 160.86 31.16 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.581 1.152 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.3 pt -137.62 171.9 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.614 1.166 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.1 144.32 47.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.612 1.565 . . . . 0.0 108.026 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -136.83 137.27 39.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.843 0.747 . . . . 0.0 111.217 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.12 169.98 21.08 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -64.53 141.42 58.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.392 178.662 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 m170 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.44 100.89 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.428 ' CE1' ' HG ' ' A' ' 144' ' ' SER . 22.5 m-70 -86.95 142.48 27.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.334 0.588 . . . . 0.0 112.235 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.66 143.18 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.81 2.444 . . . . 0.0 108.515 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -93.78 136.04 34.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.417 2.687 . . . . 0.0 108.014 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.6 140.71 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.495 -2.78 . . . . 0.0 103.495 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 175.98 29.65 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.84 16.96 10.49 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 124.618 1.167 . . . . 0.0 112.68 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.25 149.3 45.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 0.0 110.961 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -70.83 144.49 90.72 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.45 -3.74 6.97 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 114.929 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.5 -21.83 20.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.949 1.7 . . . . 0.0 111.662 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.47 HD11 ' HA3' ' A' ' 164' ' ' GLY . 46.0 mm -67.64 134.48 30.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 127.891 2.476 . . . . 0.0 111.123 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -106.15 173.07 6.47 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.182 0.991 . . . . 0.0 108.792 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.5 m -60.24 -30.37 69.37 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.562 -1.336 . . . . 0.0 109.714 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -68.99 -32.42 71.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 110.343 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.43 -41.21 85.16 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.46 -48.42 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -55.22 -41.54 72.19 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.068 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -52.25 60.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.819 0.847 . . . . 0.0 110.928 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.89 77.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -94.93 -2.72 49.98 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.74 99.54 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.639 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.73 -2.93 9.39 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-N 121.792 1.676 . . . . 0.0 112.727 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.75 -19.55 18.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.139 0.881 . . . . 0.0 111.452 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.06 170.12 30.55 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 122.096 0.831 . . . . 0.0 112.394 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -78.14 101.94 7.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.61 1.195 . . . . 0.0 109.15 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mt -76.74 148.36 6.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 t -111.41 -73.26 0.68 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.39 136.39 41.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.943 1.697 . . . . 0.0 108.778 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -163.65 138.83 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.25 151.22 22.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.353 0.979 . . . . 0.0 111.485 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 t -99.26 117.36 44.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.99 145.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -131.51 151.26 51.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -61.66 115.88 4.32 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -58.0 -17.34 16.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.843 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.6 -7.07 28.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.4 p -139.81 -28.54 0.75 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.72 1.145 . . . . 0.0 111.869 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 13.02 71.52 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.859 1.218 . . . . 0.0 110.617 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.15 153.63 22.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.797 1.298 . . . . 0.0 108.387 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.3 t -55.8 128.44 34.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.721 0.691 . . . . 0.0 111.406 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -78.8 -17.43 55.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.03 -23.8 34.25 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.167 0.889 . . . . 0.0 112.931 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.265 27.0 p90 -102.64 159.61 15.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.366 1.583 . . . . 0.0 110.43 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.42 178.17 33.04 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.609 1.099 . . . . 0.0 110.768 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -142.49 159.84 41.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.94 151.36 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.675 1.99 . . . . 0.0 106.939 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.428 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 2.6 t -132.88 119.67 20.49 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.643 1.977 . . . . 0.0 108.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -103.69 149.59 24.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.723 1.609 . . . . 0.0 111.202 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -71.16 -35.83 71.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.196 0.998 . . . . 0.0 110.279 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -122.99 153.31 39.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.717 1.207 . . . . 0.0 111.562 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -61.44 -50.2 73.76 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 110.753 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.0 -44.4 20.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.797 2.039 . . . . 0.0 112.577 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.87 -50.12 73.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.787 1.235 . . . . 0.0 109.844 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.39 94.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.075 0.95 . . . . 0.0 110.576 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -59.4 -54.7 43.67 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.69 1.196 . . . . 0.0 109.678 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -53.92 -45.36 71.16 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.02 62.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.224 1.409 . . . . 0.0 111.803 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.33 -39.53 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.818 1.645 . . . . 0.0 110.511 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.02 -62.17 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -65.55 -52.16 54.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 116.406 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -71.67 -21.79 61.75 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.032 1.287 . . . . 0.0 112.746 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.15 121.92 25.64 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.859 0.743 . . . . 0.0 111.857 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.86 71.41 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 118.627 -1.096 . . . . 0.0 113.963 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.87 175.04 9.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.105 1.452 . . . . 0.0 108.68 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 8.5 m95 -105.23 157.96 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.69 120.44 9.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.47 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 71.18 -39.23 0.56 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.448 1.023 . . . . 0.0 115.178 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.79 -5.19 0.03 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.954 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -137.4 162.26 34.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.421 2.111 . . . . 0.0 109.413 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 162' ' ' TRP . 52.5 mt-30 -70.83 159.37 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.101 0.56 . . . . 0.0 110.809 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 pt -130.54 165.81 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.782 1.233 . . . . 0.0 110.248 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -121.66 147.76 45.46 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 56.0 p -133.91 142.43 47.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 108.571 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -166.31 167.56 15.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.805 1.184 . . . . 0.0 109.138 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -68.46 126.85 30.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.025 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.788 0.327 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -112.11 146.63 37.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.6 147.92 49.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.536 0.684 . . . . 0.0 111.524 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.21 138.17 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.7 2.0 . . . . 0.0 109.38 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -96.1 134.13 39.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.604 2.362 . . . . 0.0 106.036 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.37 142.2 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.59 -179.98 23.13 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.897 0.771 . . . . 0.0 111.961 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 62.0 18.76 10.2 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.701 2.0 . . . . 0.0 111.749 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.3 mt -62.42 132.61 53.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.245 1.418 . . . . 0.0 110.717 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.42 151.33 77.49 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -60.19 -24.05 75.84 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.94 2.427 . . . . 0.0 114.955 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.13 -22.52 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.08 -1.012 . . . . 0.0 113.061 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.636 HD11 ' HA3' ' A' ' 164' ' ' GLY . 44.3 mm -58.89 122.7 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.022 0.915 . . . . 0.0 111.226 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.5 t -110.66 176.11 5.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.516 1.526 . . . . 0.0 107.173 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.8 m -65.19 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 120.428 -1.42 . . . . 0.0 112.8 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -70.42 -33.49 71.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -48.25 79.55 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 110.33 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 mt -60.54 -50.33 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 26.9 mtmt -55.36 -48.16 74.66 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.591 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.38 68.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.911 0.885 . . . . 0.0 110.398 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -44.28 96.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -89.94 -8.88 50.72 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.03 -46.88 99.83 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 117.1 -1.429 . . . . 0.0 114.122 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.11 -3.83 10.48 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.115 1.791 . . . . 0.0 112.775 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.4 -11.82 22.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.601 0.637 . . . . 0.0 111.967 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.98 164.99 14.19 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -72.32 124.75 25.76 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.58 147.73 5.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.27 -65.41 1.18 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -102.4 133.71 46.89 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.904 0.882 . . . . 0.0 110.893 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.523 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -157.56 136.34 11.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.586 0.755 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -163.34 158.42 21.29 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.97 1.708 . . . . 0.0 110.642 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.72 130.44 50.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 138.15 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -132.79 158.28 42.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.484 0.714 . . . . 0.0 109.858 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -61.53 114.83 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.23 -20.33 26.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.216 1.371 . . . . 0.0 112.81 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.8 -21.13 23.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.7 p -135.71 -15.46 1.82 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.94 1.245 . . . . 0.0 114.051 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.3 86.31 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.936 1.255 . . . . 0.0 114.02 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.2 152.17 30.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.364 1.582 . . . . 0.0 109.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -54.77 126.84 25.78 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.792 0.837 . . . . 0.0 112.059 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -72.59 -52.38 15.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 143.75 -21.54 2.17 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.712 3.053 . . . . 0.0 110.449 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.269 7.1 p90 -103.13 168.59 9.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.652 1.581 . . . . 0.0 113.997 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.82 175.06 33.02 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.509 1.528 . . . . 0.0 111.005 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -135.91 147.17 48.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.48 1.112 . . . . 0.0 109.553 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.64 144.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.9 t -136.13 140.27 43.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.233 1.413 . . . . 0.0 107.438 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.11 150.77 46.52 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.443 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -67.58 -14.24 62.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.221 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -133.82 156.12 48.61 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 120.161 1.346 . . . . 0.0 110.234 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -71.37 -53.05 15.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -51.03 -34.94 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.419 2.288 . . . . 0.0 112.018 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -60.27 -54.54 44.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.011 0.924 . . . . 0.0 108.608 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.33 76.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -56.28 -48.77 75.96 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.357 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.91 -45.03 87.14 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.166 0.439 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.16 85.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.076 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 88.9 mt -54.26 -35.94 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.387 1.903 . . . . 0.0 110.312 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -76.63 -62.35 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.054 0.542 . . . . 0.0 111.656 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -63.85 -45.25 90.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.02 2.128 . . . . 0.0 114.032 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.31 -24.97 57.52 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.82 98.36 0.29 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.29 -9.41 11.03 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.878 1.228 . . . . 0.0 112.264 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -76.15 178.64 6.24 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.749 1.275 . . . . 0.0 108.469 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -121.01 158.84 26.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.25 1.42 . . . . 0.0 107.986 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 tp -154.92 130.69 10.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.636 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 70.45 -25.52 0.47 Allowed Glycine 0 N--CA 1.464 0.566 0 C-N-CA 125.208 1.385 . . . . 0.0 115.707 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.56 -2.24 0.47 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 117.791 -1.56 . . . . 0.0 113.605 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -136.81 157.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.474 2.137 . . . . 0.0 110.99 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -66.97 153.56 43.3 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.75 152.55 32.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.801 0.84 . . . . 0.0 111.008 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -106.52 145.42 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.817 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.0 p -139.04 123.32 18.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.634 1.106 . . . . 0.0 110.202 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -149.22 172.2 15.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.756 0.707 . . . . 0.0 109.603 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -66.98 130.5 43.33 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.715 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.4 m170 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -125.45 107.07 10.29 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.005 1.322 . . . . 0.0 111.653 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -85.07 128.43 34.64 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 110.727 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.46 138.98 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.984 2.514 . . . . 0.0 106.908 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -93.53 142.18 27.63 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.659 1.983 . . . . 0.0 107.075 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.94 137.1 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.49 179.43 18.76 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.407 -0.808 . . . . 0.0 111.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.57 15.43 6.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.156 3.382 . . . . 0.0 115.007 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.69 149.26 22.32 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.732 1.613 . . . . 0.0 111.596 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.4 t -65.45 145.35 99.07 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.98 -8.3 7.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.089 2.526 . . . . 0.0 115.304 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -98.12 -16.41 19.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.806 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.663 HD11 ' HA3' ' A' ' 164' ' ' GLY . 23.5 mm -58.29 116.81 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 t -91.1 174.34 7.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.655 0.741 . . . . 0.0 109.273 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -64.15 -31.93 73.31 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.391 -1.443 . . . . 0.0 111.595 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.42 -24.96 57.17 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.554 -0.716 . . . . 0.0 111.237 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.1 -46.66 76.83 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.19 -51.41 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -53.65 -49.27 68.28 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 117.579 -1.2 . . . . 0.0 110.709 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.37 81.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.375 0.989 . . . . 0.0 111.77 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.49 92.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.67 -9.95 39.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -47.14 99.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.61 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.06 -5.83 11.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.267 1.845 . . . . 0.0 112.39 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.04 -11.24 23.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.707 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 160.21 165.8 17.79 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 120.071 1.305 . . . . 0.0 114.17 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -76.4 119.18 19.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.2 mt -94.9 149.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 t -114.38 -67.39 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.23 125.26 48.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.77 136.14 32.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -160.94 153.41 20.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 119.441 1.019 . . . . 0.0 111.873 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.6 t -106.98 115.06 47.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.7 139.1 17.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 125.182 1.393 . . . . 0.0 107.625 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -130.83 153.66 48.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.607 -0.683 . . . . 0.0 110.484 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.55 107.57 1.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.5 ptm -54.03 -13.97 0.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 -19.04 17.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.688 1.131 . . . . 0.0 112.816 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 p -130.24 -22.44 2.81 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.98 16.97 73.52 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.605 2.05 . . . . 0.0 112.716 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -84.77 155.22 21.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 1.435 . . . . 0.0 109.105 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.9 t -62.95 122.4 15.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.882 0.31 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -71.5 -25.4 62.25 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.34 38.48 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.003 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -103.79 165.95 10.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.256 2.028 . . . . 0.0 110.506 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.52 177.4 33.51 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.841 0.734 . . . . 0.0 111.819 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -135.5 148.24 49.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.09 1.356 . . . . 0.0 109.698 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.7 t -137.43 120.17 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.138 1.775 . . . . 0.0 107.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -105.27 114.23 28.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.259 1.823 . . . . 0.0 108.898 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.93 148.95 23.45 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.66 1.184 . . . . 0.0 109.12 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -67.88 -40.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.211 0.604 . . . . 0.0 110.243 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -110.91 145.54 38.14 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.03 0.932 . . . . 0.0 112.183 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.32 -46.94 86.45 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.012 0.925 . . . . 0.0 112.141 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -34.26 69.4 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.485 1.114 . . . . 0.0 112.966 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.05 -47.49 79.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.39 71.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.968 1.307 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.51 -47.91 78.32 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.504 0.721 . . . . 0.0 110.293 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -55.57 -49.3 73.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.63 72.56 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 81.4 mt -49.91 -44.42 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.633 1.561 . . . . 0.0 110.221 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -73.09 -58.24 3.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.193 0.997 . . . . 0.0 113.294 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -68.58 -51.06 46.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.403 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -67.69 -20.79 65.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.191 0.905 . . . . 0.0 112.749 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.98 90.29 0.58 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.86 -6.15 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.776 1.655 . . . . 0.0 111.752 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -86.84 172.85 9.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.946 0.873 . . . . 0.0 110.172 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -113.03 154.77 25.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.997 1.319 . . . . 0.0 109.199 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.0 tp -153.71 128.01 9.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.593 1.557 . . . . 0.0 107.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.663 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 63.92 22.96 67.13 Favored Glycine 0 N--CA 1.464 0.504 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.401 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 98.38 -2.75 59.35 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 115.956 -2.58 . . . . 0.0 115.836 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -140.4 160.91 38.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 121.525 2.663 . . . . 0.0 111.655 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.73 159.08 28.65 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.76 154.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.477 1.111 . . . . 0.0 109.112 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -115.99 129.76 56.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.5 p -116.7 153.61 32.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.248 1.419 . . . . 0.0 108.961 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -175.51 166.57 3.26 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.733 1.213 . . . . 0.0 108.928 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -70.12 126.13 28.79 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.221 0 CA-C-N 118.27 0.486 . . . . 0.0 110.75 179.402 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 . . . . . 0 C--O 1.237 0.4 0 CA-C-O 121.225 0.536 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -99.74 101.45 12.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.27 154.5 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.413 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 110.745 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.96 129.52 34.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.13 137.69 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.93 -176.98 21.15 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 61.84 18.89 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.627 1.971 . . . . 0.0 112.627 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 mt -69.86 151.24 45.92 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.473 -1.392 . . . . 0.0 110.909 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -67.63 146.41 98.53 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.44 -4.36 6.62 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.626 2.884 . . . . 0.0 113.682 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -96.81 -21.34 17.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.882 1.273 . . . . 0.0 111.156 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.3 132.38 23.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.309 1.044 . . . . 0.0 108.953 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -112.13 172.17 7.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.227 1.013 . . . . 0.0 108.809 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -56.3 -29.85 61.77 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.146 1.378 . . . . 0.0 110.776 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -73.03 -34.94 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.704 0.801 . . . . 0.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.47 -49.13 74.84 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mt -59.17 -49.57 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -54.92 -42.32 72.08 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.656 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.97 77.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.828 0.74 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.53 98.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -89.42 -14.52 35.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.349 0.66 . . . . 0.0 112.354 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.72 99.51 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.047 0.939 . . . . 0.0 113.405 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.72 -6.68 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 121.396 1.534 . . . . 0.0 112.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.89 -18.59 17.05 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.364 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 168.23 169.34 31.58 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 119.57 1.077 . . . . 0.0 112.04 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -74.41 124.01 25.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.7 mt -100.1 150.48 5.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.58 -61.55 1.6 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -101.41 140.5 35.61 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.7 5.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.421 1.088 . . . . 0.0 108.384 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -162.77 161.64 26.29 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.713 1.205 . . . . 0.0 110.74 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.47 134.66 53.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.46 144.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -133.9 162.88 30.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.556 1.143 . . . . 0.0 109.583 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -71.31 119.14 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.447 1.499 . . . . 0.0 107.589 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.4 ptp -59.18 -16.59 21.28 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.65 -13.92 20.09 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.2 p -137.6 -15.46 1.4 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.306 1.412 . . . . 0.0 113.975 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.64 14.34 81.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.57 1.081 . . . . 0.0 110.904 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.92 141.58 37.48 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.834 1.253 . . . . 0.0 108.567 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.29 123.36 14.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.094 0.957 . . . . 0.0 112.209 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.56 -42.68 64.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.22 -15.27 7.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.757 1.17 . . . . 0.0 112.621 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.027 1.413 . . . . 0.0 108.075 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.05 33.74 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.813 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -131.89 156.4 46.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.323 1.062 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.67 135.22 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.4 m -123.96 112.74 17.57 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.425 1.09 . . . . 0.0 108.16 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -97.53 155.6 16.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.24 0.962 . . . . 0.0 110.025 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.72 -41.51 62.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -103.1 147.44 26.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.004 0.522 . . . . 0.0 111.751 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.468 ' HE3' ' CH2' ' A' ' 172' ' ' TRP . 11.0 tptm -64.42 -46.69 82.14 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.989 0.916 . . . . 0.0 109.248 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -33.3 68.6 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.538 1.535 . . . . 0.0 113.606 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.61 -49.82 71.83 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.47 -51.74 67.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.183 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -51.67 -52.65 46.4 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.116 0.966 . . . . 0.0 111.615 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -55.07 -50.47 69.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.104 0.562 . . . . 0.0 110.283 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.98 86.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 117.281 -1.342 . . . . 0.0 110.399 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.75 -36.98 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 123.513 2.869 . . . . 0.0 110.968 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -76.27 -65.19 0.95 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -62.37 -49.49 75.32 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.638 1.975 . . . . 0.0 114.3 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 86.0 mmm -68.95 -28.8 66.96 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.79 78.26 0.2 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.69 1.138 . . . . 0.0 114.633 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.26 -15.24 2.09 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.567 2.032 . . . . 0.0 111.802 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -71.58 171.37 11.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.039 0.92 . . . . 0.0 109.792 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -109.45 143.45 39.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.31 121.37 24.6 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.55 -57.48 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.03 1.776 . . . . 0.0 111.488 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.48 2.06 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.809 -1.55 . . . . 0.0 115.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -143.84 157.86 44.08 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.66 2.73 . . . . 0.0 112.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -67.49 136.17 54.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.246 0.618 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.0 166.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.272 1.035 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.49 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.898 1.679 . . . . 0.0 107.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 39.2 p -137.18 134.84 36.76 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.27 170.78 21.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.468 ' CH2' ' HE3' ' A' ' 148' ' ' LYS . 22.2 m95 -62.18 128.2 34.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.002 0.819 . . . . 0.0 109.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.324 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.6 m170 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -105.56 143.25 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -109.84 153.5 24.33 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.077 0.551 . . . . 0.0 112.062 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.45 148.72 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.712 2.005 . . . . 0.0 110.39 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -100.22 139.78 35.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.349 2.66 . . . . 0.0 107.014 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.03 129.5 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.47 179.87 17.66 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 111.94 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 64.34 9.95 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.74 3.216 . . . . 0.0 113.784 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.4 146.3 16.17 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.953 1.301 . . . . 0.0 111.04 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.5 t -63.04 141.23 97.71 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.06 -15.55 18.03 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.937 2.425 . . . . 0.0 114.928 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.79 -17.95 39.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 113.054 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.64 HD11 ' HA3' ' A' ' 164' ' ' GLY . 27.9 mm -58.51 135.22 23.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.243 1.417 . . . . 0.0 110.724 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 111' ' ' GLU . 1.3 t -116.53 176.33 5.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.985 0.898 . . . . 0.0 111.488 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 -35.25 72.64 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.082 -1.011 . . . . 0.0 111.458 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' H ' HG23 ' A' ' 109' ' ' THR . 8.6 mt-10 -79.97 -18.12 51.18 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.317 0.647 . . . . 0.0 111.329 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.94 -50.09 21.64 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 mt -57.96 -50.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -54.87 -47.71 73.9 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.539 -1.22 . . . . 0.0 110.903 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.6 -33.87 70.49 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.691 1.132 . . . . 0.0 111.898 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.22 -46.37 64.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.923 0.889 . . . . 0.0 112.246 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -92.51 -1.66 56.79 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.41 95.37 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.876 1.67 . . . . 0.0 112.334 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.65 -0.57 5.41 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 121.091 1.425 . . . . 0.0 113.75 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -98.64 -10.75 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.955 0.798 . . . . 0.0 111.156 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.19 175.57 19.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 35.4 mtt180 -70.56 137.95 50.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.172 -0.605 . . . . 0.0 110.017 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.95 138.41 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.5 t -100.47 -72.93 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 144' ' ' SER . 6.9 t70 -102.43 142.52 33.51 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.08 1.752 . . . . 0.0 110.235 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.68 129.1 2.56 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.064 0.847 . . . . 0.0 109.409 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -162.26 150.85 14.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.618 0.367 . . . . 0.0 111.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.06 136.99 23.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.11 146.78 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -139.53 145.8 39.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -67.43 129.65 40.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -65.59 -18.78 65.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.466 0.706 . . . . 0.0 111.465 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.41 -12.43 22.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -134.3 -18.9 1.97 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.358 0.981 . . . . 0.0 113.287 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.49 72.78 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.94 153.62 18.23 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -59.91 130.15 45.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -20.57 57.45 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.466 -0.778 . . . . 0.0 111.947 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.16 -30.2 10.88 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.98 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -101.89 163.86 12.03 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.527 1.164 . . . . 0.0 108.315 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.7 171.64 27.43 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.849 1.69 . . . . 0.0 109.091 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -136.02 146.66 47.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -133.61 158.69 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.856 1.663 . . . . 0.0 106.726 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 125' ' ' ASP . 32.4 t -143.18 135.4 27.11 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.45 166.28 15.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.448 0.699 . . . . 0.0 111.12 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 122' ' ' ARG . 82.4 m-85 -79.66 -26.42 41.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 117.753 -1.117 . . . . 0.0 113.939 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.35 150.76 45.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.814 1.643 . . . . 0.0 110.714 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -62.25 -48.6 79.22 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.114 0.483 . . . . 0.0 110.153 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -29.66 67.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.973 1.309 . . . . 0.0 112.615 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.03 -54.65 38.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.83 -57.88 11.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.201 2.2 . . . . 0.0 111.838 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.23 -51.49 25.23 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.364 1.466 . . . . 0.0 111.387 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -55.06 -45.69 75.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.412 0.445 . . . . 0.0 111.257 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.96 78.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.559 -1.21 . . . . 0.0 110.85 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.5 mt -52.02 -44.42 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 120.634 1.561 . . . . 0.0 108.069 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -68.08 -61.45 1.85 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.186 1.394 . . . . 0.0 111.678 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.7 -60.04 4.06 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.92 2.088 . . . . 0.0 114.465 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.31 -20.35 66.03 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.29 1.036 . . . . 0.0 113.665 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.11 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.46 49.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.593 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -69.72 167.56 16.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.44 1.62 . . . . 0.0 108.218 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -108.81 141.95 40.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.7 tp -140.97 129.55 22.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.64 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 79.56 -53.87 4.3 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.668 1.127 . . . . 0.0 110.326 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.11 6.15 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.429 1.014 . . . . 0.0 113.809 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -136.31 159.02 43.02 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.867 1.834 . . . . 0.0 108.595 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -68.15 166.04 16.99 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.44 145.35 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 109.351 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 ptt-85 -108.41 136.53 47.88 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 p -122.6 153.37 39.39 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.023 1.329 . . . . 0.0 108.191 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -173.21 165.86 4.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.843 0.857 . . . . 0.0 109.124 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -66.64 120.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 CA-C-N 118.326 0.512 . . . . 0.0 111.177 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m170 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.42 100.34 8.24 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.35 131.4 36.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.05 141.72 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 128.102 2.561 . . . . 0.0 109.521 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -88.89 131.0 35.31 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 127.013 2.125 . . . . 0.0 105.671 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.33 139.33 51.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.39 -177.94 22.26 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.268 77.1 m-20 68.12 13.93 9.19 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.62 1.968 . . . . 0.0 113.251 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.7 mt -64.53 140.06 58.83 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 t -67.89 150.14 97.91 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -60.76 -4.05 3.23 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.809 3.006 . . . . 0.0 114.927 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.85 -17.12 17.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.016 1.326 . . . . 0.0 111.783 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.3 mm -61.85 136.9 24.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.03 1.332 . . . . 0.0 109.517 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -108.57 174.52 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.033 0.92 . . . . 0.0 108.715 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -64.67 -27.54 68.99 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.547 -1.345 . . . . 0.0 110.647 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.91 -32.66 67.61 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.86 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.32 -47.29 84.92 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mt -60.11 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 22.0 mtmt -53.53 -47.63 69.8 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 120.329 -1.482 . . . . 0.0 111.97 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.51 93.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.755 0.822 . . . . 0.0 111.633 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -58.55 -45.87 88.03 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.711 1.204 . . . . 0.0 113.602 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -89.56 -10.77 44.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 113.035 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.05 -47.56 98.56 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 124.817 1.247 . . . . 0.0 112.192 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.91 -7.16 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 121.791 1.675 . . . . 0.0 113.184 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.64 -13.28 20.41 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.428 1.013 . . . . 0.0 112.003 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 159.19 174.09 28.46 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 120.541 1.519 . . . . 0.0 112.724 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -71.7 127.55 32.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.9 mt -102.16 139.51 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.8 p -99.29 -79.02 0.49 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.66 126.05 49.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.764 2.826 . . . . 0.0 110.793 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.411 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -149.05 140.31 23.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.664 1.186 . . . . 0.0 107.943 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -162.7 151.54 14.86 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 t -94.32 127.26 46.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.18 141.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -125.63 161.03 28.15 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.885 1.326 . . . . 0.0 110.22 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.29 130.37 40.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.633 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -7.97 55.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 -21.81 12.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.626 1.103 . . . . 0.0 112.208 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -131.68 -8.24 3.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 31.31 78.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.209 -0.773 . . . . 0.0 112.143 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -100.98 157.19 16.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.192 1.397 . . . . 0.0 108.235 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -62.08 125.9 25.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.215 0.916 . . . . 0.0 111.314 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -74.65 -21.05 59.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.49 -15.7 55.73 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.36 1.457 . . . . 0.0 113.027 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.256 49.5 p90 -103.02 163.36 12.26 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.277 1.539 . . . . 0.0 109.282 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.5 169.3 32.8 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.337 -0.852 . . . . 0.0 111.384 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -129.77 149.82 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.913 0.885 . . . . 0.0 109.111 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.43 138.81 47.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 131.81 53.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.81 155.75 31.97 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.172 0.989 . . . . 0.0 109.744 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -76.39 -20.02 57.56 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.094 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -129.45 151.14 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.865 1.211 . . . . 0.0 112.781 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.543 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 7.6 ttmt -68.95 -50.74 46.62 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 110.196 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -47.71 69.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.097 1.359 . . . . 0.0 113.271 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -60.61 -46.93 88.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.41 83.29 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.961 1.305 . . . . 0.0 109.981 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -57.09 -45.67 83.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.82 1.248 . . . . 0.0 110.448 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -53.62 -48.05 69.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.55 87.82 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.936 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.7 mt -55.21 -37.93 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 121.804 2.093 . . . . 0.0 110.274 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -72.71 -65.77 0.75 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.616 0.766 . . . . 0.0 111.427 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -67.07 -44.41 80.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.872 2.069 . . . . 0.0 116.547 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -77.79 -20.79 52.66 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.831 1.196 . . . . 0.0 112.872 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.21 112.35 4.64 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.31 -9.54 65.04 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -70.91 169.71 14.2 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 119.753 1.776 . . . . 0.0 109.842 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -104.65 132.11 51.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 108.941 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 116' ' ' ALA . 21.9 tp -123.83 118.95 28.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 108.143 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.82 -6.51 1.4 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.273 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.0 3.61 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.232 1.516 . . . . 0.0 115.331 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.796 2.298 . . . . 0.0 110.342 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.37 163.03 11.33 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.448 0.468 . . . . 0.0 109.976 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.23 153.76 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.753 1.221 . . . . 0.0 109.756 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -113.74 142.86 45.52 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.4 p -136.89 135.99 38.31 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.552 0.741 . . . . 0.0 109.524 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.46 174.08 15.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.218 0.607 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.543 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 83.9 m95 -70.57 118.24 13.11 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.538 -1.352 . . . . 0.0 108.153 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 118.78 0.718 . . . . 0.0 109.077 179.3 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--O 1.236 0.359 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.13 100.65 6.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 144' ' ' SER . 1.3 m80 -71.38 167.29 19.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.369 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.32 142.94 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 127.875 2.47 . . . . 0.0 106.561 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -103.65 137.06 42.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -132.72 140.25 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 -179.26 21.15 Favored Glycine 0 N--CA 1.454 -0.153 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.26 4.69 2.22 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.466 2.306 . . . . 0.0 113.258 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -51.2 139.09 19.26 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 110.527 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 t -62.59 145.26 95.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.49 -18.1 37.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.489 2.793 . . . . 0.0 115.136 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.62 -13.21 43.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.084 -1.01 . . . . 0.0 112.652 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.66 138.71 22.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.5 t -118.45 175.13 5.86 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.502 1.144 . . . . 0.0 109.117 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.3 m -58.92 -30.15 67.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.226 1.01 . . . . 0.0 111.748 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.75 -43.37 68.96 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 125.92 1.688 . . . . 0.0 110.878 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.74 -51.92 65.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.214 1.405 . . . . 0.0 109.28 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.67 -48.14 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.59 -45.24 69.95 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.814 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.27 -45.94 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.084 0.856 . . . . 0.0 110.796 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.67 -47.54 85.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 113.197 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -87.35 -10.89 50.95 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.39 -48.52 95.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.66 -3.3 6.47 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 CA-C-N 121.47 1.561 . . . . 0.0 112.959 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.88 -17.71 18.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.069 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.57 162.17 16.21 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.584 1.084 . . . . 0.0 111.503 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -73.65 120.53 19.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.62 153.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.5 t -117.31 -68.44 0.92 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -102.03 145.04 29.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.469 1.107 . . . . 0.0 108.891 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.04 129.85 2.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.2 158.16 32.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.473 0.654 . . . . 0.0 110.777 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.22 120.1 56.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.43 141.8 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 137' ' ' SER . 46.0 mttm -135.41 157.3 47.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.5 ptp -59.88 -20.47 57.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.59 -9.22 16.65 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -131.83 -19.55 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.048 1.295 . . . . 0.0 113.083 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.81 2.41 56.96 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.291 0.948 . . . . 0.0 112.865 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -80.05 148.55 31.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' A' ' 130' ' ' LYS . 17.8 m -63.78 134.79 55.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.507 1.146 . . . . 0.0 112.33 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -77.71 -13.7 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.534 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.9 55.23 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.016 -1.435 . . . . 0.0 113.464 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -102.52 165.1 11.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.019 1.41 . . . . 0.0 109.112 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.32 179.79 28.55 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.471 1.034 . . . . 0.0 111.966 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.28 154.04 51.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 109.089 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -145.83 149.3 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 37.9 t -142.48 115.49 8.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.005 1.722 . . . . 0.0 107.393 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.91 158.17 15.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.805 1.242 . . . . 0.0 111.391 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.1 -14.83 61.95 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.66 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -143.56 156.84 44.71 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.857 1.208 . . . . 0.0 110.195 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.8 tttt -68.49 -43.03 77.77 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.923 1.289 . . . . 0.0 111.93 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.51 -41.75 66.66 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 111.658 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -62.15 -48.98 77.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.901 1.28 . . . . 0.0 108.893 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.56 66.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.367 1.067 . . . . 0.0 110.311 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.37 -50.0 63.29 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.844 1.658 . . . . 0.0 109.753 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -55.41 -55.4 32.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.552 1.141 . . . . 0.0 109.16 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.48 91.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.748 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.52 -49.26 44.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 121.136 1.789 . . . . 0.0 108.411 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.31 -67.22 0.46 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.132 0.573 . . . . 0.0 111.991 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -58.93 -50.43 74.07 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 83.8 mmm -69.29 -17.75 63.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.346 0.975 . . . . 0.0 111.95 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.26 79.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.445 2.45 . . . . 0.0 113.37 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 126.78 -8.74 7.25 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.062 1.791 . . . . 0.0 112.627 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -70.99 170.32 13.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.033 1.417 . . . . 0.0 109.67 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -111.14 150.79 28.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.385 1.074 . . . . 0.0 109.991 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 47.0 tp -155.51 130.1 9.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.805 2.042 . . . . 0.0 106.505 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.1 27.3 71.22 Favored Glycine 0 N--CA 1.465 0.59 0 O-C-N 121.49 -0.756 . . . . 0.0 114.032 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.78 4.4 87.34 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.439 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -137.57 155.35 49.31 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.81 2.305 . . . . 0.0 110.899 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -71.55 160.44 32.7 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.57 169.96 15.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -123.63 152.24 42.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.9 p -141.83 150.21 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 107.575 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -175.52 171.12 2.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -67.17 111.36 3.88 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.582 -0.699 . . . . 0.0 109.817 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 C-N-CA 124.549 1.14 . . . . 0.0 110.843 179.427 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 m80 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.6 99.23 7.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.0 127.4 32.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 113.338 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.55 148.21 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 126.788 2.035 . . . . 0.0 108.091 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -105.01 136.62 44.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 129.471 3.109 . . . . 0.0 106.95 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -129.27 142.83 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -149.84 -178.83 25.14 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.04 1.97 2.98 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.854 2.461 . . . . 0.0 114.382 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -50.19 149.26 2.97 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.829 2.452 . . . . 0.0 113.681 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 161.76 68.1 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.83 -29.44 15.46 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.145 1.23 . . . . 0.0 113.111 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.41 -16.94 61.84 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.851 1.66 . . . . 0.0 114.117 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -59.74 117.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.668 1.187 . . . . 0.0 110.116 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -100.3 171.03 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 127' ' ' ARG . 85.3 m -55.1 -30.95 60.78 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 121.019 -1.05 . . . . 0.0 111.53 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.71 -33.75 64.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.122 0.969 . . . . 0.0 111.761 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -47.98 83.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.6 mt -61.22 -55.55 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.426 ' HE3' HG22 ' A' ' 110' ' ' THR . 22.5 mtmt -51.68 -47.93 63.65 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.501 1.046 . . . . 0.0 112.301 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.12 72.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.596 0.758 . . . . 0.0 112.14 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.409 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -73.08 -43.85 61.28 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.364 1.066 . . . . 0.0 112.014 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.26 -9.58 47.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.824 1.249 . . . . 0.0 112.851 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.3 99.54 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 126.6 1.96 . . . . 0.0 113.318 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.9 -0.84 9.04 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.501 1.572 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.66 -25.18 14.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.087 0.858 . . . . 0.0 110.967 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.44 34.7 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 121.137 -0.977 . . . . 0.0 111.201 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -77.78 117.45 19.18 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -88.4 145.3 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 p -100.54 -81.42 0.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -103.04 141.46 35.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.299 1.84 . . . . 0.0 111.196 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.13 141.85 5.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.106 2.163 . . . . 0.0 108.065 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.485 ' HA ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -161.9 169.6 20.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.784 1.234 . . . . 0.0 109.136 178.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.98 124.98 67.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.443 HG21 ' CD2' ' A' ' 140' ' ' TYR . 47.9 t -64.88 140.78 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.37 148.21 50.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 59.6 t0 -59.02 131.14 50.16 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.7 tpt -59.78 -30.41 68.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.366 0.53 . . . . 0.0 112.25 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.12 -41.05 9.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.3 p -95.85 -15.87 22.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.15 0.886 . . . . 0.0 112.943 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.92 12.52 57.46 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.283 0.944 . . . . 0.0 112.584 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.92 150.01 27.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.888 1.275 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 t -56.15 109.66 0.63 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.323 2.249 . . . . 0.0 109.142 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 131' ' ' ASP . 20.7 mttt -67.81 -23.4 65.18 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.47 -18.84 46.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.443 ' CD2' HG21 ' A' ' 129' ' ' VAL 0.288 27.5 p90 -103.21 157.9 16.69 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.635 -1.509 . . . . 0.0 109.71 176.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.22 176.6 25.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.564 1.554 . . . . 0.0 111.077 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.77 152.0 44.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.02 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.0 t -147.25 130.65 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 108.027 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -118.77 127.81 53.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.744 2.018 . . . . 0.0 107.011 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.55 165.69 12.25 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.701 1.137 . . . . 0.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -74.43 -9.57 58.72 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.575 -0.703 . . . . 0.0 112.512 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -146.59 165.86 28.25 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.595 1.088 . . . . 0.0 112.09 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -73.85 -47.28 39.49 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.802 1.241 . . . . 0.0 111.543 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -39.06 76.9 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.702 0.801 . . . . 0.0 111.935 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.66 -48.42 77.64 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -54.89 15.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.322 1.849 . . . . 0.0 111.45 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -55.87 -44.15 77.83 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.176 0.99 . . . . 0.0 111.918 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.74 -45.26 86.07 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.74 79.62 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.684 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.69 -37.62 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 120.354 1.434 . . . . 0.0 110.399 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -73.07 -67.6 0.56 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.417 1.087 . . . . 0.0 110.632 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -58.69 -57.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.467 2.307 . . . . 0.0 114.295 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -65.34 -24.51 67.28 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.48 90.47 0.12 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.222 0.915 . . . . 0.0 111.971 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.49 -6.88 9.79 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.193 1.378 . . . . 0.0 113.308 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -74.97 174.3 9.51 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.093 1.446 . . . . 0.0 109.481 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -109.74 129.35 55.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' A' ' 116' ' ' ALA . 39.3 tp -125.25 124.22 41.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.901 1.68 . . . . 0.0 108.934 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.1 -59.21 1.84 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 125.005 1.288 . . . . 0.0 111.554 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.75 -3.04 0.03 OUTLIER Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.947 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -141.49 165.98 26.02 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.384 2.092 . . . . 0.0 111.5 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -67.57 161.67 25.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.351 0.66 . . . . 0.0 110.645 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.7 pt -138.71 157.64 29.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.533 1.133 . . . . 0.0 109.977 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -122.32 148.02 45.54 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.1 p -138.91 134.66 33.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.649 1.113 . . . . 0.0 110.409 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -157.02 176.92 12.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.571 1.148 . . . . 0.0 108.895 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -74.44 133.75 42.39 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.593 -1.317 . . . . 0.0 110.47 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.174 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m170 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.41 109.91 13.89 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -91.03 150.32 21.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.658 0.742 . . . . 0.0 111.733 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.2 t -129.39 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.126 1.77 . . . . 0.0 108.907 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -101.3 143.29 31.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.996 3.318 . . . . 0.0 106.753 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.78 146.39 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.89 173.91 26.04 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 119.031 0.832 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.5 t0 61.38 17.81 8.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.986 2.914 . . . . 0.0 114.211 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.451 HD13 HD11 ' A' ' 113' ' ' ILE . 12.9 mt -59.31 135.68 57.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.343 1.457 . . . . 0.0 110.143 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 t -60.12 148.48 77.98 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.21 52.23 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.665 1.576 . . . . 0.0 113.364 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -76.48 -29.85 57.05 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.862 0.756 . . . . 0.0 110.591 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.31 115.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.517 1.527 . . . . 0.0 108.986 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 t -100.05 174.39 6.19 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.138 1.375 . . . . 0.0 109.714 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.4 m -57.76 -36.84 72.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.317 -0.864 . . . . 0.0 111.463 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.59 -44.36 78.31 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.08 1.352 . . . . 0.0 109.981 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.63 80.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.276 1.03 . . . . 0.0 109.666 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 104' ' ' LEU . 10.9 mt -60.14 -50.55 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -52.78 -48.05 67.12 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.259 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.14 -34.68 70.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.658 1.117 . . . . 0.0 111.675 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.74 -45.82 60.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.285 1.034 . . . . 0.0 111.503 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -87.69 -4.49 58.91 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.54 94.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.655 2.382 . . . . 0.0 114.664 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.21 -1.34 7.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 122.181 1.815 . . . . 0.0 112.516 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.4 -9.5 25.15 Favored 'General case' 0 N--CA 1.461 0.116 0 O-C-N 121.175 -0.953 . . . . 0.0 111.503 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.46 -155.83 26.54 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 111.832 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -100.27 131.24 46.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.384 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.18 133.63 43.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.726 1.61 . . . . 0.0 108.772 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.7 p -99.8 -73.03 0.65 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -103.47 148.99 25.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.288 1.835 . . . . 0.0 109.053 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.62 4.21 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.899 1.28 . . . . 0.0 108.967 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.8 ptm85 -161.01 147.67 15.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.44 0.564 . . . . 0.0 112.173 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.02 120.18 40.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.37 137.58 24.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -136.25 160.93 37.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.92 135.78 54.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -68.87 -14.37 62.99 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.773 -0.58 . . . . 0.0 110.015 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.5 17.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.079 1.752 . . . . 0.0 115.157 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 p -136.72 -23.32 1.21 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 112.254 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.8 4.54 62.26 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.345 -1.253 . . . . 0.0 110.839 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -81.82 150.9 27.63 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.93 1.865 . . . . 0.0 108.467 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 t -56.35 120.4 7.58 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -70.55 -35.3 73.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 127.89 -29.63 4.13 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.987 1.755 . . . . 0.0 110.404 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -102.15 166.51 10.56 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.601 1.16 . . . . 0.0 111.749 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.85 170.84 31.29 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.419 1.485 . . . . 0.0 110.173 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -129.38 150.15 50.86 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.091 1.356 . . . . 0.0 108.523 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.78 159.8 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 127.515 2.326 . . . . 0.0 105.028 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.9 t -142.63 130.75 21.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.806 2.042 . . . . 0.0 107.721 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.52 134.84 54.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.111 1.364 . . . . 0.0 109.368 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -64.31 -39.41 93.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.425 0.69 . . . . 0.0 109.639 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -111.11 145.64 38.22 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.04 1.336 . . . . 0.0 107.905 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.39 -45.11 81.13 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -38.66 55.75 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 112.882 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.83 -49.93 75.49 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.4 77.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.25 -51.31 67.03 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.115 0.566 . . . . 0.0 110.82 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.85 -48.82 74.84 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.34 70.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.995 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.24 -42.07 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 121.006 1.73 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -77.52 -36.94 51.95 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -87.93 -53.46 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.137 1.375 . . . . 0.0 112.044 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 72.7 mmm -68.28 -21.62 64.78 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.881 0.764 . . . . 0.0 112.329 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 109.03 1.96 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 124.478 1.037 . . . . 0.0 111.266 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.25 -6.35 66.01 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.155 -0.803 . . . . 0.0 113.611 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -73.05 179.15 3.92 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.34 1.07 . . . . 0.0 109.176 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.52 152.67 27.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.885 0.874 . . . . 0.0 109.041 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.1 tp -158.87 131.21 6.77 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.229 2.212 . . . . 0.0 105.66 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.9 30.23 77.1 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 119.085 0.857 . . . . 0.0 111.074 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.68 14.14 72.29 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.228 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -135.19 150.61 50.16 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.876 1.838 . . . . 0.0 109.339 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 21.1 pt -130.09 172.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.27 1.028 . . . . 0.0 108.989 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -131.62 154.4 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.982 1.713 . . . . 0.0 107.304 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.4 p -142.92 147.28 35.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.709 0.804 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -167.19 167.37 14.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -69.44 136.06 51.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.526 1.057 . . . . 0.0 108.322 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.9 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 m170 . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.33 114.45 20.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.23 1.412 . . . . 0.0 107.246 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 132.7 34.74 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.337 1.055 . . . . 0.0 111.506 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.87 144.97 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.501 2.32 . . . . 0.0 109.013 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.84 139.03 38.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 127.455 2.302 . . . . 0.0 106.552 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.423 HG12 HD21 ' A' ' 104' ' ' LEU . 2.5 t -134.94 143.9 36.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.71 173.54 26.89 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.582 1.083 . . . . 0.0 113.91 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 57.45 23.26 8.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 129.085 2.954 . . . . 0.0 115.289 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.423 HD21 HG12 ' A' ' 101' ' ' VAL . 27.5 mt -60.95 145.82 49.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.513 1.525 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t -59.38 143.75 85.01 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.69 -15.5 31.89 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.595 2.197 . . . . 0.0 116.294 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.05 -28.9 29.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.932 1.693 . . . . 0.0 111.551 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -56.42 113.73 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.656 1.582 . . . . 0.0 110.57 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -97.52 179.43 4.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.135 0.969 . . . . 0.0 109.241 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 127' ' ' ARG . 23.8 m -55.97 -33.08 64.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.632 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -69.3 -46.8 66.29 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 110.057 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.84 -44.49 73.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 110.186 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.67 -54.65 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -50.65 -51.05 52.72 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.871 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.92 69.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.089 1.356 . . . . 0.0 111.257 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.59 96.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -90.8 -7.78 51.43 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.29 94.61 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.806 1.642 . . . . 0.0 113.282 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.79 -0.96 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 121.251 1.482 . . . . 0.0 113.099 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.97 -34.56 10.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.403 1.001 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.13 177.9 47.2 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 122.991 1.328 . . . . 0.0 111.473 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 87.2 mtt180 -74.35 123.11 24.0 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.756 -1.222 . . . . 0.0 107.938 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 126' ' ' ALA . 60.5 mt -101.17 154.71 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.2 t -125.73 -65.33 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -102.02 134.6 44.97 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 123' ' ' ILE . . . -164.94 128.94 2.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' HA ' HG23 ' A' ' 110' ' ' THR . 14.4 ptt180 -162.99 170.91 17.32 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.109 0.564 . . . . 0.0 111.724 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.93 130.26 51.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.536 1.534 . . . . 0.0 107.936 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 135.5 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -134.81 160.28 38.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.29 158.42 35.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.302 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.6 ptm -91.02 -16.22 28.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.792 1.237 . . . . 0.0 113.491 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.4 -26.64 11.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.872 1.214 . . . . 0.0 112.706 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.5 p -114.84 -19.75 10.87 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.87 50.36 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 121.655 0.586 . . . . 0.0 112.746 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.62 145.59 34.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -66.1 139.0 58.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.631 0.729 . . . . 0.0 112.274 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -81.75 -8.68 59.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.242 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.9 -12.91 65.96 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 124.43 1.014 . . . . 0.0 112.723 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.292 3.2 p90 -102.96 169.35 8.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.777 1.788 . . . . 0.0 109.876 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 178.44 30.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.356 0.503 . . . . 0.0 112.33 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.9 148.15 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.256 1.422 . . . . 0.0 108.117 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.99 124.83 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.035 1.734 . . . . 0.0 106.939 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.9 m -109.62 125.92 53.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.815 1.189 . . . . 0.0 108.69 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -109.98 148.52 31.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 122' ' ' ARG . 62.9 m-85 -69.63 -17.92 63.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.334 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -132.03 148.52 52.51 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.703 1.138 . . . . 0.0 109.124 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -63.62 -55.72 21.42 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.247 0.619 . . . . 0.0 109.497 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -39.53 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.687 1.595 . . . . 0.0 113.107 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.19 -48.25 80.87 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.66 74.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.772 0.829 . . . . 0.0 110.117 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 155' ' ' ILE . 5.2 mm-40 -53.48 -47.3 69.93 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.172 1.389 . . . . 0.0 110.909 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -57.23 -43.62 83.05 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.31 84.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.851 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 152' ' ' GLU . 89.0 mt -53.05 -52.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.997 1.726 . . . . 0.0 107.633 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -60.25 -66.46 0.52 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.38 1.472 . . . . 0.0 113.011 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.89 -49.74 69.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.736 2.014 . . . . 0.0 115.183 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -73.15 -19.61 61.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.696 1.135 . . . . 0.0 112.638 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.45 96.88 0.36 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.64 -11.05 11.24 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.607 1.099 . . . . 0.0 111.428 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -73.91 170.13 16.0 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.594 1.197 . . . . 0.0 107.836 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -113.38 136.51 52.69 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.449 1.1 . . . . 0.0 108.268 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.21 121.58 18.18 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.13 21.82 79.47 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.025 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.98 6.14 79.74 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.975 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -133.77 147.04 51.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.301 2.05 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.83 138.6 52.75 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -108.15 163.94 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.982 0.896 . . . . 0.0 109.849 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -124.49 149.48 46.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.901 1.281 . . . . 0.0 107.66 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.9 p -139.29 140.36 37.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.298 1.039 . . . . 0.0 109.628 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -163.3 173.03 13.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.157 1.383 . . . . 0.0 108.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -71.45 124.44 24.63 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.343 1.057 . . . . 0.0 110.957 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.636 178.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m170 . . . . . 0 C--O 1.232 0.171 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.72 115.48 30.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.1 151.7 18.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.151 0.907 . . . . 0.0 110.91 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.95 136.97 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 126.899 2.079 . . . . 0.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -85.59 132.67 34.13 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.448 2.299 . . . . 0.0 105.646 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.73 135.02 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.4 -175.97 14.27 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.613 -0.679 . . . . 0.0 111.444 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 61.74 21.13 11.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.972 2.509 . . . . 0.0 114.25 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.32 153.5 43.63 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.884 -1.135 . . . . 0.0 111.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 t -71.39 157.32 90.26 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.63 -6.51 18.82 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.424 2.083 . . . . 0.0 114.173 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.29 -15.32 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 112.811 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -58.25 137.37 20.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 109.84 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -112.21 168.86 9.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.669 1.187 . . . . 0.0 108.284 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 m -60.37 -30.2 69.41 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.907 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.86 -34.23 62.24 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.77 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -48.07 80.66 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.7 mt -58.76 -52.4 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 24.0 mtmt -52.77 -47.62 67.38 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 117.679 -1.153 . . . . 0.0 112.093 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.24 67.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.254 0.934 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -64.58 -50.12 68.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.122 1.369 . . . . 0.0 113.413 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 -11.34 47.11 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.44 90.58 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.423 1.489 . . . . 0.0 112.395 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.1 -10.76 21.94 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.752 1.661 . . . . 0.0 112.583 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -98.13 -10.51 24.08 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.501 1.046 . . . . 0.0 111.532 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.51 165.89 21.43 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 120.026 1.285 . . . . 0.0 111.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 68.3 mtt-85 -77.17 130.12 36.88 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.2 mt -101.99 132.42 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.2 1.0 . . . . 0.0 109.229 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.18 -66.21 0.92 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.05 133.56 46.69 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.314 0.645 . . . . 0.0 110.132 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -155.61 137.43 14.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -160.36 157.98 28.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.663 0.665 . . . . 0.0 111.626 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.21 119.56 50.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.9 t -66.09 133.09 31.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -129.88 151.64 50.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.06 128.55 36.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.8 ptp -66.89 -10.35 47.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.844 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.57 -17.03 26.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.296 1.039 . . . . 0.0 113.738 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.3 p -141.93 -34.08 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.09 14.48 51.54 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.558 -1.135 . . . . 0.0 111.053 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.94 149.56 24.71 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.539 1.67 . . . . 0.0 107.896 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.5 m -53.34 117.31 2.96 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.598 1.159 . . . . 0.0 112.345 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -64.24 -25.03 67.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.334 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.67 -30.81 4.78 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.442 1.972 . . . . 0.0 111.915 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -102.9 172.72 6.66 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.001 1.32 . . . . 0.0 113.501 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.99 175.95 34.36 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.938 2.208 . . . . 0.0 108.908 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.04 151.45 45.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.03 143.59 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.7 m -130.64 128.86 41.83 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.648 1.579 . . . . 0.0 107.708 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -110.75 163.3 13.91 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.544 1.138 . . . . 0.0 110.085 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.53 -28.8 52.08 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.589 0.756 . . . . 0.0 111.748 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -124.89 160.36 29.01 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.083 0.953 . . . . 0.0 111.957 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.566 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 20.1 tptm -65.32 -51.82 58.09 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.632 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -50.99 -45.79 61.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 125.579 1.552 . . . . 0.0 113.134 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -56.96 -43.88 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.963 0.79 . . . . 0.0 110.227 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -50.96 43.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.042 0.937 . . . . 0.0 110.307 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -54.08 -50.79 66.0 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.623 1.169 . . . . 0.0 110.668 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -51.51 -52.67 44.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.709 2.004 . . . . 0.0 108.847 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -47.46 79.54 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.333 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.01 -27.07 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 121.481 1.946 . . . . 0.0 111.342 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -84.77 -70.99 0.54 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.923 0.889 . . . . 0.0 109.932 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -56.62 -50.26 72.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.333 2.253 . . . . 0.0 113.588 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 66.4 mmm -78.01 -20.95 51.54 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.286 1.035 . . . . 0.0 113.659 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.11 75.74 0.25 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.731 1.157 . . . . 0.0 114.563 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.6 -5.15 2.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.049 1.785 . . . . 0.0 112.556 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -76.82 -177.02 4.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.226 1.41 . . . . 0.0 110.819 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -112.85 157.47 21.36 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.347 1.459 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 116' ' ' ALA . 65.5 tp -151.35 126.28 9.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.366 1.466 . . . . 0.0 108.774 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.89 -67.8 0.13 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 126.555 2.026 . . . . 0.0 112.776 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.26 1.99 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.841 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -148.58 167.99 23.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.123 2.461 . . . . 0.0 111.947 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -72.95 147.77 44.92 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -115.6 169.29 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 110.776 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -127.59 146.84 50.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.804 2.041 . . . . 0.0 107.888 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.9 p -142.56 151.04 41.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.23 0.923 . . . . 0.0 109.913 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -173.75 172.73 3.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.148 2.179 . . . . 0.0 108.767 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.566 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 40.1 m95 -67.63 148.53 51.26 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.242 -1.536 . . . . 0.0 111.155 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 178.052 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.0 m170 . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.889 0.376 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.61 100.5 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -81.83 153.88 26.18 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.1 133.68 55.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 127.379 2.272 . . . . 0.0 109.735 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -84.83 142.81 29.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.99 135.61 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.61 27.64 Favored Glycine 0 C--O 1.228 -0.254 0 O-C-N 121.206 -0.934 . . . . 0.0 111.47 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.79 7.47 5.9 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.746 2.418 . . . . 0.0 113.749 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt -52.45 149.22 5.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.384 2.274 . . . . 0.0 112.4 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.53 150.71 93.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.63 -14.14 42.91 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.115 1.876 . . . . 0.0 114.632 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.3 -10.66 29.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.613 1.565 . . . . 0.0 112.433 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -61.5 143.26 15.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 119.587 1.085 . . . . 0.0 110.102 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.6 t -122.17 173.72 7.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 127' ' ' ARG . 52.9 m -62.29 -31.66 72.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.937 0.895 . . . . 0.0 110.715 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -74.03 -34.1 63.98 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.95 -42.91 99.18 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.77 -54.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -50.36 -45.96 55.55 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.321 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.61 75.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.668 0.605 . . . . 0.0 111.544 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.9 85.8 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.01 -8.36 55.72 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.169 0.587 . . . . 0.0 111.13 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.15 97.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 116.956 -1.497 . . . . 0.0 113.523 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.08 -3.42 8.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 122.31 1.861 . . . . 0.0 112.467 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -99.46 -16.15 18.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.42 1.088 . . . . 0.0 109.803 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.48 171.66 20.89 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 122.495 1.053 . . . . 0.0 113.079 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -77.87 123.04 26.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.3 mt -94.48 163.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.97 -69.32 0.82 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.7 136.77 41.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.872 1.269 . . . . 0.0 110.255 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.06 139.27 4.94 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.637 1.108 . . . . 0.0 109.184 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HA ' HG23 ' A' ' 110' ' ' THR . 2.4 ptm180 -162.63 169.34 20.3 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.17 119.78 59.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.887 2.075 . . . . 0.0 105.698 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.3 t -67.24 141.55 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -132.8 155.42 48.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 110.188 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -57.03 117.96 4.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.07 -18.41 64.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 -13.53 18.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 -18.34 2.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.863 1.21 . . . . 0.0 113.997 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.24 87.8 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.213 0.911 . . . . 0.0 113.775 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.84 155.82 25.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.644 1.722 . . . . 0.0 109.408 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.0 t -60.19 126.47 27.64 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.866 0.866 . . . . 0.0 111.091 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -73.27 -48.43 34.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.59 -25.79 3.09 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -103.22 159.02 15.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.464 1.105 . . . . 0.0 111.495 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.9 176.39 29.46 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.932 1.729 . . . . 0.0 109.504 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.29 156.85 45.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.78 0.832 . . . . 0.0 109.348 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.3 t -138.57 154.9 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.2 t -144.07 125.68 15.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.34 156.65 24.03 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.677 1.191 . . . . 0.0 111.237 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.96 -23.07 61.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.975 1.31 . . . . 0.0 113.681 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -137.22 153.99 50.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.479 1.036 . . . . 0.0 109.972 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.49 -48.82 79.36 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -34.68 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.914 1.285 . . . . 0.0 112.874 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.24 -47.63 73.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.1 54.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.645 1.178 . . . . 0.0 111.538 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 155' ' ' ILE . 44.4 mt-10 -53.32 -45.55 69.06 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.395 1.078 . . . . 0.0 111.85 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -53.86 -47.56 70.89 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.775 0.83 . . . . 0.0 108.876 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.73 -47.37 72.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.424 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 152' ' ' GLU . 63.8 mt -51.74 -44.5 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.682 1.583 . . . . 0.0 110.154 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -69.89 -67.96 0.45 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.23 1.412 . . . . 0.0 112.925 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -66.68 -43.19 85.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.565 1.546 . . . . 0.0 115.053 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 74.0 mmm -75.97 -21.55 56.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.598 1.545 . . . . 0.0 112.332 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.31 4.87 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.95 -5.7 69.04 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.527 1.061 . . . . 0.0 112.898 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -73.61 171.21 13.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.467 1.634 . . . . 0.0 109.468 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.405 ' CD1' ' HG2' ' A' ' 167' ' ' GLN . 20.5 m95 -101.94 143.82 31.34 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.06 122.81 12.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.194 0.998 . . . . 0.0 109.434 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.59 3.66 2.39 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 118.073 -1.404 . . . . 0.0 115.896 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 133.65 -13.23 4.81 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-O 116.767 -2.129 . . . . 0.0 115.183 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -137.22 162.54 33.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 121.037 2.419 . . . . 0.0 110.019 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.405 ' HG2' ' CD1' ' A' ' 162' ' ' TRP . 44.1 mt-30 -72.85 162.86 28.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.979 0.354 . . . . 0.0 110.318 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.1 pt -136.94 163.44 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.517 1.127 . . . . 0.0 110.974 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -126.5 151.35 47.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.31 1.444 . . . . 0.0 108.464 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.8 p -141.83 156.74 45.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.671 1.188 . . . . 0.0 109.534 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 172' ' ' TRP . 3.5 t-20 -173.95 173.84 3.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 109.259 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.415 ' H ' ' ND2' ' A' ' 171' ' ' ASN . 50.4 m95 -67.51 116.19 7.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 123.691 0.796 . . . . 0.0 112.821 -179.781 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m170 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.381 0.61 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 101.19 8.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.53 146.99 24.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.025 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -123.93 142.83 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.253 1.821 . . . . 0.0 108.47 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -97.02 135.32 39.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 106.351 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.39 139.3 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 -178.33 22.28 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.53 12.63 4.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.722 2.009 . . . . 0.0 113.162 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -55.16 148.13 14.87 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.753 2.021 . . . . 0.0 111.645 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -64.26 142.61 98.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.3 -17.67 27.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.524 2.816 . . . . 0.0 116.315 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -98.62 -5.64 31.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.277 0.944 . . . . 0.0 113.042 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 142.72 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 119.569 1.077 . . . . 0.0 108.374 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.8 t -115.31 169.2 9.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 122.233 1.016 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -61.73 -35.32 77.73 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.766 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -66.29 -34.8 78.82 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.824 1.25 . . . . 0.0 109.998 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.58 -42.77 86.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 108.762 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.34 -43.5 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -54.52 -43.75 72.16 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.606 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.91 73.9 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.85 0.719 . . . . 0.0 111.519 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.35 -43.62 71.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -94.61 -9.39 35.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.756 -0.59 . . . . 0.0 112.295 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.67 93.98 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.94 1.296 . . . . 0.0 114.015 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.04 -7.16 14.53 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 121.87 1.703 . . . . 0.0 112.63 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.41 -12.95 19.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.307 0.958 . . . . 0.0 112.053 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 171.0 -173.7 44.7 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.475 1.489 . . . . 0.0 111.499 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -101.64 129.77 47.85 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.2 mt -100.33 160.8 3.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 126.437 1.895 . . . . 0.0 109.408 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 t -126.93 -69.24 0.77 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.578 1.551 . . . . 0.0 106.837 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.99 138.17 38.39 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.46 4.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.893 1.677 . . . . 0.0 107.435 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -160.74 156.04 24.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.55 1.068 . . . . 0.0 111.726 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.65 121.59 51.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.97 144.49 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -140.91 148.66 40.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.53 121.71 12.21 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.485 1.114 . . . . 0.0 108.165 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.1 ptm -58.49 -22.63 55.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.57 -9.8 18.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.4 p -131.99 -20.27 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.94 1.246 . . . . 0.0 113.02 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.78 6.56 82.04 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.375 0.988 . . . . 0.0 112.756 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -76.51 149.16 36.76 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 t -58.17 129.59 42.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -78.05 -12.79 60.02 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.51 -24.59 28.6 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-O 118.564 -1.131 . . . . 0.0 113.75 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -102.87 166.45 10.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.252 1.026 . . . . 0.0 109.311 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.63 174.14 33.68 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.215 1.388 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.16 157.01 46.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.489 0.716 . . . . 0.0 109.121 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -143.95 133.81 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.074 1.75 . . . . 0.0 106.775 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 t -115.95 129.75 56.53 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.749 2.02 . . . . 0.0 108.254 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.12 155.43 26.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.55 -23.29 61.73 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.528 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -135.81 156.47 48.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.507 1.503 . . . . 0.0 110.994 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.38 -46.11 74.26 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.573 0.749 . . . . 0.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -39.87 72.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.21 1.804 . . . . 0.0 111.177 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -57.44 -52.92 63.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.69 53.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.732 1.213 . . . . 0.0 111.122 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -50.29 -49.02 54.71 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.373 1.069 . . . . 0.0 111.221 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -52.23 -57.35 9.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.275 1.03 . . . . 0.0 110.211 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.17 94.7 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 116.779 -1.582 . . . . 0.0 113.523 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.0 mt -50.97 -34.74 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 121.581 1.991 . . . . 0.0 110.69 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -79.96 -63.42 1.42 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.33 0.652 . . . . 0.0 111.009 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.58 -49.91 69.32 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.7 mmm -68.29 -31.39 70.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.441 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.68 92.7 0.11 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.817 0.722 . . . . 0.0 111.31 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 138.56 -18.0 3.26 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.901 1.239 . . . . 0.0 111.786 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 167.72 20.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.402 1.101 . . . . 0.0 110.672 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -107.0 116.3 31.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.0 tp -116.3 127.3 54.58 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.753 1.221 . . . . 0.0 107.763 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 -63.28 4.18 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.31 5.9 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.208 -1.884 . . . . 0.0 112.808 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -136.13 154.49 50.97 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.213 2.007 . . . . 0.0 110.358 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -68.73 148.45 50.36 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.6 pt -116.88 160.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.454 1.102 . . . . 0.0 110.974 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -118.16 143.91 46.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.389 1.876 . . . . 0.0 105.985 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.6 p -138.89 123.09 18.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -149.94 174.36 12.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -69.07 155.22 40.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.029 179.688 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -123.86 113.61 18.74 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.09 1.356 . . . . 0.0 108.086 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.77 151.65 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.76 0.79 . . . . 0.0 111.229 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.17 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 128.859 2.863 . . . . 0.0 107.875 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -95.45 133.06 39.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 106.172 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -127.31 138.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.07 179.63 19.83 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.706 -0.621 . . . . 0.0 111.835 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.284 7.2 t0 60.57 10.88 2.76 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 129.93 3.292 . . . . 0.0 114.982 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.2 mt -52.35 138.61 26.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.66 1.984 . . . . 0.0 110.462 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.83 151.35 64.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.96 -19.43 68.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.038 1.826 . . . . 0.0 114.239 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -82.73 -23.41 34.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.691 1.197 . . . . 0.0 113.598 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mm -56.89 130.61 19.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.283 1.033 . . . . 0.0 110.451 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -107.9 167.53 9.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.159 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.8 m -61.32 -21.61 64.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.056 -1.652 . . . . 0.0 111.969 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.76 -36.77 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.828 1.651 . . . . 0.0 109.96 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.91 -50.95 71.78 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.32 -52.62 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.271 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -53.55 -48.36 69.18 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.994 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.66 -45.87 90.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.623 0.769 . . . . 0.0 111.833 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -60.35 -49.13 78.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.67 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -84.48 -8.28 59.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.947 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.3 93.75 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 120.215 1.371 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.58 -6.07 15.72 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 122.1 1.786 . . . . 0.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.62 -18.21 17.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.73 0.812 . . . . 0.0 110.913 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 170.17 175.23 38.91 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 123.596 1.665 . . . . 0.0 114.651 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -86.03 117.68 25.03 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.5 mt -100.36 158.01 3.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.12 1.368 . . . . 0.0 107.818 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 t -134.95 -62.61 0.72 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.83 126.47 48.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.831 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.22 136.62 13.09 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -162.65 157.03 21.32 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.492 0.587 . . . . 0.0 112.004 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.91 122.65 58.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.49 141.8 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -130.85 155.69 46.3 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.747 0.784 . . . . 0.0 109.083 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.49 124.51 23.77 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.068 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.8 ptp -64.54 -20.2 66.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.87 10.47 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.826 1.194 . . . . 0.0 113.845 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 80.5 p -104.05 -19.25 14.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.017 1.327 . . . . 0.0 114.303 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.0 78.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.195 0.903 . . . . 0.0 112.607 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -83.6 157.27 22.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.06 1.344 . . . . 0.0 109.154 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 t -62.06 124.99 22.3 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.718 0.807 . . . . 0.0 111.221 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -71.4 -31.61 67.47 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.27 -29.96 5.98 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.081 1.324 . . . . 0.0 110.601 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -103.31 164.99 11.3 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.305 -1.115 . . . . 0.0 111.574 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.6 178.37 33.09 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.695 1.616 . . . . 0.0 110.015 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.38 153.87 51.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.399 1.079 . . . . 0.0 108.419 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.2 t -140.24 143.61 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 12.9 t -131.35 135.3 47.12 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.738 1.615 . . . . 0.0 107.234 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 148.58 43.37 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 124.529 1.143 . . . . 0.0 109.381 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.03 -48.12 59.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -92.33 143.1 26.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.652 0.781 . . . . 0.0 109.238 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.34 -45.32 84.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.527 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -36.71 63.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.976 1.711 . . . . 0.0 112.078 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.17 -47.05 87.95 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.25 -52.54 61.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.73 0.812 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.08 -54.75 14.62 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 110.511 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -51.15 -56.55 12.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.882 1.673 . . . . 0.0 111.537 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.45 91.89 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.079 -1.438 . . . . 0.0 112.111 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.8 mt -53.01 -45.77 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 122.06 2.209 . . . . 0.0 109.784 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.72 -64.76 0.79 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.049 1.34 . . . . 0.0 111.106 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.89 -57.62 10.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.247 1.819 . . . . 0.0 114.193 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.3 mmm -64.91 -21.96 66.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.361 1.437 . . . . 0.0 113.669 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.34 110.45 3.12 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 119.227 0.921 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.4 -5.71 70.99 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.752 1.168 . . . . 0.0 112.134 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -76.71 170.67 16.03 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 118.852 1.326 . . . . 0.0 107.605 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -102.01 142.67 32.92 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 116' ' ' ALA . 22.7 tp -131.71 124.08 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.014 2.126 . . . . 0.0 106.214 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.39 -78.35 0.84 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.9 -2.27 0.15 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.069 -1.961 . . . . 0.0 114.544 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -129.22 163.72 25.0 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.16 2.48 . . . . 0.0 109.995 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -77.93 165.18 24.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.338 0.589 . . . . 0.0 109.581 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.14 159.08 38.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.675 0.79 . . . . 0.0 110.925 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -113.77 139.54 49.03 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 p -137.06 132.37 34.07 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.138 0.881 . . . . 0.0 109.448 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -157.1 167.43 30.45 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -61.08 132.87 55.16 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.19 0 CA-C-N 118.134 0.425 . . . . 0.0 111.673 -179.785 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.432 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 126.33 26.96 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.608 0.763 . . . . 0.0 109.744 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.4 m -71.76 178.44 3.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.75 1.22 . . . . 0.0 110.825 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.48 102.03 2.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.7 m -79.71 157.38 27.2 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.939 0.869 . . . . 0.0 109.949 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 m -63.2 -50.66 69.41 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.447 0.699 . . . . 0.0 112.294 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 91.48 0.1 Allowed Glycine 0 C--N 1.336 0.537 0 O-C-N 121.384 -0.822 . . . . 0.0 112.206 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -84.42 1.29 46.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.027 0.931 . . . . 0.0 112.48 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -110.99 127.32 55.48 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 119.831 -1.793 . . . . 0.0 108.014 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -29.11 69.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.191 0.45 . . . . 0.0 110.722 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.99 141.42 38.94 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.25 . . . . 0.0 111.621 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -93.18 76.77 4.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.791 1.637 . . . . 0.0 108.127 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.8 m -109.87 -43.12 4.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -89.11 21.89 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.551 0.741 . . . . 0.0 110.129 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -113.38 159.01 19.89 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.106 -0.996 . . . . 0.0 110.715 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -105.39 102.59 12.06 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.317 1.847 . . . . 0.0 107.894 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.96 146.82 25.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.306 0.643 . . . . 0.0 110.568 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -130.61 138.18 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.344 1.858 . . . . 0.0 110.207 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -86.82 143.0 27.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.242 1.817 . . . . 0.0 106.686 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.13 137.37 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.5 -174.54 17.79 Favored Glycine 0 N--CA 1.463 0.498 0 O-C-N 120.865 -1.147 . . . . 0.0 111.164 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.7 8.94 4.8 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.067 2.147 . . . . 0.0 112.36 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -55.84 148.13 17.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.009 1.323 . . . . 0.0 111.519 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.11 162.32 69.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.14 -16.78 49.77 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.623 2.215 . . . . 0.0 114.632 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -100.87 -15.06 17.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.583 1.083 . . . . 0.0 112.288 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.417 HD11 ' HA3' ' A' ' 164' ' ' GLY . 28.3 mm -57.69 114.25 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 109.387 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 t -95.34 178.83 5.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 m -64.54 -30.91 71.94 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.928 -1.107 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -73.02 -30.12 63.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.315 1.046 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.04 -48.6 70.54 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -51.65 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -55.37 -38.65 69.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 120.904 -1.122 . . . . 0.0 112.34 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.17 64.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 123.672 0.608 . . . . 0.0 110.078 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.73 84.23 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.742 1.217 . . . . 0.0 113.547 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -88.47 -6.34 57.69 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.27 94.95 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.862 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.92 -5.96 14.7 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.529 1.486 . . . . 0.0 113.535 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -98.82 -20.97 16.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.775 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 169.33 175.16 38.36 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-O 122.943 1.301 . . . . 0.0 114.155 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.9 mtm105 -81.61 121.54 26.46 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.3 mt -100.79 153.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.377 1.071 . . . . 0.0 109.073 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.0 t -130.28 -61.07 0.99 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.77 132.89 45.95 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 134.71 6.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.198 0.999 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -162.84 163.38 26.53 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.957 0.798 . . . . 0.0 112.228 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 52.2 t -105.02 120.59 55.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.597 HG12 ' HG3' ' A' ' 138' ' ' LYS . 95.3 t -66.03 140.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -133.23 147.1 51.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.71 130.26 45.63 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.079 1.352 . . . . 0.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 23.6 ptm -76.02 -9.41 58.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.77 -24.29 16.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.864 1.211 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.5 p -128.48 -18.49 3.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.433 1.015 . . . . 0.0 113.043 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.52 19.11 78.47 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.592 1.091 . . . . 0.0 113.391 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -100.3 163.35 12.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.542 1.171 . . . . 0.0 109.867 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -46.27 126.21 7.55 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.885 1.274 . . . . 0.0 113.885 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.597 ' HG3' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -79.5 -22.5 43.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 117.442 -1.266 . . . . 0.0 110.699 178.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.93 -30.12 8.31 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.547 2.023 . . . . 0.0 110.644 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.503 ' CZ ' HG11 ' A' ' 129' ' ' VAL 0.264 29.9 p90 -102.88 169.37 8.63 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.422 1.089 . . . . 0.0 112.171 178.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.57 172.72 33.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 127.371 2.415 . . . . 0.0 108.379 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -140.37 149.95 43.33 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.54 155.75 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 126.662 1.985 . . . . 0.0 106.031 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.0 t -145.32 118.02 8.65 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.506 1.122 . . . . 0.0 108.354 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -99.46 152.12 20.35 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.17 1.388 . . . . 0.0 110.631 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -74.37 -24.41 59.15 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.394 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -125.44 151.27 46.44 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.782 1.233 . . . . 0.0 110.55 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.01 -49.24 73.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -31.46 17.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.456 1.903 . . . . 0.0 113.307 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.78 -55.28 10.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 108.347 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.71 76.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.971 1.708 . . . . 0.0 110.81 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.18 -50.01 70.42 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.583 1.153 . . . . 0.0 109.295 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -55.22 -50.91 68.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.752 0.421 . . . . 0.0 111.294 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.22 -55.12 37.66 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.033 1.733 . . . . 0.0 111.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.4 mt -46.68 -49.9 6.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 120.367 1.44 . . . . 0.0 110.971 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.36 -60.78 2.6 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 124.288 0.992 . . . . 0.0 112.316 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -66.02 -58.07 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.2 mmm -58.19 -28.58 64.92 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.93 77.43 0.81 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 125.021 1.296 . . . . 0.0 110.123 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.17 -10.35 2.26 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 127.3 2.381 . . . . 0.0 111.838 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -80.18 165.52 22.34 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.879 1.34 . . . . 0.0 109.456 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -107.6 133.54 51.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.991 0.916 . . . . 0.0 108.853 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.88 130.48 46.91 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.565 1.946 . . . . 0.0 106.645 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 66.44 12.55 58.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.106 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.88 0.25 62.24 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 119.312 1.556 . . . . 0.0 112.564 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.26 157.06 46.4 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.427 1.614 . . . . 0.0 108.928 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -68.78 174.84 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.787 0.803 . . . . 0.0 109.308 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 pt -142.96 160.05 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.734 2.014 . . . . 0.0 108.025 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -123.51 140.6 52.84 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.4 p -138.93 149.23 44.56 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.957 0.903 . . . . 0.0 111.808 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -173.43 178.07 2.45 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.906 2.082 . . . . 0.0 109.352 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.12 126.65 30.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.55 -37.21 77.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 112.855 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.9 t -148.36 139.89 23.58 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -141.24 -178.0 5.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.553 1.541 . . . . 0.0 108.276 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -138.63 135.47 17.99 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.147 1.379 . . . . 0.0 108.062 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.13 148.39 56.14 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.223 2.615 . . . . 0.0 111.984 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.04 167.36 27.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.532 2.822 . . . . 0.0 111.957 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.72 156.28 77.77 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.36 -66.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.36 2.04 . . . . 0.0 112.172 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 182' ' ' SER . 13.9 tttm -150.93 171.77 16.73 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.968 0.907 . . . . 0.0 109.443 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.414 ' H ' ' HG2' ' A' ' 181' ' ' LYS . 7.2 t -137.47 152.05 49.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.471 1.109 . . . . 0.0 109.05 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.14 -176.72 5.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.708 2.003 . . . . 0.0 107.649 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -137.42 158.59 44.07 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.83 174.99 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.774 0.829 . . . . 0.0 109.817 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 p -144.6 8.39 1.32 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.614 1.565 . . . . 0.0 111.463 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -53.05 -38.89 62.85 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.965 2.106 . . . . 0.0 113.772 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.1 m -69.76 56.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.465 1.906 . . . . 0.0 113.689 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -91.72 161.71 14.78 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.519 -1.363 . . . . 0.0 108.485 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 174.94 13.92 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 127.483 2.313 . . . . 0.0 108.618 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.8 t -137.31 -80.81 0.37 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.93 65.39 1.55 Allowed Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.149 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.05 89.88 0.77 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.788 2.326 . . . . 0.0 107.916 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.46 169.04 25.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.573 1.149 . . . . 0.0 109.278 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.4 p -153.75 179.18 9.09 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.742 1.617 . . . . 0.0 108.221 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.838 0 C-N-CA 128.25 2.833 . . . . 0.0 106.882 179.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.1 p -62.95 169.44 3.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.602 1.201 . . . . 0.0 112.221 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 p -59.34 129.09 40.37 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.245 1.418 . . . . 0.0 109.419 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.11 -170.59 54.76 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.3 t -141.25 132.11 25.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.04 1.32 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.888 2.875 . . . . 0.0 117.956 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.36 -153.54 21.4 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 120.924 1.693 . . . . 0.0 111.267 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -52.16 91.68 0.01 OUTLIER 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.785 2.434 . . . . 0.0 113.197 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -130.37 160.64 33.37 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.1 0.96 . . . . 0.0 111.361 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -164.6 162.76 21.75 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.847 2.459 . . . . 0.0 107.159 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -135.64 73.53 1.47 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.3 p 48.8 19.37 0.25 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.32 2.248 . . . . 0.0 115.373 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -49.47 -24.41 2.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.361 2.664 . . . . 0.0 117.273 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -133.82 11.85 4.0 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.741 1.155 . . . . 0.0 110.305 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -90.17 167.3 12.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.723 0.809 . . . . 0.0 109.405 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -113.08 161.36 17.18 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -132.72 133.79 43.95 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 t -106.36 134.27 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 126.169 1.788 . . . . 0.0 109.571 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -85.59 136.1 33.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.215 1.806 . . . . 0.0 106.68 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.52 HG12 HD21 ' A' ' 104' ' ' LEU . 15.8 t -131.71 133.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.02 -174.35 18.1 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 62.8 12.33 5.62 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.227 2.611 . . . . 0.0 111.951 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.52 HD21 HG12 ' A' ' 101' ' ' VAL . 53.8 mt -59.55 142.68 52.15 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.639 1.576 . . . . 0.0 111.322 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.7 t -59.87 143.81 86.89 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -59.95 -5.33 3.61 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.413 2.742 . . . . 0.0 115.382 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.4 -14.38 18.36 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.285 2.234 . . . . 0.0 112.721 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.1 mm -58.05 136.2 21.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 119.316 0.962 . . . . 0.0 109.831 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -108.33 168.85 9.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.387 1.089 . . . . 0.0 108.843 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.0 m -60.82 -29.51 69.52 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.895 1.278 . . . . 0.0 109.381 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -70.24 -40.8 74.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 109.277 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.75 -47.54 85.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.738 0.815 . . . . 0.0 109.17 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 113' ' ' ILE . 27.9 mt -60.75 -49.53 84.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 22.8 mtmt -54.88 -48.53 72.86 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.762 -1.211 . . . . 0.0 110.99 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.33 -34.4 73.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.967 0.907 . . . . 0.0 112.614 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -75.31 -44.89 42.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.756 1.223 . . . . 0.0 113.842 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -86.04 -10.68 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.0 -50.37 86.82 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 126.481 1.913 . . . . 0.0 114.445 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -65.03 -4.17 8.46 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.464 1.443 . . . . 0.0 113.282 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -99.05 -9.63 23.66 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.47 15.1 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.094 1.316 . . . . 0.0 109.89 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -75.18 116.35 15.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.596 -0.943 . . . . 0.0 109.827 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -77.48 153.5 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 p -112.53 -73.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.011 1.724 . . . . 0.0 107.032 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.97 142.8 32.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.988 2.115 . . . . 0.0 108.117 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.416 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -161.84 124.03 2.9 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 110.101 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -153.53 164.5 38.12 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.594 0.712 . . . . 0.0 111.8 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.2 121.64 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.341 1.857 . . . . 0.0 106.968 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 140' ' ' TYR . 75.1 t -64.68 139.28 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -134.84 153.35 52.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -60.84 116.41 4.42 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 125.368 1.467 . . . . 0.0 109.115 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 15.4 ptp -64.09 -9.01 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.26 -15.87 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.467 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 72.4 p -137.91 -29.64 0.84 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.94 1.246 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.66 62.55 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.217 1.389 . . . . 0.0 112.037 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -80.14 154.97 27.69 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.696 1.248 . . . . 0.0 109.094 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 m -56.04 123.58 14.88 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.546 1.139 . . . . 0.0 111.857 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -76.88 -22.56 53.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.121 0.568 . . . . 0.0 111.692 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.73 -26.53 10.68 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 127.006 2.241 . . . . 0.0 112.619 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CE2' HG11 ' A' ' 129' ' ' VAL . 7.3 p90 -103.06 168.09 9.41 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.764 1.225 . . . . 0.0 112.389 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.84 177.85 31.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.785 2.136 . . . . 0.0 109.307 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -138.79 155.42 48.18 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.031 0.932 . . . . 0.0 109.938 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.3 t -142.89 125.56 13.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.174 1.39 . . . . 0.0 108.405 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -112.92 142.15 45.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.16 163.07 22.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.65 -19.95 60.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.892 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.19 169.12 16.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.722 1.209 . . . . 0.0 111.607 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -77.81 -52.74 8.43 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 124.578 1.151 . . . . 0.0 110.808 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -49.61 -48.92 48.66 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.182 1.793 . . . . 0.0 111.096 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.86 -43.96 69.97 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 124.091 0.869 . . . . 0.0 110.124 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.42 -56.04 12.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.135 1.374 . . . . 0.0 110.167 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -52.08 -48.33 64.74 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.333 1.453 . . . . 0.0 111.185 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -53.14 -46.0 68.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 109.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.88 -43.23 65.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.855 1.262 . . . . 0.0 110.18 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 95.5 mt -49.52 -44.54 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 120.8 1.636 . . . . 0.0 108.704 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.4 -70.87 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -61.14 -43.46 98.84 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 68.2 mmm -71.93 -22.59 61.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.594 1.543 . . . . 0.0 111.494 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.0 113.55 5.75 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 118.96 0.8 . . . . 0.0 111.834 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.22 60.29 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-O 118.325 -1.264 . . . . 0.0 113.119 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.6 169.05 17.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.964 1.382 . . . . 0.0 108.795 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.9 m95 -105.33 137.29 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 116' ' ' ALA . 50.4 tp -124.79 127.88 47.87 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.78 -101.17 0.44 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 105.695 -2.962 . . . . 0.0 105.695 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.75 10.85 7.5 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 116.355 -2.358 . . . . 0.0 115.729 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.98 159.25 43.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 121.971 2.886 . . . . 0.0 112.969 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -72.37 153.97 41.17 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.17 151.97 27.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 123.409 0.684 . . . . 0.0 111.457 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -111.64 126.52 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.995 1.318 . . . . 0.0 108.387 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 55.9 p -113.54 141.58 46.98 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.238 1.415 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -167.45 177.12 6.16 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.086 1.755 . . . . 0.0 107.459 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -77.69 152.62 33.64 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.76 4.48 18.84 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.478 -0.764 . . . . 0.0 112.21 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.2 p -142.68 159.0 43.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.368 1.467 . . . . 0.0 109.886 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -173.18 164.66 4.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.071 1.749 . . . . 0.0 109.849 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -82.53 141.39 45.2 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.09 159.12 54.46 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 121.702 1.601 . . . . 0.0 109.482 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.15 171.9 17.41 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 124.103 3.202 . . . . 0.0 111.746 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.79 147.62 62.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.802 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.07 100.6 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.311 2.674 . . . . 0.0 107.39 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -159.9 158.46 30.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.97 0.805 . . . . 0.0 112.436 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 p -160.91 -177.79 6.37 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.379 2.272 . . . . 0.0 107.517 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t 160.56 173.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.733 4.013 . . . . 0.0 107.557 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -163.81 -171.51 2.52 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.621 2.768 . . . . 0.0 108.226 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -163.6 152.4 13.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.331 2.253 . . . . 0.0 106.518 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 42.0 p -154.39 71.81 0.85 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.082 0.855 . . . . 0.0 110.671 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -76.31 79.34 3.07 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.819 -0.551 . . . . 0.0 110.59 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 21.9 p -60.2 -44.84 94.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.548 0.739 . . . . 0.0 109.92 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 35.1 tttm 49.78 20.73 0.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.962 2.105 . . . . 0.0 114.894 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -142.74 146.52 34.39 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.68 1.592 . . . . 0.0 106.919 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.4 p -77.95 -46.69 20.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.537 1.135 . . . . 0.0 108.856 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 173.33 174.83 40.65 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.562 2.03 . . . . 0.0 108.972 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.27 168.02 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.21 2.607 . . . . 0.0 110.981 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.4 p -147.84 117.01 6.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.2 p -150.68 91.18 1.7 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.792 0 C-N-CA 127.499 2.476 . . . . 0.0 106.971 -179.595 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.7 t -69.51 -23.33 63.59 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.263 -0.551 . . . . 0.0 111.954 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.7 p -147.07 176.02 10.25 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.044 0.938 . . . . 0.0 111.967 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.76 -173.11 14.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.787 2.613 . . . . 0.0 107.015 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p -146.91 139.64 25.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -102.79 164.5 11.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.393 1.477 . . . . 0.0 112.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.74 -116.05 0.62 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.73 154.58 41.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 152.17 18.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? 59.92 2.34 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.155 1.382 . . . . 0.0 113.889 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -55.54 131.13 45.44 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 120.388 1.449 . . . . 0.0 109.309 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.3 p -111.41 -1.44 15.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.21 1.004 . . . . 0.0 112.031 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -63.81 -4.99 3.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.973 1.709 . . . . 0.0 115.037 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -122.86 6.97 9.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.973 2.109 . . . . 0.0 110.841 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -109.47 177.84 4.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.38 1.072 . . . . 0.0 111.327 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -113.52 139.56 48.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -118.52 142.85 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.042 1.292 . . . . 0.0 110.214 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.08 154.36 28.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.668 2.387 . . . . 0.0 109.704 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -103.82 141.42 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.579 3.152 . . . . 0.0 108.709 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.61 140.33 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.44 178.86 24.78 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 119.652 1.114 . . . . 0.0 111.543 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t0 70.41 -1.69 2.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.762 2.825 . . . . 0.0 114.525 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 mt -47.78 139.01 7.91 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 127.283 2.233 . . . . 0.0 113.892 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.7 t -62.65 148.12 91.64 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -61.83 -18.1 58.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.161 1.908 . . . . 0.0 113.822 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -76.43 -25.49 54.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mm -57.84 124.11 11.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.448 1.499 . . . . 0.0 110.613 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -106.93 175.3 5.54 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.134 0.974 . . . . 0.0 109.03 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.7 m -56.73 -33.52 66.62 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.52 -0.737 . . . . 0.0 111.851 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -68.39 -42.56 78.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.133 1.773 . . . . 0.0 112.142 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -54.63 -51.54 65.08 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.326 1.05 . . . . 0.0 109.482 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.0 mt -60.12 -53.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.2 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -51.1 -44.77 61.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 117.885 -1.055 . . . . 0.0 112.092 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.09 81.88 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.948 0.78 . . . . 0.0 110.734 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -57.51 -46.79 83.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -86.12 -5.76 59.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.402 1.081 . . . . 0.0 113.152 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -47.2 99.3 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.54 -3.9 12.0 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 CA-C-N 121.111 1.432 . . . . 0.0 112.388 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.95 -18.91 18.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.251 0.932 . . . . 0.0 110.719 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.4 168.19 25.0 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 118.887 0.767 . . . . 0.0 111.708 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.85 130.72 40.5 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.2 mt -100.26 154.26 4.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.0 t -116.06 -72.65 0.68 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.12 139.97 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.815 1.646 . . . . 0.0 109.303 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.33 135.53 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -162.77 163.01 26.9 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 118.577 0.626 . . . . 0.0 110.703 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 92.6 t -102.59 123.28 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.66 138.16 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -132.15 151.5 51.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 107.739 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -60.01 123.23 16.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.356 1.462 . . . . 0.0 109.97 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 12.4 tpt -62.84 -12.9 27.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.835 0.854 . . . . 0.0 113.166 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.82 -10.77 18.82 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.8 p -141.93 -25.17 0.68 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.95 11.95 75.39 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.183 0.897 . . . . 0.0 110.907 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -82.31 143.92 30.95 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -55.46 125.8 22.46 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -73.07 -22.91 60.51 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.13 -18.28 42.84 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.936 1.255 . . . . 0.0 112.128 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.282 31.8 p90 -103.14 161.75 13.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.332 1.566 . . . . 0.0 109.573 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.38 175.03 28.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.938 1.256 . . . . 0.0 110.763 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.93 153.37 51.81 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.102 1.361 . . . . 0.0 108.96 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.65 131.22 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 126.254 1.822 . . . . 0.0 106.516 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.3 m -122.14 132.02 54.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.081 0.952 . . . . 0.0 109.368 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.96 156.29 26.5 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.189 1.396 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -72.59 -24.05 61.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.717 1.207 . . . . 0.0 112.959 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -131.18 156.25 45.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.23 0.923 . . . . 0.0 110.183 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -67.16 -48.39 68.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.852 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -47.72 -49.28 28.49 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.71 1.604 . . . . 0.0 112.881 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.77 -49.78 67.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.636 1.574 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.16 -49.82 63.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.716 1.206 . . . . 0.0 112.018 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -51.38 -49.0 62.36 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.422 1.889 . . . . 0.0 109.867 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -54.23 -52.18 62.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.061 0.944 . . . . 0.0 110.54 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.22 89.92 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 117.363 -1.303 . . . . 0.0 111.755 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.4 mt -51.42 -48.05 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 121.739 2.063 . . . . 0.0 109.44 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -66.42 -60.17 3.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -68.57 -48.44 64.23 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.34 2.256 . . . . 0.0 115.516 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.41 -22.84 58.97 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.176 0.898 . . . . 0.0 111.807 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.87 97.84 0.17 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.496 1.046 . . . . 0.0 111.203 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 114.14 -7.72 23.17 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.246 -1.308 . . . . 0.0 113.857 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.27 174.54 9.37 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.754 1.277 . . . . 0.0 109.951 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 15.3 m95 -109.38 146.42 34.45 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' A' ' 116' ' ' ALA . 37.5 tp -139.58 128.37 23.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.994 2.118 . . . . 0.0 106.904 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 48.19 32.22 9.36 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.78 1.181 . . . . 0.0 114.818 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.65 -5.24 51.04 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 117.704 1.841 . . . . 0.0 117.704 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -141.76 157.58 44.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 122.037 2.919 . . . . 0.0 110.738 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 162' ' ' TRP . 39.6 mt-30 -65.93 161.21 21.78 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 124.296 0.997 . . . . 0.0 110.658 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.82 155.96 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.541 1.136 . . . . 0.0 108.717 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.3 p -137.2 155.37 49.61 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.992 0.917 . . . . 0.0 110.174 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -176.24 165.05 2.77 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.742 1.217 . . . . 0.0 108.719 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -73.77 122.36 22.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.7 108.65 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.8 p -140.74 159.65 41.75 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.67 1.588 . . . . 0.0 108.894 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -160.93 -166.99 1.71 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.406 1.882 . . . . 0.0 107.658 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -139.09 157.64 70.9 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 124.221 1.009 . . . . 0.0 108.856 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.7 148.27 52.53 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.986 1.791 . . . . 0.0 109.624 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.81 166.85 28.38 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.524 2.15 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -138.77 153.68 72.31 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.993 0.917 . . . . 0.0 109.015 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -74.5 179.84 5.52 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.778 2.985 . . . . 0.0 112.912 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -94.01 137.22 33.46 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.288 1.435 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -86.42 -177.43 6.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.042 0.537 . . . . 0.0 110.158 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.4 p -146.42 162.22 38.72 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.47 1.108 . . . . 0.0 109.363 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -172.24 162.07 5.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.237 1.815 . . . . 0.0 107.975 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -171.25 140.74 1.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.39 2.676 . . . . 0.0 104.606 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 69.0 m -164.51 27.9 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.81 2.044 . . . . 0.0 111.422 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.93 140.74 56.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.069 1.304 . . . . 0.0 110.766 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.9 t -167.11 171.44 10.95 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.013 1.325 . . . . 0.0 107.613 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -154.55 150.46 27.78 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.035 -1.041 . . . . 0.0 109.834 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -143.46 177.83 8.19 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.009 2.524 . . . . 0.0 106.362 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.3 p 160.71 141.18 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 128.678 2.791 . . . . 0.0 108.507 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.51 156.33 27.23 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.32 174.88 9.52 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.285 2.657 . . . . 0.0 110.68 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 10.5 t -156.96 152.68 26.97 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 t -166.15 166.06 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.877 1.671 . . . . 0.0 107.047 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.78 0 C-N-CA 128.055 2.74 . . . . 0.0 106.901 -179.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.46 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 m -145.59 -165.47 2.2 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.318 2.247 . . . . 0.0 107.36 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.3 -8.99 46.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.755 1.222 . . . . 0.0 112.385 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.44 -69.52 1.07 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.973 -0.904 . . . . 0.0 113.8 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.14 107.96 0.32 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -61.96 -23.11 66.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.42 1.888 . . . . 0.0 111.204 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.36 158.97 31.5 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 128.24 2.828 . . . . 0.0 106.793 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -95.92 -28.74 14.54 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.209 1.404 . . . . 0.0 114.392 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -148.78 158.63 44.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.519 1.054 . . . . 0.0 110.418 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.02 -43.36 6.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.605 . . . . 0.0 108.981 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -93.64 19.07 9.05 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.745 1.618 . . . . 0.0 113.585 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.7 p 55.08 2.44 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.678 2.391 . . . . 0.0 116.224 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 t -53.8 -6.14 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.203 2.601 . . . . 0.0 117.408 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.4 21.41 2.04 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 121.294 1.861 . . . . 0.0 111.845 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -94.44 165.57 12.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.756 0.822 . . . . 0.0 109.996 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.74 112.4 25.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.57 148.75 22.05 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.812 0.695 . . . . 0.0 111.157 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.32 140.72 48.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 129.07 2.948 . . . . 0.0 109.166 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -92.03 141.14 28.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.845 2.858 . . . . 0.0 107.24 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -135.9 143.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 -176.21 23.59 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.88 14.12 9.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.35 2.26 . . . . 0.0 113.126 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.6 mt -62.98 137.18 58.19 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.164 1.785 . . . . 0.0 112.415 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.5 t -62.85 143.46 97.1 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.24 -14.37 33.7 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.806 2.337 . . . . 0.0 114.679 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.26 -23.96 37.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.314 0.961 . . . . 0.0 111.667 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.0 mm -58.24 143.24 12.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.62 1.568 . . . . 0.0 110.231 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.5 t -121.75 179.29 4.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.859 1.314 . . . . 0.0 110.038 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 m -57.03 -39.37 74.69 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.591 1.956 . . . . 0.0 112.145 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.51 -37.48 80.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.251 1.82 . . . . 0.0 111.417 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.03 -49.71 76.29 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 44.4 mt -57.58 -52.29 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -54.11 -46.58 72.17 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.163 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.99 81.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.149 0.886 . . . . 0.0 111.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -65.27 -53.05 50.04 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.852 1.261 . . . . 0.0 113.67 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -84.46 -15.55 45.66 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.18 -48.75 93.37 Favored Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 124.875 1.27 . . . . 0.0 112.329 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.61 -5.16 8.13 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 121.548 1.498 . . . . 0.0 113.479 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -99.11 -14.89 19.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.413 1.006 . . . . 0.0 111.091 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 161.31 157.96 9.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.636 1.589 . . . . 0.0 110.528 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -73.39 107.21 5.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.086 1.354 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.3 140.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 126.507 1.923 . . . . 0.0 109.229 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 p -99.8 -71.44 0.7 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.24 142.86 32.8 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 128.319 2.647 . . . . 0.0 109.823 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -162.73 131.67 4.13 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.903 1.281 . . . . 0.0 108.278 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -155.42 157.3 36.81 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.223 0.92 . . . . 0.0 111.948 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.3 t -106.26 119.19 55.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.61 139.08 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 121.716 -0.615 . . . . 0.0 109.361 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -133.65 150.39 51.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.326 1.05 . . . . 0.0 108.533 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.82 137.96 52.24 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.589 0.356 . . . . 0.0 111.875 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.2 ptm -71.61 -17.83 62.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.38 -11.93 31.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 120.378 1.445 . . . . 0.0 114.217 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 62.1 p -140.24 -16.15 0.96 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.77 16.17 74.15 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -86.79 148.79 25.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 118.323 1.061 . . . . 0.0 110.48 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 123.62 14.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.293 1.437 . . . . 0.0 111.156 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -71.45 -53.82 12.7 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.232 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 141.11 -28.08 2.39 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.131 2.301 . . . . 0.0 112.78 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -102.59 161.55 13.63 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.257 1.423 . . . . 0.0 112.704 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.66 168.99 26.67 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.643 1.116 . . . . 0.0 110.382 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -132.72 142.08 48.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.578 1.151 . . . . 0.0 108.789 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.6 t -133.51 143.13 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.302 1.441 . . . . 0.0 107.484 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.4 t -119.94 130.58 54.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.572 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -114.43 150.23 35.04 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.441 1.096 . . . . 0.0 113.677 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -70.81 -14.76 62.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.313 1.445 . . . . 0.0 114.134 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -138.89 159.75 41.38 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.963 1.711 . . . . 0.0 108.13 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -64.64 -53.16 51.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -29.07 68.65 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 126.145 1.778 . . . . 0.0 112.661 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -64.06 -43.15 96.36 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.32 -47.33 50.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.705 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -55.69 -47.15 77.26 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.176 0.898 . . . . 0.0 110.873 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -49.95 -51.36 41.84 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 126.08 1.752 . . . . 0.0 108.002 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.51 -47.53 66.72 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 117.189 -1.386 . . . . 0.0 111.936 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 78.5 mt -49.55 -48.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 122.452 2.387 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -64.74 -59.9 3.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.834 1.653 . . . . 0.0 112.789 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -71.31 -44.61 64.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.907 1.683 . . . . 0.0 115.231 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.5 mmm -72.63 -21.41 61.11 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 110.27 2.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.16 62.36 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.869 -1.517 . . . . 0.0 113.903 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -69.73 166.45 19.2 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.518 1.659 . . . . 0.0 108.982 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -106.27 99.2 8.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.542 1.137 . . . . 0.0 109.642 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 116' ' ' ALA . 23.3 tp -85.01 111.98 20.2 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.11 -129.87 38.19 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.93 87.81 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 115.826 -2.652 . . . . 0.0 117.497 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -147.41 157.21 43.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 123.209 3.505 . . . . 0.0 115.267 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.03 163.19 17.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.5 pt -134.92 165.8 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.013 0.911 . . . . 0.0 110.673 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -123.31 147.13 47.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 127.474 2.31 . . . . 0.0 105.462 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.6 p -138.22 148.35 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.44 1.096 . . . . 0.0 110.702 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -170.08 171.08 7.14 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -69.67 138.75 53.24 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.72 7.56 20.1 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 t -138.41 158.22 44.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.514 1.126 . . . . 0.0 108.492 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -162.32 153.22 17.51 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.014 2.526 . . . . 0.0 106.321 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -135.32 156.01 78.28 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 153.28 75.32 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.631 2.22 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.94 160.53 47.44 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.644 2.229 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.99 150.4 85.82 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-O 118.539 -0.743 . . . . 0.0 109.193 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.83 124.13 11.52 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.919 2.413 . . . . 0.0 106.133 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.82 116.41 10.17 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.741 -0.784 . . . . 0.0 108.907 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 p -130.06 163.41 26.58 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.931 1.292 . . . . 0.0 108.572 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -179.38 163.48 1.25 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.761 2.024 . . . . 0.0 107.691 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -112.37 86.02 2.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.322 1.449 . . . . 0.0 108.393 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -131.38 144.79 51.47 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.36 93.2 0.93 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.539 -0.726 . . . . 0.0 111.263 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -147.56 122.5 10.03 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.081 -1.012 . . . . 0.0 108.763 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.2 t -141.78 146.59 36.12 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -119.12 85.16 2.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -138.08 169.89 16.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.275 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.5 m 52.51 29.22 6.82 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.768 1.227 . . . . 0.0 113.825 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.38 51.51 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.2 163.1 40.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.361 2.041 . . . . 0.0 110.308 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.3 m -162.61 173.63 13.67 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.155 2.182 . . . . 0.0 107.135 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.0 t -156.06 -178.93 7.67 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.861 1 C-N-CA 132.783 4.992 . . . . 0.0 103.608 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.891 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -132.51 169.53 16.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.789 1.636 . . . . 0.0 110.27 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.1 m -65.63 164.13 14.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.089 0.556 . . . . 0.0 111.922 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.33 0.26 65.87 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.013 0.816 . . . . 0.0 113.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.4 t -122.87 145.54 48.36 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 118.685 1.243 . . . . 0.0 107.879 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t -133.72 105.66 6.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.249 1.82 . . . . 0.0 107.076 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.09 79.38 0.18 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -108.01 153.02 23.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.131 1.372 . . . . 0.0 110.235 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -143.18 113.33 7.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.46 1.504 . . . . 0.0 109.052 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -140.41 -177.61 5.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.499 2.32 . . . . 0.0 108.071 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -120.15 171.66 8.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.044 0.937 . . . . 0.0 110.084 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.6 p -91.64 16.15 11.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.597 1.959 . . . . 0.0 113.289 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.7 p -47.26 -26.69 1.28 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.17 61.06 1.36 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -124.29 172.08 9.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.566 1.546 . . . . 0.0 109.22 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.69 100.94 6.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -80.73 144.52 32.13 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.8 t -124.39 135.41 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.296 1.838 . . . . 0.0 107.853 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -85.92 136.43 33.28 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.047 2.139 . . . . 0.0 106.492 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.41 142.52 41.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.62 179.36 25.52 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.283 0.944 . . . . 0.0 111.168 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 63.91 15.45 9.14 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.073 2.549 . . . . 0.0 113.901 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.48 145.59 55.93 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.857 1.263 . . . . 0.0 111.333 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 t -68.46 149.79 97.9 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.46 -16.75 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.038 1.825 . . . . 0.0 113.5 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -78.46 -16.59 57.39 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.301 1.04 . . . . 0.0 112.777 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.556 HD11 ' HA3' ' A' ' 164' ' ' GLY . 32.1 mm -70.82 121.49 20.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.5 1.12 . . . . 0.0 109.669 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 111' ' ' GLU . 4.7 t -99.78 -179.19 4.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.426 1.091 . . . . 0.0 109.923 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 74.3 m -62.93 -33.08 74.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.523 ' H ' HG23 ' A' ' 109' ' ' THR . 26.0 mt-10 -69.49 -41.81 75.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.786 0.834 . . . . 0.0 109.914 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -56.15 -49.96 72.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.745 0.818 . . . . 0.0 109.172 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.7 mt -59.77 -54.51 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -51.91 -41.44 61.99 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 116.945 -1.502 . . . . 0.0 112.584 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.05 -45.97 79.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.345 0.975 . . . . 0.0 110.085 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.02 -5.99 54.57 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.02 99.74 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-O 117.471 -1.252 . . . . 0.0 114.164 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.34 -5.65 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 CA-C-N 121.721 1.65 . . . . 0.0 112.131 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.06 -43.93 7.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 119.751 1.159 . . . . 0.0 108.806 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.84 164.27 36.32 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -80.8 118.47 22.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.43 157.99 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 126.035 1.734 . . . . 0.0 107.748 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.7 t -123.84 -69.45 0.81 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.38 130.16 47.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 107.817 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.2 137.84 9.7 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 120.051 1.296 . . . . 0.0 108.774 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.16 173.09 15.62 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 111.313 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.47 138.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 103.95 -2.611 . . . . 0.0 103.95 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.28 133.83 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -123.6 164.32 19.26 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.31 142.52 43.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.724 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.6 ptp -75.63 -29.68 59.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 121.788 -0.57 . . . . 0.0 109.892 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.84 -45.27 15.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -104.75 -18.36 14.29 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.94 12.26 74.93 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.978 -0.451 . . . . 0.0 113.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -85.46 155.06 21.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.481 1.112 . . . . 0.0 109.966 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 t -57.81 126.35 27.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.896 0.878 . . . . 0.0 108.849 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -70.08 -65.85 0.67 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.698 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 150.72 -18.82 0.99 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 128.152 2.786 . . . . 0.0 110.245 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -102.93 162.88 12.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.072 -1.252 . . . . 0.0 112.585 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.49 176.99 29.68 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.28 1.419 . . . . 0.0 110.613 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.33 151.29 46.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.603 0.761 . . . . 0.0 109.359 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 50.2 t -143.8 121.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.382 1.473 . . . . 0.0 109.072 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -107.0 125.37 50.91 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 109.317 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -105.47 159.65 15.77 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.288 1.035 . . . . 0.0 110.709 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.17 -30.0 65.89 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.196 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -132.02 158.78 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.773 1.17 . . . . 0.0 111.033 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -60.56 -53.94 51.43 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.03 1.332 . . . . 0.0 112.33 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.03 -41.16 67.75 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.788 2.035 . . . . 0.0 112.619 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -58.31 -45.43 88.06 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.209 1.004 . . . . 0.0 109.301 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.53 -50.36 45.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.271 1.028 . . . . 0.0 110.687 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.47 -48.73 62.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.207 1.403 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -56.17 -34.93 66.65 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -81.53 -45.33 16.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 116.923 -1.513 . . . . 0.0 109.6 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 79.5 mt -49.03 -39.39 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 122.083 2.22 . . . . 0.0 109.747 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -68.69 -71.09 0.23 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.528 1.131 . . . . 0.0 111.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -64.18 -45.61 87.61 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 127.802 2.441 . . . . 0.0 116.14 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.8 mmm -76.65 -21.14 55.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.737 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.6 64.43 0.62 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 116.266 1.266 . . . . 0.0 116.266 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.93 -11.15 0.5 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.504 2.002 . . . . 0.0 112.231 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.04 167.38 11.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.174 0.987 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.25 123.04 47.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.4 tp -115.38 118.18 32.51 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.273 1.429 . . . . 0.0 109.255 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.556 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 64.11 5.99 17.58 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.7 1.143 . . . . 0.0 113.686 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 124.6 -5.96 8.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 117.042 -1.977 . . . . 0.0 114.683 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -133.28 148.17 51.93 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.519 2.659 . . . . 0.0 112.018 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -64.49 154.78 34.85 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.496 0.718 . . . . 0.0 110.413 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 26.4 pt -128.58 163.45 33.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 110.698 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -124.84 141.37 52.16 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.7 p -139.52 141.78 37.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.484 1.038 . . . . 0.0 111.035 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -163.28 176.79 9.56 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.857 1.663 . . . . 0.0 108.166 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -70.38 152.9 43.59 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.149 -1.595 . . . . 0.0 109.031 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 9.72 5.5 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.6 t -136.28 168.69 18.95 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.422 1.489 . . . . 0.0 109.469 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -132.63 -170.78 2.51 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.659 2.384 . . . . 0.0 106.284 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -135.31 155.67 78.55 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 119.149 0.886 . . . . 0.0 110.23 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.78 162.33 39.98 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.142 1.895 . . . . 0.0 109.898 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.72 173.07 15.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.955 2.437 . . . . 0.0 111.703 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.42 149.81 55.76 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.33 -20.15 32.53 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.051 1.834 . . . . 0.0 111.596 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -54.25 119.53 5.27 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.178 1.391 . . . . 0.0 109.628 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.7 t -129.35 101.75 6.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.6 m -77.24 136.35 38.53 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.393 1.077 . . . . 0.0 108.402 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.76 173.92 9.87 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.943 0.497 . . . . 0.0 110.447 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.26 150.8 32.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.396 1.478 . . . . 0.0 107.19 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.4 p -167.57 174.75 7.55 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -150.37 130.59 13.63 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 124.766 1.226 . . . . 0.0 108.037 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 22.1 m -120.24 133.32 55.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.13 134.75 2.48 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.37 128.76 4.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 11.4 p -161.41 110.84 1.59 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.24 78.6 0.28 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.194 -1.337 . . . . 0.0 110.94 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.2 167.16 27.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.401 2.067 . . . . 0.0 110.334 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.4 p -149.15 163.95 36.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.417 1.087 . . . . 0.0 109.038 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.3 t -157.81 164.61 36.83 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.406 0 C-N-CA 128.207 2.813 . . . . 0.0 106.678 -179.507 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 t -159.3 -164.44 1.38 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.578 2.351 . . . . 0.0 106.31 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 t -69.76 160.49 31.6 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.067 -1.02 . . . . 0.0 108.961 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.72 111.26 1.35 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.236 1.398 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.4 t -152.06 92.49 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.952 0.876 . . . . 0.0 109.082 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.7 p -121.36 -174.28 2.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 109.205 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.57 174.94 21.73 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.568 1.08 . . . . 0.0 112.231 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -77.25 166.25 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.29 0.636 . . . . 0.0 110.108 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.51 111.16 18.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 111.613 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -99.58 54.45 0.95 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.22 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.706 0.802 . . . . 0.0 111.007 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -138.66 -0.28 1.96 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.044 0.937 . . . . 0.0 112.973 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -56.58 -37.89 71.21 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.298 -1.501 . . . . 0.0 114.202 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -79.83 -8.58 59.37 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.305 -0.872 . . . . 0.0 112.13 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -84.93 167.41 15.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.256 0.934 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.07 100.16 7.04 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.957 1.303 . . . . 0.0 110.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.98 146.3 35.51 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 122.102 0.954 . . . . 0.0 111.545 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.2 t -129.2 141.77 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 129.524 3.13 . . . . 0.0 109.426 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -95.23 136.52 35.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.611 2.364 . . . . 0.0 107.578 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.444 HG12 HD21 ' A' ' 104' ' ' LEU . 7.1 t -132.33 135.3 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.68 -178.57 21.28 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 121.537 -0.727 . . . . 0.0 111.64 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.93 7.22 6.12 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.957 2.503 . . . . 0.0 113.268 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD21 HG12 ' A' ' 101' ' ' VAL . 24.6 mt -58.14 145.51 36.67 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.66 2.384 . . . . 0.0 111.36 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -67.14 148.0 98.91 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.36 -10.53 11.09 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.098 2.532 . . . . 0.0 114.4 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.18 -23.45 21.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.627 1.103 . . . . 0.0 113.002 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.8 mm -57.97 128.15 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.008 0.923 . . . . 0.0 109.395 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 111' ' ' GLU . 4.5 t -107.76 177.9 4.68 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.893 1.33 . . . . 0.0 111.131 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 m -60.23 -31.42 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.428 1.091 . . . . 0.0 111.042 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 109' ' ' THR . 5.4 mt-10 -73.7 -36.52 65.28 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.054 0.942 . . . . 0.0 111.267 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -60.53 -49.62 76.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.3 mt -59.44 -54.2 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -51.79 -47.26 64.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.316 0.962 . . . . 0.0 111.38 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.68 83.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.531 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.22 -39.54 63.03 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -88.85 -10.98 46.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.016 0.926 . . . . 0.0 112.608 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.98 -47.83 97.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.936 1.294 . . . . 0.0 111.236 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.22 -3.82 6.81 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 CA-C-N 121.872 1.704 . . . . 0.0 113.906 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -99.92 -15.28 18.4 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.216 0.916 . . . . 0.0 112.003 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.48 177.72 30.85 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 122.407 1.004 . . . . 0.0 111.702 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -74.08 131.45 41.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.21 135.75 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -74.89 0.59 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -103.53 141.5 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.846 2.059 . . . . 0.0 108.655 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.22 127.48 2.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.932 1.242 . . . . 0.0 109.03 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -154.85 162.54 41.07 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.1 0.864 . . . . 0.0 111.601 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.4 t -107.01 120.08 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.82 135.43 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -131.7 151.16 51.84 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.77 144.4 56.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.88 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 tpt -83.0 -19.43 37.02 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.036 0.835 . . . . 0.0 111.701 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.85 -9.36 37.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.002 -1.061 . . . . 0.0 113.509 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.7 p -136.79 -25.36 1.11 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.355 0.979 . . . . 0.0 112.398 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.0 81.22 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -92.2 156.45 17.31 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.884 1.342 . . . . 0.0 109.559 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.6 m -54.16 126.15 21.8 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.382 1.073 . . . . 0.0 111.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -75.36 -32.78 60.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.828 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.22 -25.52 7.39 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.714 2.578 . . . . 0.0 111.259 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -102.57 161.2 13.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.527 1.163 . . . . 0.0 112.281 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.1 172.79 28.31 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.642 1.591 . . . . 0.0 109.317 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -135.03 155.02 51.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.51 1.124 . . . . 0.0 108.555 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.8 t -145.31 146.81 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 128.071 2.548 . . . . 0.0 104.509 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 t -145.2 112.76 6.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.755 1.616 . . . . 0.0 109.79 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -86.88 152.39 22.49 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.588 1.155 . . . . 0.0 112.131 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -70.27 -34.82 73.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.642 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -112.52 146.86 37.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 125.16 1.384 . . . . 0.0 108.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.55 -49.24 74.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.42 -33.47 59.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.52 1.128 . . . . 0.0 113.913 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -62.24 -46.79 87.29 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.14 -49.41 69.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.998 1.319 . . . . 0.0 110.186 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -55.47 -45.13 76.96 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.162 0.585 . . . . 0.0 110.501 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -54.36 -50.59 67.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.144 0.577 . . . . 0.0 110.465 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.12 78.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.413 1.485 . . . . 0.0 111.285 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 89.0 mt -51.49 -47.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 121.815 2.098 . . . . 0.0 110.375 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -67.77 -56.13 10.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 124.129 0.893 . . . . 0.0 112.109 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -70.05 -52.8 21.1 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -65.57 -17.62 64.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -75.99 79.91 1.12 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 123.793 0.711 . . . . 0.0 111.918 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 132.69 -5.75 5.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.795 2.14 . . . . 0.0 111.379 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -73.76 178.8 4.57 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.208 1.004 . . . . 0.0 108.77 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -118.85 150.47 39.79 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.9 tp -138.44 126.97 23.3 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.808 1.643 . . . . 0.0 106.64 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 -86.84 0.49 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.72 5.6 1.79 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.83 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -141.19 164.28 30.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.93 1.865 . . . . 0.0 112.98 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.0 160.86 31.16 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.581 1.152 . . . . 0.0 109.794 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.3 pt -137.62 171.9 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.614 1.166 . . . . 0.0 109.992 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -135.1 144.32 47.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.612 1.565 . . . . 0.0 108.026 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -136.83 137.27 39.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.843 0.747 . . . . 0.0 111.217 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.12 169.98 21.08 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -64.53 141.42 58.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.36 60.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.392 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.5 p -85.94 165.0 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.401 1.08 . . . . 0.0 108.916 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -152.88 171.82 17.71 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.011 1.325 . . . . 0.0 108.013 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.16 133.42 20.16 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.29 165.86 20.95 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.158 2.572 . . . . 0.0 112.995 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.54 177.36 8.07 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.806 2.337 . . . . 0.0 111.1 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -131.36 137.68 31.09 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.26 88.48 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.861 3.041 . . . . 0.0 112.302 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -159.85 129.03 5.15 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.879 -1.138 . . . . 0.0 109.077 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.7 p -150.69 -176.82 5.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.926 1.29 . . . . 0.0 108.047 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.5 t -131.55 -176.31 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.773 1.229 . . . . 0.0 109.73 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -117.04 169.34 9.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.611 1.564 . . . . 0.0 108.17 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.07 -176.03 5.05 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.449 0.7 . . . . 0.0 110.048 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 m -135.29 16.45 3.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.668 0.787 . . . . 0.0 111.513 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -74.35 17.94 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.493 1.117 . . . . 0.0 112.117 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 12.8 p -71.29 58.88 0.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.115 2.566 . . . . 0.0 110.009 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -49.98 -55.39 14.83 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 126.546 1.938 . . . . 0.0 113.425 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -168.99 158.01 8.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.7 m -67.33 142.51 56.79 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.38 68.18 1.68 Allowed Glycine 0 CA--C 1.533 1.171 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.12 27.21 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.625 2.216 . . . . 0.0 113.003 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.3 p -144.26 158.41 43.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.328 1.451 . . . . 0.0 108.813 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.4 166.79 22.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.192 2.197 . . . . 0.0 106.396 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.413 0 N-CA-C 107.321 -2.311 . . . . 0.0 107.321 -179.422 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.779 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 p -86.46 -179.55 6.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.686 0.795 . . . . 0.0 110.566 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 t -117.96 -19.26 9.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.975 1.31 . . . . 0.0 110.4 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.04 86.42 1.7 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 105.291 -3.124 . . . . 0.0 105.291 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.9 m -130.65 46.67 2.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.321 1.448 . . . . 0.0 108.788 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.5 m -58.14 15.98 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.111 2.964 . . . . 0.0 116.641 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -59.37 -10.01 9.9 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.439 1.472 . . . . 0.0 114.195 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -140.32 139.81 35.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.024 1.912 . . . . 0.0 107.147 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -126.18 155.41 41.8 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -171.0 143.05 1.92 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.997 2.119 . . . . 0.0 106.337 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 38.58 36.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 129.082 2.953 . . . . 0.0 113.361 178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p 55.21 14.02 0.96 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.885 1.674 . . . . 0.0 114.008 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -56.18 -16.01 4.63 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.45 1.9 . . . . 0.0 115.518 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -123.17 3.24 9.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.317 0.962 . . . . 0.0 111.411 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -78.01 171.58 14.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.087 0.955 . . . . 0.0 108.701 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -120.44 100.89 7.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.428 ' CE1' ' HG ' ' A' ' 144' ' ' SER . 22.5 m-70 -86.95 142.48 27.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.334 0.588 . . . . 0.0 112.235 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.66 143.18 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 127.81 2.444 . . . . 0.0 108.515 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -93.78 136.04 34.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.417 2.687 . . . . 0.0 108.014 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.6 140.71 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.495 -2.78 . . . . 0.0 103.495 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.91 175.98 29.65 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.84 16.96 10.49 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 124.618 1.167 . . . . 0.0 112.68 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.25 149.3 45.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 0.0 110.961 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -70.83 144.49 90.72 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.45 -3.74 6.97 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 114.929 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.5 -21.83 20.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.949 1.7 . . . . 0.0 111.662 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.47 HD11 ' HA3' ' A' ' 164' ' ' GLY . 46.0 mm -67.64 134.48 30.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 127.891 2.476 . . . . 0.0 111.123 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -106.15 173.07 6.47 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.182 0.991 . . . . 0.0 108.792 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.5 m -60.24 -30.37 69.37 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.562 -1.336 . . . . 0.0 109.714 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -68.99 -32.42 71.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.035 0.934 . . . . 0.0 110.343 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.43 -41.21 85.16 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.46 -48.42 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -55.22 -41.54 72.19 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.068 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -52.25 60.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.819 0.847 . . . . 0.0 110.928 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.39 -41.89 77.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -94.93 -2.72 49.98 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.74 99.54 Favored Pre-proline 0 N--CA 1.466 0.34 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.639 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.73 -2.93 9.39 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-N 121.792 1.676 . . . . 0.0 112.727 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -97.75 -19.55 18.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.139 0.881 . . . . 0.0 111.452 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.06 170.12 30.55 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 122.096 0.831 . . . . 0.0 112.394 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -78.14 101.94 7.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.61 1.195 . . . . 0.0 109.15 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.6 mt -76.74 148.36 6.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 t -111.41 -73.26 0.68 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.39 136.39 41.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.943 1.697 . . . . 0.0 108.778 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -163.65 138.83 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.25 151.22 22.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.353 0.979 . . . . 0.0 111.485 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 t -99.26 117.36 44.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.99 145.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -131.51 151.26 51.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -61.66 115.88 4.32 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -58.0 -17.34 16.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.843 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.6 -7.07 28.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.4 p -139.81 -28.54 0.75 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.72 1.145 . . . . 0.0 111.869 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 13.02 71.52 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.859 1.218 . . . . 0.0 110.617 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.15 153.63 22.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.797 1.298 . . . . 0.0 108.387 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 37.3 t -55.8 128.44 34.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.721 0.691 . . . . 0.0 111.406 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -78.8 -17.43 55.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.03 -23.8 34.25 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.167 0.889 . . . . 0.0 112.931 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.265 27.0 p90 -102.64 159.61 15.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.366 1.583 . . . . 0.0 110.43 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.42 178.17 33.04 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.609 1.099 . . . . 0.0 110.768 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -142.49 159.84 41.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.94 151.36 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.675 1.99 . . . . 0.0 106.939 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.428 ' HG ' ' CE1' ' A' ' 98' ' ' HIS . 2.6 t -132.88 119.67 20.49 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 126.643 1.977 . . . . 0.0 108.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -103.69 149.59 24.82 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.723 1.609 . . . . 0.0 111.202 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -71.16 -35.83 71.81 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.196 0.998 . . . . 0.0 110.279 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -122.99 153.31 39.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.717 1.207 . . . . 0.0 111.562 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -61.44 -50.2 73.76 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 125.049 1.339 . . . . 0.0 110.753 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.0 -44.4 20.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.797 2.039 . . . . 0.0 112.577 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.87 -50.12 73.51 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.787 1.235 . . . . 0.0 109.844 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.92 -42.39 94.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.075 0.95 . . . . 0.0 110.576 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -59.4 -54.7 43.67 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.69 1.196 . . . . 0.0 109.678 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -53.92 -45.36 71.16 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.02 62.41 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.224 1.409 . . . . 0.0 111.803 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.1 mt -55.33 -39.53 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.818 1.645 . . . . 0.0 110.511 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.02 -62.17 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -65.55 -52.16 54.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 116.406 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.9 mmm -71.67 -21.79 61.75 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.032 1.287 . . . . 0.0 112.746 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -56.15 121.92 25.64 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 123.859 0.743 . . . . 0.0 111.857 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.45 -5.86 71.41 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-O 118.627 -1.096 . . . . 0.0 113.963 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.87 175.04 9.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.105 1.452 . . . . 0.0 108.68 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 167' ' ' GLN . 8.5 m95 -105.23 157.96 16.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.69 120.44 9.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.47 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 71.18 -39.23 0.56 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.448 1.023 . . . . 0.0 115.178 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.79 -5.19 0.03 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.716 -1.602 . . . . 0.0 114.954 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -137.4 162.26 34.1 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.421 2.111 . . . . 0.0 109.413 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 162' ' ' TRP . 52.5 mt-30 -70.83 159.37 34.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.101 0.56 . . . . 0.0 110.809 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 pt -130.54 165.81 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.782 1.233 . . . . 0.0 110.248 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -121.66 147.76 45.46 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 56.0 p -133.91 142.43 47.75 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.958 0.903 . . . . 0.0 108.571 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -166.31 167.56 15.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 119.805 1.184 . . . . 0.0 109.138 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -68.46 126.85 30.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.97 -25.56 66.38 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.4 t -150.25 156.36 41.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.844 1.258 . . . . 0.0 108.138 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -166.89 169.89 12.72 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.812 2.445 . . . . 0.0 108.482 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -143.98 133.18 11.42 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.45 150.83 58.63 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 108.739 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.07 166.1 26.06 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.821 2.348 . . . . 0.0 112.423 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -119.31 141.08 29.99 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.762 1.225 . . . . 0.0 109.325 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.91 110.69 2.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.878 3.052 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -136.14 77.21 1.64 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.824 1.65 . . . . 0.0 108.396 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.2 t -66.02 113.54 4.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.0 t -77.66 162.88 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -152.39 134.37 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -137.89 -11.41 1.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.777 0.831 . . . . 0.0 112.215 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.6 87.72 0.49 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.668 1.987 . . . . 0.0 110.995 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -143.43 169.03 18.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.057 1.343 . . . . 0.0 109.32 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -145.71 168.25 21.16 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.419 1.088 . . . . 0.0 109.391 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -166.3 118.54 1.04 Allowed 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 124.527 1.131 . . . . 0.0 108.431 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -136.06 145.15 45.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 m -159.29 170.93 20.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.948 1.299 . . . . 0.0 108.057 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -151.2 69.93 0.31 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.34 171.52 17.93 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.424 2.083 . . . . 0.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -152.11 176.29 11.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 106.832 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 21.6 m -150.63 177.96 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.895 1.678 . . . . 0.0 107.586 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 C-N-CA 127.625 2.536 . . . . 0.0 106.831 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p 51.17 19.86 0.79 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.507 1.923 . . . . 0.0 113.666 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.5 p -68.29 -21.44 64.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.211 2.205 . . . . 0.0 113.975 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.44 -56.81 3.33 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.586 1.089 . . . . 0.0 112.454 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 t -40.25 -55.11 2.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.369 2.668 . . . . 0.0 111.991 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 m -163.18 178.56 8.13 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.77 2.028 . . . . 0.0 108.167 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.73 55.42 3.88 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -51.98 167.04 0.13 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.59 2.756 . . . . 0.0 113.798 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 11.54 28.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -142.99 142.14 31.55 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.67 1.123 . . . . 0.0 107.98 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -92.22 164.52 13.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.176 0.988 . . . . 0.0 111.69 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -70.88 -0.72 9.75 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.459 2.304 . . . . 0.0 115.226 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 t -41.16 -30.59 0.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.635 2.374 . . . . 0.0 116.747 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -130.92 32.91 4.26 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.074 1.306 . . . . 0.0 110.961 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.09 175.11 5.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.05 0.94 . . . . 0.0 110.417 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -112.11 146.63 37.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -126.6 147.92 49.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.536 0.684 . . . . 0.0 111.524 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.21 138.17 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.7 2.0 . . . . 0.0 109.38 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -96.1 134.13 39.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.604 2.362 . . . . 0.0 106.036 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.37 142.2 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.59 -179.98 23.13 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.897 0.771 . . . . 0.0 111.961 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 62.0 18.76 10.2 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.701 2.0 . . . . 0.0 111.749 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.3 mt -62.42 132.61 53.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.245 1.418 . . . . 0.0 110.717 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.42 151.33 77.49 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -60.19 -24.05 75.84 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.94 2.427 . . . . 0.0 114.955 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.13 -22.52 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.08 -1.012 . . . . 0.0 113.061 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.636 HD11 ' HA3' ' A' ' 164' ' ' GLY . 44.3 mm -58.89 122.7 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.022 0.915 . . . . 0.0 111.226 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.5 t -110.66 176.11 5.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.516 1.526 . . . . 0.0 107.173 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 79.8 m -65.19 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 120.428 -1.42 . . . . 0.0 112.8 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -70.42 -33.49 71.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -48.25 79.55 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 110.33 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 mt -60.54 -50.33 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 26.9 mtmt -55.36 -48.16 74.66 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.591 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.38 68.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.911 0.885 . . . . 0.0 110.398 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -44.28 96.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -89.94 -8.88 50.72 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.03 -46.88 99.83 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 117.1 -1.429 . . . . 0.0 114.122 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.11 -3.83 10.48 Favored 'Trans proline' 0 C--N 1.351 0.708 0 CA-C-N 122.115 1.791 . . . . 0.0 112.775 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.4 -11.82 22.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.601 0.637 . . . . 0.0 111.967 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.98 164.99 14.19 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -72.32 124.75 25.76 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.58 147.73 5.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.27 -65.41 1.18 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -102.4 133.71 46.89 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.904 0.882 . . . . 0.0 110.893 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.523 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -157.56 136.34 11.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.586 0.755 . . . . 0.0 109.759 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -163.34 158.42 21.29 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.97 1.708 . . . . 0.0 110.642 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.5 t -100.72 130.44 50.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 138.15 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -132.79 158.28 42.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.484 0.714 . . . . 0.0 109.858 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -61.53 114.83 3.47 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.23 -20.33 26.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.216 1.371 . . . . 0.0 112.81 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.8 -21.13 23.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.7 p -135.71 -15.46 1.82 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.94 1.245 . . . . 0.0 114.051 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.3 86.31 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.936 1.255 . . . . 0.0 114.02 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.2 152.17 30.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.364 1.582 . . . . 0.0 109.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -54.77 126.84 25.78 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.792 0.837 . . . . 0.0 112.059 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -72.59 -52.38 15.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 143.75 -21.54 2.17 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 128.712 3.053 . . . . 0.0 110.449 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.269 7.1 p90 -103.13 168.59 9.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.652 1.581 . . . . 0.0 113.997 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.82 175.06 33.02 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.509 1.528 . . . . 0.0 111.005 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -135.91 147.17 48.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.48 1.112 . . . . 0.0 109.553 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.64 144.24 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.9 t -136.13 140.27 43.55 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.233 1.413 . . . . 0.0 107.438 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.11 150.77 46.52 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.443 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -67.58 -14.24 62.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.221 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -133.82 156.12 48.61 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 120.161 1.346 . . . . 0.0 110.234 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -71.37 -53.05 15.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -51.03 -34.94 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.419 2.288 . . . . 0.0 112.018 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -60.27 -54.54 44.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.011 0.924 . . . . 0.0 108.608 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.33 76.71 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -56.28 -48.77 75.96 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.856 -0.592 . . . . 0.0 111.357 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.91 -45.03 87.14 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.166 0.439 . . . . 0.0 110.869 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.16 85.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.868 -1.063 . . . . 0.0 110.076 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 88.9 mt -54.26 -35.94 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 121.387 1.903 . . . . 0.0 110.312 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -76.63 -62.35 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.054 0.542 . . . . 0.0 111.656 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -63.85 -45.25 90.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.02 2.128 . . . . 0.0 114.032 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 81.9 mmm -75.31 -24.97 57.52 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -64.82 98.36 0.29 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 120.29 -9.41 11.03 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.878 1.228 . . . . 0.0 112.264 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -76.15 178.64 6.24 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.749 1.275 . . . . 0.0 108.469 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -121.01 158.84 26.89 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.25 1.42 . . . . 0.0 107.986 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 tp -154.92 130.69 10.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.636 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 70.45 -25.52 0.47 Allowed Glycine 0 N--CA 1.464 0.566 0 C-N-CA 125.208 1.385 . . . . 0.0 115.707 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.56 -2.24 0.47 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 117.791 -1.56 . . . . 0.0 113.605 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -136.81 157.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.474 2.137 . . . . 0.0 110.99 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -66.97 153.56 43.3 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.75 152.55 32.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.801 0.84 . . . . 0.0 111.008 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -106.52 145.42 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.485 -1.245 . . . . 0.0 107.817 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.0 p -139.04 123.32 18.14 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.634 1.106 . . . . 0.0 110.202 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -149.22 172.2 15.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.756 0.707 . . . . 0.0 109.603 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -66.98 130.5 43.33 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.8 -18.83 46.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.5 p -135.2 93.21 2.96 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.604 1.562 . . . . 0.0 109.884 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -140.06 123.48 17.06 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.171 -0.956 . . . . 0.0 108.927 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -134.72 151.8 76.45 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 126.008 1.723 . . . . 0.0 108.969 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.59 159.02 43.28 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.679 2.253 . . . . 0.0 110.487 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.23 -173.46 1.45 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.111 3.208 . . . . 0.0 108.83 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -110.6 157.68 37.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.346 -1.472 . . . . 0.0 108.803 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.42 1.45 7.38 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.762 2.308 . . . . 0.0 112.72 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -152.94 153.33 32.76 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.9 2.08 . . . . 0.0 106.96 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -129.19 -166.06 1.6 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.35 1.86 . . . . 0.0 107.939 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 -151.77 0.49 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -154.08 172.51 17.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 120.229 1.377 . . . . 0.0 108.281 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -122.79 103.1 8.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.3 t -117.11 127.39 54.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.67 145.16 56.26 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.2 t -79.58 175.02 10.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.588 1.155 . . . . 0.0 110.289 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -153.15 133.7 13.69 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 120.933 -1.104 . . . . 0.0 108.329 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -75.07 158.19 33.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.6 m -139.29 164.91 28.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.335 1.854 . . . . 0.0 107.606 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -146.07 88.8 0.16 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.91 172.7 15.82 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.397 2.065 . . . . 0.0 110.048 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 63.1 m -158.95 171.89 19.2 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.7 t -154.86 163.25 40.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 C-N-CA 128.764 3.078 . . . . 0.0 106.423 -179.62 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.664 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.6 m -112.85 157.73 21.05 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.412 0.685 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.72 126.08 20.69 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.824 0.85 . . . . 0.0 111.817 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.85 -70.66 3.08 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 123.985 0.803 . . . . 0.0 113.263 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -74.45 79.93 1.92 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.931 1.292 . . . . 0.0 113.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 t -74.59 -68.18 0.56 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.81 -147.29 19.71 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -116.94 32.15 6.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.794 0.838 . . . . 0.0 112.729 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.0 110.28 8.41 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.9 31.06 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.943 1.697 . . . . 0.0 110.736 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -62.95 163.29 9.9 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.9 p 56.35 21.83 5.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.946 1.299 . . . . 0.0 111.825 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.1 77.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.245 -1.534 . . . . 0.0 111.033 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.92 -13.94 61.36 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.446 0.699 . . . . 0.0 112.361 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -86.28 172.96 10.07 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.412 1.085 . . . . 0.0 108.431 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -125.45 107.07 10.29 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.005 1.322 . . . . 0.0 111.653 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -85.07 128.43 34.64 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.5 1.12 . . . . 0.0 110.727 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 97.6 t -111.46 138.98 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 127.984 2.514 . . . . 0.0 106.908 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -93.53 142.18 27.63 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.659 1.983 . . . . 0.0 107.075 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -136.94 137.1 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.49 179.43 18.76 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.407 -0.808 . . . . 0.0 111.864 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.57 15.43 6.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.156 3.382 . . . . 0.0 115.007 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.69 149.26 22.32 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.732 1.613 . . . . 0.0 111.596 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.4 t -65.45 145.35 99.07 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.98 -8.3 7.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.089 2.526 . . . . 0.0 115.304 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -98.12 -16.41 19.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.806 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.663 HD11 ' HA3' ' A' ' 164' ' ' GLY . 23.5 mm -58.29 116.81 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 t -91.1 174.34 7.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.655 0.741 . . . . 0.0 109.273 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -64.15 -31.93 73.31 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.391 -1.443 . . . . 0.0 111.595 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -75.42 -24.96 57.17 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.554 -0.716 . . . . 0.0 111.237 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -66.1 -46.66 76.83 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.19 -51.41 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -53.65 -49.27 68.28 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 117.579 -1.2 . . . . 0.0 110.709 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.37 81.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.375 0.989 . . . . 0.0 111.77 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.49 92.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.67 -9.95 39.01 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -47.14 99.58 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.61 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.06 -5.83 11.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.267 1.845 . . . . 0.0 112.39 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -98.04 -11.24 23.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.707 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 160.21 165.8 17.79 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 120.071 1.305 . . . . 0.0 114.17 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -76.4 119.18 19.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 38.2 mt -94.9 149.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 t -114.38 -67.39 1.0 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.23 125.26 48.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.77 136.14 32.2 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -160.94 153.41 20.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 119.441 1.019 . . . . 0.0 111.873 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.6 t -106.98 115.06 47.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.7 139.1 17.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 125.182 1.393 . . . . 0.0 107.625 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -130.83 153.66 48.86 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.607 -0.683 . . . . 0.0 110.484 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.55 107.57 1.43 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.5 ptm -54.03 -13.97 0.93 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 -19.04 17.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.688 1.131 . . . . 0.0 112.816 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 p -130.24 -22.44 2.81 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.98 16.97 73.52 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.605 2.05 . . . . 0.0 112.716 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -84.77 155.22 21.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 1.435 . . . . 0.0 109.105 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.9 t -62.95 122.4 15.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.882 0.31 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -71.5 -25.4 62.25 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.53 -15.34 38.48 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.003 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -103.79 165.95 10.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.256 2.028 . . . . 0.0 110.506 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.52 177.4 33.51 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.841 0.734 . . . . 0.0 111.819 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -135.5 148.24 49.13 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.09 1.356 . . . . 0.0 109.698 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 65.7 t -137.43 120.17 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.138 1.775 . . . . 0.0 107.156 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 t -105.27 114.23 28.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.259 1.823 . . . . 0.0 108.898 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -98.93 148.95 23.45 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.66 1.184 . . . . 0.0 109.12 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -67.88 -40.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.211 0.604 . . . . 0.0 110.243 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -110.91 145.54 38.14 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.03 0.932 . . . . 0.0 112.183 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.32 -46.94 86.45 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.012 0.925 . . . . 0.0 112.141 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.78 -34.26 69.4 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.485 1.114 . . . . 0.0 112.966 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -64.05 -47.49 79.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.39 71.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.968 1.307 . . . . 0.0 111.139 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.51 -47.91 78.32 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.504 0.721 . . . . 0.0 110.293 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -55.57 -49.3 73.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.63 72.56 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 81.4 mt -49.91 -44.42 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.633 1.561 . . . . 0.0 110.221 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -73.09 -58.24 3.45 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.193 0.997 . . . . 0.0 113.294 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -68.58 -51.06 46.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.403 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -67.69 -20.79 65.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.191 0.905 . . . . 0.0 112.749 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.98 90.29 0.58 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.86 -6.15 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.776 1.655 . . . . 0.0 111.752 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -86.84 172.85 9.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.946 0.873 . . . . 0.0 110.172 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -113.03 154.77 25.99 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.997 1.319 . . . . 0.0 109.199 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.0 tp -153.71 128.01 9.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.593 1.557 . . . . 0.0 107.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.663 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 63.92 22.96 67.13 Favored Glycine 0 N--CA 1.464 0.504 0 CA-C-O 119.226 -0.763 . . . . 0.0 114.401 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 98.38 -2.75 59.35 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 115.956 -2.58 . . . . 0.0 115.836 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -140.4 160.91 38.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 121.525 2.663 . . . . 0.0 111.655 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.73 159.08 28.65 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.76 154.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 124.477 1.111 . . . . 0.0 109.112 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -115.99 129.76 56.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.5 p -116.7 153.61 32.05 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.248 1.419 . . . . 0.0 108.961 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -175.51 166.57 3.26 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.733 1.213 . . . . 0.0 108.928 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -70.12 126.13 28.79 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.06 -52.76 6.04 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.27 0.486 . . . . 0.0 110.75 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.7 t -51.34 -58.34 6.47 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -142.41 142.84 32.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.861 1.664 . . . . 0.0 111.229 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -78.26 133.86 63.75 Favored Pre-proline 0 C--O 1.238 0.463 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.02 154.06 71.28 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.753 1.635 . . . . 0.0 110.105 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.99 176.34 10.25 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.031 2.487 . . . . 0.0 110.412 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.94 142.66 97.52 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.79 95.57 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.832 2.355 . . . . 0.0 106.597 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -68.45 121.87 17.25 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.172 -0.955 . . . . 0.0 109.497 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.3 t -123.98 93.63 3.98 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 28.7 m -142.92 146.85 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.808 1.643 . . . . 0.0 107.055 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -83.88 81.41 8.78 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -153.76 140.34 18.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -85.64 163.05 18.53 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.692 0.758 . . . . 0.0 109.752 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -153.28 165.87 34.35 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.534 1.134 . . . . 0.0 110.972 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 13.6 t -163.45 138.97 6.55 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.221 1.809 . . . . 0.0 106.622 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -177.31 129.56 0.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.208 1.403 . . . . 0.0 110.63 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -151.48 167.58 27.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.3 t -143.85 174.63 10.66 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.281 1.832 . . . . 0.0 107.311 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -176.27 81.4 0.07 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 120.074 1.307 . . . . 0.0 114.545 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.61 169.64 21.86 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.093 1.862 . . . . 0.0 108.948 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 26.4 m -143.08 -174.48 4.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 109.626 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 75.6 m -73.46 159.97 32.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.302 -2.388 . . . . 0.0 109.296 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 77.6 p -35.5 93.89 0.01 OUTLIER 'General case' 0 C--O 1.239 0.544 0 C-N-CA 127.885 2.474 . . . . 0.0 114.14 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 p -160.72 127.48 4.16 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.468 2.307 . . . . 0.0 106.173 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.0 138.58 8.96 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 m -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 t -128.23 -10.99 5.25 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.097 1.359 . . . . 0.0 110.713 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.37 148.58 37.24 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 124.158 0.885 . . . . 0.0 110.895 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.53 -22.36 66.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.595 0.758 . . . . 0.0 113.004 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -134.36 -68.84 0.54 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.034 1.333 . . . . 0.0 111.52 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -149.48 125.88 10.86 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.446 0.698 . . . . 0.0 111.388 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -87.07 70.41 10.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -72.96 -1.3 16.47 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.248 -0.907 . . . . 0.0 112.745 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -52.55 0.32 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.139 3.376 . . . . 0.0 117.069 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.65 -3.14 0.47 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.255 1.822 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -73.01 156.11 39.14 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.616 0.767 . . . . 0.0 110.696 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -99.74 101.45 12.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.27 154.5 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.413 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 126.022 1.729 . . . . 0.0 110.745 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.96 129.52 34.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.13 137.69 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.93 -176.98 21.15 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 61.84 18.89 10.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.627 1.971 . . . . 0.0 112.627 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 mt -69.86 151.24 45.92 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 120.473 -1.392 . . . . 0.0 110.909 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.6 t -67.63 146.41 98.53 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.44 -4.36 6.62 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.626 2.884 . . . . 0.0 113.682 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -96.81 -21.34 17.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.882 1.273 . . . . 0.0 111.156 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.3 132.38 23.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.309 1.044 . . . . 0.0 108.953 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -112.13 172.17 7.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.227 1.013 . . . . 0.0 108.809 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -56.3 -29.85 61.77 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.146 1.378 . . . . 0.0 110.776 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -73.03 -34.94 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.704 0.801 . . . . 0.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.47 -49.13 74.84 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mt -59.17 -49.57 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -54.92 -42.32 72.08 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.656 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.97 77.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.828 0.74 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.53 98.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -89.42 -14.52 35.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.349 0.66 . . . . 0.0 112.354 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.72 99.51 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.047 0.939 . . . . 0.0 113.405 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.72 -6.68 16.11 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 121.396 1.534 . . . . 0.0 112.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -99.89 -18.59 17.05 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.364 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 168.23 169.34 31.58 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 119.57 1.077 . . . . 0.0 112.04 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -74.41 124.01 25.73 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.7 mt -100.1 150.48 5.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.58 -61.55 1.6 Allowed 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -101.41 140.5 35.61 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.7 5.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.421 1.088 . . . . 0.0 108.384 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -162.77 161.64 26.29 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.713 1.205 . . . . 0.0 110.74 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.47 134.66 53.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.46 144.06 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -133.9 162.88 30.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.556 1.143 . . . . 0.0 109.583 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -71.31 119.14 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.447 1.499 . . . . 0.0 107.589 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.4 ptp -59.18 -16.59 21.28 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.65 -13.92 20.09 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 68.2 p -137.6 -15.46 1.4 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.306 1.412 . . . . 0.0 113.975 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.64 14.34 81.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.57 1.081 . . . . 0.0 110.904 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.92 141.58 37.48 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.834 1.253 . . . . 0.0 108.567 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.29 123.36 14.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.094 0.957 . . . . 0.0 112.209 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -72.56 -42.68 64.38 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 125.22 -15.27 7.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.757 1.17 . . . . 0.0 112.621 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.027 1.413 . . . . 0.0 108.075 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.05 33.74 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.813 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -131.89 156.4 46.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.323 1.062 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.6 t -141.67 135.22 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 66.4 m -123.96 112.74 17.57 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.425 1.09 . . . . 0.0 108.16 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -97.53 155.6 16.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.24 0.962 . . . . 0.0 110.025 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.72 -41.51 62.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.205 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -103.1 147.44 26.98 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.004 0.522 . . . . 0.0 111.751 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' HE3' ' CH2' ' A' ' 172' ' ' TRP . 11.0 tptm -64.42 -46.69 82.14 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.989 0.916 . . . . 0.0 109.248 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -33.3 68.6 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.538 1.535 . . . . 0.0 113.606 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -63.61 -49.82 71.83 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.47 -51.74 67.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.183 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -51.67 -52.65 46.4 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.116 0.966 . . . . 0.0 111.615 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -55.07 -50.47 69.06 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.104 0.562 . . . . 0.0 110.283 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.98 86.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 117.281 -1.342 . . . . 0.0 110.399 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.75 -36.98 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 123.513 2.869 . . . . 0.0 110.968 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -76.27 -65.19 0.95 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.232 1.013 . . . . 0.0 110.771 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -62.37 -49.49 75.32 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.638 1.975 . . . . 0.0 114.3 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 86.0 mmm -68.95 -28.8 66.96 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.79 78.26 0.2 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.69 1.138 . . . . 0.0 114.633 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.26 -15.24 2.09 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.567 2.032 . . . . 0.0 111.802 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -71.58 171.37 11.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.039 0.92 . . . . 0.0 109.792 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -109.45 143.45 39.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.31 121.37 24.6 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.55 -57.48 1.25 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.03 1.776 . . . . 0.0 111.488 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -165.48 2.06 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 CA-C-O 117.809 -1.55 . . . . 0.0 115.218 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -143.84 157.86 44.08 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.66 2.73 . . . . 0.0 112.144 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -67.49 136.17 54.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.246 0.618 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.0 166.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.272 1.035 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.49 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.898 1.679 . . . . 0.0 107.161 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 39.2 p -137.18 134.84 36.76 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -156.27 170.78 21.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.468 ' CH2' ' HE3' ' A' ' 148' ' ' LYS . 22.2 m95 -62.18 128.2 34.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.002 0.819 . . . . 0.0 109.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.36 -56.2 18.33 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.9 p -68.3 170.95 7.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.926 0.869 . . . . 0.0 112.813 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -130.15 151.56 50.55 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -146.23 150.53 41.72 Favored Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.01 158.1 59.25 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.232 1.955 . . . . 0.0 111.206 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.53 179.86 5.98 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.818 3.012 . . . . 0.0 111.5 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.03 158.26 72.66 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.124 0.97 . . . . 0.0 108.729 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.46 167.58 23.63 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.629 2.219 . . . . 0.0 110.78 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -153.0 128.05 9.69 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.7 t -159.04 159.68 34.98 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.076 1.351 . . . . 0.0 107.827 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.3 t -150.34 176.49 10.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.54 1.136 . . . . 0.0 108.774 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -137.18 173.8 11.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.302 1.841 . . . . 0.0 109.596 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 187' ' ' ASN . 0.0 OUTLIER -150.32 159.99 44.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 128.305 2.642 . . . . 0.0 105.63 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 53.2 m -159.6 28.47 0.19 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.216 1.406 . . . . 0.0 113.264 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.415 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 0.0 OUTLIER -61.04 -14.88 26.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 119.854 -1.779 . . . . 0.0 115.756 -178.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.6 m -25.89 118.47 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.128 2.971 . . . . 0.0 114.659 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 170.14 16.83 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.208 -0.932 . . . . 0.0 109.747 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.4 169.93 23.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.45 1.5 . . . . 0.0 108.375 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 18.2 t -176.24 161.17 2.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.625 2.77 . . . . 0.0 105.535 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 133.82 68.35 0.07 OUTLIER Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.701 -1.055 . . . . 0.0 113.422 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.96 166.97 27.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 119.817 1.809 . . . . 0.0 109.107 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 56.7 m -155.57 169.19 24.87 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.774 -1.204 . . . . 0.0 108.78 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.1 m -78.71 173.43 12.47 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.211 1.005 . . . . 0.0 110.417 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.844 0 C-N-CA 128.72 3.057 . . . . 0.0 106.453 179.504 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 159.0 10.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.453 1.901 . . . . 0.0 111.044 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 t -161.75 149.99 15.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.41 148.1 26.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.0 m -148.65 -65.72 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 118.983 1.391 . . . . 0.0 109.047 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 m 30.7 66.43 0.14 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 127.172 2.189 . . . . 0.0 113.816 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.5 -72.61 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.264 -1.135 . . . . 0.0 110.264 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -72.31 158.49 35.72 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.709 1.204 . . . . 0.0 111.953 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.72 169.2 18.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.701 2.001 . . . . 0.0 107.073 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.02 28.67 1.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.169 0.988 . . . . 0.0 108.397 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.05 27.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 129.913 3.285 . . . . 0.0 113.518 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.15 46.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.315 2.646 . . . . 0.0 114.2 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.8 m -64.55 161.25 17.79 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.99 -1.069 . . . . 0.0 109.481 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 61.75 -12.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.433 2.293 . . . . 0.0 114.799 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -89.12 149.24 23.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -105.56 143.25 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -109.84 153.5 24.33 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.077 0.551 . . . . 0.0 112.062 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -129.45 148.72 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 126.712 2.005 . . . . 0.0 110.39 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -100.22 139.78 35.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.349 2.66 . . . . 0.0 107.014 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -137.03 129.5 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.47 179.87 17.66 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 111.94 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 64.34 9.95 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.74 3.216 . . . . 0.0 113.784 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.4 146.3 16.17 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.953 1.301 . . . . 0.0 111.04 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.5 t -63.04 141.23 97.71 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.06 -15.55 18.03 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.937 2.425 . . . . 0.0 114.928 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.79 -17.95 39.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.388 1.075 . . . . 0.0 113.054 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.64 HD11 ' HA3' ' A' ' 164' ' ' GLY . 27.9 mm -58.51 135.22 23.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.243 1.417 . . . . 0.0 110.724 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 111' ' ' GLU . 1.3 t -116.53 176.33 5.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.985 0.898 . . . . 0.0 111.488 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.8 m -58.85 -35.25 72.64 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.082 -1.011 . . . . 0.0 111.458 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' H ' HG23 ' A' ' 109' ' ' THR . 8.6 mt-10 -79.97 -18.12 51.18 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.317 0.647 . . . . 0.0 111.329 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.94 -50.09 21.64 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.7 mt -57.96 -50.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -54.87 -47.71 73.9 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.539 -1.22 . . . . 0.0 110.903 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.6 -33.87 70.49 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.691 1.132 . . . . 0.0 111.898 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.22 -46.37 64.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.923 0.889 . . . . 0.0 112.246 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -92.51 -1.66 56.79 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.68 -48.41 95.37 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 125.876 1.67 . . . . 0.0 112.334 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.65 -0.57 5.41 Favored 'Trans proline' 0 C--N 1.357 1.0 0 CA-C-N 121.091 1.425 . . . . 0.0 113.75 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -98.64 -10.75 22.85 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.955 0.798 . . . . 0.0 111.156 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 146.19 175.57 19.32 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 35.4 mtt180 -70.56 137.95 50.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.172 -0.605 . . . . 0.0 110.017 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.95 138.41 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.5 t -100.47 -72.93 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 144' ' ' SER . 6.9 t70 -102.43 142.52 33.51 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.08 1.752 . . . . 0.0 110.235 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.68 129.1 2.56 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.064 0.847 . . . . 0.0 109.409 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -162.26 150.85 14.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.618 0.367 . . . . 0.0 111.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.06 136.99 23.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.11 146.78 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -139.53 145.8 39.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -67.43 129.65 40.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -65.59 -18.78 65.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.466 0.706 . . . . 0.0 111.465 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.41 -12.43 22.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -134.3 -18.9 1.97 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.358 0.981 . . . . 0.0 113.287 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.49 72.78 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.94 153.62 18.23 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -59.91 130.15 45.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.16 -20.57 57.45 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.466 -0.778 . . . . 0.0 111.947 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.16 -30.2 10.88 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.98 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -101.89 163.86 12.03 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.527 1.164 . . . . 0.0 108.315 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.7 171.64 27.43 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.849 1.69 . . . . 0.0 109.091 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -136.02 146.66 47.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.4 t -133.61 158.69 42.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.856 1.663 . . . . 0.0 106.726 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 125' ' ' ASP . 32.4 t -143.18 135.4 27.11 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.45 166.28 15.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.448 0.699 . . . . 0.0 111.12 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 122' ' ' ARG . 82.4 m-85 -79.66 -26.42 41.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 117.753 -1.117 . . . . 0.0 113.939 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -124.35 150.76 45.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.814 1.643 . . . . 0.0 110.714 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -62.25 -48.6 79.22 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.114 0.483 . . . . 0.0 110.153 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -29.66 67.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.973 1.309 . . . . 0.0 112.615 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.03 -54.65 38.56 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.83 -57.88 11.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 127.201 2.2 . . . . 0.0 111.838 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.23 -51.49 25.23 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.364 1.466 . . . . 0.0 111.387 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -55.06 -45.69 75.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 123.412 0.445 . . . . 0.0 111.257 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.96 78.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 117.559 -1.21 . . . . 0.0 110.85 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 97.5 mt -52.02 -44.42 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 120.634 1.561 . . . . 0.0 108.069 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -68.08 -61.45 1.85 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.186 1.394 . . . . 0.0 111.678 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.7 -60.04 4.06 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.92 2.088 . . . . 0.0 114.465 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.31 -20.35 66.03 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.29 1.036 . . . . 0.0 113.665 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.11 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.46 49.96 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.593 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -69.72 167.56 16.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.44 1.62 . . . . 0.0 108.218 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -108.81 141.95 40.09 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.7 tp -140.97 129.55 22.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.64 ' HA3' HD11 ' A' ' 108' ' ' ILE . . . 79.56 -53.87 4.3 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 124.668 1.127 . . . . 0.0 110.326 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 170.11 6.15 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.429 1.014 . . . . 0.0 113.809 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -136.31 159.02 43.02 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.867 1.834 . . . . 0.0 108.595 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -68.15 166.04 16.99 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.44 145.35 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 121.617 0.722 . . . . 0.0 109.351 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.7 ptt-85 -108.41 136.53 47.88 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.6 p -122.6 153.37 39.39 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.023 1.329 . . . . 0.0 108.191 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -173.21 165.86 4.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.843 0.857 . . . . 0.0 109.124 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -66.64 120.89 14.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.26 77.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.326 0.512 . . . . 0.0 111.177 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.2 t -66.73 152.09 46.14 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.439 1.495 . . . . 0.0 110.089 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -126.89 166.68 17.03 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.701 1.201 . . . . 0.0 109.034 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 176' ' ' LYS . 0.7 OUTLIER -146.12 131.95 9.43 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.68 150.98 87.31 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.837 3.025 . . . . 0.0 114.267 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.13 164.3 35.8 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.756 2.304 . . . . 0.0 112.398 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -151.88 160.94 30.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.288 2.235 . . . . 0.0 108.604 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -83.58 162.13 14.57 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.87 3.047 . . . . 0.0 111.503 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.86 143.57 6.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.257 1.423 . . . . 0.0 109.375 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.0 t -172.47 105.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -143.53 123.21 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -164.88 171.62 13.89 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.249 2.22 . . . . 0.0 106.592 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -163.29 103.24 0.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.2 t -175.88 146.69 0.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.208 2.203 . . . . 0.0 105.991 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -154.84 160.24 41.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.0 p -142.61 170.67 15.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.468 0.707 . . . . 0.0 109.223 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.67 -58.02 0.36 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.21 167.4 22.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.905 2.082 . . . . 0.0 106.633 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.3 p -154.51 178.55 9.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.087 2.155 . . . . 0.0 106.499 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 40.01 62.57 1.45 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.183 1.373 . . . . 0.0 114.097 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.42 108.49 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.373 2.049 . . . . 0.0 110.6 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 10.0 t -144.04 147.07 33.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.2 p -162.38 175.89 11.08 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.162 1.385 . . . . 0.0 108.03 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.425 0 C-N-CA 127.975 2.702 . . . . 0.0 106.631 179.821 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.74 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.3 m -154.88 161.99 41.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.576 1.95 . . . . 0.0 107.441 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.0 t -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.868 0.758 . . . . 0.0 110.141 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.45 161.68 29.97 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 125.222 1.391 . . . . 0.0 110.133 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.9 m -89.0 -175.57 4.88 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.598 0.713 . . . . 0.0 110.613 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.6 p -118.5 177.08 4.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.163 2.185 . . . . 0.0 107.157 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.7 143.36 5.57 Favored Glycine 0 C--O 1.236 0.229 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -80.8 110.98 16.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -79.9 63.28 4.39 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.6 -45.48 77.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.917 1.687 . . . . 0.0 110.827 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -70.88 127.37 32.37 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.1 p -72.81 4.25 4.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.607 1.563 . . . . 0.0 114.36 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -31.74 -56.74 0.29 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 118.743 2.868 . . . . 0.0 118.743 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.97 13.82 27.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.318 1.047 . . . . 0.0 112.552 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -73.44 168.58 18.95 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.42 100.34 8.24 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.35 131.4 36.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.05 141.72 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 128.102 2.561 . . . . 0.0 109.521 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -88.89 131.0 35.31 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 127.013 2.125 . . . . 0.0 105.671 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.33 139.33 51.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.39 -177.94 22.26 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.268 77.1 m-20 68.12 13.93 9.19 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.62 1.968 . . . . 0.0 113.251 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.7 mt -64.53 140.06 58.83 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 t -67.89 150.14 97.91 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -60.76 -4.05 3.23 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.809 3.006 . . . . 0.0 114.927 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -99.85 -17.12 17.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.016 1.326 . . . . 0.0 111.783 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.3 mm -61.85 136.9 24.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.03 1.332 . . . . 0.0 109.517 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.7 t -108.57 174.52 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.033 0.92 . . . . 0.0 108.715 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.8 m -64.67 -27.54 68.99 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.547 -1.345 . . . . 0.0 110.647 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.91 -32.66 67.61 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.573 -0.727 . . . . 0.0 109.86 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.32 -47.29 84.92 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mt -60.11 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 22.0 mtmt -53.53 -47.63 69.8 Favored 'General case' 0 C--O 1.225 -0.227 0 O-C-N 120.329 -1.482 . . . . 0.0 111.97 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.55 -45.51 93.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.755 0.822 . . . . 0.0 111.633 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -58.55 -45.87 88.03 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.711 1.204 . . . . 0.0 113.602 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -89.56 -10.77 44.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.722 1.209 . . . . 0.0 113.035 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.05 -47.56 98.56 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 124.817 1.247 . . . . 0.0 112.192 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -62.91 -7.16 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 121.791 1.675 . . . . 0.0 113.184 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.64 -13.28 20.41 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.428 1.013 . . . . 0.0 112.003 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 159.19 174.09 28.46 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 120.541 1.519 . . . . 0.0 112.724 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -71.7 127.55 32.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.9 mt -102.16 139.51 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.8 p -99.29 -79.02 0.49 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -102.66 126.05 49.62 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.764 2.826 . . . . 0.0 110.793 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.411 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -149.05 140.31 23.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.664 1.186 . . . . 0.0 107.943 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -162.7 151.54 14.86 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 t -94.32 127.26 46.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.18 141.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -125.63 161.03 28.15 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.885 1.326 . . . . 0.0 110.22 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.29 130.37 40.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.633 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -7.97 55.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 -21.81 12.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.626 1.103 . . . . 0.0 112.208 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 71.7 p -131.68 -8.24 3.61 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.627 1.344 . . . . 0.0 114.627 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 31.31 78.28 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.209 -0.773 . . . . 0.0 112.143 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -100.98 157.19 16.94 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.192 1.397 . . . . 0.0 108.235 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 36.5 t -62.08 125.9 25.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.215 0.916 . . . . 0.0 111.314 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -74.65 -21.05 59.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.49 -15.7 55.73 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.36 1.457 . . . . 0.0 113.027 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.256 49.5 p90 -103.02 163.36 12.26 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.277 1.539 . . . . 0.0 109.282 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.5 169.3 32.8 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.337 -0.852 . . . . 0.0 111.384 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -129.77 149.82 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.913 0.885 . . . . 0.0 109.111 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.43 138.81 47.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 131.81 53.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -119.81 155.75 31.97 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.172 0.989 . . . . 0.0 109.744 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -76.39 -20.02 57.56 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.094 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -129.45 151.14 50.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.865 1.211 . . . . 0.0 112.781 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.543 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 7.6 ttmt -68.95 -50.74 46.62 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.882 1.273 . . . . 0.0 110.196 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -47.71 69.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.097 1.359 . . . . 0.0 113.271 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -60.61 -46.93 88.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.41 83.29 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.961 1.305 . . . . 0.0 109.981 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -57.09 -45.67 83.18 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.82 1.248 . . . . 0.0 110.448 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -53.62 -48.05 69.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.55 87.82 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.936 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.7 mt -55.21 -37.93 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 121.804 2.093 . . . . 0.0 110.274 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -72.71 -65.77 0.75 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.616 0.766 . . . . 0.0 111.427 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -67.07 -44.41 80.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.872 2.069 . . . . 0.0 116.547 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -77.79 -20.79 52.66 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.831 1.196 . . . . 0.0 112.872 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.21 112.35 4.64 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.31 -9.54 65.04 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -70.91 169.71 14.2 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 119.753 1.776 . . . . 0.0 109.842 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -104.65 132.11 51.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.718 0.807 . . . . 0.0 108.941 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 116' ' ' ALA . 21.9 tp -123.83 118.95 28.29 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 108.143 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.82 -6.51 1.4 Allowed Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.273 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.0 3.61 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.232 1.516 . . . . 0.0 115.331 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -135.27 154.16 51.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.796 2.298 . . . . 0.0 110.342 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -63.37 163.03 11.33 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.448 0.468 . . . . 0.0 109.976 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.23 153.76 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 124.753 1.221 . . . . 0.0 109.756 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -113.74 142.86 45.52 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.4 p -136.89 135.99 38.31 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.552 0.741 . . . . 0.0 109.524 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.46 174.08 15.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.218 0.607 . . . . 0.0 109.879 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.543 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 83.9 m95 -70.57 118.24 13.11 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 120.538 -1.352 . . . . 0.0 108.153 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.14 -44.88 95.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.78 0.718 . . . . 0.0 109.077 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.6 p -73.26 100.6 3.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -71.54 109.54 5.55 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.844 -1.16 . . . . 0.0 110.705 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.34 150.71 69.65 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 125.674 1.589 . . . . 0.0 108.953 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 159.02 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.828 1.686 . . . . 0.0 108.704 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.95 154.02 63.21 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 N-CA-C 107.669 -1.704 . . . . 0.0 107.669 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -153.24 151.93 26.79 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 118.389 0.54 . . . . 0.0 111.398 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.75 166.88 26.34 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.961 2.441 . . . . 0.0 110.543 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -143.97 125.67 15.07 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.783 2.433 . . . . 0.0 104.865 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.17 -60.25 3.32 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.984 0.914 . . . . 0.0 110.372 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 -178.96 7.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -92.28 -66.8 0.9 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 128.034 2.534 . . . . 0.0 110.058 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -161.69 -174.97 4.46 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.589 0.755 . . . . 0.0 111.212 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.2 t -157.63 88.2 0.98 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.43 1.092 . . . . 0.0 109.163 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -155.38 133.32 11.42 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.625 -0.672 . . . . 0.0 109.35 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.1 p -66.45 153.38 42.99 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -53.86 128.6 30.65 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -130.67 178.38 6.68 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 63.7 p -156.61 172.51 18.44 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.945 2.098 . . . . 0.0 106.621 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -143.63 149.31 21.29 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.23 177.04 7.72 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.709 2.272 . . . . 0.0 109.982 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.8 t -141.28 140.29 33.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.9 t -160.24 163.71 33.29 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 107.083 -2.407 . . . . 0.0 107.083 -179.364 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 92.5 p -61.91 -27.91 69.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.297 0.549 . . . . 0.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.56 121.53 30.1 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -165.31 113.63 0.56 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.0 m -72.57 -42.74 64.28 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.2 p 58.25 -52.36 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.763 3.225 . . . . 0.0 116.51 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.85 158.55 50.0 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 119.154 0.888 . . . . 0.0 113.549 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -138.75 50.86 1.84 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.064 1.746 . . . . 0.0 107.936 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.02 156.64 27.44 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.984 -1.072 . . . . 0.0 109.946 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -120.34 -1.35 10.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.917 1.287 . . . . 0.0 112.178 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -113.26 -172.76 2.12 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.666 1.121 . . . . 0.0 109.049 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.9 p -123.11 41.39 3.48 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.519 1.527 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.7 p -70.5 134.12 47.43 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 59.75 13.45 3.51 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.272 1.829 . . . . 0.0 114.211 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -84.5 178.35 7.76 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.826 0.85 . . . . 0.0 109.096 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.13 100.65 6.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 144' ' ' SER . 1.3 m80 -71.38 167.29 19.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.369 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.32 142.94 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 127.875 2.47 . . . . 0.0 106.561 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -103.65 137.06 42.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -132.72 140.25 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.92 -179.26 21.15 Favored Glycine 0 N--CA 1.454 -0.153 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.26 4.69 2.22 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.466 2.306 . . . . 0.0 113.258 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -51.2 139.09 19.26 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 110.527 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 t -62.59 145.26 95.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.49 -18.1 37.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.489 2.793 . . . . 0.0 115.136 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.62 -13.21 43.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.084 -1.01 . . . . 0.0 112.652 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.66 138.71 22.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.5 t -118.45 175.13 5.86 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.502 1.144 . . . . 0.0 109.117 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 50.3 m -58.92 -30.15 67.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.226 1.01 . . . . 0.0 111.748 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.75 -43.37 68.96 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 125.92 1.688 . . . . 0.0 110.878 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.74 -51.92 65.68 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.214 1.405 . . . . 0.0 109.28 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.67 -48.14 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.59 -45.24 69.95 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.846 -1.073 . . . . 0.0 110.814 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.27 -45.94 85.86 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.084 0.856 . . . . 0.0 110.796 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.67 -47.54 85.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 113.197 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -87.35 -10.89 50.95 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.39 -48.52 95.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.66 -3.3 6.47 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 CA-C-N 121.47 1.561 . . . . 0.0 112.959 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.88 -17.71 18.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.069 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.57 162.17 16.21 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 119.584 1.084 . . . . 0.0 111.503 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -73.65 120.53 19.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.62 153.24 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.5 t -117.31 -68.44 0.92 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -102.03 145.04 29.86 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.469 1.107 . . . . 0.0 108.891 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.04 129.85 2.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.2 158.16 32.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.473 0.654 . . . . 0.0 110.777 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.22 120.1 56.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.43 141.8 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 137' ' ' SER . 46.0 mttm -135.41 157.3 47.23 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -71.23 127.16 31.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 21.5 ptp -59.88 -20.47 57.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.59 -9.22 16.65 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.0 p -131.83 -19.55 2.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.048 1.295 . . . . 0.0 113.083 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.81 2.41 56.96 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.291 0.948 . . . . 0.0 112.865 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -80.05 148.55 31.02 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' A' ' 130' ' ' LYS . 17.8 m -63.78 134.79 55.92 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.507 1.146 . . . . 0.0 112.33 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -77.71 -13.7 59.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.534 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.16 -18.9 55.23 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.016 -1.435 . . . . 0.0 113.464 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -102.52 165.1 11.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.019 1.41 . . . . 0.0 109.112 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.32 179.79 28.55 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.471 1.034 . . . . 0.0 111.966 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.28 154.04 51.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 109.089 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.7 t -145.83 149.3 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 37.9 t -142.48 115.49 8.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.005 1.722 . . . . 0.0 107.393 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.91 158.17 15.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.805 1.242 . . . . 0.0 111.391 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.1 -14.83 61.95 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.66 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -143.56 156.84 44.71 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.857 1.208 . . . . 0.0 110.195 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.8 tttt -68.49 -43.03 77.77 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.923 1.289 . . . . 0.0 111.93 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -53.51 -41.75 66.66 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.726 1.21 . . . . 0.0 111.658 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -62.15 -48.98 77.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.901 1.28 . . . . 0.0 108.893 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.56 66.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.367 1.067 . . . . 0.0 110.311 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.37 -50.0 63.29 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.844 1.658 . . . . 0.0 109.753 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -55.41 -55.4 32.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.552 1.141 . . . . 0.0 109.16 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.48 91.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 117.624 -1.179 . . . . 0.0 111.748 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.52 -49.26 44.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 121.136 1.789 . . . . 0.0 108.411 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.31 -67.22 0.46 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.132 0.573 . . . . 0.0 111.991 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -58.93 -50.43 74.07 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 83.8 mmm -69.29 -17.75 63.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.346 0.975 . . . . 0.0 111.95 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.26 79.5 0.08 OUTLIER Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.445 2.45 . . . . 0.0 113.37 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 126.78 -8.74 7.25 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.062 1.791 . . . . 0.0 112.627 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -70.99 170.32 13.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.033 1.417 . . . . 0.0 109.67 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -111.14 150.79 28.96 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.385 1.074 . . . . 0.0 109.991 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 47.0 tp -155.51 130.1 9.1 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.805 2.042 . . . . 0.0 106.505 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.1 27.3 71.22 Favored Glycine 0 N--CA 1.465 0.59 0 O-C-N 121.49 -0.756 . . . . 0.0 114.032 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.78 4.4 87.34 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 117.755 -1.581 . . . . 0.0 113.439 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -137.57 155.35 49.31 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.81 2.305 . . . . 0.0 110.899 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -71.55 160.44 32.7 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.8 pt -124.57 169.96 15.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -123.63 152.24 42.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.9 p -141.83 150.21 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 107.575 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -175.52 171.12 2.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -67.17 111.36 3.88 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.582 -0.699 . . . . 0.0 109.817 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.65 -31.61 64.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.549 1.14 . . . . 0.0 110.843 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.9 p -79.48 -8.22 58.98 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 126.17 1.788 . . . . 0.0 113.644 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -156.14 81.37 0.99 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.536 1.062 . . . . 0.0 111.645 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -75.63 137.11 70.6 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.0 161.04 41.99 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.19 1.927 . . . . 0.0 109.693 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.0 151.44 81.44 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.534 2.156 . . . . 0.0 111.566 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.71 156.24 73.0 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.261 1.024 . . . . 0.0 111.407 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.89 161.5 41.28 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.886 1.724 . . . . 0.0 109.426 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.34 175.08 9.89 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.837 1.655 . . . . 0.0 109.433 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.8 t -83.94 131.61 34.84 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.343 1.857 . . . . 0.0 106.055 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 28.7 p -133.91 74.4 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -62.35 150.67 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.07 0.948 . . . . 0.0 108.681 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -136.48 156.15 49.0 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.511 1.124 . . . . 0.0 109.186 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.4 t -159.3 84.97 0.79 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -135.1 154.84 51.53 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 62.3 m -158.74 127.89 5.54 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -156.96 82.09 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.358 0.981 . . . . 0.0 110.88 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.57 162.84 28.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.7 p -160.56 176.78 11.2 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.933 1.693 . . . . 0.0 108.283 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.62 87.81 0.43 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 105.89 -2.884 . . . . 0.0 105.89 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.29 -7.59 16.09 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.114 2.543 . . . . 0.0 113.262 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.2 p -136.43 172.02 13.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.848 1.659 . . . . 0.0 109.559 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 10.4 t -77.67 1.08 20.97 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.685 0.794 . . . . 0.0 112.498 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.713 0 C-N-CA 129.352 3.358 . . . . 0.0 106.53 -179.679 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -53.89 139.77 32.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.717 0.758 . . . . 0.0 110.4 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 t 170.96 166.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.567 3.147 . . . . 0.0 105.627 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.38 -146.25 2.41 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.4 m -73.59 159.33 33.27 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.58 -0.953 . . . . 0.0 109.416 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -156.94 -176.18 5.84 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.343 1.457 . . . . 0.0 108.67 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.11 126.33 2.95 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.942 1.258 . . . . 0.0 110.781 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -128.69 -3.97 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.109 0.964 . . . . 0.0 112.219 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 153.43 44.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -68.42 -8.35 39.77 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -67.34 162.52 22.68 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.947 0.899 . . . . 0.0 109.481 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.9 p -114.92 92.85 4.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.1 p -111.12 -27.71 8.61 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -88.51 -14.62 37.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.72 0.808 . . . . 0.0 112.341 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -80.79 168.38 18.87 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.684 1.193 . . . . 0.0 112.335 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.6 99.23 7.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.0 127.4 32.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.0 0.905 . . . . 0.0 113.338 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.55 148.21 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 126.788 2.035 . . . . 0.0 108.091 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -105.01 136.62 44.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 129.471 3.109 . . . . 0.0 106.95 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.3 t -129.27 142.83 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -149.84 -178.83 25.14 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.04 1.97 2.98 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.854 2.461 . . . . 0.0 114.382 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -50.19 149.26 2.97 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.829 2.452 . . . . 0.0 113.681 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.61 161.76 68.1 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.83 -29.44 15.46 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.145 1.23 . . . . 0.0 113.111 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.41 -16.94 61.84 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.851 1.66 . . . . 0.0 114.117 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -59.74 117.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.668 1.187 . . . . 0.0 110.116 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.8 t -100.3 171.03 8.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 127' ' ' ARG . 85.3 m -55.1 -30.95 60.78 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 121.019 -1.05 . . . . 0.0 111.53 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.71 -33.75 64.52 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.122 0.969 . . . . 0.0 111.761 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.12 -47.98 83.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.6 mt -61.22 -55.55 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.426 ' HE3' HG22 ' A' ' 110' ' ' THR . 22.5 mtmt -51.68 -47.93 63.65 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.501 1.046 . . . . 0.0 112.301 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.12 72.05 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.596 0.758 . . . . 0.0 112.14 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.409 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -73.08 -43.85 61.28 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.364 1.066 . . . . 0.0 112.014 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -90.26 -9.58 47.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.824 1.249 . . . . 0.0 112.851 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.16 -44.3 99.54 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 126.6 1.96 . . . . 0.0 113.318 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.9 -0.84 9.04 Favored 'Trans proline' 0 C--N 1.354 0.82 0 CA-C-N 121.501 1.572 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -98.66 -25.18 14.79 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.087 0.858 . . . . 0.0 110.967 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.44 34.7 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 121.137 -0.977 . . . . 0.0 111.201 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -77.78 117.45 19.18 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mt -88.4 145.3 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 p -100.54 -81.42 0.47 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -103.04 141.46 35.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.299 1.84 . . . . 0.0 111.196 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.13 141.85 5.75 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.106 2.163 . . . . 0.0 108.065 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.485 ' HA ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -161.9 169.6 20.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.784 1.234 . . . . 0.0 109.136 178.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.98 124.98 67.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.443 HG21 ' CD2' ' A' ' 140' ' ' TYR . 47.9 t -64.88 140.78 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.37 148.21 50.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 59.6 t0 -59.02 131.14 50.16 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.7 tpt -59.78 -30.41 68.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.366 0.53 . . . . 0.0 112.25 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.12 -41.05 9.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 61.3 p -95.85 -15.87 22.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.15 0.886 . . . . 0.0 112.943 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 65.92 12.52 57.46 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.283 0.944 . . . . 0.0 112.584 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.92 150.01 27.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.888 1.275 . . . . 0.0 110.599 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 t -56.15 109.66 0.63 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.323 2.249 . . . . 0.0 109.142 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 131' ' ' ASP . 20.7 mttt -67.81 -23.4 65.18 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.47 -18.84 46.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.443 ' CD2' HG21 ' A' ' 129' ' ' VAL 0.288 27.5 p90 -103.21 157.9 16.69 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.635 -1.509 . . . . 0.0 109.71 176.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.22 176.6 25.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.564 1.554 . . . . 0.0 111.077 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.77 152.0 44.88 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.02 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 55.0 t -147.25 130.65 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 108.027 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -118.77 127.81 53.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.744 2.018 . . . . 0.0 107.011 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.55 165.69 12.25 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.701 1.137 . . . . 0.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -74.43 -9.57 58.72 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.575 -0.703 . . . . 0.0 112.512 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -146.59 165.86 28.25 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 119.595 1.088 . . . . 0.0 112.09 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -73.85 -47.28 39.49 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.802 1.241 . . . . 0.0 111.543 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -39.06 76.9 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.702 0.801 . . . . 0.0 111.935 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.66 -48.42 77.64 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -54.89 15.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.322 1.849 . . . . 0.0 111.45 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -55.87 -44.15 77.83 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.176 0.99 . . . . 0.0 111.918 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.74 -45.26 86.07 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 121.217 0.532 . . . . 0.0 110.151 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.99 -44.74 79.62 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.684 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 92.0 mt -52.69 -37.62 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 120.354 1.434 . . . . 0.0 110.399 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -73.07 -67.6 0.56 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.417 1.087 . . . . 0.0 110.632 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -58.69 -57.93 10.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.467 2.307 . . . . 0.0 114.295 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -65.34 -24.51 67.28 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -65.48 90.47 0.12 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.222 0.915 . . . . 0.0 111.971 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.49 -6.88 9.79 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.193 1.378 . . . . 0.0 113.308 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -74.97 174.3 9.51 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.093 1.446 . . . . 0.0 109.481 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -109.74 129.35 55.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' A' ' 116' ' ' ALA . 39.3 tp -125.25 124.22 41.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.901 1.68 . . . . 0.0 108.934 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.1 -59.21 1.84 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 125.005 1.288 . . . . 0.0 111.554 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.75 -3.04 0.03 OUTLIER Glycine 0 CA--C 1.53 1.005 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.947 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -141.49 165.98 26.02 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.384 2.092 . . . . 0.0 111.5 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -67.57 161.67 25.1 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.351 0.66 . . . . 0.0 110.645 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 28.7 pt -138.71 157.64 29.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.533 1.133 . . . . 0.0 109.977 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -122.32 148.02 45.54 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.1 p -138.91 134.66 33.51 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 119.649 1.113 . . . . 0.0 110.409 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -157.02 176.92 12.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.571 1.148 . . . . 0.0 108.895 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -74.44 133.75 42.39 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.593 -1.317 . . . . 0.0 110.47 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.37 -52.35 9.3 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 p -65.82 125.66 26.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -133.95 -169.25 2.27 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.19 1.396 . . . . 0.0 111.298 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -136.37 158.12 74.07 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 125.204 1.402 . . . . 0.0 110.66 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.85 169.95 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.692 3.594 . . . . 0.0 111.569 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.84 174.82 10.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.181 3.254 . . . . 0.0 110.974 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.37 33.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 120.543 -1.348 . . . . 0.0 112.1 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -90.73 168.84 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.615 2.877 . . . . 0.0 109.635 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.48 134.21 25.16 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.292 -0.88 . . . . 0.0 109.761 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.2 t -163.58 112.8 1.27 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.2 1.4 . . . . 0.0 108.04 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.7 t -162.15 145.73 11.95 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -179.56 163.25 1.18 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.349 2.26 . . . . 0.0 108.402 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.51 148.61 1.21 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 128.965 2.906 . . . . 0.0 104.128 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 28.3 p -162.05 12.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.946 0.898 . . . . 0.0 111.554 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.13 152.14 41.34 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.878 1.217 . . . . 0.0 111.606 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.8 m -159.2 131.82 6.81 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -137.71 153.77 49.74 Favored 'General case' 0 C--N 1.335 -0.03 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -151.37 -176.86 5.75 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.113 1.765 . . . . 0.0 107.381 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.6 m -139.13 -16.5 1.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.965 1.706 . . . . 0.0 112.551 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 44.67 72.53 0.34 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.568 1.556 . . . . 0.0 113.776 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.98 -6.1 17.9 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.514 2.142 . . . . 0.0 113.96 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.4 t 71.69 -12.8 0.61 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.819 2.048 . . . . 0.0 112.894 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.2 p -78.46 -16.4 57.59 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.261 0.937 . . . . 0.0 109.374 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 1 C-N-CA 133.588 5.375 . . . . 0.0 104.65 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.4 m 51.77 18.87 0.81 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.803 2.441 . . . . 0.0 115.127 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -72.72 -17.6 61.6 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.671 1.188 . . . . 0.0 111.049 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.35 164.72 38.02 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.1 t -66.95 -46.08 75.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.611 1.564 . . . . 0.0 111.041 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.9 p -71.2 168.27 17.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.717 0.77 . . . . 0.0 112.022 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.83 112.75 0.54 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -49.03 135.2 16.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.085 0.942 . . . . 0.0 110.966 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -155.61 137.18 14.17 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.537 1.135 . . . . 0.0 110.56 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 -17.36 34.21 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 124.332 1.02 . . . . 0.0 109.365 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.52 155.31 40.21 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.522 1.929 . . . . 0.0 108.385 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.439 HG21 ' HB2' ' A' ' 125' ' ' ASP . 70.6 p -128.07 18.52 6.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.527 1.131 . . . . 0.0 111.34 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.92 -10.18 1.02 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.016 2.126 . . . . 0.0 115.978 -178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -136.9 13.08 3.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.899 1.279 . . . . 0.0 111.296 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -86.39 -174.61 5.11 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.531 1.133 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -124.41 109.91 13.89 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -91.03 150.32 21.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.658 0.742 . . . . 0.0 111.733 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.2 t -129.39 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.126 1.77 . . . . 0.0 108.907 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -101.3 143.29 31.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.996 3.318 . . . . 0.0 106.753 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.78 146.39 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.89 173.91 26.04 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 119.031 0.832 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.5 t0 61.38 17.81 8.7 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.986 2.914 . . . . 0.0 114.211 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.451 HD13 HD11 ' A' ' 113' ' ' ILE . 12.9 mt -59.31 135.68 57.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.343 1.457 . . . . 0.0 110.143 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 t -60.12 148.48 77.98 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -61.43 -17.21 52.23 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.665 1.576 . . . . 0.0 113.364 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -76.48 -29.85 57.05 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.862 0.756 . . . . 0.0 110.591 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.9 mm -58.31 115.47 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.517 1.527 . . . . 0.0 108.986 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 t -100.05 174.39 6.19 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.138 1.375 . . . . 0.0 109.714 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.4 m -57.76 -36.84 72.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.317 -0.864 . . . . 0.0 111.463 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.59 -44.36 78.31 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.08 1.352 . . . . 0.0 109.981 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.96 -47.63 80.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.276 1.03 . . . . 0.0 109.666 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 104' ' ' LEU . 10.9 mt -60.14 -50.55 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -52.78 -48.05 67.12 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.259 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.14 -34.68 70.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.658 1.117 . . . . 0.0 111.675 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.74 -45.82 60.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.285 1.034 . . . . 0.0 111.503 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -87.69 -4.49 58.91 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.54 94.08 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.655 2.382 . . . . 0.0 114.664 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.21 -1.34 7.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 122.181 1.815 . . . . 0.0 112.516 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -98.4 -9.5 25.15 Favored 'General case' 0 N--CA 1.461 0.116 0 O-C-N 121.175 -0.953 . . . . 0.0 111.503 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.46 -155.83 26.54 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 111.832 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -100.27 131.24 46.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.862 0.865 . . . . 0.0 110.384 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.18 133.63 43.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.726 1.61 . . . . 0.0 108.772 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.7 p -99.8 -73.03 0.65 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.439 ' HB2' HG21 ' A' ' 93' ' ' THR . 45.8 t0 -103.47 148.99 25.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.288 1.835 . . . . 0.0 109.053 177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.62 4.21 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.899 1.28 . . . . 0.0 108.967 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.8 ptm85 -161.01 147.67 15.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.44 0.564 . . . . 0.0 112.173 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -92.02 120.18 40.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.37 137.58 24.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -136.25 160.93 37.21 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.92 135.78 54.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.7 ptp -68.87 -14.37 62.99 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.773 -0.58 . . . . 0.0 110.015 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.57 -6.5 17.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.079 1.752 . . . . 0.0 115.157 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 p -136.72 -23.32 1.21 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.471 1.032 . . . . 0.0 112.254 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.8 4.54 62.26 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.345 -1.253 . . . . 0.0 110.839 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -81.82 150.9 27.63 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.93 1.865 . . . . 0.0 108.467 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 t -56.35 120.4 7.58 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -70.55 -35.3 73.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.137 -0.459 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 127.89 -29.63 4.13 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.987 1.755 . . . . 0.0 110.404 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -102.15 166.51 10.56 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.601 1.16 . . . . 0.0 111.749 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.85 170.84 31.29 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.419 1.485 . . . . 0.0 110.173 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -129.38 150.15 50.86 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.091 1.356 . . . . 0.0 108.523 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.4 t -137.78 159.8 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 127.515 2.326 . . . . 0.0 105.028 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.9 t -142.63 130.75 21.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.806 2.042 . . . . 0.0 107.721 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.52 134.84 54.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.111 1.364 . . . . 0.0 109.368 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -64.31 -39.41 93.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.425 0.69 . . . . 0.0 109.639 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -111.11 145.64 38.22 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.04 1.336 . . . . 0.0 107.905 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -66.39 -45.11 81.13 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -38.66 55.75 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 112.882 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.83 -49.93 75.49 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.4 77.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.078 1.351 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.25 -51.31 67.03 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.115 0.566 . . . . 0.0 110.82 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.85 -48.82 74.84 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.34 70.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.927 -1.035 . . . . 0.0 111.995 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.24 -42.07 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 121.006 1.73 . . . . 0.0 110.94 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -77.52 -36.94 51.95 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -87.93 -53.46 4.73 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.137 1.375 . . . . 0.0 112.044 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 72.7 mmm -68.28 -21.62 64.78 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.881 0.764 . . . . 0.0 112.329 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.78 109.03 1.96 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 124.478 1.037 . . . . 0.0 111.266 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 96.25 -6.35 66.01 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.155 -0.803 . . . . 0.0 113.611 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -73.05 179.15 3.92 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.34 1.07 . . . . 0.0 109.176 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -111.52 152.67 27.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.885 0.874 . . . . 0.0 109.041 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.1 tp -158.87 131.21 6.77 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.229 2.212 . . . . 0.0 105.66 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 63.9 30.23 77.1 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 119.085 0.857 . . . . 0.0 111.074 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.68 14.14 72.29 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.228 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -135.19 150.61 50.16 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.876 1.838 . . . . 0.0 109.339 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 21.1 pt -130.09 172.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.27 1.028 . . . . 0.0 108.989 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -131.62 154.4 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.982 1.713 . . . . 0.0 107.304 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.4 p -142.92 147.28 35.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.709 0.804 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -167.19 167.37 14.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -69.44 136.06 51.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.526 1.057 . . . . 0.0 108.322 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -88.32 152.22 22.08 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 29.7 p -136.12 147.98 48.03 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.426 0.631 . . . . 0.0 111.45 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -71.0 142.66 50.95 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -55.66 139.75 68.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.472 1.109 . . . . 0.0 111.064 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.34 160.6 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.775 1.65 . . . . 0.0 111.227 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.69 -176.85 3.38 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.364 3.376 . . . . 0.0 111.552 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.78 151.17 93.27 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.36 -45.14 15.86 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.991 1.794 . . . . 0.0 113.123 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -159.07 165.46 33.84 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.236 0.614 . . . . 0.0 109.882 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.3 m -83.11 160.58 21.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 36.5 p -61.6 157.16 18.06 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 119.707 1.14 . . . . 0.0 110.662 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -149.34 16.55 0.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.086 1.355 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -55.45 112.46 1.12 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.924 1.29 . . . . 0.0 108.805 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.0 t -153.84 169.55 23.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.63 0.729 . . . . 0.0 109.65 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 31.86 0.22 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.822 -0.549 . . . . 0.0 111.875 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 10.1 m -61.08 83.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.385 2.274 . . . . 0.0 112.422 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.5 166.12 10.24 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 128.771 2.828 . . . . 0.0 106.707 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -145.88 163.01 36.42 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.52 1.128 . . . . 0.0 108.15 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 t -171.89 -178.27 2.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.012 2.125 . . . . 0.0 107.245 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 116.94 78.89 0.7 Allowed Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.096 -1.391 . . . . 0.0 109.703 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -58.97 -50.33 9.19 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.525 2.15 . . . . 0.0 111.199 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m 64.08 -6.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.915 1.686 . . . . 0.0 114.925 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.0 p -75.91 -17.01 59.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.34 1.456 . . . . 0.0 111.129 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 C-N-CA 132.126 4.679 . . . . 0.0 105.226 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.641 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.5 m -83.68 -167.65 1.8 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.4 p -127.71 161.59 28.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 109.557 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 119.78 125.61 3.35 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 124.989 1.28 . . . . 0.0 110.029 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -54.07 132.45 42.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.717 1.607 . . . . 0.0 110.529 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.9 m -65.59 -56.24 13.33 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.839 0.29 . . . . 0.0 111.143 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.96 106.42 0.15 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -76.12 69.9 2.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 109.375 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -85.1 173.19 10.66 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.945 1.298 . . . . 0.0 109.385 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.93 -52.39 65.71 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.808 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -61.19 136.02 57.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.6 p -68.46 38.39 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.685 2.794 . . . . 0.0 113.271 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.1 m -59.41 123.06 15.56 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.679 3.191 . . . . 0.0 108.765 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.4 t30 68.57 0.01 2.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.747 1.619 . . . . 0.0 113.936 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -73.6 173.27 9.97 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.169 0.988 . . . . 0.0 109.586 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.33 114.45 20.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.23 1.412 . . . . 0.0 107.246 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 132.7 34.74 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.337 1.055 . . . . 0.0 111.506 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.87 144.97 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 127.501 2.32 . . . . 0.0 109.013 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.84 139.03 38.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 127.455 2.302 . . . . 0.0 106.552 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.423 HG12 HD21 ' A' ' 104' ' ' LEU . 2.5 t -134.94 143.9 36.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.71 173.54 26.89 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.582 1.083 . . . . 0.0 113.91 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.1 t70 57.45 23.26 8.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 129.085 2.954 . . . . 0.0 115.289 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.423 HD21 HG12 ' A' ' 101' ' ' VAL . 27.5 mt -60.95 145.82 49.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.513 1.525 . . . . 0.0 109.467 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 t -59.38 143.75 85.01 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.69 -15.5 31.89 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.595 2.197 . . . . 0.0 116.294 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -83.05 -28.9 29.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.932 1.693 . . . . 0.0 111.551 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -56.42 113.73 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.656 1.582 . . . . 0.0 110.57 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.4 t -97.52 179.43 4.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.135 0.969 . . . . 0.0 109.241 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 127' ' ' ARG . 23.8 m -55.97 -33.08 64.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.632 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -69.3 -46.8 66.29 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 110.057 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.84 -44.49 73.97 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 110.186 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.4 mt -61.67 -54.65 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -50.65 -51.05 52.72 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.871 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.92 69.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.089 1.356 . . . . 0.0 111.257 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.59 96.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -90.8 -7.78 51.43 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.29 94.61 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 125.806 1.642 . . . . 0.0 113.282 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.79 -0.96 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 121.251 1.482 . . . . 0.0 113.099 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.97 -34.56 10.77 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.403 1.001 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.13 177.9 47.2 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 122.991 1.328 . . . . 0.0 111.473 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 87.2 mtt180 -74.35 123.11 24.0 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.756 -1.222 . . . . 0.0 107.938 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 126' ' ' ALA . 60.5 mt -101.17 154.71 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.2 t -125.73 -65.33 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -102.02 134.6 44.97 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 123' ' ' ILE . . . -164.94 128.94 2.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' HA ' HG23 ' A' ' 110' ' ' THR . 14.4 ptt180 -162.99 170.91 17.32 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.109 0.564 . . . . 0.0 111.724 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.93 130.26 51.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.536 1.534 . . . . 0.0 107.936 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 135.5 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -134.81 160.28 38.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.29 158.42 35.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.302 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.6 ptm -91.02 -16.22 28.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.792 1.237 . . . . 0.0 113.491 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.4 -26.64 11.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.872 1.214 . . . . 0.0 112.706 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.5 p -114.84 -19.75 10.87 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.23 9.87 50.36 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 121.655 0.586 . . . . 0.0 112.746 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -78.62 145.59 34.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -66.1 139.0 58.13 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.631 0.729 . . . . 0.0 112.274 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -81.75 -8.68 59.72 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.242 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.9 -12.91 65.96 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 124.43 1.014 . . . . 0.0 112.723 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . 0.292 3.2 p90 -102.96 169.35 8.63 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.777 1.788 . . . . 0.0 109.876 177.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -153.4 178.44 30.41 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 123.356 0.503 . . . . 0.0 112.33 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -140.9 148.15 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.256 1.422 . . . . 0.0 108.117 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.99 124.83 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.035 1.734 . . . . 0.0 106.939 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.9 m -109.62 125.92 53.08 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 119.815 1.189 . . . . 0.0 108.69 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -109.98 148.52 31.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 122' ' ' ARG . 62.9 m-85 -69.63 -17.92 63.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.334 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -132.03 148.52 52.51 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.703 1.138 . . . . 0.0 109.124 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -63.62 -55.72 21.42 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.247 0.619 . . . . 0.0 109.497 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -39.53 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.687 1.595 . . . . 0.0 113.107 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.19 -48.25 80.87 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.38 -48.66 74.62 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.772 0.829 . . . . 0.0 110.117 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 155' ' ' ILE . 5.2 mm-40 -53.48 -47.3 69.93 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.172 1.389 . . . . 0.0 110.909 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -57.23 -43.62 83.05 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.31 84.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.851 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 152' ' ' GLU . 89.0 mt -53.05 -52.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.997 1.726 . . . . 0.0 107.633 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -60.25 -66.46 0.52 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.38 1.472 . . . . 0.0 113.011 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.89 -49.74 69.27 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.736 2.014 . . . . 0.0 115.183 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.5 mmm -73.15 -19.61 61.09 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.696 1.135 . . . . 0.0 112.638 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -67.45 96.88 0.36 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.64 -11.05 11.24 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.607 1.099 . . . . 0.0 111.428 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -73.91 170.13 16.0 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.594 1.197 . . . . 0.0 107.836 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -113.38 136.51 52.69 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.449 1.1 . . . . 0.0 108.268 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.21 121.58 18.18 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.13 21.82 79.47 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.025 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.98 6.14 79.74 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.975 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -133.77 147.04 51.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.301 2.05 . . . . 0.0 110.389 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.83 138.6 52.75 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -108.15 163.94 5.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.982 0.896 . . . . 0.0 109.849 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -124.49 149.48 46.81 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.901 1.281 . . . . 0.0 107.66 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.9 p -139.29 140.36 37.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.298 1.039 . . . . 0.0 109.628 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -163.3 173.03 13.82 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.157 1.383 . . . . 0.0 108.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -71.45 124.44 24.63 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.343 1.057 . . . . 0.0 110.957 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.48 -12.02 60.92 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.636 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.3 p -89.0 164.89 14.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.886 1.275 . . . . 0.0 109.139 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -142.57 148.73 38.02 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.102 -0.999 . . . . 0.0 108.77 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.9 pttp -69.29 150.49 97.2 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 161.85 42.89 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 N-CA-C 108.116 -1.532 . . . . 0.0 108.116 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.4 168.71 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.198 1.932 . . . . 0.0 108.734 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -126.94 159.97 61.74 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 110.448 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.35 121.16 8.68 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.756 2.304 . . . . 0.0 110.745 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.98 124.35 28.62 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.7 t -83.69 153.04 24.42 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.5 p -156.98 127.87 6.72 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.542 1.937 . . . . 0.0 108.065 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.41 158.12 40.97 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -153.8 144.24 22.35 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.4 t -175.13 162.82 3.08 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.829 1.652 . . . . 0.0 107.607 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -161.24 161.93 30.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.47 1.108 . . . . 0.0 108.537 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.2 m -160.93 110.18 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 189' ' ' LYS . 0.3 OUTLIER -141.49 129.15 21.53 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.09 166.85 14.47 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.726 2.011 . . . . 0.0 107.991 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.2 t 176.34 -174.35 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.707 3.203 . . . . 0.0 106.041 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.25 44.44 1.08 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-O 117.584 -1.676 . . . . 0.0 115.45 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.88 156.9 47.94 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 121.151 2.476 . . . . 0.0 109.111 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 8.5 t -154.19 -177.11 6.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.936 1.295 . . . . 0.0 107.677 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 2.6 p -134.32 5.98 3.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.527 1.931 . . . . 0.0 111.07 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.75 0 C-N-CA 129.794 3.568 . . . . 0.0 106.702 179.76 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.866 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 m -60.0 118.15 5.94 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -146.55 148.0 31.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.23 170.26 30.88 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.7 t -50.69 127.51 18.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.045 1.338 . . . . 0.0 110.416 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -136.91 74.58 1.49 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.47 0.708 . . . . 0.0 109.166 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.17 91.96 0.96 Allowed Glycine 0 C--N 1.334 0.471 0 CA-C-O 118.699 -1.056 . . . . 0.0 113.664 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -59.32 -22.18 60.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.972 0.886 . . . . 0.0 110.521 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.35 81.07 1.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.681 1.992 . . . . 0.0 109.092 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 4.8 mmpt? -144.66 -177.34 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -51.99 122.32 8.22 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.562 1.145 . . . . 0.0 108.718 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 p -58.09 -1.28 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.589 2.756 . . . . 0.0 113.213 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.7 t -49.44 -27.31 4.05 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.402 2.681 . . . . 0.0 113.553 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -96.23 -11.54 25.88 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m170 -81.15 157.9 25.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.803 0.729 . . . . 0.0 109.487 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.72 115.48 30.3 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.1 151.7 18.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.151 0.907 . . . . 0.0 110.91 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.95 136.97 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 126.899 2.079 . . . . 0.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -85.59 132.67 34.13 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.448 2.299 . . . . 0.0 105.646 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.73 135.02 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.4 -175.97 14.27 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.613 -0.679 . . . . 0.0 111.444 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 61.74 21.13 11.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.972 2.509 . . . . 0.0 114.25 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.32 153.5 43.63 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.884 -1.135 . . . . 0.0 111.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 t -71.39 157.32 90.26 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.63 -6.51 18.82 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.424 2.083 . . . . 0.0 114.173 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -96.29 -15.32 22.01 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.009 1.724 . . . . 0.0 112.811 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -58.25 137.37 20.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.888 0.875 . . . . 0.0 109.84 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -112.21 168.86 9.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.669 1.187 . . . . 0.0 108.284 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.7 m -60.37 -30.2 69.41 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.907 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.86 -34.23 62.24 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.77 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -48.07 80.66 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.7 mt -58.76 -52.4 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.524 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 24.0 mtmt -52.77 -47.62 67.38 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 117.679 -1.153 . . . . 0.0 112.093 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.24 67.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.254 0.934 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -64.58 -50.12 68.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.122 1.369 . . . . 0.0 113.413 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -88.17 -11.34 47.11 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.44 90.58 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 125.423 1.489 . . . . 0.0 112.395 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -63.1 -10.76 21.94 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.752 1.661 . . . . 0.0 112.583 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -98.13 -10.51 24.08 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.501 1.046 . . . . 0.0 111.532 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.51 165.89 21.43 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 120.026 1.285 . . . . 0.0 111.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 68.3 mtt-85 -77.17 130.12 36.88 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.2 mt -101.99 132.42 47.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.2 1.0 . . . . 0.0 109.229 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.18 -66.21 0.92 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.05 133.56 46.69 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.314 0.645 . . . . 0.0 110.132 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . . . -155.61 137.43 14.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -160.36 157.98 28.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.663 0.665 . . . . 0.0 111.626 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.21 119.56 50.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.9 t -66.09 133.09 31.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -129.88 151.64 50.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.06 128.55 36.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 24.8 ptp -66.89 -10.35 47.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.844 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.57 -17.03 26.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.296 1.039 . . . . 0.0 113.738 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.3 p -141.93 -34.08 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.09 14.48 51.54 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.558 -1.135 . . . . 0.0 111.053 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.94 149.56 24.71 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.539 1.67 . . . . 0.0 107.896 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.5 m -53.34 117.31 2.96 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.598 1.159 . . . . 0.0 112.345 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -64.24 -25.03 67.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.334 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.67 -30.81 4.78 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.442 1.972 . . . . 0.0 111.915 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -102.9 172.72 6.66 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.001 1.32 . . . . 0.0 113.501 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.99 175.95 34.36 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.938 2.208 . . . . 0.0 108.908 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.04 151.45 45.44 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.03 143.59 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.7 m -130.64 128.86 41.83 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.648 1.579 . . . . 0.0 107.708 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -110.75 163.3 13.91 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.544 1.138 . . . . 0.0 110.085 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.53 -28.8 52.08 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.589 0.756 . . . . 0.0 111.748 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -124.89 160.36 29.01 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.083 0.953 . . . . 0.0 111.957 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.566 ' HE2' ' CH2' ' A' ' 172' ' ' TRP . 20.1 tptm -65.32 -51.82 58.09 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.632 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -50.99 -45.79 61.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 125.579 1.552 . . . . 0.0 113.134 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -56.96 -43.88 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.963 0.79 . . . . 0.0 110.227 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -50.96 43.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.042 0.937 . . . . 0.0 110.307 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -54.08 -50.79 66.0 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.623 1.169 . . . . 0.0 110.668 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -51.51 -52.67 44.85 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.709 2.004 . . . . 0.0 108.847 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -47.46 79.54 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.333 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.01 -27.07 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 121.481 1.946 . . . . 0.0 111.342 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -84.77 -70.99 0.54 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.923 0.889 . . . . 0.0 109.932 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -56.62 -50.26 72.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.333 2.253 . . . . 0.0 113.588 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 66.4 mmm -78.01 -20.95 51.54 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.286 1.035 . . . . 0.0 113.659 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -68.11 75.74 0.25 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.731 1.157 . . . . 0.0 114.563 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.6 -5.15 2.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.049 1.785 . . . . 0.0 112.556 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.2 mm-40 -76.82 -177.02 4.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.226 1.41 . . . . 0.0 110.819 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -112.85 157.47 21.36 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 125.347 1.459 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 116' ' ' ALA . 65.5 tp -151.35 126.28 9.74 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.366 1.466 . . . . 0.0 108.774 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.89 -67.8 0.13 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 126.555 2.026 . . . . 0.0 112.776 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -151.26 1.99 0.4 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 117.275 -1.847 . . . . 0.0 115.841 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 -148.58 167.99 23.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 121.123 2.461 . . . . 0.0 111.947 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -72.95 147.77 44.92 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.8 pt -115.6 169.29 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 110.776 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -127.59 146.84 50.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.804 2.041 . . . . 0.0 107.888 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.9 p -142.56 151.04 41.16 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.23 0.923 . . . . 0.0 109.913 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -173.75 172.73 3.47 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.148 2.179 . . . . 0.0 108.767 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.566 ' CH2' ' HE2' ' A' ' 148' ' ' LYS . 40.1 m95 -67.63 148.53 51.26 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.242 -1.536 . . . . 0.0 111.155 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.42 114.67 28.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.8 p 62.14 -15.81 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.452 3.101 . . . . 0.0 115.989 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.04 178.55 6.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.863 1.665 . . . . 0.0 113.64 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.401 ' HE3' ' HD2' ' A' ' 177' ' ' PRO . 26.9 mmmt -146.71 152.79 45.69 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.704 2.002 . . . . 0.0 107.494 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.401 ' HD2' ' HE3' ' A' ' 176' ' ' LYS . 90.2 Cg_endo -74.42 166.35 29.66 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.331 2.688 . . . . 0.0 110.417 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.14 163.93 36.79 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.381 2.054 . . . . 0.0 108.711 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.82 154.76 88.3 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.126 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.25 2.54 5.49 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.447 2.765 . . . . 0.0 113.505 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -145.99 82.16 1.61 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 104.16 -2.534 . . . . 0.0 104.16 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.4 t -153.83 176.76 11.77 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.188 0.518 . . . . 0.0 109.75 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.94 149.13 29.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -170.59 154.68 4.64 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.992 1.717 . . . . 0.0 107.862 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -177.94 171.94 1.71 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.17 1.788 . . . . 0.0 107.555 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.9 t -159.41 153.27 23.14 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -129.67 80.56 1.97 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 108.278 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.9 t -147.65 144.6 28.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.2 155.48 8.01 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.919 1.688 . . . . 0.0 106.547 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -148.75 -179.01 6.67 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 p -172.15 111.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.84 135.76 2.54 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.166 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.91 -15.87 26.2 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.143 2.562 . . . . 0.0 113.06 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.5 t -58.82 142.01 51.58 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.009 1.324 . . . . 0.0 110.839 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 12.1 t -54.24 -36.54 63.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.054 1.342 . . . . 0.0 112.296 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.867 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -179.157 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 t -68.48 79.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.992 1.317 . . . . 0.0 110.033 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.51 -179.58 6.64 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 128.293 2.637 . . . . 0.0 109.266 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.65 64.56 0.3 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 124.965 1.269 . . . . 0.0 111.564 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.3 t -79.4 67.61 5.19 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -145.14 95.08 2.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.45 166.31 20.72 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.3 148.83 16.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.064 1.746 . . . . 0.0 107.882 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.48 4.7 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 110.242 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -75.88 -77.85 0.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -55.68 163.66 1.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.63 2.372 . . . . 0.0 113.689 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.1 p -81.43 148.89 29.06 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.89 -37.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.092 -1.005 . . . . 0.0 112.016 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -141.25 15.86 2.23 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.63 1.572 . . . . 0.0 111.255 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -68.84 175.39 3.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 125.61 1.564 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.61 100.5 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -81.83 153.88 26.18 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.1 133.68 55.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 127.379 2.272 . . . . 0.0 109.735 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -84.83 142.81 29.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.99 135.61 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.61 27.64 Favored Glycine 0 C--O 1.228 -0.254 0 O-C-N 121.206 -0.934 . . . . 0.0 111.47 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 71.79 7.47 5.9 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.746 2.418 . . . . 0.0 113.749 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt -52.45 149.22 5.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.384 2.274 . . . . 0.0 112.4 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.53 150.71 93.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.63 -14.14 42.91 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.115 1.876 . . . . 0.0 114.632 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.3 -10.66 29.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.613 1.565 . . . . 0.0 112.433 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -61.5 143.26 15.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 119.587 1.085 . . . . 0.0 110.102 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.6 t -122.17 173.72 7.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 127' ' ' ARG . 52.9 m -62.29 -31.66 72.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.937 0.895 . . . . 0.0 110.715 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -74.03 -34.1 63.98 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.95 -42.91 99.18 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.77 -54.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -50.36 -45.96 55.55 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.321 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.61 75.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.668 0.605 . . . . 0.0 111.544 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.9 85.8 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.01 -8.36 55.72 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.169 0.587 . . . . 0.0 111.13 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.15 97.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 116.956 -1.497 . . . . 0.0 113.523 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.08 -3.42 8.46 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 122.31 1.861 . . . . 0.0 112.467 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -99.46 -16.15 18.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.42 1.088 . . . . 0.0 109.803 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.48 171.66 20.89 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 122.495 1.053 . . . . 0.0 113.079 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -77.87 123.04 26.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 44.3 mt -94.48 163.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.97 -69.32 0.82 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.7 136.77 41.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.872 1.269 . . . . 0.0 110.255 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.06 139.27 4.94 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.637 1.108 . . . . 0.0 109.184 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HA ' HG23 ' A' ' 110' ' ' THR . 2.4 ptm180 -162.63 169.34 20.3 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.17 119.78 59.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 126.887 2.075 . . . . 0.0 105.698 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.3 t -67.24 141.55 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -132.8 155.42 48.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.604 -0.685 . . . . 0.0 110.188 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -57.03 117.96 4.52 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.07 -18.41 64.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.25 -13.53 18.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 -18.34 2.03 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.863 1.21 . . . . 0.0 113.997 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.24 87.8 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.213 0.911 . . . . 0.0 113.775 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.84 155.82 25.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.644 1.722 . . . . 0.0 109.408 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.0 t -60.19 126.47 27.64 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.866 0.866 . . . . 0.0 111.091 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -73.27 -48.43 34.77 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.59 -25.79 3.09 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -103.22 159.02 15.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.464 1.105 . . . . 0.0 111.495 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.9 176.39 29.46 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.932 1.729 . . . . 0.0 109.504 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.29 156.85 45.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.78 0.832 . . . . 0.0 109.348 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.3 t -138.57 154.9 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.2 t -144.07 125.68 15.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.34 156.65 24.03 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.677 1.191 . . . . 0.0 111.237 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.96 -23.07 61.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.975 1.31 . . . . 0.0 113.681 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -137.22 153.99 50.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.479 1.036 . . . . 0.0 109.972 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -61.49 -48.82 79.36 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -34.68 62.19 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.914 1.285 . . . . 0.0 112.874 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -66.24 -47.63 73.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.7 -52.1 54.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.645 1.178 . . . . 0.0 111.538 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 155' ' ' ILE . 44.4 mt-10 -53.32 -45.55 69.06 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.395 1.078 . . . . 0.0 111.85 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -53.86 -47.56 70.89 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.775 0.83 . . . . 0.0 108.876 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.73 -47.37 72.49 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.424 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 152' ' ' GLU . 63.8 mt -51.74 -44.5 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.682 1.583 . . . . 0.0 110.154 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -69.89 -67.96 0.45 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.23 1.412 . . . . 0.0 112.925 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -66.68 -43.19 85.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.565 1.546 . . . . 0.0 115.053 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 74.0 mmm -75.97 -21.55 56.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.598 1.545 . . . . 0.0 112.332 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.31 4.87 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.95 -5.7 69.04 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.527 1.061 . . . . 0.0 112.898 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -73.61 171.21 13.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.467 1.634 . . . . 0.0 109.468 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.405 ' CD1' ' HG2' ' A' ' 167' ' ' GLN . 20.5 m95 -101.94 143.82 31.34 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 55.6 tp -144.06 122.81 12.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.194 0.998 . . . . 0.0 109.434 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 59.59 3.66 2.39 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 118.073 -1.404 . . . . 0.0 115.896 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 133.65 -13.23 4.81 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-O 116.767 -2.129 . . . . 0.0 115.183 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -137.22 162.54 33.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 121.037 2.419 . . . . 0.0 110.019 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.405 ' HG2' ' CD1' ' A' ' 162' ' ' TRP . 44.1 mt-30 -72.85 162.86 28.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.979 0.354 . . . . 0.0 110.318 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.1 pt -136.94 163.44 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.517 1.127 . . . . 0.0 110.974 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -126.5 151.35 47.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.31 1.444 . . . . 0.0 108.464 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.8 p -141.83 156.74 45.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.671 1.188 . . . . 0.0 109.534 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 172' ' ' TRP . 3.5 t-20 -173.95 173.84 3.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.811 1.644 . . . . 0.0 109.259 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.415 ' H ' ' ND2' ' A' ' 171' ' ' ASN . 50.4 m95 -67.51 116.19 7.97 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.52 -22.49 61.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.691 0.796 . . . . 0.0 112.821 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.9 t -130.1 131.32 45.69 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.7 tpt85 -121.34 45.72 2.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -59.98 131.06 89.23 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.82 157.31 60.71 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.261 1.974 . . . . 0.0 112.195 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.47 -177.24 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.569 2.846 . . . . 0.0 109.307 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -145.12 147.97 36.48 Favored Pre-proline 0 C--O 1.236 0.358 0 C-N-CA 123.638 0.775 . . . . 0.0 108.987 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.56 62.76 7.82 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.0 3.133 . . . . 0.0 110.296 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -125.25 147.52 49.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 20.4 t -134.23 -60.44 0.81 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.6 m 61.76 30.74 18.48 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.723 0.809 . . . . 0.0 110.5 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -67.13 163.76 19.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.912 0.885 . . . . 0.0 109.574 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.86 -177.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.101 1.76 . . . . 0.0 107.164 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.9 p -146.32 133.17 20.1 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -138.67 109.42 6.66 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.147 0.885 . . . . 0.0 109.862 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.1 m -73.2 46.98 0.19 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.26 1.824 . . . . 0.0 110.543 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -81.6 102.94 10.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.685 1.594 . . . . 0.0 111.515 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 139.24 58.4 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.1 m -70.31 136.12 49.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.325 0.584 . . . . 0.0 111.621 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.2 176.04 21.59 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.11 114.79 2.34 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.638 2.225 . . . . 0.0 109.62 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.72 30.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.545 0.738 . . . . 0.0 109.503 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 7.4 t -78.21 -177.58 5.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.632 0.729 . . . . 0.0 109.542 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.642 0 N-CA-C 104.599 -3.4 . . . . 0.0 104.599 179.665 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.324 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.4 p -100.01 171.56 7.76 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.9 m -137.94 162.53 33.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.0 110.216 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 125.0 -178.86 16.37 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.0 t -78.28 156.17 29.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.538 1.169 . . . . 0.0 108.784 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.8 m -71.38 169.62 14.93 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.03 177.14 34.89 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -69.97 164.74 23.24 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.149 0.976 . . . . 0.0 108.574 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -115.6 -35.81 4.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.412 1.485 . . . . 0.0 108.385 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -63.21 -31.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.546 1.138 . . . . 0.0 111.327 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.62 148.44 22.1 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.125 0.97 . . . . 0.0 113.362 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.9 p -119.97 13.42 12.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.765 1.626 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -53.54 -2.32 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.913 2.485 . . . . 0.0 117.254 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -150.84 16.16 0.76 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.485 1.514 . . . . 0.0 110.43 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.22 168.33 18.62 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.705 0.802 . . . . 0.0 111.068 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -115.47 101.19 8.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.53 146.99 24.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.025 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -123.93 142.83 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.253 1.821 . . . . 0.0 108.47 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -97.02 135.32 39.18 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 106.351 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.39 139.3 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 -178.33 22.28 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.53 12.63 4.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.722 2.009 . . . . 0.0 113.162 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -55.16 148.13 14.87 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.753 2.021 . . . . 0.0 111.645 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -64.26 142.61 98.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.3 -17.67 27.34 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.524 2.816 . . . . 0.0 116.315 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -98.62 -5.64 31.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.277 0.944 . . . . 0.0 113.042 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 142.72 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 119.569 1.077 . . . . 0.0 108.374 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.8 t -115.31 169.2 9.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 122.233 1.016 . . . . 0.0 110.095 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -61.73 -35.32 77.73 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.804 -1.185 . . . . 0.0 109.766 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -66.29 -34.8 78.82 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.824 1.25 . . . . 0.0 109.998 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.58 -42.77 86.49 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 108.762 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.34 -43.5 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -54.52 -43.75 72.16 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.606 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.28 -48.91 73.9 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.85 0.719 . . . . 0.0 111.519 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.35 -43.62 71.44 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -94.61 -9.39 35.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.756 -0.59 . . . . 0.0 112.295 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.81 -47.67 93.98 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.94 1.296 . . . . 0.0 114.015 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.04 -7.16 14.53 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 121.87 1.703 . . . . 0.0 112.63 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.41 -12.95 19.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.307 0.958 . . . . 0.0 112.053 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 171.0 -173.7 44.7 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.475 1.489 . . . . 0.0 111.499 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -101.64 129.77 47.85 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.2 mt -100.33 160.8 3.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 126.437 1.895 . . . . 0.0 109.408 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 t -126.93 -69.24 0.77 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.578 1.551 . . . . 0.0 106.837 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -100.99 138.17 38.39 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.89 132.46 4.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.893 1.677 . . . . 0.0 107.435 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -160.74 156.04 24.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.55 1.068 . . . . 0.0 111.726 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.65 121.59 51.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.97 144.49 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -140.91 148.66 40.79 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.53 121.71 12.21 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.485 1.114 . . . . 0.0 108.165 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 25.1 ptm -58.49 -22.63 55.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.57 -9.8 18.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.4 p -131.99 -20.27 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.94 1.246 . . . . 0.0 113.02 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.78 6.56 82.04 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.375 0.988 . . . . 0.0 112.756 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -76.51 149.16 36.76 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.1 t -58.17 129.59 42.67 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -78.05 -12.79 60.02 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 95.51 -24.59 28.6 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-O 118.564 -1.131 . . . . 0.0 113.75 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -102.87 166.45 10.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.252 1.026 . . . . 0.0 109.311 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -155.63 174.14 33.68 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.215 1.388 . . . . 0.0 110.068 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.16 157.01 46.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.489 0.716 . . . . 0.0 109.121 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -143.95 133.81 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.074 1.75 . . . . 0.0 106.775 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 t -115.95 129.75 56.53 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.749 2.02 . . . . 0.0 108.254 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.12 155.43 26.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -71.55 -23.29 61.73 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.528 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -135.81 156.47 48.75 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.507 1.503 . . . . 0.0 110.994 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.38 -46.11 74.26 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.573 0.749 . . . . 0.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -39.87 72.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.21 1.804 . . . . 0.0 111.177 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -57.44 -52.92 63.44 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.69 53.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.732 1.213 . . . . 0.0 111.122 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -50.29 -49.02 54.71 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.373 1.069 . . . . 0.0 111.221 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -52.23 -57.35 9.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.275 1.03 . . . . 0.0 110.211 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.87 -40.17 94.7 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 116.779 -1.582 . . . . 0.0 113.523 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 80.0 mt -50.97 -34.74 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 121.581 1.991 . . . . 0.0 110.69 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -79.96 -63.42 1.42 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.33 0.652 . . . . 0.0 111.009 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.58 -49.91 69.32 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 80.7 mmm -68.29 -31.39 70.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.441 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -63.68 92.7 0.11 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.817 0.722 . . . . 0.0 111.31 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 138.56 -18.0 3.26 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.901 1.239 . . . . 0.0 111.786 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 167.72 20.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.402 1.101 . . . . 0.0 110.672 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -107.0 116.3 31.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.0 tp -116.3 127.3 54.58 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.753 1.221 . . . . 0.0 107.763 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 -63.28 4.18 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.31 5.9 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.208 -1.884 . . . . 0.0 112.808 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -136.13 154.49 50.97 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.213 2.007 . . . . 0.0 110.358 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -68.73 148.45 50.36 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.6 pt -116.88 160.85 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.454 1.102 . . . . 0.0 110.974 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -118.16 143.91 46.12 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.389 1.876 . . . . 0.0 105.985 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.6 p -138.89 123.09 18.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -149.94 174.36 12.78 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -69.07 155.22 40.73 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.72 3.15 50.23 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.029 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.9 p -74.39 145.76 43.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.177 -0.952 . . . . 0.0 111.162 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -80.29 124.51 28.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -152.88 133.11 7.51 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 119.938 1.245 . . . . 0.0 110.484 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.22 159.91 50.02 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.708 1.605 . . . . 0.0 110.238 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.12 156.46 51.57 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.917 1.744 . . . . 0.0 110.679 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.01 154.84 94.0 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.99 170.91 16.9 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.164 1.909 . . . . 0.0 112.173 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -152.82 151.65 30.68 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.652 1.181 . . . . 0.0 109.654 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.9 p -133.11 169.38 16.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.579 1.152 . . . . 0.0 108.541 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 12.7 t -143.9 165.45 27.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.698 0.799 . . . . 0.0 109.008 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -171.06 151.56 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.961 2.504 . . . . 0.0 105.961 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -131.28 151.37 51.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.4 m -165.24 169.26 16.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.654 1.182 . . . . 0.0 109.278 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -153.2 169.09 23.86 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.081 1.752 . . . . 0.0 107.049 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 14.5 t -149.14 179.92 7.52 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -140.59 99.13 3.56 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.357 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 176.14 9.59 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 60.4 m -137.55 135.02 36.31 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.92 93.59 0.71 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.74 152.6 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 CA-C-N 119.754 1.777 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.2 m -77.43 166.51 23.02 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.1 t -141.87 11.36 2.02 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.468 1.507 . . . . 0.0 110.041 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 1 C-N-CA 130.909 4.099 . . . . 0.0 105.395 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.903 0 CA-C-O 119.417 -0.657 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.29 121.97 29.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.9 p -149.68 -170.43 3.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.555 1.542 . . . . 0.0 107.79 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.25 14.53 66.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.184 0.902 . . . . 0.0 112.52 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -50.13 97.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 129.103 2.961 . . . . 0.0 110.542 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t 58.16 13.93 2.53 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.078 1.351 . . . . 0.0 111.582 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -112.02 96.66 0.87 Allowed Glycine 0 C--N 1.341 0.831 0 C-N-CA 126.703 2.097 . . . . 0.0 113.862 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -73.46 166.47 23.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -141.17 158.49 43.83 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.502 0.721 . . . . 0.0 109.942 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -80.46 -14.88 57.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.198 0.999 . . . . 0.0 110.111 177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -108.3 112.86 25.54 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.562 1.145 . . . . 0.0 110.117 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.8 p -63.39 99.57 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.5 m -120.76 -5.87 9.65 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -143.0 -7.66 0.82 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.898 1.279 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -72.57 166.95 21.7 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.539 1.935 . . . . 0.0 111.23 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -123.86 113.61 18.74 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.09 1.356 . . . . 0.0 108.086 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -85.77 151.65 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.76 0.79 . . . . 0.0 111.229 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.17 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 128.859 2.863 . . . . 0.0 107.875 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -95.45 133.06 39.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 106.172 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.5 t -127.31 138.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.07 179.63 19.83 Favored Glycine 0 CA--C 1.519 0.297 0 O-C-N 121.706 -0.621 . . . . 0.0 111.835 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . 0.284 7.2 t0 60.57 10.88 2.76 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 129.93 3.292 . . . . 0.0 114.982 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.2 mt -52.35 138.61 26.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.66 1.984 . . . . 0.0 110.462 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.83 151.35 64.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -62.96 -19.43 68.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.038 1.826 . . . . 0.0 114.239 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -82.73 -23.41 34.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.691 1.197 . . . . 0.0 113.598 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mm -56.89 130.61 19.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 124.283 1.033 . . . . 0.0 110.451 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 t -107.9 167.53 9.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.159 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.8 m -61.32 -21.61 64.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.056 -1.652 . . . . 0.0 111.969 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -75.76 -36.77 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.828 1.651 . . . . 0.0 109.96 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.91 -50.95 71.78 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.0 mt -58.32 -52.62 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.271 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -53.55 -48.36 69.18 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.994 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.66 -45.87 90.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.623 0.769 . . . . 0.0 111.833 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 163' ' ' LEU . . . -60.35 -49.13 78.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.67 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -84.48 -8.28 59.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.822 -0.609 . . . . 0.0 111.947 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.3 93.75 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 120.215 1.371 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.58 -6.07 15.72 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 122.1 1.786 . . . . 0.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -99.62 -18.21 17.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.73 0.812 . . . . 0.0 110.913 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 170.17 175.23 38.91 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 123.596 1.665 . . . . 0.0 114.651 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -86.03 117.68 25.03 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 43.5 mt -100.36 158.01 3.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.12 1.368 . . . . 0.0 107.818 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.8 t -134.95 -62.61 0.72 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -101.83 126.47 48.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.831 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.22 136.62 13.09 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -162.65 157.03 21.32 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.492 0.587 . . . . 0.0 112.004 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.91 122.65 58.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.49 141.8 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -130.85 155.69 46.3 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.747 0.784 . . . . 0.0 109.083 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -68.49 124.51 23.77 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.068 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.8 ptp -64.54 -20.2 66.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.71 -42.87 10.47 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.826 1.194 . . . . 0.0 113.845 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 80.5 p -104.05 -19.25 14.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.017 1.327 . . . . 0.0 114.303 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.0 15.0 78.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.195 0.903 . . . . 0.0 112.607 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -83.6 157.27 22.35 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.06 1.344 . . . . 0.0 109.154 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 t -62.06 124.99 22.3 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.718 0.807 . . . . 0.0 111.221 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -71.4 -31.61 67.47 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 119.27 -29.96 5.98 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.081 1.324 . . . . 0.0 110.601 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -103.31 164.99 11.3 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.305 -1.115 . . . . 0.0 111.574 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -156.6 178.37 33.09 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 125.695 1.616 . . . . 0.0 110.015 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -135.38 153.87 51.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.399 1.079 . . . . 0.0 108.419 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.2 t -140.24 143.61 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 12.9 t -131.35 135.3 47.12 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.738 1.615 . . . . 0.0 107.234 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 148.58 43.37 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 124.529 1.143 . . . . 0.0 109.381 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.03 -48.12 59.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -92.33 143.1 26.73 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.652 0.781 . . . . 0.0 109.238 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.34 -45.32 84.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.527 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -36.71 63.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.976 1.711 . . . . 0.0 112.078 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -61.17 -47.05 87.95 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.25 -52.54 61.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.73 0.812 . . . . 0.0 109.77 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -49.08 -54.75 14.62 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.454 1.502 . . . . 0.0 110.511 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -51.15 -56.55 12.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.882 1.673 . . . . 0.0 111.537 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.45 91.89 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.079 -1.438 . . . . 0.0 112.111 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.8 mt -53.01 -45.77 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 122.06 2.209 . . . . 0.0 109.784 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.72 -64.76 0.79 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.049 1.34 . . . . 0.0 111.106 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -62.89 -57.62 10.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.247 1.819 . . . . 0.0 114.193 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 75.3 mmm -64.91 -21.96 66.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.361 1.437 . . . . 0.0 113.669 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -61.34 110.45 3.12 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 119.227 0.921 . . . . 0.0 112.17 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.4 -5.71 70.99 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.752 1.168 . . . . 0.0 112.134 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -76.71 170.67 16.03 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 118.852 1.326 . . . . 0.0 107.605 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -102.01 142.67 32.92 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 116' ' ' ALA . 22.7 tp -131.71 124.08 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 127.014 2.126 . . . . 0.0 106.214 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.39 -78.35 0.84 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -153.9 -2.27 0.15 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.069 -1.961 . . . . 0.0 114.544 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -129.22 163.72 25.0 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.16 2.48 . . . . 0.0 109.995 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -77.93 165.18 24.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.338 0.589 . . . . 0.0 109.581 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 36.0 pt -136.14 159.08 38.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.675 0.79 . . . . 0.0 110.925 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -113.77 139.54 49.03 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.8 p -137.06 132.37 34.07 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.138 0.881 . . . . 0.0 109.448 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -157.1 167.43 30.45 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 40.4 m95 -61.08 132.87 55.16 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.1 69.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.134 0.425 . . . . 0.0 111.673 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 62.7 p -126.29 119.91 28.58 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.79 0.723 . . . . 0.0 109.611 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -141.64 160.53 39.98 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.483 1.913 . . . . 0.0 106.938 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -155.37 137.1 9.6 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.39 150.33 84.44 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.405 1.403 . . . . 0.0 109.057 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.32 165.55 31.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.225 1.95 . . . . 0.0 109.304 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -128.47 159.03 69.78 Favored Pre-proline 0 C--O 1.233 0.216 0 O-C-N 121.34 -0.85 . . . . 0.0 111.874 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.97 -6.91 19.84 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.514 2.809 . . . . 0.0 112.307 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -107.71 138.61 43.63 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.773 2.029 . . . . 0.0 108.27 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.8 t -136.77 -176.05 4.23 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.901 1.28 . . . . 0.0 108.568 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 p -90.26 138.55 31.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.658 1.183 . . . . 0.0 110.573 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -121.43 -11.02 8.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.822 1.649 . . . . 0.0 112.535 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -60.58 156.82 15.63 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.467 1.507 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 13.4 p -127.41 158.23 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.056 1.343 . . . . 0.0 108.145 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -158.03 173.57 16.55 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.2 t -87.36 -178.88 6.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.815 0.846 . . . . 0.0 109.298 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.05 159.89 29.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.409 1.484 . . . . 0.0 108.63 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.36 10.51 4.47 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.207 2.203 . . . . 0.0 108.666 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 64.8 m -143.03 179.79 6.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.066 2.546 . . . . 0.0 108.329 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 124.97 78.26 0.33 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-O 118.635 -1.092 . . . . 0.0 110.966 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.49 134.02 16.53 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.833 2.356 . . . . 0.0 108.451 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 61.3 m -138.02 164.87 27.98 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.234 1.014 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 5.7 t -144.9 -22.24 0.5 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.109 1.364 . . . . 0.0 110.525 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.328 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -179.723 . . . . . . . . 0 0 . 1 stop_ save_